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Abstract 
 
The first preparation of metal-nucleated heterotrimers, asymmetric remote metal binding 
sites and CuI2 centers in de novo designed alpha-helical three-stranded coiled coils (3SCCs) is 
provided in this thesis. Peptides with Ala or Leu in the layer directly above a Cys3 site, 
[sequence: Ac-GLKALEEK LKAXEEK CKALEEK (LKALEEK)2G-NH2], with X=A (peptide 
A) and X=L (peptide B) were mixed as 2(A) and 1(B), with PbII to form, PbII(AAB) 
heterotrimers over the pH range 7.4  to 9.4 with a distinct 207Pb NMR chemical shift, (5600 ppm) 
compared to AAA (5575 ppm) and BBB PbII-homotrimers (5650 ppm). The coexistence of AAB 
and AAA chemical shifts in appropriate ratios confirms the formation of heterotrimers. The 
ability to make heterotrimeric 3SCCs removes previous restrictions due to the inherent self-
association of the peptides, allowing for the design and analysis of asymmetric metal binding 
sites as observed in nature.  
AAB aggregates containing a second metal binding site with 0-3 Asp residues above a 
His3 site (AspXHis3) are described for potential catalytic applications. Prior to this thesis work, 
only symmetric metal binding sites could be achieved within the 3SCC scaffold. An Asp residue 
may be added to the Leu/Cys or the Ala/Cys containing helix. UV-Vis, EPR and XAS analysis of 
CoII-bound homotrimers reveal that 6-coordinate, highly symmetric CoII-homotrimers are formed 
whereas less symmetric, 5-coordinate environments result for the CoII-heterotrimers. The 
similarities between the heterotrimers and CoII-substituted carboxypeptidase A support direct 
CoII-Asp coordination in AAB systems. ZnII XAS analysis indicates ZnII is 4-coordinate in all 
ZnII-homo- and heterotrimers, demonstrating that CoII and ZnII coordinate differently. The 
spectroscopic evidence confirms the first inclusion of asymmetric metal binding sites within 
3SCCs. 
Competition between CuI and PbII for Cys3 reveals unprecedented CuI2 sites. XAS of CuI-
peptides are consistent with CuI-CuI back-scatterering (2.66 Å) and 2 or 3 CuI-S distances (2.20 
Å). UV-Vis studies confirm a 2:1 binding stoichiometry. Mixtures of PbII and CuI yield 
CuIPbIICys3 proteins. Preformed CuI2Cys3 inhibits binding of PbII while addition of one 
 xxiv 
equivalent of CuI to PbIICys3 does not displace PbII as CuICys3 features develop. Excess CuI is 
required to displace PbII, indicating comparable CuI and PbII binding affinities.  
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Chapter 1. De Novo Protein Design as a Methodology  
for Synthetic Bioinorganic Chemistry 
 
Introduction: A Synthetic Approach for Bioinorganic Chemistry 
While metalloproteins have been known for nearly a century, it was only in the 
1960’s that inorganic chemists attempted to synthesize these fascinating biological co-
factors. This successful approach often utilizes multidentate ligands containing relevant 
heteroatoms to bind metals in appropriate oxidation states and coordination numbers. A 
major strategic advantage was that small molecules were easy to crystalize, allowing 
well-defined complexes to be used as models for spectroscopy and reactivity of enigmatic 
metalloprotein sites. Through these studies, the mysteries of many interesting 
bioinorganic systems were revealed (vide infra). 
While this chemical methodology was being practiced, major advances in biology 
were realized. This included the ability to isolate and manipulate genomes or individual 
strands of DNA, achieving selective mutations of proteins, crystalizing and structurally 
interrogating metalloproteins and developing automated synthesis, both at peptide and 
DNA levels, which allowed for the preparation of newly minted proteins. This ease of 
synthetic access to real proteins, with defined metal binding sites, which could now be 
defined at the same high resolution as small molecules, ushered in the field of de novo 
metalloprotein design. No longer was one restricted to ligands that were analogues of 
amino acids, no longer was chemistry often required to be completed in organic solvents 
to mimic a protein environment or confer stability on the metal site, no longer would one 
need to complete multi-step and tedious chemical syntheses to develop chirality around 
the metal center or probe second or third coordination sphere effects on spectroscopy and 
catalysis. In essence, bioinorganic chemistry was ready to be launched into the world of 
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synthetic biology. As defined by the European Union in a Report of a New and Emerging 
Science and Technology (NEST) High-Level Expert Group: 
"Synthetic biology is the engineering of biology: the synthesis of complex, 
biologically based (or inspired) systems which display functions that do not exist in 
nature. This engineering perspective may be applied at all levels of the hierarchy of 
biological structures – from individual molecules to whole cells, tissues and organisms. 
In essence, synthetic biology will enable the design of ‘biological systems’ in a rational 
and systematic way."1 
At the most reductionist level, de novo protein design, the process of using 
peptide sequences that are not existent in, but indeed inspired by nature, allows for the 
building of new function. The ultimate goal of this approach is to obtain stable peptide 
scaffolds with a desired functionality.  Of particular interest to the Pecoraro laboratory is 
the utilization of α-helical proteins, such as the self-associating amphipathic α-helical 
coiled coils, to study metal binding in protein-like environments.  The coiled-coil motif 
consists of amphipathic α-helices that undergo hydrophobic collapse when dissolved in 
aqueous solution resulting in a secondary structure stabilized by interior hydrophobic 
interactions and exterior electrostatic interactions.  
The peptide sequences that result in such coiled-coils consist of heptad repeats, 
where a primary structure is repeated ever seven residues denoted abcdefg. Within the 
heptad repeat, hydrophobic residues are found at the a and d positions and electrostatic 
residues at the e and g positions. The pitch of 3.6 residues per turn results in a 
misalignment of the a residues from one heptad repeat to the next, and the same is 
observed for the d residues, resulting in a super-coil of the α-helical structure.2 
 The identities of the residues located at both the hydrophobic positions and the 
hydrophilic positions have been shown to influence the oligiomeric preferences of the 
coiled-coil. The impact of the hydrophobic residues on the number of helices that 
associate directly relates to the different geometries of the a and d positions with respect 
to the helical backbone.3,4 Combining Val residues at the a position with Leu residues at 
the d positions, provides a 3SCC; however, inclusion of a single Asn at the a position in 
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the one heptad, was shown to produce a two-stranded coiled coil (2SCC, Table 1-1).5,6 
Inclusion of Leu residues at the a positions and Ile at the d positions yields formation of a 
4SCC, and Ile or Leu residues at both the a and d positions exclusively yields a 3SCC 
(Table 1-1).7,8 Although Val is similar to Ile, inclusion of Leu residues at the a and Val 
residues at the d position results in a 3SCC, not a 4SCC as one might predict (Table 1-
1).7 Inversion to Ile residues in the a sites and Leu residues at the d sites provides 
2SCCs.7  
Table 1-1. Comparison of the number of self-associating helices as 
related to identity of the hydrophobic residues in positions a and d 
within the heptad repeat. 
a position d position #SCC Notes Reference 
Ile Leu 2  7 
Ile Ile 3  8 
Leu Leu 3  8 
Leu Ile 4  7 
Leu Val 3  7 
Val Leu 2 One Asn layer 5 
Val Leu 3  6 
5,7,8 
Coil-Ser, as designed by Lovejoy et al., was based loosely off the previously 
reported Hodges peptide (a 2SCC) with five amino acid substitutions within the sequence 
to enhance helical formation and contained all Leu residues at the a and d residues (Table 
1-1).9 The system was originally designed to mimic a 2SCC; however, initial crystal 
structures provided an anti-parallel orientation of Coil-Ser with an up-up-down topology. 
Within the hydrophobic interior, eight Leu layers are observed composed of alternating d, 
d’, a’’ and a, a’, d’’ residues (where residues a and d, a’ and d’, and a’’ and d’’ 
correspond to positions on helix 1, 2, and 3, respectively. Atomic solvation (hydrophobic) 
energy calculations (based on the method of Eisenberg and McLachlan and the atomic 
solvation parameters of Eisenberg et al.10,11) provided a net hydrophobic stabilization 
energy for both the parallel (-11.2 kcal/mol per helix) and antiparallel (-10.7 kcal/mol per 
helix) orientations of Coil-Ser. These energies, although very similar, support a more 
stable anti-parallel structure with a net energy difference compared to the parallel 
orientation of only 0.5 kcal/mol per helix. Additionally, repulsive interactions are 
observed when looking at the interhelical amino salt bridges resulting in salt bridges only 
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between helix 1 and 2. These results indicated that the hydrophobic collapse drives the 
formation of the antiparallel structure and presence of interhelical salt bridges are an 
indirect consequence, not a driving force, in the formation of coiled coils. Multiple 
subsequent crystal structures of substituted CoilSer have shown both parallel and anti-
parallel orientations (vide infra).  
Modification of the Coil-Ser sequence to include Val at the a positions resulted in 
a single, parallel homotrimer named VaLd, as determined by sedimentation equilibrium 
and X-ray crystallography.6,12 In this sequence, eight hydrophobic layers are observed 
with alternating Val a, a’, a’’ and Leu d, d’, d’’ residues. Glu and Lys salt bridges are 
formed at each helical interface. A calculated atomic solvation energy of  
-18.4 kcal/mol per helix provides an increase in stability compared to both the parallel 
and anitparallel Coil-Ser peptide. Comparison of the Coil-Ser and VaLd crystal structures 
provides very similar structures when superimposing a monomer from each trimer; 
however, crystals of these systems grow in different space groups (P321 and P212121 for 
VaLd and Coil-Ser, respectively).9,12 Additionally, trimer stacking is observed for VaLd 
and not for Coil-Ser. These studies show that preferred packing of all Val residues in the 
a layers and all Leu residues in the d layers provides selective parallel 3SCC formation 
whereas all Leu residues in both a and d layers can result in either parallel or antiparallel 
orientations depending on experimental conditions and additional sequence perturbations.  
The hydrophobicity of the residues flanking the a and d position has also been 
shown to influence the number of helices that associate within a coiled-coil peptide. For 
example, for both 2- and 3SCC, the e and g residues show electrostatic interactions; 
however, the b and c positions offer further contributions to the ionic interactions 
between the helices within 4SCC.13,14 If polar groups are introduced into the a and d 
positions, the peptides show a preference for 2SCC to allow for partial solvation of the 
polar sidechains, as mentioned above where an Asn residue was included within the 
peptide sequence.  
The Pecoraro laboratory has used these α-helical designed systems to generate 
well-defined secondary and tertiary protein structures capable of constraining metals into 
native-like structures or functions. Significant advances in understanding have allowed 
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for enhancement of the specificity and selectivity of metal binding. Designed three-helix 
bundles (3HB) are now being tested for practical applications as bioimaging agents (MRI 
contrast and luminescent probes) or for removal of uranyl ions from ocean water.15,16 
 
Heavy Metal Binding to Designed 3SCC, Tris-Thiolate Sites 
Many reviews have covered metalloprotein design and redesign with respect to 
inclusion and alterations of metal binding sites to obtain functional metalloproteins.17–22 
Our laboratory utilizes de novo designed three-stranded α-helical coiled coils (3SCC) and 
α-helical bundles to build, study and manipulate metal binding sites in pseudo-three-fold 
symmetric assemblies. Herein, I discuss how these peptides can impose uncommon 
coordination geometries, differentially recognize either the same metal in different 
geometries or different metals in different regions of the same scaffold, and then discuss 
how these insights have been used to generate catalytic systems capable of hydrolytic or 
redox transformations. I will also discuss the advances I have made during my 
dissertation work as they relate to three different facets of bioinorganic de novo design 
peptide chemistry.  
In 1992, our laboratory initiated a collaboration with Bill DeGrado to study metal 
binding sites in de novo designed peptides. The TRI family of 3SCC was developed, that 
exploits a heptad repeat, a seven-amino acid sequence (LaKbAcLdEeEfKg),23 containing 
hydrophobic Leu residues (a and d), charged residues capable of H-bonding and salt 
bridging (e and g), and fills the remaining locations (b, c, and f) with either helix-
inducing or water solubilizing residues. Acetylated or amidated terminal glycine residues 
also induce the helical structure.  Hydrophobic collapse drives the formation of coiled 
coils forming layers of leucine residues (alternating between a and d positions) along the 
interior of the coiled coil that may be substituted with metal binding residues. Depending 
on the pH, our TRI peptides can from either two-stranded (pH<4.5) or three-stranded 
(pH>5.5) coiled coils, consistent with the trends as outlined above (Figure 1-1).24 Moving 
from N- to C-termini, there are three residues above (sequence dXXXa) and two below 
(aXXd) an a layer within the alpha helical interior. This layer separation is reversed from 
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the d site perspective, resulting in changes of the side chain orientations between a and d 
site metal environments (Figure 1-2). The pattern between adjacent leucine layers 
becomes aXXd above and dXXXa below the d site. The TRI peptides have four heptad 
repeats with the sequence given in Table 1-2. This sequence can be truncated to 3-
heptads (BABY) or elongated to 5-heptads (GRAND).  
 
Figure 1-1. Helical wheel diagram for parallel (a) two, and (b) three-stranded coiled 
coils. Hydrophobic interactions are shown highlighted in green and electrostatic 
interactions are highlighted in black. Figure adapted from 24.24  
Extensive studies have demonstrated that these three-stranded coiled coils adopt 
native folds in aqueous solution rather than forming molten globules.25 Analytical 
ultracentrifugation, HPLC analysis and diffusion based NMR techniques demonstrated 
that at pH ≥5.5 the TRI peptides form parallel 3SCC. Folding free energies indicated that 
these 3SCC were highly stable constructs that only denatured in the presence of 
multimolar guandinium chloride (i.e. ~2-4 mM GuHCl)6,25. Subsequently, numerous 
structures of apo CoilSer derivatives, a related sequence used in crystallographic studies, 
have appeared which confirm the parallel 3SCC assignment (Table 1-2). 
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Figure 1-2. Side view of two-heptad repeats in one TRI helix showing the difference in 
distance between aXXd (4.8-5.0 Å) and dXXXa (5.5-5.7 Å). 
Polyhedra for inorganic ions binding to proteinacious ligands provide 
coordination numbers from two to six and are generated through triangular structures. 
Trigonal environments are achieved by introducing a metal binding ligand into an a or d 
site, resulting in a three-fold symmetric binding site within the 3SCC (Figure 1-3).26 
Metal ion binding into the plane, or layer, of the three ligands provides a trigonal planar 
geometry, whereas displacing the metal up or down from such a plane generates trigonal 
pyramidal geometry. Pseudo tetrahedral and trigonal bipyramidal polyhedra are obtained 
by placing one or two ligands above (and below) trigonal planes, respectively. Octahedral 
structures can be realized by placing a second trigonal plane at a 60-degree angle above 
the first. The 3SCC motif was selected precisely because the C3 symmetry accesses all of 
these polyhedra. 
Designing a metal binding site into the TRI peptides is easily accomplished by 
substituting a Leu residue for a coordinating amino acid such as Cys (e.g., substitution of 
Leu to Cys in the 16th position gives TRIL16C, Table 1-2, Figure 1-4). While removing a 
Leu layer is destabilizing, subsequent metal binding provides sufficient stability to afford 
a 
d 
a 
b 
e 
f 
b 
d 
e 
f 
~4.8-5.0 Å 
~5.5-5.7 Å 
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well-folded metalloproteins. This cysteine substitution allows binding of heavy metals 
such as HgII, PbII, AsIII, CdII and BiIII (vide infra).27  
Table 1-2. Peptide Sequences 
Peptide Sequence 
             abcdefg 
BABY Ac-G LKALEEK LKALEEK LKALEEK G-NH2 
BABYL9C Ac-G LKALEEK CKALEEK LKALEEK G-NH2 
TRI Ac-G LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
TRIL12C Ac-G LKALEEK LKACEEK LKALEEK LKALEEK G-NH2 
TRIL12AL16C Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRIL12DLL16C Ac-G LKALEEK LKADLEEKCKALEEK LKALEEK G-NH2 
TRIL16C Ac-G LKALEEK LKALEEK CKALEEK LKALEEK G-NH2 
TRIL2WL16C Ac-G WKALEEK LKALEEK CKALEEK LKALEEK G-NH2 
TRIL16Pen Ac-G LKALEEK LKALEEK PenKALEEKLKALEEK G-NH2 
TRIL9C Ac-G LKALEEK CKALEEK LKALEEK LKALEEK G-NH2 
TRIL9CL19C Ac-G LKALEEK CKALEEK LKACEEK LKALEEK G-NH2 
TRIL9CL23H Ac-G LKALEEK CKALEEK LKALEEK HKALEEK G-NH2 
TRIL9HL23C Ac-G LKALEEK HKALEEK LKALEEK CKALEEK G-NH2 
TRIL23H Ac-G LKALEEK LKALEEK LKALEEK HKALEEK G-NH2 
TRIL9CL19TL23H Ac-G LKALEEK CKALEEK LKATEEK HKALEEK G-NH2 
TRIK22EL23HE27K Ac-G LKALEEK LKALEEK LKALEEE HKALKEK G-NH2 
GRAND Ac-G LKALEEK LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
GRL16CL26TL30H Ac-G LKALEEK LKALEEK CKALEEK LKATEEK HKALEEK G-NH2 
GRL16CL26DL30H Ac-G LKALEEK LKALEEK CKALEEK LKADEEK HKALEEK G-NH2 
CoilSer Ac-E WEALEKK LAALESK LQALEKK LEALEH G-NH2 
CSL9C Ac-E WEALEKK CAALESK LQALEKK LEALEH G-NH2 
CSL19C Ac-E WEALEKK LAALESK LQACEKK LEALEH G-NH2 
CSL16C Ac-E WEALEKK LAALESK CQALEKK LEALEH G-NH2 
CSL16Pen Ac-E WEALEKK LAALESK PenQALEKKLEALEH G-NH2 
CSL9PenL23H Ac-E WEALEKK PenAALESKLQALEKK HEALEH G-NH2 
GRANDCoilSer Ac-E WEALEKK LAALESK LQALEKK LQALEKK LEALEH G-NH2 
GRCSL12AL16C Ac-E WEALEKK LAAAESK CQALEKK LQALEKK LEALEH G-NH2 
GRCSL16PenL26AL30C Ac-E WEALEKK LAALESK PenQALEKKLQALEKK LEALEH G-NH2 
GRCSL16CL30H Ac-E WEALEKK LAALESK CQALEKK LQALEKK HEALEH G-NH2 
α3D MGSWAEFKQRLAAIKTRLQALGGSEAELAAFEKEIAAFESELQA 
YKGKGNPEVELRKEAAAIRDELQAYRHN 
α3DIV MGSWAEFKQRLAAIKTRCQALGGSEAECAAFEKEIAAFESELQA 
YKGKGNPEVELRKEAAAIRDECQAYRHN 
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Figure 1-3. Pymol models of possible metal-binding geometries in a 3SCC. The metal-
binding ligands are Cys residues and the metal is colored purple. (a) side-on view (top) 
and top-down view (bottom) of two-coordinate or linear geometry, (b) side-on view (top) 
and top-down view (bottom) of three-coordinate trigonal planar geometry, (c) side-on 
view (top) and top-down view (bottom) of four-coordinate tetrahedral geometry, (d) side-
on view of five-coordinate trigonal bipyramidal geometry, and (e) side-on view of six-
coordinate octahedral metal geometry. Models are generated using the crystal structure of 
AsIIIS(CSL9C)3 PDB:2JGO.28 Figure adapted from Ref 26.26 
 
 
Figure 1-4. Pymol representation of the engineering of a tris-thiolate site within a 
3SCC. Substitution of a Leu layer for Cys (middle) residues produces a tris-thiolate site 
for heavy metal binding (right). Figure adapted from Reference 29.29 
Mn+ LeuàCys 
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Initially, the Pecoraro laboratory chose Cys ligands for the hydrophobic interior as 
this amino acid is small, neutral and the metal ion preferences are distinctly different 
from the exterior carboxylate residues. Beyond the obvious objective (selective metal 
binding within a 3SCC), constraining metals in less common coordination geometries 
was desired. MerR, a metalloregulatory protein, is responsible for regulating the 
expression of the mer operon and binds to DNA in the presence (transcriptional activator) 
and absence (transcriptional repressor) of HgII, was proposed to bind HgII as a trigonal 
plane rather than the nearly ubiquitous linear HgII adducts observed in most proteins.30–33 
While trigonal HgII thiolate complexes had been crystallized from non-aqueous 
solution,31,34,35 such structures were unstable in water, especially at the nanomolar 
concentrations where HgII was recognized by MerR. Thus, our first objective was to 
impose a third sulfur ligand onto HgII within a protein environment in aqueous solution. 
A tris-Cys site was designed in TRI in an a position, generating TRIL9C and 
TRIL16C (Table 1-2). Studies determined that both linear and trigonal HgII-thiol 
coordination can be achieved. At pH <4.5, where the apo-peptide predominately forms a 
dimer, or conditions of 1:0.67 ratios of HgII:trimer (pH >5.5), spectroscopic features 
consistent with two-coordinate linear HgII complexes were observed (Table 1-3).25,36,37  
 
Table 1-3. Comparison of HgII-bound MerR and TRI peptides  
Sample δa λ (Δε)b Åc ω (η)d 
HgIIMerR -106e 
-109 (DNA)e 
242 (19.8)f 
260 (14.6)f 
290 (6.45)f 
2.43g 1.19 (0.25)h 
HgII(TRILXC)2 -834i 240 (2.7)i 2.30i 1.47 (0.13)j 
HgII(TRILXC)3- -179 i 247 (19.2)i 
265 (11.9)i 
295 (5.8) i 
2.41i 1.17 (0.25)j,k 
HgII(Cys)42- -300 to -500e,l 280 (NR)f 2.54g 0.33 (0.0)m 
TRILXC: X=9 or 16, both a site cysteine modifications. a δ given in ppm for 
199Hg NMR. b λ given in nm and Δε as mM-1cm-1. c Average Hg-S EXAFS bond 
lengths. d ω is given in rad/ns and η is a unitless quantity for 199mHg PAC. 
eReference 6, pH 6.02.  fReference 30, pH 7.0. gReference 27, pH 7.5. 
hReference 31, pH NR.  iReference 34, pH 8.5.  jReference 35, pH 8.1,  kpH 8.7.  
lVaried pH. mReference 32, pH NR. 
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Between pH 5.5 and 8, with an excess of trimer to HgII, a 3SCC exists with a linear HgII 
and the third thiol uncoordinated. At pH >8 a three-coordinate, trigonal geometry was 
obtained with markedly different spectral features, closely matching HgIIMerR (Table 1-
3).36,37 Thus, under conditions sufficient to deprotonate all three thiols, a trigonal planar 
geometry resulted.  
Trigonal HgIIS3 sites are easily obtained when the thiol ligands are included at a 
positions. Higher pH values (pH ≥9) were required to obtain trigonal HgII in d sites as 
found in TRIL12C.38 For structural studies, the TRI and GR peptides have yet to produce 
good 3-D crystals, and therefore we use CoilSer (CS) peptides as crystallographic 
analogs. The sequence of CS (found in Table 1-2) is similar to that of TRI and GRCS is 
similar to that of GR, with four or five, 7-residue heptad repeat units that promote helix 
formation, respectively. X-ray analysis of apo-CSL9C and CSL19C revealed that the 
preferred cysteine rotamers in a site peptides (e.g., CSL9C) positioned thiol groups into 
the helical interior, whereas cysteine sulfur atoms in CSL19C, a d site Cys3, were 
oriented towards the helical interface (Figure 1-5), suggesting a significant rearrangement 
energy to form HgIIS3 at the d site.25,39 X-ray analysis of HgIISCSL12C has determined 
that at low pH conditions (pH 6.0), HgII binds to the d site in a linear fashion and the 
3SCC crystallizes as an antiparallel 3SCC. This is only the second situation in which the 
CS peptides have been observed as antiparallel 3SCC (Unpublished data from Dr. Leela 
Ruckthong).9 
 
 
Figure 1-5. Pymol representations of the top-down view of the three-fold axis of X-ray 
structures of A) a site apo-(CSL9C)3 (PDB: 3LJM), with S-S distances of 3.3, 3.3 and 3.4 
Å. B) d site apo-(CSL19C)3 (PDB: 2X6P), an enlarged metal binding site with Sγ-Sγ 
distances of 3.4, 4.6, and 4.6 Å.39 
B
)A) 
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Recently, crystal structures of both apo-(CSL16C)3 and 
HgIISZnIIN(GRCSL16L30H)3 were obtained and refined to 1.42 Å and 2.09 Å, 
respectively (Table 1-2, Figure 1-6).29 It was determined that upon binding of HgII to the 
L16C site, that although it contains the requisite number of ligands for trigonal metal 
coordination, it requires significant rearrangement of the thiol side chains to support 
three-coordinate HgII ligation. In fact, the Sγ-Sγ distance must expand by nearly 0.9Å to 
accommodate HgII binding and the corresponding χ1 angles rotate from -69.20° to -
151.88° (Table 1-4, Figure 1-6). This rearrangement required for metal ligation is defined 
as a pre-disposed Cys3 site.*  Notably, there is a water molecule located directly above 
the HgII ion at a distance of 2.79 Å (Figure 1-6C). This distance is too long for a direct 
HgII-OH2 bond (estimated at ~2.2-2.3 Å) but is close enough at 3.39 Å to hydrogen bond 
with sulfur p-orbitals of the cysteine major conformer. 
Introduction of an Ala “hole” (relating to the reduced steric bulk within the 
hydrophobic interior, as compared to the packing of three Leu residues) in layer above an 
a Cys3 site does not greatly alter the geometry or coordination of HgII. Dr. Leela 
Ruckthong recently solved and refined the structure of HgIIS(GRCSL12AL16C)3 to 1.92 
Å (Figure 1-7).29 Similar to HgIISZnIIN(GRCSL16L30H)3, the Cys3 site is pre-disposed 
for HgII binding with a χ1 of -147.85 and a Sγ-Sγ distance 4.20 Å (Table 1-4). The 
primary coordination of HgII in the Cys3 metal binding site is essentially identical within 
GRCSL12AL16C and GRCSL16L30H. One difference in the secondary coordination 
sphere of the HgII metal binding site is the presence of 3 additional water molecules, in 
addition to the water molecule observed in HgIISZnIIN(GRCSL16L30H)3 that is directly 
above the HgII metal ion (referred to from now on as the central H2O). Introduction of the 
Ala residues allows for the central H2O molecule, still located along the helical axis, to 
move away from the HgII to a distance of 3.56 Å, nearly 0.77 Å farther from the metal 
ion than in GRCSL16CL30H (Figure 1-7). This movement results in a distance too far 
                                                
* A pre-disposed site is defined as the placement of the proper number and type of ligands at an 
appropriate layer within a 3SCC to bind a metal but significant rearrangement is required for the a 
proper geometry and metrical parameters of metal binding to occur. A pre-organized site is 
defined as not only the proper number and type of ligands within a layer, but in addition requires 
no, or very little perturbation, of the protein ligands to complex the desired metal in the proper 
geometry.29  
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from the sulfur atoms to form a hydrogen bonds, as was previously observed in 
HgIISZnIIN(GRCSL16L30H)3. However, the three additional water molecules, located 
near the helical interface, are only 2.63 Å from the central H2O molecule and 3.25 Å 
from the sulfur atoms of the Cys ligands. These distances allow for an internal hydrogen-
bonding network between the four water molecules as well as between the interface water 
molecules and the sulfur atoms of the Cys residues. This is the first instance in which a 
hydrogen-bonding network is observed within the hydrophobic interior of the CS family 
of 3SCC. 
Concurrent with both L16C and L12AL16C HgIICys3 crystal structures, a 
structure of ZnIIS(GRCSL12AL16C)3 was also obtained and refined to 1.89Å.29 Similarly 
to HgIIS(GRCSL12AL16C)3, the χ1 angle of ZnII bound to Cys3 is -146.96° with a slightly 
shorter Sγ-Sγ distance of 3.94 Å, to accommodate the smaller ZnII ion (Table 1-4, Figure 
1-8). Unlike HgII, the ZnII ion is observed to bind in a pseudo-tetrahedral geometry with 
three Cys ligands and direct coordination to one exogenous solvent molecule. Similarly to 
the HgII crystal structures, the changes required for metal binding result in a classification 
of the L16C site being pre-disposed for ZnII chelation. Additionally, three non-
coordinating water molecules are observed in the structure of ZnIIS(GRCSL12AL16C)3, 
very similar to those observed in HgIIS(GRCSL12AL16C)3 (Figure 1-9). The waters 
located close to the helical interface are 3.65 Å from the ZnII ion and 2.43 Å away from 
the central water molecule. An overlay of ZnIIS(GRCSL12AL16C)3 and 
HgIIS(GRCSL12AL16C)3 show very similar locations of the water molecules that are 
close to the helical interface, but a significant discrepancy is observed for the location of 
the central water molecule, which can be explained by the direct coordination to the ZnII 
ion but not to the HgII ion. These results indicate that regardless of ion, ZnII or HgII, the 
space introduced in the layer above the Cys3 site at the 16th position by an L12A 
substitution is very similar in size and capable of accommodating 4 water molecules.  
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Figure 1-6. Pymol representations of the pre-disposed L16C site and resulting Cys3 
perturbations upon HgII binding. A) Top down view of the major conformers of Cys 
residues in apo-(CSL16C)3. B) Top down and C) side view of the major, bound Cys 
residues of HgIISZnIIN(GRCSL16CL30H)3+. D) Top and E) side view showing the overlay 
of apo-(CSL16C)3 and HgIISZnIIN(GRCSL16CL30H)3+. Main chains of 
HgIISZnIIN(GRCSL16CL30H)3+ are shown in green and apo-(CSL16C)3 in orange. 
Cysteine side chains are shown as sticks. HgII is represented as a blue sphere and the 
observed water molecule is shown in red. Figure adapted from Reference 29. 
A 
B C 
D E 
 15 
 
Figure 1-7. Pymol representations of HgII binding to GRCSL12AL16C. Top down view 
of the major Cys conformers of HgIIS(GRCSL12AL16C)3- showing A) a 4.2 Å Sγ-Sγ 
distance and B) a 2.44 Å HgII-S distance. C) Top down and D) side on views of the water 
molecules that occupy the space introduced via the L12A substitution. Main chain helices 
are shown in pale yellow ribbons, 16Cys (sulfur = bright yellow) and 12Ala (green) side 
chains are present as sticks. The HgII ion is shown as an orange sphere and the 
uncoordinated water molecules are represented as blue spheres. Figure adapted from 
Reference 29. 
 
 
  
A B 
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Figure 1-8. Pymol representations of ZnII binding to GRCSL12AL16C. A) Top down 
and B) side on views of the first coordination sphere of the tetrahedral binding site. 
NOTE: The three uncoordinated waters present above the metal binding site in the crystal 
structure are omitted from panels A and B for clarity. All water molecules are included in 
the (C) top down and (D) side on views. Main chain helices are shown as light red 
ribbons, 16Cys (sulfur = bright yellow) and 12Ala (green) side chains are present as 
sticks. The ZnII ion is shown as an grey sphere and the water molecules are represented as 
red spheres. Figure adapted from Reference 29. 
 
 
 
A B 
C D 
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Figure 1-9. Pymol overlay representations comparing ZnII and HgII binding and 
surrounding water molecules in GRCSL12AL16C. A) Top down and B) side on views of 
the overlay of ZnIIS(GRCSL12AL16C)3- and HgIIS(GRCSL12AL16C)3- crystal structures 
(PDB codes not yet deposited). Main chain helices are shown in pale yellow and light red 
ribbons for the HgII and ZnII structures, respectively. Sulfur atoms are shown in bright 
yellow. Cys and Ala residues are represented as sticks. ZnII and HgII ions are shown in 
grey and orange, respectively. Water molecules are shown as red and blue for the 
ZnIIS(GRCSL12AL16C)3- and HgIIS(GRCSL12AL16C)3- structures, respectively. Figure 
adapted from Reference 29. 
 
Table 1-4. Comparison of apo- and Metallated Crystal Structure Metrical Parameters 
 Metal Binding Site* 
 Cys3 Pen3 Ala3/Cys3 
 apo HgII PbII AsIII apo HgII HgII ZnII 
χ1 (°) -69.20 -151.88 -68.38 -59.66 -49.85 -50.23 -147.85 -146.96 
Sγ-Sγ (Å) 3.29 4.16 3.49 3.29 3.71 3.84 4.20 3.94 
# of H2O - 1 0 0 - 0 4 1** 
M-S distance 
(Å) 
- 2.43 2.65 2.28 - 2.21 2.44  
S-M-S angle (°) - 118.36 82.37  - 119.92 118.74  
Pre-disposed or 
Pre-organized 
 Pre-
disposed 
Pre-
organized 
Pre-
organized 
 Pre-
organized 
Pre-
disposed 
Pre-
disposed 
Geometry  Trigonal pyramidal 
Trigonal 
planar 
Trigonal 
pyramidal 
 Trigonal 
planar 
Trigonal 
planar 
Tetrahedral 
*All sites included in table are a sites. **H2O molecules is directly coordinated to ZnII. All data 
from Ref 29. 
Interestingly, the preorganization of the metal site differs when comparing apo-
(CSL16Pen)329 to HgIISZnIIN/O(CSL9PenL23H)340 crystal structures. While one still 
observes trigonal coordination of the HgII ion, there is very little difference observed in 
the cysteine torsion angles upon binding HgII to penicillamine (Figure 1-10). In fact, only 
a slight elongation of the Sγ-Sγ distance of 0.13 Å and a small χ1 angle rotation from  
A B 
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-49.85° to -50.23° is required (Table 1-4). These minimal changes for HgII binding to a 
Pen3 site shows that instead of simply being pre-disposed, we now have what is referred 
to as a pre-organized metal binding site. There is a difference in rigidity of the 
coordinating sulfur atoms between Cys and Pen ligands, likely due to the restriction 
imposed by the steric bulk of the γ-methyl groups on the rotation of the thiol group about 
the Cβ atom. Indeed, differences are observed between the HgII-bound Cys3 and Pen3 
sites. For example the bond distance of HgII-Pen3 is 2.21 Å, a decrease in bond length of 
0.22 Å when compared to HgII-Cys3 (Table 1-4). This indicates that the bulk of the γ-
methyl groups reduces the space available in comparison to the Cys3 binding site. 
Additionally, the HgII-bound Pen3 torsion angle of -50.23° varies drastically from that of 
HgII-bound Cys3 at -151.88°. In all apo-(CSL16Pen)3, HgIISZnIIN/O(CSL9PenL23H)3, and 
apo-(CSL16C)3 are very similar in structure, but significant differences are observed 
between these three structures in comparison with HgIISZnIIN/O(GRCSL16L30H)3 (Figure 
1-10). Therefore, the simple inclusion of methyl groups to Cys to form Pen results in a 
conversion from a pre-disposed to a pre-organized thiol-rich HgIIS3 binding site.  
Cysteine substituted GRAND and BABY also bind HgII in an unprecedented 
trigonal geometry in water (experimental parameters are consistent with comparable TRI 
peptides).38,41 The more stable GRAND peptides form trigonal HgII complexes at 
subnanomolar concentrations putting it on par with MerR. Studies with BABYL9C 
demonstrated how metals can nucleate protein folding.42 At ten mM, pH 8.5, BABYL9C 
is unfolded. Addition of HgII associates the peptides forming HgII (BABYL9C)2, 
matching the HgII linear structural preference. Because this system was designed to form 
a 3SCC, a third BABYL9C is recruited generating HgII(BABYL9C)3, providing a three-
coordinate HgII ion (Figure 1-11).42 Thus, initially the metal induces its preferred 
structure, forcing an incorrect protein aggregation that ultimately rearranges to the 
desired 3SCC constraining the HgII into an uncommon geometry.  
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Figure 1-10. Pymol representations of the perturbations of a Pen3 binding site upon HgII 
binding and comparison of HgII binding to GRCSL16CL30H and CSL9PenL23H. A) Top 
down view of an overlay of apo-CSL16Pen and HgIISZnIIN/O(OH2)(CSL9PenL23H)3n+.40 
Main atoms are shown as ribbon diagrams in which the apo-structure is in grey and 
metallated-structure is in cyan, HgII ion is shown in grey. B) Top down and C) side on 
view of the overlay of the Cys ligands from apo-(CSL16C)3 (shown in orange) and Pen 
ligands from apo-(CSL16Pen)3 (shown in light blue, PDB code: 3H5F).43 D) Top down 
view and E) side on view comparing the trigonal structures of HgIICys3 from 
HgIISZnIIN(GRCSL16CL30H)3+ (shown in green, HgII shown in blue) and HgIIPen3 from 
HgIISZnIIN/O(OH2)(CSL9PenL23H)3n+ (shown in dark teal, HgII shown in grey) PDB: 
3PBJ). Cys residues are represented as sticks with bright yellow sulfur atoms. Figure 
adapted from Reference 29. 
 
A 
B C 
D E 
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Figure 1-11. Schematic showing the proposed kinetic mechanism for cooperative folding 
of a three-stranded coiled coil around trigonal thiolato Hg(II) by an unstructured peptide 
(BabyL9C). Figure adapted from Reference 42.42 
The SmtB/ArsR families of metalloregulators represent an alternative set of 
multithiolate containing proteins that are responsible for controlling detoxification of 
heavy metals (e.g., CdII, AsIII, and PbII in bacteria). CadC is a regulator for CdII 
detoxification (Staphylococcus aureus).44 CadC has four cysteines that may sequester the 
metal.45 Whether CdII binds to CadC as a tetrathiolate S4 structure or as an S3O site with 
an exogenously bound water has been discussed, providing another synthetic target for 
protein design. Furthermore, the copper metalloregulator CmtR might bind CdII in an 
unprecedented trigonal planar structure46 providing our next objective, imposing a lower 
than desired coordination number.  
CdII binding to TRIL16C and TRIL12C (Table 1-2) at pH 8.5 was explored via 
EXAFS, UV-Vis, 113Cd NMR and 113mCd PAC spectroscopies. Similar complexes were 
formed with CdII in either a or d sites and, as was seen for HgII, the pKa’s for binding the 
third cysteine are different at 7.2 and 6.8 (TRIL12C and TRIL16C, respectively).47 
Because of the a and d site similarity, I will focus this discussion on the a site peptides 
with respect to CdII binding. 113Cd NMR and 113mCd PAC spectroscopies are the most 
informative techniques for clarifying this system.  One 113Cd NMR signal was observed 
at 625 ppm for TRIL16C,47 which is within the range of previously reported CdIIS3 and 
CdIIS3O shifts. However, it was found using 113mCd PAC spectroscopy (Figure 1-12) that 
there were two CdII species present simultaneously, a CdIIS3O complex (60%, ω0≈0.350 
rad/ns) and a CdIIS3 specie (40%, ω0≈0.450 rad/ns). The apparently contradictory 
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speciation is a consequence of different experimental timescales. 113Cd NMR probes the 
solution at millisecond intervals whereas 113mCd PAC interrogates the center on the 
nanosecond regime. Thus, it was concluded that the CdIIS3O and CdIIS3 forms 
interconvert rapidly on the NMR, but not the PAC, timescales. Further examination of 
numerous derivatives, some of which are described below, led to a correlation using 
113Cd NMR to quantify the proportion of CdIIS3O and CdIIS3 in a sample.48 For a site 
peptides, CdII chemical shifts at ~575 ppm correspond to pure CdIIS3O, whereas CdIIS3 
exhibits a single resonance at ~680-700 ppm. This 113Cd NMR correlation allows us to 
assess whether a pure CdIIS3O or CdIIS3 species or a mixture is prepared. 
 
Figure 1-12. 111mCd PAC and 113Cd NMR spectra of (top row) CdIIS(CSL16C)3-, (middle 
row) CdIIS(CSL12AL16C)3-, and (bottom row) CdIIS(CSL16Pen)3-. Lines correlate to the 
CdIIS3O (solid) and CdIIS3 (dashed) species. Figure adapted from Reference 24.24 
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It was reasoned that a pure CdIIS3O center would result by removing the sterically 
constraining leucines in the layer above the cysteines (TRIL12AL16C, Table 1-2). The 
alanine substitution allowed water to enter the cavity above the metal, leading to a 
compound with 100% ω0≈0.340 rad/ns and 574 ppm.49  
Synthesizing the first water soluble CdIIS3 species was more challenging. 
Ultimately, two different strategies were successful. The first exploited the utilization of a 
penicillamine ligand, which is bulkier than cysteine, having methyl groups rather than 
protons at the C-β position (TRIL16Pen, Table 1-2). It was hypothesized that the methyl 
groups would block water from the hydrophobic region above the metal. Addition of CdII 
at pH 8.5 to TRIL16Pen gave CdII(TRIL16Pen)3 a 100% CdIIS3 complex (ω0≈0.454 
rad/ns, 684 ppm).49 Crystallographic analysis of apo-(CSL16Pen)3 revealed that the 
geminal methyls on the β-C would not block the bound water.43 The packing of the 
leucines in the 12th position also did not become perturbed, so other factors must lead to 
the desired structure. 
Pure CdIIS3 was also achieved by exploiting D-amino acids using 
TRIL12DLL16C (Table 1-2). The reasoning here was that the leucine sidechain 
orientation shifted toward the metal binding site, blocking water access. Indeed, this 
hypothesis was correct forming a pure CdIIS3 complex (ω0≈0.456 rad/ns, 697 ppm).50 
These two examples not only provide the only known synthetic cases where CdIIS3 can be 
prepared in water, but this was also the first application of using alternative chirality to 
modify the coordination geometry of a metal in a protein.  
Having successfully designed both CdIIS3O and CdIIS3 binding sites, a new 
peptide was designed with a single peptide with two distinct cysteine-binding sites 
capable of complexing CdII with different affinities or geometries. The relative affinities 
of CdII binding to peptides containing either a or d Cys sites predicted that the metal 
could be bound selectively first to the a position and then d. Preparation of TRIL9CL19C 
confirmed this supposition as one equivalent of CdII bound exclusively to the L9C (a 
site), while a second bound to the d site (Table 1-2, Figure 1-13).51 Further success was 
realized when mixtures of CdII and PbII were shown to place PbII in the preferred d site 
while CdII occupied the a site.52 From the perspective of molecular recognition and the 
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development of multicenter designed proteins, these observations were major 
advancements to the field.  
 
Figure 1-13. 113Cd NMR spectra of 4 mM TRIL9CL19C at pH 8.5 with (a) 0.9, (b) 1.1 
and (c) 2 equiv of 113CdCl2. Figure adapted from Reference 51.51 
Peptides that could distinguish metals based on coordination number were our 
next targets. A sequence was designed that contained both an alanine/cysteine site as well 
as a penicillamine site in a peptide containing an extra heptad in order to retain sufficient 
aggregate stability. Addition of two equivalents of CdII to GRL16PenL26AL30C (Table 
1-2) led to two 113Cd NMR signals at 687 and 588 ppm correlating to the previously 
characterized CdIIS3 and CdIIS3O sites.53 The first equivalent of CdII bound exclusively to 
the pseudo-tetrahedral S3O site, and occupation of the trigonal S3 site only occurred with 
a second equivalent of CdII (Figure 1-14). Therefore, a 3SCC capable of sequestering CdII 
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simultaneously in two different geometries was designed exhibiting different affinities 
and physical properties. 
 
Figure 1-14. 113Cd NMR spectra of solutions containing 2.6 mM trimer 
GRL16PenL26AL30C and different amounts of 113Cd(NO3)2 at pH 9.6. Figure adapted 
from Reference 53.53 
Unlike CadC, which forms three- and four-coordinate CdII structures, ArsR has 
three cysteine residues that bind AsIII with three As-S bonds of 2.25Å in a proposed 
trigonal pyramidal geometry, however, structures of the proteins are unavailable.54 The 
crystal structure of AsIIIS(CSL9C)3 (1.8 Å resolution28, Figure 1-15) revealed 2.28 Å As-S 
bond distances, in close agreement to AsIIIArsR.54 This first crystallographic report of 
AsIIIS3 in a biologically relevant scaffold confirmed a trigonal pyramidal polyhedron, but 
in an unanticipated endo-isomer orienting the stereochemically active lone pair toward 
the C-terminus. Prior descriptions had assumed an exo-structure.28    
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Figure 1-15. (A) Top down and (B) side-on view of pymol representations of trigonal 
pyramidal coordination in AsIIIS(CSL9C)3 (PDB: 2JGO).28 Main chain atoms are shown 
as ribbon diagrams in green, cysteine residues are shown as sticks with sulfur ions in 
bright yellow. The AsIII ion is shown as a purple sphere.  
LeadII can also form hemidirected trigonal pyramidal geometries in proteins such 
as aminolevulinic acid dehydratase.55 Because PbII is larger than AsIII, one might expect 
different coordination preferences within the TRI peptides. EXAFS analysis of PbII-TRI 
peptides yielded three 2.63 Å metal-sulfur distances.56 Computational methods and 
experiments demonstrated that PbII prefers binding to d site cysteines, which provide 
more space in the interior of the 3SCC in comparison to the a site cysteines, and the pKa 
of TRIL16C is higher (pKa= 6.3) than TRIL12C (pKa= 6.0).27 This trend is in contrast to 
CdII and HgII. Thus, one can conceive of distinguishing metal sites based on differential 
cysteine substitution at the a or d layers. The first report of a 207Pb NMR chemical shift 
for the PbII(SR)3 chromophore was achieved using PbII-TRI peptides. This technique is 
astoundingly sensitive as changing the Cys residue from a to d sites or altering the sterics 
around the PbII results in NMR shifts of >200 ppm (Figure 1-16).57  
Recently, a crystal structure of PbIISZnIIN(GRCSL16CL30H)3 was collected and 
refined to 2.17Å.29 Comparison to apo-(CSL16C)3 provides minimal expansion of the Sγ-
Sγ distance of only 0.2Å and minimal rotation of the χ1 angles from -69.20° to -68.38° 
upon PbII binding, indicating the L16C site is pre-organized for PbII binding (Figure 1-
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17, Table 1-4). Additionally, the PbII ion coordinates in a trigonal pyramidal geometry 
and the metal ion sits below the plane of the cysteine methyl groups (1.69Å) confirming 
an endo-configuration of PbII binding. This geometry and endo-configuration were 
previously observed with the AsIIIS(CSL9C)3 crystal structure. In both cases the bulky 
and hemi-directed lone pairs of both AsIII and PbII point down toward the C-terminus of 
the 3SCC. Closer examination of the AsIII structure provides Sγ-Sγ distances of 3.29Å and 
χ1 angles -59.66°, similar to the values for apo-(CSL9C)3 of 3.22Å and -70.57° (Table 1-
4). The larger discrepancy observed, when considering AsIII binding in comparison to PbII 
binding, of the χ1 angles is assumed to be due to the smaller size of the AsIII ion. 
However, in both cases, while AsIII and PbII binding are not identical, these structures 
show that Cys3 a sites (such as L16C and L9C) are pre-organized for the binding of 
trigonal pyramidal ions such as PbII and AsIII. This observation is independent of ion 
charge or size. 
 
Figure 1-16. Natural-abundance 207Pb NMR spectra (104.435 MHz) of PbII-bound three-
stranded coiled coil peptides (10-12 mM); PbIIS(CSL12C)3- (top) and PbIIS(CSL16C)3- 
(bottom). Figure adapted from Reference 57.57 
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Figure 1-17. Pymol representation of trigonal pyramidal coordination in 
PbIISZnIIN(GRCSL16CL30H)3+ and comparison with apo-(CSL16C)3. Top down view 
from the N-termini of the PbIICys3 (A) and apo-Cys3 (B) site showing a slight expansion 
of Sγ-Sγ distance from 3.29 to 3.49 Å upon PbII binding. C) Side on view of PbIICys3 
showing endo-conformation and a PbII-S distance of 2.65 Å. D) Top down from the N-
termini and E) side on view of the overly of PbIISZnIIN(GRCSL16CL30H)3+ and apo-
(CSL16C)3 showing the pre-organization of L16C sites for PbII binding. Main chain 
atoms are shown as ribbon diagrams in purple (PbII structure) and orange (apo-structure), 
12Leu and 16Cys side chains are shown as sticks with sulfur ions in bright yellow. The 
PbII ion is shown as a grey sphere. Figure adapted from Reference 29. 
 
A
 
B
 
C
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Therefore, Cys3 sites within our 3SCC are pre-organized for PbII and AsIII binding 
yet pre-disposed for binding of ZnII or HgII. Considering the trend of atomic radii of AsIII 
~ ZnII < HgII < PbII, it is clear that pre-organization or pre-disposition for metal binding 
is not dependent on metal ion size. However, it seems that pre-organization or pre-
disposition for metal binding correlates, instead, to metal binding geometry. That is, 
when a metal binds in a trigonal pyramidal geometry as found with PbII and AsIII to our 
Cys3 sites, minimal perturbations are observed in the cysteine ligand torsion angles 
indicating that the apoprotein is pre-organized for metal binding. Interestingly, this is 
also observed when HgII binds to a Pen3 site, suggesting that the packing of the extra 
methyl groups also influences the pre-disposition or pre-organization of the site. 
However, when metals bind to the Cys3 site in a trigonal planar or pseudo-tetrahedral 
geometry, as with HgII and ZnII, significant perturbations of the cysteine ligands are 
observed suggesting the site is pre-disposed for metals that bind with these geometries. 
Water molecules are not observed in neither the case of 
PbIISZnIIN(GRCSL16CL30H)3 nor AsIIIS(CSL9C)3. Therefore, it appears that when the 
Cys3 site is pre-organized for metal binding the structure does not contain an interior 
water molecule, but when the Cys3 site is pre-disposed for metal binding the structure 
contains at least one water molecule. This indicates that the pre-organized orientation of 
the sulfur ligands results in less space between the 16Cys layer and the 12Leu layer as 
compared to the pre-disposed orientation of the Cys residues. This observation is again 
independent of ion charge or size.  
However, there is a significant difference in the size of PbII vs AsIII, and since this 
is not accommodated for in the layer above the Cys3 binding site, it must be 
accommodated for in the layer below. Indeed, when the Leu packing is analyzed in the 
19th position, the layer below the Cys3 binding site, a change is observed between the PbII 
and AsIII crystal structures (Figure 1-18). This is interesting since, as mentioned above, 
the space available between the 16th and 19th position (a to d site) is smaller than that 
between the 12th and 16th position (d to a site). This indicates that when a site is pre-
organized for metal binding of a trigonal pyramidal geometry the energy requirement for 
rotating the Cys3 ligands is greater than that required to alter the packing of the Leu 
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residues in the 19th position, ultimately resulting in the changing of the conformations of 
the Leu residues. For my dissertation work, PbIICys3 binding sites are incorporated into 
3SCC in combination with steric matching of surrounding hydrophobic residues to obtain 
asymmetric 3SCC (vide infra). 
 
Figure 1-18. Pymol representations of the overlay of PbIISZnIIN(GRCSL16CL30H)3+ and 
AsIIIS(CSL9C)3 (PDB: 2JGO).28 A) Top down from the N-termini and B) side on view of 
the Cys3 binding site. Main chains are shown in purple and red for the PbII and AsIII 
structures, respectively. PbII and AsIII ions are shown in grey and purple spheres, 
respectively. Cysteine residues are shown as sticks and sulfur atoms are shown in bright 
yellow. Figure adapted from Reference 29. 
Clearly, significant understandings of factors that define protein-metal 
interactions were achieved using the TRI and GR peptides. Metal ions can be placed 
within environments that match their coordination preferences (PbII, AsIII), or that impose 
higher (HgII) or lower (CdII) coordination numbers. Furthermore, one can now 
differentiate binding of metals at sites within a protein based on coordination preference, 
coordination number or ion type. However, a current and significant limitation of using 
the TRI and GR families of peptides is the inherent symmetry obtained by the self-
assembling nature of the 3SCC. Therefore, the first goal of my dissertation, as detailed in 
Chapter 2, is to selectively obtain quantitatively asymmetric, or heterotrimeric, 3SCC 
using a PbIICys3 binding site in combination with steric matching of hydrophobic 
residues in the helical layers directly adjacent to the PbII binding site.  
One strategy to incorporate asymmetry utilized in the Pecoraro lab is to employ a 
single polypeptide chain that can be site specifically mutated to generate channels or 
A B
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acid-base catalysts. An appealing system is α3D, a 3HB from the DeGrado laboratory.58 α 
3D (Table 1-2) was optimized to have a helix-turn-helix-turn-helix motif. Computational 
modeling suggested four sites where three cysteine residues could replace hydrophobes. 
The fourth model, a3DIV (Table 1-2) was chosen as the test peptide to assess heavy metal 
binding (Figure 1-19). Comparison of the NMR structures of α3D and α3DIV reveal a 
pre-disposed metal binding site for HgII binding upon replacement of three leucines with 
cysteines with little perturbation of the scaffold (one cysteine residue must rearrange to 
bind HgII, Figure 1-19).59,60 Metal complexation was strong and led to higher protein 
stability with HgII bound as a three coordinate complex, probably T-shaped, while PbII 
adopted a trigonal pyramidal geometry. CdII adopted two structures CdIIS3O or CdIIS3N, 
with either coordinated water or His72, respectively.60 
 
Figure 1-19: Pymol representation of a3DIV. A) The twenty lowest energy NMR 
structures of α 3DIV, a single polypeptide chain 3HB and B) close up of the metal Cys3 
binding site in α 3DIV.59 
 
A
B
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Numerous attempts at obtaining selective and quantitative parallel asymmetric 
3SCC have been reported. There are two possible heterotrimeric arrangements when 
forming asymmetric 3SCC, depending on the identities of the three independent helices. 
For instance, one helix can be changed to obtain a trimer with two of the same helices 
and one different, denoted as an AAB heterotrimer. Or, one could attempt to design a 
heterotrimer with all three helices being different, affording an ABC heterotrimer. 
Nautiyal and Alber used a combination of positive and negative design principles 
to promote formation of heterotrimeric assemblies based solely on the ionic interactions 
at the helical interfaces.61 The utilization of both positive and negative design promoted 
maximal complementary interhelical salt-bridging interactions in heterotrimeric scaffolds 
and would result in charge repulsion if symmetric homotrimers were formed. Jalan et al. 
also used both negative and positive design to form heterotrimeric assemblies with 
varying collagen peptides based on helical charge pairing based on register alignment 
(Figure 1-20).62 Diss and Kennan used similar charge pairing between helicies as well as 
buried urea groups within the hydrophobic core of the 3SCC to promote formation of 
heterotrimers (Figure 1-20).63 LeBruin et al. appended bidentate 2,2’-bipyridyl ligands to 
the end of collagen helices that induce heterotrimer formation upon octahedral binding of 
NiII.64 All of these examples promoted formation of ABC heterotrimers (Figure 1-20).  
ABB and ABC heterotrimers have been obtained in both the Keenan and Tanaka 
labs using a steric matching approach. Schnarr and Keenan initially obtained an AAB 
heterotrimer by pairing a bulky non-natural amino acid, cyclohexylanlanine (CHA) with 
small alanine residues. When only one layer is substituted, an AAB heterotrimer is 
formed but is not significantly more stable than the corresponding homotrimers.65 When 
included in three alternating layers along the helical axis a selective ABC heterotrimer 
was obtained (Figure 1-21).66 Concurrently, Tanaka and coworkers combined steric 
matching of one bulky tryptophan and two smaller alanine residues; however, when only 
this steric matching layer was utilized both the AAB heterotrimer and BBB homotrimer 
were observed.67 To destabilize homotrimer formation and promote heterotrimer 
formation, they then combined the Ala2Trp matching with electrostatic alterations on the 
exterior of the helices to obtain pure, and stable heterotrimeric mixtures.68  
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Figure 1-20. Schematics showing previous techniques for obtaining heterotrimeric 3SCC 
systems. Top: Schematic illustration of hydroxyproline-free ABC heterotrimer composed 
of (PKG)10, (DKG)10, and (EPG)10 peptides electrostatically stabilized through multiple 
lysine-aspartate and lysine-glutamate salt bridges.62 Schematic representing ABC 
heterotrimer with varying charged residues in the salt bridging positions to promote 
maximal ion pairing to form a parallel heterotrimer as well as the buried varying core 
polar residues.63  Bottom: Computer-generated model of the NiII-assembled Ni:c1:c2:c3 
heterotrimer. C1: bpy-GPOGPOGPOGPOGPOGPO-NH2. C2: bpy-
GGPOGPOGPOGPOGPOGPOGP-NH2. C3: bpy-GOGPOGPOGPOGPOGPOG-NH2.64  
Thus far, interior bound metals have not been used to nucleate heterotrimeric 
formation. Moreover, asymmetric scaffolds have never been used to generate asymmetric 
metal binding sites with potential catalytic activity. Therefore, the primary goal of 
Chapter 2 of my dissertation is to combine steric matching of natural amino acids in 
combination with a PbII binding site to nucleate specific formation of a parallel A2B type 
heterotrimer. This approach will require no changes in exterior residues or salt-bridging 
interactions and will only require two neighboring layers within the helices for selective 
formation, instead of altering layers throughout the entire scaffold, therefore leaving 
space within the scaffold for a second metal binding site. The ability to use an 
asymmetric scaffold to generate a second, asymmetric, and potentially catalytic, site will 
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be discussed more below. I will utilize multiple spectroscopic techniques to study the 
symmetry of the trimers with respect to the PbIICys3 binding site. I will discuss how the 
presence of a transition metal, for binding to a second metal binding site elsewhere in the 
scaffold, should have a lower affinity for the Cys3 site than PbII as not to distrupt the 
heterotrimer specificity. Primarily, 207Pb NMR will be used to analyze the difference 
between homotrimer and heterotrimer formation. I will also discuss how the identity of 
the heavy metal used to obtain heterotrimeric systems is important and how switching to 
HgII from PbII allows for formation of heterotrimeric systems with less than ideal 
selectivity. 
 
Figure 1-21. Helical wheel projection of the 1:1:1 T9/T16/T23 complex (viewed down the 
helical axis from the N to C terminus), showing only core residues. The sequence of each 
peptide is also given. The tic-tac-toe arrangement of cyclohexylalanine residues (X) is 
depicted schematically at the right. Ac = acetyl and Am = amide. Figure adapted from 
Ref 62.   
Concurrent with my thesis work, a crystal structure of PbIIS(GRCSL12AL16C)3- 
was solved and refined by Dr. Leela Ruckthong. I will discuss the implications of how 
the metal binds within this structure in comparison to PbIIS(GRCSL16CL30H)3-, and how 
these observations may give shed some light onto the formation of PbII-bound 
heterotrimers and why different spectroscopic characteristics are observed. I will also 
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discuss how the location of the Ala/Leu pairing with respect to the Cys3 binding site 
effects heterotrimer formation.  
 
Transition Metal Binding to 3SCC, Spectroscopic Analysis of Second, Asymmetric 
Metal Binding Sites 
After achieving control of heavy metal coordination chemistry, the Pecoraro 
laboratory embarked on defining the structure and environment surrounding transition 
metals with the intention of generating new catalysis and redox centers. Many non-heme 
metal centers in proteins utilize imidazole ligands. This presented a new concern for 
designing catalytic centers. Could far larger residues, such as histidine, be incorporated 
within the hydrophobic interior of 3SCC without disrupting the assembly?  Our first 
system, TRIL9CL23H, exploited our ability to incorporate metals into 3SCC site 
selectively. At the N-terminal end of the construct, a high affinity binding site for HgII 
was designed using the existing cysteine methodology to confer additional aggregate 
stability. Guanidinium denaturation titrations demonstrated that HgIICys3 served this 
function.25 A second substitution at Leu23 with histidine yielded a His3 catalytic binding 
site offering a structural model of Carbonic Anhydrase (CA). The 23rd position was 
chosen since it was an a site that was located away from the center of the sequence to 
minimize steric disruption of the 3SCC, but not at the ends of the sequence to obtain a 
more structured binding site. CA has a His3 coordination sphere in a b-sheet rich domain 
that binds ZnII in a pseudo-tetrahedral environment with a fourth exogenous water ligand 
(Figure 1-22).69  
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Figure 1-22. Pymol representation of the active site of Carbonic Anhydrase (PDB: 
2CBA)70 showing the primary His3 ZnII-binding site with an exogenous H2O/OH- ligand. 
Also shown is Thr199, a secondary sphere ligand shown to play an important role in 
catalysis.  
The construct, HgIISZnIIN/O(OH2)(TRIL9CL23H)3, allowed us to address two 
fundamental issues in bioinorganic chemistry. First, could a catalytic metal center found 
in a b-sheet structure be constructed within an entirely a-helical domain? Second, if such 
a structural match occurred, would such a center be competent to catalyze the native 
reaction? Spectroscopic studies (199Hg NMR, UV-Vis) proved that a trigonal HgII was 
correctly formed. Ultimately, a crystal structure of HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ 
was obtained and refined to 2.2Å resolution (Figure 1-23). The model showed excellent 
overlay in the primary coordination sphere to the crystal structure of CA, with Zn-N and 
Zn-O distances within experimental error (Figure 1-24).40 Therefore, imidazole is well 
accommodated within the 3SCC, ZnII and HgII bind exclusively to their intended binding 
sites, HgII behaved as a structural site providing additional stability against denaturation 
and a CA like ZnIIHis3/water site was viable in a drastically different protein fold.  
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Figure 1-23. Ribbon diagrams of the HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ parallel 3SCC 
(one of two different three-helix bundles present in the asymmetric unit) at pH 8.5. 
Shown are the main chain atoms represented as helical ribbons (cyan) and the Pen and 
His side chains in stick form (sulfur = yellow, nitrogen = blue, oxygen = red). A. One of 
two trimers found in the asymmetric unit of the crystal structure. B. Top-down view of 
the structural trigonal thiolate site, HgIIS3, confirming the proposed structure of HgII in 
Cys-containing TRI peptides. This metal site should mimic well the structural site in 
metalloregulatory protein MerR. C. Side view of the tetrahedral catalytic site, ZnIIHis3O, 
which closely mimics carbonic anhydrase and matrix metalloproteinase active sites. All 
figures shown are 2Fo-Fc electron density contoured at 1.5σ overlaid. Figure adapted 
from Ref 40.40  
 
Figure 1-24. Overlay of the ZnIIHis3O site in HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ (teal, 
PDB: 3PBJ) with the active site of human CAII (tan, PDB: 2CBA). Left: Side-on view of 
the overlay with CAII. The solvent molecule (from PDB 3PBJ) is shown in red. Right: 
Top-down view of the overlay with CAII. The model displays an excellent structural 
overlay for the first coordination sphere atoms with CAII; however, the orientation of the 
imidazoles differs between the two proteins. Another subtle difference is that the present 
structure has three ε amino nitrogens bound to the Zn(II) ion, whereas CAII has a mixed 
two ε and one δ coordination sphere. Figure adapted from Ref 40. 
A
B C
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The reaction catalyzed by CA is essentially diffusion limited hydration of CO2 to 
bicarbonate and water.71,72 Ester hydrolysis, via a similar mechanism as CO2 hydration 
(ZnII-OH nucelophilic attack), is often analyzed due to the significantly slower reaction 
times. When reported, HgIISZnII(OH)N/O(TRIL9CL23H)3 was the fastest CA mimic of p-
nitrophenolacetate (pNPA) hydrolysis with a kcat/KM of 23.3 M-1s-1 at pH 9.5, only ~100-
fold slower than native CAII, and was a 550-fold increase over other small molecule 
mimics.40,72,73 Access of small molecule substrates is viewed to be via breathing modes of 
the protein scaffold at the helical interface.74 The pKa=9.0 was two log units higher than 
that reported for CAII (pKa = 6.8).75,76 Two other designed ZnII enzymes have since been 
reported that have faster pNPA hydrolysis rates.77,78 However, to date 
HgIISZnII(OH)N/O(TRIL9CL23H)3 is still the fastest reported CA mimic for the native CO2 
hydration reaction with a rate of 1.8 x 105 M-1s-1 at pH 9.5. This system is 430-fold faster 
than the best previously reported small molecule mimic reacting solely in water and only 
~370-fold slower than the fastest CA, CAII.71,72,79 Thus HgIISZnII 
(OH)N/O(TRIL9CL23H)3n+ is a fantastic structural model of CA and the first reported de 
novo designed peptide that rivaled the rates of catalysis of a native enzyme.  This first 
generation construct sought to mimic only the first coordination sphere of CAII and did 
not provide residues to facilitate acid-base catalysis. Interestingly, CA mutants that delete 
a specific active site threonine have catalytic efficiencies 100-fold lower and a water pKa 
~8.8.80,81 Our work clearly shows that, within 2 log units, the native protein fold is not 
essential for catalytic activity and that including an acid-base catalyst could confer the 
missing activity and altered pH dependence. 
Dr. Melissa Zastrow determined whether the catalytic efficiency of our CA mimic 
depended on the position of the ZnII site within the 3SCC. First, TRIL9CL23H was 
inverted to TRIL9HL23C (Table 1-2, Figure 1-25B), which yielded a pNPA activity of 
15.5 M-1s-1, 67% of the HgIISZnII(OH)N/O(TRIL9CL23H)3n+ activity.74 Next, she 
examined how changing from an a to a d His3 site would affect the rates. The second 
peptide left the L9C position untouched but moved the His3 to the 19th position 
(TRIL9CL19H, Table 1-2, Figure 1-25C). This peptide showed slightly less activity, 13.9 
M-1s-1, 60% in comparison to HgIISZnII(OH)N/O(TRIL9CL23H)3n+. Finally, a peptide only 
containing ZnII was prepared (TRIL23H, Table 1-2), which was stable and showed that 
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the HgII did not influence enzymatic activity. Additionally the kinetic pKa’s of these 
constructs were 9.2, a slight increase over the parent peptide (pKa = 9.0). These studies 
show that HgII could be removed from the design and that the His3 site can be relocated 
across the peptide scaffold without diminishing activity or altering pKa’s. Improvement 
on the current activity will require the design of second coordination sphere 
modifications, such as acid-base catalysts.  
 
Figure 1-25. Comparison of the X-ray crystal structure of (a) 
HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ (PDB: 3PBJ) with Pymol models of (b) 
HgIISZnII(OH2)N/O(TRIL9HL23C)3n+ based on the coordinates of 2JGO28 and (c) 
HgIISZnII(OH2)N/O(CSL9CL19H)3n+ based on the coordinates of 3PBJ.40 Models were 
prepared in Pymol using the mutagenesis option and Pymol’s rotamer library. Figure 
adapted from Ref 74.74  
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Some of the most interesting bioinorganic systems complete redox catalysis. 
From a synthetic perspective, such a scaffold is far more difficult to prepare than for 
hydrolytic chemistry as one must control the coordination environment of the metal in at 
least two oxidation states. Copper nitrite reductase, CuNiR, contains a type 2 copper 
binding site where copper, not unlike ZnII in CA, is coordinated to three histidine residues 
and an exogenous water molecule (Figure 1-26).82 Once the crystal structure of 
HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ was obtained it was hypothesized that CuI/II may 
bind in a similar fashion to offer a structural and functional model of CuNiR (Figure 1-
27). Due to the potential redox sensitivity of thiols, TRIL23H was used since it was 
previously determined that HgIIS3 was not required for stability and did not influence 
catalysis (Table 1-2). Spectroscopic examination supports a five-coordinate CuII structure 
with three bound imidazoles.83 The reduced CuI state has been interrogated by 1H NMR 
and XAS, indicating that a trigonal planar CuI structure forms from pH 5.8-7.5. Thus, 
neither copper oxidation state fully reflects the present structural model for CuNiR.  
 
Figure 1-26. Active site of Copper nitrite reductase, CuNiR. CuNiR carries out the 
dissimilatory reduction of nitrite to nitric oxide and has both a type 1 and type 2 copper 
center in the active site. The Cu ion in the T2 center, where catalysis occurs, is 
coordinated by three histidine ligands and an exogenous water molecule. The Cu ion in 
the T1 center, where the electron transfer occurs, is coordinated by two histidine residues, 
one cysteine residue and one methionine residue. Figure adapted from Ref 84.84  
CuT2 
CuT1 
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Figure 1-27. Overlay of the ZnIIN3O site in HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ with 
the active site of Copper Nitrite Reductase (CuNiR, PDB: 2DY2).85 
HgIISZnIIO/N(CSL9PenL23H)3+ is shown in green (PDB 3PBJ)40 and CuNiR in teal (PDB 
2DY2). Left: Side-on view of the overlay with CuNiR. The solvent molecules are shown 
in red. Right: Top-down view of the overlay with CuNiR. The model displays an 
excellent structural overlay for the first coordination sphere atoms with CuNiR; however, 
the orientation of the imidazoles differs between the two proteins. Overlay was 
performed manually in Pymol.  
An important parameter for any redox cofactor is its reduction potential. Using 
fluorescence quenching and UV-Vis spectroscopy, the binding affinities of both CuI and 
CuII to (TRIL23H)3 were determined and then standard reduction potentials calculated. 
Values of ~400-500 mV were obtained, slightly higher than that reported for CuNiR 
(140-310 mV) suggesting that the trigonal planar CuI state stabilizes the reduced 
CuI(TRIL23H)3n+.85 This system was quantitatively reduced from CuII to CuI by sodium 
ascorbate and produces NO when CuI is reacted with nitrite. Like CuNiR, the reaction is 
pH dependent with a maximal rate at pH 5.9 (5.2 x 10-4 s-1). Although significantly less 
than CuNiR (~1,500 s-1 at pH 5.8), CuI(TRIL23H)3n+ is the only stable and most highly 
active aqueous, homogeneous mimic for the native enzyme.86 
The electrostatics surrounding the metal binding site can greatly affect the 
center’s redox potential. Dr. Fanging Yu re-designed CuI/II(TRIL23H)3 to alter charged 
residues on the exterior of the 3SCC in hopes of optimizing both redox potential and 
catalytic efficiency (Figure 1-28). Inverting the K22 and E27 residues, 
(TRIK22EL23HE27K, Table 1-2), enhanced CuI affinity (100-fold) and a increased the 
rate 1.5-fold.87 Additional peptides were designed keeping the K22E mutation but altered 
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other lysine or glutamate residues, changing the charge of the trimer from 0 to -3, -6, -9 
and -12; however, all of these charge-modified peptides resulted in more positive 
reduction potentials (490-500 mV). These data demonstrated that surface mutations 
influence the reduction potential over a 100 mV range and the reaction rate by a factor of 
four. Recent studies show that altering the layer directly above the His3 site from a Leu 
layer to an Ala layer, or an Ile layer, results in a 70-fold increase over the parent peptide 
(Figure 1-29).88 
 
Figure 1-28. Pymol models of the re-designed CuI/II(TRIL23H)3n+ with altered exterior 
charged residues. I. TRIW-EHE27K; II. TRIW-EHE27Q; III. TRIW-EH; IV. TRIW-
EHK24Q; V. TRIW-EHK24E; VI. TRIW-H; VII. TRIW-HK22Q; VIII. TRIW-HK24E; 
IX. TRIW-EMH. These models are made based on the crystal structure of 
HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ (PDB code: 3PBJ). Residues are color-coded by 
charge; red: negative, blue: positive, neutral: purple. The same color texts (I-IX) 
represent the same Δcharge. Going from the left to right, Δcharge is 0. -3. -6, -9, and -12 in a 
neutral pH range. Figure adapted from Ref 84. 
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Figure 1-29. PyMol models of (A) ILE19, (B) LEU19, and (C) ALA19 showing the 
change of steric packing above the copper center. The PyMol models were made based 
on the crystal structure of ZnIINHgIIS(CSL9PenL23H)3+ (PDB code: 3PBJ)40. Cyan 
spheres: CuI. Peptide strands are represented by helices and His23 side chains are 
represented by sticks. Residues at the 19th position are shown in spheres to illustrate the 
space-filling above the copper center. CuI is represented in cyan spheres and nitrogen 
atoms are highlighted in blue. Figure adapted from Ref 88.88  
It can be concluded, from these catalytic studies, that major advances in preparing 
water soluble and stable catalysts can be realized using metalloprotein design. 
Furthermore, metal coordination geometries can be recapitulated in dramatically 
different protein folds. None-the-less, there are major challenges for further synthetic 
development. We must learn how to place acid-base catalysts in defined orientations 
within the helical assembly. In some cases, substrate, water and proton channels are 
important for catalysis, yet we still do not have a method to mimic such structures in 
these scaffolds. In order to broaden the range of catalytic sites, one must generate non-
symmetric scaffolds that allow for mixed first and second coordination spheres.  
As discussed above, CA and NiR, have symmetric primary coordination 
environments with pseudo 3-fold symmetry that fit nicely into the TRI/GR family of 
3SCC. However, in both cases secondary coordination ligands, and residues even farther 
away (up to 15 Å in CAII)89, play vital roles in functionality. In particular, CA has a 
secondary acid/base catalyst, Thr199, that when substituted for Ala results in a 100-fold 
decrease in activity.80,81 A previous graduate student, Dr. Melissa Zastrow, designed a 
series of peptides in order to incorporate an acid/base catalyst in close proximity to the 
ZnIIHis3 site of HgIISZnII(OH)N/O(TRIL9CL23H)3n+ in hopes of mimicing the Thr199 
ligand of CA. It should be reiterated that at this point all changes introduce into our TRI 
and GR peptides are introduced in a three-fold, symmetric fashion.  
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The first attempt to introduce an acid/base catalyst was to simply include a Thr 
residue in the layer directly above the His3 site, yielding TRIL9CL19TL23H (Table 1-2). 
This peptide did not fold well even with the stabilizing HgIICys3 site, and only had a 
catalytic efficieny of 35% of the original, HgIISZnII(OH)N/O(TRIL9CL23H)3n+, mimic 
towards pNPA hydrolysis.90 The sequence was then elongated to GRL16CL26TL30H 
(Table 1-2) to take advantage of the additional stability introduced by the longer GR 
peptide. This peptide showed much improved folding (~90% alpha-helical in the absence 
and presence of HgII). However, the catalytic efficiency of 
HgIISZnII(OH)N/O(GRL16CL26TL30H)3n+ is only 14.8 M-1s-1 (pH 9.5) for pNPA 
hydrolysis, 66% of the original mimic. This decrease in activity indicated that simply 
including a Thr residue within close proximity of the His3 site didn’t induce a positive 
change in the catalytic rate. It was hypothesized that this decrease in rate is actually due 
to the elongation of the peptide scaffold from TRI to GR, which is probably due to the 
slower breathing motion of the peptide and subsequent decreased substrate accessibility 
to the ZnII binding site (HgIISZnII(OH)N/O(GRL2WL16CL30H)3n+ has a catalytic 
efficiency of 18.5 M-1s-1 at pH 9.5, approximately 80% of the original TRI mimic). The 
fact that the rate did not increase, even with the addition of the Thr residue in 
HgIISZnII(OH)N/O(GRL16CL26TL30H)3n+, is probably due to a less than ideal orientation 
of the Thr rotamers within the 3SCC, where the hydroxyl group may have rotated to the 
exterior of the helical interface with the methyl group facing the hydrophobic interior 
(Figure 1-30).  
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Figure 1-30. Comparison of the packing around the ZnII site in the crystal structure of 
HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ (PDB: 3PBJ) and corresponding models including 
L19T or L19D mutations. A) and B) show the top down and side on views of the ZnII site 
from HgIISZnII(OH2)N/O(CSL9PenL23H)3n+ with space filling Leu19 spheres. C) and D) 
show top down and side on views, respectively, of the L19T variant with a rotamer that 
has the hydroxyl group pointing toward the ZnII site. E) and F) show top down and side 
on views, respectively, of the L19T variant with a rotamer that has the hydroxyl group 
pointing toward the helical interface. G) and H) show side on views of the L26D variant, 
with two different rotamers, both which direct an oxygen atom toward the ZnII site. The 
rotamers shown were chosen based on the minimum amount of potential steric clashing 
with surrounding residues. Figures adapted from Ref 90.90 
A B
C D
E F
G H
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To eliminate the possibility of the hydroxyl group not pointing into the center of 
the trimer toward the ZnIIHis3 site in the acid/base substituted layer, the Thr residue was 
substituted to Asp, where the the carboxylate moiety would provide an oxygen atom to 
point toward the center of the helix regardless of the orientation (Figure 1-30). The 
resulting peptide, GRL16CL26DL30H (1-2) had a slightly lower alpha helical content in 
comparison to the Thr variant (~71-74% in the presence and absence of HgII) but 
provided a catalytic efficiency of 24.2 M-1s-1 for pNPA hydrolysis at pH 9.5, which is 
comparable to the original TRI mimic.90 A kinetic pKa for 
HgIISZnII(OH)N/O(GRL16CL26DL30H)3n+ was determined to be 9.4, the highest pKa yet 
observed for these mimics. Although these peptides were fantastic first-, and second-
generation symmetric CA mimics, this previous work suggests that simply introducing a 
residue capable of acid/base chemistry in close proximity to the ZnIIHis3 site providing 
three new Thr or Asp residues is not enough to improve the catalytic efficiency of the 
original TRI system and, therefore, a single residue capable of secondary acid/base 
interactions needs to be introduced, per trimer, into the system, not per peptide (three per 
trimer), which previously resulted in a three-fold substitution.  
At this particular point, all of the metal-binding sites our laboratory has 
engineered into our 3SCC have consisted of symmetric primary coordination sites. Thus 
far we do not have the means of including asymmetric primary coordination sites within 
our 3SCC. However, native systems, more often than not, do contain asymmetry in the 
first coordination sphere. Similar to CA, the ZnII enzymes carboxypeptidase A (CPA) and 
thermolysin (TML) have histidine residues in close proximity to the metal binding site. 
Unlike CA, the peptidases CPA and TML only have two coordinating histidine ligands, a 
coordinated carboxylate residue (aspartate or glutamate) and varying numbers of 
coordinated solvent molecules (Figure 1-31). By developing a way to incorporate 
different ligands into the primary coordination sphere within our 3SCC the number of 
sites available for us to study within our systems will increase significantly.  
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Figure 1-31. Active sites of carboxypeptidase A (CPA) and thermolysin (TML). Left: 
ZnII bound to CPA (PDB: 1YME)91 with direct ligation to two histidine residues, one 
carboxylic acid and an exogenous water molecule. Right: ZnII bound TML (PDB: 
1LNF)92 showing a primary coordination sphere of two histidine residues, one 
carboxylate, and two water molecules. Of note, there is a third histidine residue within 
hydrogen bonding distance to the coordinating carboxylic acid group.   
The second major goal of my dissertation is to evaluate whether metal induced 
steric matching of Ala/Leu in combition with PbIICys3 binding at one end of trimer can 
induce asymmetry to a second, remote metal binding site with first or second sphere 
asymmetric coordination geometry. In Chapter 3 I will discuss how I engineered a second 
metal binding site, in addition to the asymmetry-inducing PbIICys3 site, which contains 
both hisitidine and carboxylic acid residues within a 3SCC and will analyze the 
spectroscopic characteristics of these sites. . As discussed in Chapter 2, transition metal 
binding to a second site has a lower affinity for the Cys3 site than PbII, and therefore does 
not  distrupt the heterotrimer specificity, allowing for the study of transition metals in the 
second site with no concern for the integrity of the PbIICys3-induced heterotrimer. I will 
describe the spectroscopic parameters of the symmetric homotrimers (His3 and 
Carboxylate3His3 sites) when bound to transition metals (CoII and ZnII) as well as the 
change in coordination environment as observed spectroscopically when carboxylic acid 
residues are included in close proximity of the His3 binding site. In fact, when carboxylic 
acid residues are included in an asymmetric fashion in the layer directly above the His3 
site we no longer observe His3 coordination, as evidenced by the similarities between 
 47 
UV-Vis, EPR, and EXAFS data of my heterotrimers and asymmetric peptides such as 
CPA and TML (His2Carboxylate1,2(H2O)Y ZnII/CoII binding). I will also address how the 
location of the carboxylic acid residues with respect to the His3 binding site (above or 
below) effects CoII binding. I will also discuss the implications of how the work in 
Chapter 3 impacts the broader discussion of the structure-function relationship between 
metal-binding ligands and secondary/tertiary protein folds, and how in the case of my 
heterotrimeric 3SCC CoII may not be non-innocent spectrsocopic probe for ZnII.  
 
Comparative Metal Binding Studies to Cys3 Sites: Discovery of an Unexpected 
Binuclear Cu2Cys3 Binding Site within a 3SCC 
Essentially all aerobic organisms require trace amounts of copper to function; 
however, when it is not properly regulated copper becomes a toxin and, therefore, strict 
regulation of copper homeostasis is vital. Menkes syndrome and Wilson disease are the 
most common diseases due to copper deficiency in humans, and are both directly related 
to modifications of the human P1B-type ATPase ATP7A and ATP7B, respectively.   
Surface cell transporters, such as Ctr1, are responsible for the uptake and transport 
of copper ions but the mechanism of copper delivery, which is dependent on 
metallochaperones, is still debated. Multiple pathways, largely dependent on where the 
copper ion is being delivered, have been proposed; the Cox17, Atx1 and CCS pathways 
are delivery pathways to the mitochondria, the Golgi and to superoxide dismutase, 
respectively. Regardless of the differences between the proposed pathways, all of these 
copper metallochaperones contain similar thiol-rich copper binding sites with MXCXXC 
motifs within βαββαβ-folds (Figure 1-32). Considering our lab’s previous success 
studying heavy metal binding (PbII, CdII, HgII, AsIII, etc…) in three-fold symmetric Cys3-
containing environments within de novo designed 3SCC, the third major goal of my 
dissertation work, as discussed in Chapter 4, was to analyze the binding of CuI to our TRI 
and GR family of peptides, with the ultimate goal of obtaining relative affinities of CuI 
binding to Cys3 binding sites with varying secondary coordination environments. CuI-
bound TRI and GR peptides with different hydrophobes (Leu, Ala or d-Leu) in the layer 
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directly above the Cys3 binding site were synthesized and analyzed using UV-Vis and 
EXAFS spectroscopy. Interestingly, the K-edge X-ray absorption spectroscopy of CuI-
bound TRIL2WL16C (Table 1-2), at multiple pH conditions, has revealed a heavy back-
scatterer consistent with a short Cu-Cu interaction with mixed two- and three-coordinate 
Cu-S environments. Additional analysis of the Cu-S charge transfer band via UV 
spectroscopy revealed a binding stoichiometry of two copper ions to one 3SCC. These 
data support a model where a binuclear CuI site coordinated with multiple sulfur atoms 
exists in this system, much like CuI binding to the repressor CopY.93 This is the first time 
that a binuclear site has been observed within our Cys3-containing TRI/GR peptides. 
Relative binding affinities of CuI to Cys3 containing TRI and GR peptides were also 
analyzed using a competitive chelator, bathocuproine disulfonate (BCS2-). The CuI 
binding affinities will be compared with respect to the changes in affinity based on 
secondary coordination environment. 
 
Figure 1-32. Schematic showing the common βαββαβ-folds, which contain the thiol-rich 
MXCXXC motifs to which copper binds in metallochaperones. Shown is a single ACT 
domain from E. coli D-3-phosphoglycerate dehydrogenase showing the βαββαβ-motif. In 
the diagram, the triangles point up or down to indicate the direction of the strand in the β-
sheet. Numbers progress from N terminus to C terminus. Figure adapted from Ref 94.94  
 49 
As will be mentioned briefly in Chapter 2, competition has been observed 
between CuI and PbII for binding to the Cys3 site within our 3SCC. Therefore, as I set out 
to determine the association constant for CuICys3 in our peptides, one can imagine that an 
additional competition experiment between PbII and CuI could lead to a determination of 
the PbII association constant, a parameter we have previously been unable to measure due 
to the high affinity. Surprisingly, during attempts to determine PbIICys3 binding affinities, 
new spectroscopic data suggests the formation of another novel binuclear site, this time 
heteronuclear with one equivalent of CuI and one equivalent of PbII. I will discuss how 
the spectroscopic data suggest a kinetic model of CuI2Cys3 vs. CuIPbIICys3 formation as 
well as the perturbations to PbII spectrum in the presence of CuI.  Additionally, I will 
describe the binding of CuI binding when a His3 a site is present, in addition to a Cys3 
site, and what implications are observed for the preferential of CuI binding for two 
different binding sites within the same scaffold. 
In Chapter 5 I will give a summary of the major results and achievements of my 
thesis work and I will propose future directions with respect to these projects.  
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Chapter 2. Designing Heterotrimeric Three-Stranded Coiled Coils 
 
Introduction 
There are two primary approaches utilized to study the structure-function 
relationship of metalloenzyme active sites in designed systems, protein redesign and de 
novo protein design. Protein redesign consists of engineering artificial metalloenzymes 
via modifications to native scaffolds. Two examples of this approach include introduction 
of metal binding ligands as found in a native enzyme, or introduction of non-native 
cofactors into a preexisting well-folded and stable protein. The second approach, de novo 
protein design, consists of designing a peptide “from scratch”, where the protein 
sequence is not derived from a native system. Both of these approaches offer 
bioinorganic chemists avenues to re-create and analyze known native metal centers 
within simplified peptidic environments to understand better what extent biological 
function is a consequence of biological structure. Our lab, as outlined in the previous 
chapter, has utilized de novo designed three-stranded coiled coils (3SCC) to study metal 
binding sites to clarify metal binding geometry, coordination and functionality within 
simplified constructs to elucidate metal binding behavior in native systems.  
In particular, over the last several years our laboratory has utilized de novo 
peptide design of 3SCCs to obtain functional metalloenzymes capable of hydrolytic and 
redox catalysis.1–4 While these systems offer the best catalytic efficiency, in aqueous 
solutions, for the native reactions of their corresponding metalloenzyme inspiration, we 
are currently limited by the inherent symmetry introduced by the self-assembling 
characteristics of our 3SCC scaffolds. This symmetry-related limitation has, therefore, 
lead to the inability to prepare asymmetric, or heterotrimeric, assemblies, selectively, that 
would be capable of providing mixed first coordination sphere metal binding 
environments or asymmetric second coordination sphere residues to mimic nearby acid-
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base catalysts. While some native proteins contain three-fold symmetric primary binding 
sites, such as the ZnIIHis3 binding site of Carbonic Anhydrase (CA), the extended active 
sites contain extensive and essential hydrogen-bonding networks (Figure 2-1).5,6 
Attempts to introduce secondary interactions, such as hydrogen bonding donors, to the 
metal binding sites within 3SCCs results in triplicate modification, with one Thr per helix,  
due to the three-fold symmetric nature of the assembly.1 Furthermore, current metal 
binding 3SCCs cannot model the vast number of native proteins that contain asymmetric 
primary coordination spheres, such as the common facial triad (His2/3Carboxylate) metal 
binding sites found in alpha-ketoglutarate-dependent taurine deoxygenase (Figure 2-2A), 
and iron- or manganese-superoxide dismutases (Figure 2-2B), or the His2CarboxylateX 
active sites of carboxypeptidase A and thermolysin (Figures 2-2C and 2-2D).7–11 My goal 
is to lift the symmetry-related limitations by designing a peptide that combines steric 
matching of natural amino acids in close proximity to a tris-thiolate site that upon binding 
of Pb(II) provides selective formation of an A2B heterotrimeric 3SCC.  
Figure 2-1. Structure of the active site of carbonic anhydrase II. Left panel: The extended 
active site of Human CAII showing the ordered water network (PDB: 3KS3).46
 
ZnII is 
represented by a gray sphere, and the oxygen atoms of water molecules are shown as 
smaller red spheres. The dotted lines represent presumed hydrogen bonds. Selected 
amino acids of the active site are shown as stick figures with both the inward and outward 
orientations of His64 (proton shuttle) shown. Right panel: ChemDraw scheme of the 
CAII primary and secondary Zn(II)-binding site. Figure adapted from Ref 47.47 
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Figure 2-2. Asymmetric primary coordination spheres of A) alpha-ketoglutarate-
dependent taurine deoxygenase (TauD, PDB: 1GY9),7 B) iron- or manganese-superoxide 
dismutases (Fe/Mn SOD, PDB: 1ISB),48 C) carboxypeptidase A (CPA, PDB: 1YME),9 
and D) thermolysin (TML, PDB: 1LNF).10 ZnII ions are shown as purple spheres and 
FeII/III are shown as orange spheres. Selected amino acids of active site ligands are shown 
as stick figures where N atoms are highlighted in blue, oxygen in red and sulfur in yellow. 
Water molecules are shown as smaller red spheres.  
There have been numerous reports of attempts to obtain de novo deigned 
heterotrimeric 3SCCs (Chapter 1).12–15 In particular, Keenan and coworkers showed that 
steric matching of small, alanine, and bulky, cyclohexylalanine (CHA), residues allows 
for formation of ABC asymmetric 3SCC; however, to obtain pure heterotrimers three 
layers of alternating steric matching Ala2CHA layers were required (Figure 2-3).16 
Tanaka and coworkers followed this work with a similar steric matching approach that 
required using two alanine residues and one tryptophan residue (Ala2Trp), but also 
A	 B	
C	 D	
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included alterations to the salt bridging amino acids at the helical interfaces as well as 
modifications in the peptide sequence to the to destabilize undesired trimer formation.17 
Thus far, interior bound metals have not been used to nucleate heterotrimeric formation. 
Moreover, asymmetric scaffolds have never been used to generate asymmetric metal 
binding sites, with potential catalytic activity. I proposed combining steric matching of 
natural amino acids in combination with a PbIICys3 binding site to nucleate the specific 
formation of A2B type heterotrimers. This approach would require no changes in exterior 
residues or salt-bridging interactions and would only require two neighboring layers 
within the helices for selective formation. This differs from previous constructs that 
required altering layers throughout the scaffold, therefore, leaving no space within the 
coiled coil for a second, catalytic or redox active metal binding site.  
 
Figure 2-3. Helical wheel projection of the 1:1:1 T9/T16/T23 complex (viewed down the 
helical axis from the N to C terminus), showing only core residues. The sequence of each 
peptide is also given. The tic-tac-toe arrangement of cyclohexylalanine residues (X) is 
depicted schematically at the right. Ac = acetyl and Am = amide. Figure adapted from 
Ref 16.16 
Lead interactions with cysteine rich environments have been previously 
characterized within the TRI/GRAND family of peptides, Ac-G(LKALEEK)4/5G-NH2 
(Table 2-1). Our 3SCCs consist of amphipathic α-helical peptides that contain 
hydrophobic residues at the first (a) and fourth (d) positions of a heptad repeat (abcdefg). 
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Hydrophobic collapse and electrostatic interactions between the e and g positions result 
in the self-assembly of the 3SCCs. Metal binding sites, as mentioned above, can be 
engineered into the construct by substituting a hydrophobic layer with a coordinating 
ligand. Substitution of a single leucine by cysteine, in each strand, has generated sulfur 
rich Mn+Cys3 sites that associate with toxic heavy metals to form protein complexes.18–22  
Table 2-1. Peptide Sequences 
Peptide Sequence 
             abcdefg 
BABY Ac-G LKALEEK LKALEEK LKALEEK G-NH2 
BABYL12C Ac-G LKALEEK LKACEEK LKALEEK G-NH2 
TRI Ac-G LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
TRIL12AL16C Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRILWL12AL16C Ac-G WKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRIL2WL16C Ac-G WKALEEK LKALEEK CKALEEK LKALEEK G-NH2 
GRAND Ac-G LKALEEK LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
GRL12AL16CL26C Ac-G LKALEEK LKAAEEK CKALEEK LKACEEK LKALEEK G-NH2 
GRL2WL16C Ac-G WKALEEK LKALEEK CKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL12AL16L30H Ac-G WKALEEK LKAAEEK CKALEEK LKALEEK HKALEEK G-NH2 
GRL2WL16CL19AL30H Ac-G WKALEEK LKALEEK CKAAEEK LKALEEK HKALEEK G-NH2 
GRL2WL16CL30H Ac-G WKALEEK LKALEEK CKALEEK LKALEEK HKALEEK G-NH2 
CoilSer Ac-E WEALEKK LAALESK LQALEKK LEALEH G-NH2 
CSL9C Ac-E WEALEKK CAALESK LQALEKK LEALEH G-NH2 
CSL12C Ac-E WEALEKK LAACESK LQALEKK LEALEH G-NH2 
CSL16C Ac-E WEALEKK LAALESK CQALEKK LEALEH G-NH2 
CSL12AL16C Ac-E WEALEKK LAAAESK CQALEKK LEALEH G-NH2 
GRANDCoilSer Ac-E WEALEKK LAALESK LQALEKK LQALEKK LEALEH G-NH2 
GRCSL12AL16C Ac-E WEALEKK LAAAESK CQALEKK LQALEKK LEALEH G-NH2 
GRCSL16CL30H Ac-E WEALEKK LAALESK CQALEKK LQALEKK HEALEH G-NH2 
 
A particularly sensitive technique employed to analyze PbIICys3 environments is 
207Pb NMR. Historically, 207Pb NMR has been used to study multiple PbII-coordination 
environments in small molecules with mixed S/O, S/N and N/O coordinating ligands; 
however, until recently, only one example was reported using this technique to 
characterize metalloproteins.23–28 In 1996, Aramini et al. published a study utilizing 207Pb 
NMR to analyze PbII-substituted calmodulin and other calcium binding proteins 
(PbIIO7).29 Regardless of the high affinity of PbII for thiol-rich metal binding sites, it was 
not until 2011 that Neupane at al. located the 207PbIIS3 chemical shift, in a peptidic 
environment.30 This was largely due to the difficulty in identifying where a PbIIS3 signal 
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would appear in the very wide chemical shift range of 16000 ppm (compared to ~200 
ppm for 13C, or ~900 ppm for 113Cd).29 The technique has proved indispensible for 
studying PbII binding to GR and TRI peptides that contain Cys3 metal binding sites. 
Indeed, a simple change from an a to d site Cys3 results in NMR shifts of >200 ppm.30  
In this chapter, I will describe the design, preparation and spectroscopic 
characterization (with emphasis on heteronuclear NMR) of heterotrimeric de novo 
designed 3SCCs. My approach will combine steric matching of Ala and Leu residues in 
the layer directly above a Cys3 metal binding site with PbII binding to the Cys3 binding 
site. I will discuss how NMR and UV-Vis analysis support formation of a new species 
that is not due to coalescence and is not simply a combination of two homotrimeric 
peptides. I will address how the PbII site is not affected by the presence of an additional 
transition metal, such as CoII or ZnII. I will also consider the specifications required to 
form selective heterotrimeric 3SCCs such as how HgII, another thiolphilic metal that 
binds tightly to our 3SCCs, is not able to induce selective heterotrimer formation and 
how Ala/Leu pairings in the layer below the Cys3 site, with respect to the N-terminus, 
does not (yet) lead to obvious 3SCC formation. Finally, I will examine how a recently 
refined PbII-bound homotrimeric crystal structures by Dr. Leela Ruckthong may provide 
insight into why heterotrimers form in the presence of PbII and use this information to 
assess whether the basis for the initial design strategy was correct. 
 
Materials and Methods 
Peptide Synthesis and Purification. Peptides were synthesized on one of two 
instruments: an Applied Biosystems 433A synthesizer or a Biotage Initiator+Alstra 
synthesizer on a Rink Amide Methylbenzhydrylamine (MBHA) resin using standard 
Fmoc-tBu-based protection protocols (HBTu/HOBt coupling).31 Crude peptides were 
cleaved from the resin using trifluoroacetic acid (TFA), ethanedithiol, anisole, and 
thioanisole (90:3:2:5), dissolved in doubly distilled water and lyophilized to dryness. 
Purified peptides were isolated using Waters 600 HPLC on a reverse phase C18 column 
(flow rate: 20 mL/min, solvent A: 0.1% TFA in water and B:0.1% TFA in 90:10 CH-
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3CN:H2O. A linear gradient was used starting at 70:30, A:B and increasing to 20:80 over 
35 min.). ESI-MS was used to confirm the mass of purified peptide and collections were 
lyophilized to yield pure, white powder. Concentrations of all peptides were determined 
by tryptophan absorbance at 280 nm (ε = 5500 M-1cm-1).32 
Circular Dichroism (CD) and Ultraviolet-Visible (UV-Vis) Spectroscopy. CD spectra 
were collected on an AVIV 62DS spectrometer or a Jasco CD-Spectropolarimeter in a 1-
cm quartz cuvette at 25 °C. Guanidine hydrochloride (GuaHCl) titrations were carried out 
at pH 8.0 using an automated titrator with a syringe pump as described previously.33 
Fittings of the free energy change from folded to unfolded for GR-ACH and GR-CH 
were determined as previously described.34 All other peptides do not show enough 
stability of the folded state to fit the data to a two-step model and will therefore be 
compared via estimated midpoint for GuaHCl denaturation titrations. UV-Vis spectra 
were recorded in quartz cuvettes at room temperature on a Cary 100 Bio UV/Vis 
spectrometer. 
Pb(II)-binding titrations. Titrations of PbII into peptide were performed at room 
temperature and monitored via UV-Vis spectroscopy in a 1-cm quartz cuvette. LeadII 
titrations were completed in 50 mM TRIS buffer at pH 8.5 at a peptide concentration of 
30 µM 3SCC. TRIS adjustments were made using small aliquots of concentrated KOH 
and HCl. Aliquots of a PbII(NO3)2 stock solution, standardized using inductively coupled 
plasma-optical emission spectroscopy (ICP-OES, Perkin-Elmer Optima 2000 DV with 
Winlab software) were titrated into the peptide solution. For all titrations, the difference 
spectra were obtained by subtracting the background spectrum of the peptide under 
identical conditions but in the absence of metal.  
pH Titrations. Lead was bound to the peptide and diluted to a concentration of 60 µM 
trimer in water. The pH was titrated by adding small aliquots of KOH to the solution. The 
pH was monitored and allowed to stabilize before analysis of the PbIICys3 band (ε≈345 
nm) was conducted. The data was fitted to three different deprotonation models, all-
corresponding to deprotonation of thiol to thiolate in the presence of bound PbII. The 
three models correspond to different deprotonation equilibrium including (I) 1-proton 
release, (II) 2-proton simultaneous release, and (III) 2-proton released step-wise. MPep3-, 
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MPep3H, and MPep3H+ correspond to completely deprotonated, singly protonated and 
doubly protonated Metal (M, where M is PbII in these studies) bound trimer (Pep3). 
[Pep3]TOT is the total concentration of trimer in solution, and [H+] is the concentration of 
protons in solution, which is directly related to the pH (the independent variable of the 
experiment). 
 
Model (I). This scenario corresponds to an equilibrium associated with the apparent pKa 
value for the metal-chelation deprotonation of a one-proton release model, which can be 
expressed by Equation 1.  
MPep3H ⇌ H+ + MPep3-        Equation 1 
The apparent association constant for the 1-proton deprotonation model can be expressed 
using Equation 2. 
Ka = [H+][MPep3-]        Equation 2 
          [MPep3H] 
Rearrangement of Equation 2 gives Equation 3. 
[MPep3H] = [H+][MPep3-]       Equation 3 
       Ka 
The mass balance equation for [Pep3]T is expressed in Equation 4. 
Mass Balance Equation: 
[Pep3]TOT = [MPep3H] + [MPep3-]      Equation 4 
Substitution of Equation 3 into Equation 4 gives Equation 6. 
[Pep3]TOT = [H+][MPep3-] + [MPep3-]      Equation 5 
                   Ka  
               = [MPep3-]   [H+] + 1      Equation 6 
                           Ka   
This equation can then be directly related to the absorbance observed at ~345 nm by 
substituting [P3]TOT from Equation 7 (where b is the path length of the cuvette) into 
Equation 6. 
Absorbance345 nm = ε345 nm * [Pep3]TOT * b      Equation 7 
( ) 
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Rearrangement of Equation 5 can then be used to fit the titration data at Abs 345 nm 
using Prism 5 (GraphPad Software)35 to yield the apparent pKa value for a one-proton 
deprotonation step.  
 
Model (II). The scenario corresponding to the equilibrium associated with the apparent 
pKa1 and pKa2 values for the metal-chelation deprotonation of a stepwise deprotonation of 
two protons can be expressed by Equation 8. 
MP3H2+ ⇌ H+ + MP3H ⇌ H+ + MP3-     Equation 8 
The apparent association constants for each deprotonation step can be expressed using 
Equations 9 and 10. 
Ka1 = [H+][MPep3H]         Equation 9 
 [MPep3H2+] 
Ka2 = [H+][MPep3-]        Equation 10 
 [MPep3H] 
Rearrangement of Equation 10 gives Equation 11. 
[MPep3H] = [H+][MPep3-]       Equation 11 
      Ka2 
Substitution of [MPep3H] into Equation 9 gives Equation 12. 
Ka1 = [H+]2[MPep3-]        Equation 12 
          [MPep3H2+]Ka2 
Rearrangement of Equation 12 gives Equation 13.  
[MPep3H2+] = [H+]2[MPep3-]      Equation 13 
       Ka1Ka2 
The mass balance equation for [Pep3]TOT is expressed in Equation 14. 
Mass Balance Equation: 
[Pep3]TOT = [MPep3H2+] + [MPep3H] + [MPep3-]    Equation 14 
Substitution of Equation 11 and Equation 13 into Equation 14 gives Equation 16. 
[Pep3]TOT = [H+]2[MPep3-] + [H+][MPep3-] + [MPep3-]   Equation 15 
              Ka1Ka2      Ka2 
                = [MPep3-]    [H+]2  + [H+]  + 1     Equation 16 
                           Ka1Ka2    Ka2 ( ) 
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This equation can then be directly related to the absorbance observed at ~345 nm by 
substituting [Pep3]TOT from Equation 7 (where b is the path length of the cuvette) into 
Equation 16. Rearrangement of Equation 16 can then be used to fit the titration data at 
Abs 345 nm using Prism 5 (GraphPad Software)35 to yield the apparent pKa1 and pKa2 
values for the deprotonation associated with a stepwise 2-proton metal-chelation 
deprotonation of PbIICys3.  
 
Model (III). The equilibrium associated with the apparent pKa2 value for the metal-
chelation deprotonation of a simultaneous deprotonation of two protons can be expressed 
by Equation 17. 
MPep3H2+ ⇌ 2 H+ + MPep3-        Equation 17 
The apparent association constant for the simultaneous 2-proton deprotonation step can 
be expressed using Equation 18. 
Ka2 = [H+]2[MPep3-]        Equation 18 
 [MPep3H2+] 
Rearrangement of Equation 18 gives Equation 19. 
[MPep3H2+] = [H+]2[MPep3-]       Equation 19 
          Ka2 
The mass balance equation for [Pep3]TOT is expressed in Equation 20. 
Mass Balance Equation: 
[Pep3]TOT = [MPep3H2+] + [MPep3-]      Equation 20 
Substitution of Equation 19 into Equation 20 gives Equation 22. 
[Pep3]TOT = [H+]2[MPep3-] + [MPep3-]     Equation 21 
                 Ka2  
                = [MPep3-]   [H+]2  + 1      Equation 22 
                              Ka2   
This equation can then be directly related to the absorbance observed at ~345 nm by 
substituting [Pep3]TOT from Equation 7 (where b is the path length of the cuvette) into 
Equation 22. Rearrangement of Equation 22 can then be used to fit the titration data at 
Abs 345 nm using Prism 5 (GraphPad Software)35 to yield the apparent pKa2 value. 
( ) 
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Fitting the data using all three models gives a consistent pKa1 value from both the single-
deprotonation model and the simultaneous 2-proton release model. Best fits for each 
titration are discussed below. 
 
NMR Spectroscopy. NMR samples were prepared by dissolving pure, lyophilized 
peptide in 10% D2O. Metallopeptides were prepared by addition of isotopically enriched 
207Pb(NO3)2 or 199Hg(NO3)2 (92.4%, Oak Ridge National Laboratory, TN) to non-
buffered solutions of 3-5 mM peptide trimer. All samples were adjusted to the desired pH 
using small aliquots of concentrated KOH or HCl. 207Pb NMR spectra were recorded at a 
frequency of 145.9 MHz on a Varian 700 MHz spectrometer at 25 °C with spin = 0, 0.20 
ms relaxation time, and 20 ms acquisition time. 199Hg NMR spectra were recorded at a 
frequency of 125.3 MHz on a Varian 700 MHz spectrometer at 25° C with spin = 0, 
0.005 ms relaxation time, and 10 ms acquisition time. Linear predictions (10-30 points) 
were performed to remove noise, and the real FID was determined as previously 
described.30,36,37 The data were processed with an exponential line broadening of 400-600 
Hz using MestRe-C software.38 The 207Pb NMR shifts are reported as the observed signal 
plus ~2986 ppm, as reference by tetramethyllead (δ=0 ppm; toluene) using 1 M Pb(NO3)2 
in D2O (natural abundance salt, δ=-2986 ppm) as an external standard. The external 
standard was run after each experimental collection to adjust for any shifting of the 
magnetic field.  
 
Results and Discussion 
PbII-Nucleated Heterotrimers with Ala/Leu Pairings “above” 
 The story of preparing metal nucleated heterotrimeric 3SCCs starts with 
preliminary work completed by a previous post-doctoral researcher, Dr. Kosh Neupane, 
who spent a great deal of time analyzing the difference in selectivity between a and d 
Cys3 site binding of PbII, the specificity of where a lead ion binds first, and if the sterics 
around the site influence the metal binding preference. After locating the PbIIS3 signal, he 
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showed that the length of the peptides used did not influence the 207Pb NMR signal, as 
evidenced via analysis of PbII(BabyL12C)3- and PbII(CSL12C)3- (Table 2-1), *  both 
yielding chemical shifts of ~5800 ppm (Figure 2-4).  At the same time, he discovered that 
when PbII is bound to a peptide containing cysteine substitution at a d site, the 207Pb 
NMR signal observed was nearly ~200 ppm downfield with respect to a corresponding a 
site modified peptide (Figure 2-4).30 Additionally, if one peptide contained both an a and 
a d site cysteine, such as GRL12AL16CL26C (Table 2-1), the first equivalent of PbII 
would bind exclusively to the a site and occupation of the d site was observed only upon 
addition of a second equivalent of PbII (Figure 2-4). Removing some of the hydrophobic 
packing around an a site to produce a Cys3 site with a “hole”, TRIL12AL16C (Table 2-1), 
provided an additional upfield shift, by nearly 100 ppm, from the original unaltered a site 
of CSL9C (Table 2-1, Figure 2-5).37  
																																																								*	The nomenclature used to describe the metal complexes studied herein is as follows: When PbII 
is bound to the Cys3 site, the peptide, for example TRI-C, will be referred to as: PbIIS(TRI-C)3-, 
where ‘S’ represents the atom that coordinates the PbII ion. When a second metal, Mn+, is 
introduced to bind to the His3 site, a subscript of ‘N’ will be included to denote His binding. The 
charge of the complex corresponds to the sum of the oxidation states of the metals, minus the 
charge of the coordinated ligands. In the case of a PbIICys3 site, the charge is (-), from PbII and 
three thiol ligands. When M2+ is included the total charge will be (+) from two divalent metals and 
three deprotonated thiolate ligands, for example: PbIISZnIIN(GRCSL16CL30H)3+.	
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Figure 2-4. 207Pb NMR spectra of PbII-bound 3SCC peptides. a) PbII(BABYL12C)3-, b) 
PbII(CSL12C)3-, c) PbII(CSL16C)3-, d) PbII(CSL12AL16C)3-, e) 
PbII2(GRL12AL16L26C)32-, f) PbII(GRL12AL16CL26C)34-. All spectra were recorded for 
10–12 h using natural- abundance Pb(NO3)2 , (207Pb=22.6%), pH 7.35, at 25 °C. Figure 
adapted from Ref 30.30 
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Figure 2-5. 207Pb NMR Spectra of PbII bound peptides showing the selective binding of 
PbII to the peptide with a hole above the metal binding site. a) PbII(CSL9C)3-, b) 
PbII(TRIL12AL16C)3-, c) Equimolar ratio of CSL9C and TRIL12AL16C with 1 
equivalent of PbII(NO3)2, d) Equimolar ratio of CSL9C and TRIL12AL16C with 2 
equivalent of PbII(NO3)2 . The concentration of metallopeptides used is approximately 5 
mM. All spectra were recorded at room temperature (25 °C) for 2 hr using isotopically 
enriched PbII(NO3)2, pH 7.45. Figure adapted from Ref 49.49 
It was at this point that we started to ask the question – can the high-affinity 
PbIICys3 site be combined with the steric matching of Ala and Leu residues to make 
heterotrimers? In order to exploit the steric matching concept mentioned above the 
leucine layer at the 12th position were substituted for an alanine layer. The bulky amino 
acid to be used, and paired with two alanine-containing helices, was leucine. In Kennan’s 
work, smaller hydrophobes substituted for cyclohexylalanine, such as cyclopropylalanine 
(isostructural to leucine), were insufficient to generate a single, stable heterotrimeric 
aggregate. Thus, one might predict that access to such parallel heterotrimeric systems 
using leucine as the bulky residue, in the TRI or GR peptides, should be difficult. 
However, both experimental and computational studies, as mentioned above, indicated 
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that PbII binding to cysteine substituted TRI and GR peptides was sensitive to the steric 
constraints of the second coordination sphere, presumably due to the metal’s large size 
and bulky lone pair.37 Additionally, substitution of the leucine layers within the 3SCCs 
has been determined to destabilize the peptide scaffold as layers of hydrophobic packing 
residues within the helical core are removed. Therefore, the peptide scaffold itself is most 
stable with Leu residues over Ala residues, but the PbII ion is expected to bind better in 
the presence of an Ala layer.  Based on these considerations, the subsequent question was 
could mixed assemblies containing peptides with either leucine, TRIL2WL16C, or 
alanine, TRIL2WL12AL16C (already biased toward heterotrimer formation based on the 
steric matching approach, Table 2-1), be stabilized by combining helical stability (from 
the Leu residues) as well as exploiting the PbII steric preference (allowing space via Ala 
substitutions to accommodate the bulky metal ion)?  
It has been shown that 207Pb NMR is particularly powerful for discerning PbII 
binding to homoleptic (a metal binding environment with identical ligands), Cys3 sites in 
designed proteins as demonstrated by the approximately 75 ppm chemical shift 
separation of PbIIS(TRIL2WL12AL16C)3-, designated PbIIS(TRI-AC)3-, and 
PbIIS(TRIL2WL16C)3-, designated PbIIS(TRI-C)3- (Figure 2-6). Above pH 6, these 
peptides have been shown to form well-behaved parallel three stranded coiled-coils with 
characteristic circular dichroism and guanadinium chloride denaturation isotherms 
characteristic of cooperative unfolding in the presence and absence of metals.19,33,39 These 
resonances represent the upper and lower limits that would be expected in subsequent 
experiments involving heterotrimeric species.30 207Pb NMR was then used to analyze 
mixtures of these peptides.  
When adding two equivalents of the PbIIS(TRI-C)3- and one equivalent of 
PbIIS(TRI-AC)3- in the presence of one equivalent PbII(NO3)2, two peaks are observed at 
new chemical shifts (δ= 5631 and 5604 ppm), with a clear dominance of the more 
downfield shifted species (Figure 2-6b). However, switching the stoichiometry to two 
equivalents of PbIIS(TRI-AC)3- and one equivalent of PbIIS(TRI-C)3- resulted in only one 
observed resonance, corresponding to the smaller of the two peaks found with the 
opposite stoichiometry (δ=5604 ppm, Figure 2-6c). From these results I deduce that 
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mixing together two equivalents of PbIIS(TRI-AC)3- and one equivalent of PbIIS(TRI-C)3- 
selectively provides a new heterotrimeric 3SCC, here on referred to as the PbIIS[(TRI-
AC)2(TRI-C)1]-. However, when analyzing the stoichiometric mixture of PbIIS[(TRI-
AC)1(TRI-C)2]-,  it appears that a mixture of both the PbIIS(TRI-AC)1(TRI-C)2- and 
PbIIS[(TRI-AC)2(TRI-C)1]- heterotrimers are formed. These results suggest that mixtures 
of PbIIS[(TRI-AC)n(TRI-C)3-n]- where n=2 provides selective heterotrimeric formation 
whereas n=1 does not. The stoichiometery is consistent with that used by both the 
Kennan and Tanaka labs. 
 
Figure 2-6. 207Pb NMR spectra of a) PbIIS(TRI-C)3-, b) PbIIS[(TRI-C)2(TRI-AC)1]-, c) 
PbIIS[(TRI-C)1(TRI-AC)2]-, and d) PbIIS(TRI-AC)3-. All spectra were recorded at room 
temperature (25 °C) for 5 hr using isotopically enriched PbII(NO3)2, pH 7.4. 
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One can imagine three limiting scenarios when stoichiometrically mixing peptides 
with alanines (TRI-AC, A) and leucines (TRI-C, B) in the 12-position to one equivalent 
of PbII. For consideration of statistical distributions, PbIIS(TRI-AC)3- and PbIIS(TRI-C)3- 
are referred to as A3 and B3, respectively. We consider the scenario where two 
equivalents of A are mixed with one equivalent of B. One could imagine that metallated 
homotrimeric species A3 and B3 were thermodynamically preferred for the first model, 
yielding a 2:1 ratio of these species. The second possibility is that there is no preference. 
In this case, one would expect a statistical peptide distribution based on the initial peptide 
stoichiometries, yielding A3 (8/27), A2B (12/27), AB2 (6/27) and B3 (1/27). The final 
possibility is that one heterotrimeric species is preferred, which in this case would yield 
100% A2B. 
The NMR spectra that would be observed for these conditions will depend on 
whether the system is on the slow or fast exchange time regime. If slow, individual 
resonances from each species should be observed, whereas if fast, coalescence of the 
207Pb NMR signals between the species is expected with a new peak observed at an 
intermediary distance between the two homotrimeric peaks dependent on the ratios of A3, 
A2B, AB2 and B3 aggregates present. For the first scenario where there is predicted to be 
a 2:1 ratio of A3 and B3, one would expect either two resonances at 5575 and 5650 ppm 
with ratios of 2:1, respectively, for slow exchange, or a broadened single resonance at 
5600 ppm (fast exchange). In the second case, slow exchange would lead to four peaks 
that are dependent on the chemical shifts of heterotrimeric species in a ratio of 8:12:6:1, 
while fast exchange would again yield a value at ~5600 ppm. Finally, if a single 
heterotrimeric species is formed one would expect to see a single resonance consistent 
with an A2B species.  
Examination of Figure 2-6 allows two of these five possibilities to be eliminated. 
Pure A3, PbIIS(TRI-AC)3-, and B3, PbIIS(TRI-C)3-, yield resonances at 5572 ppm and 5650 
ppm, respectively. When the ratio of A:B is varied to 1:2 or 2:1 a single resonance is 
observed with chemical shift value of 5631 ppm and 5601 ppm, respectively. These 
spectra are consistent either with fast exchange for the first two scenarios described 
above or for the existence of a single AB2 or A2B. However, the data are inconsistent 
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with slow exchange spectra with either a statistical distribution of A3, A2B, AB2 and B3 
aggregates or a 2:1 mixture of A3 and B3 peptides. An important hint to the behavior of 
this system is provided by careful inspection of Figure 2-6b where a minor resonance is 
observed at 5601 ppm. If this resonance is real, it indicates that the system cannot be at 
the fast exchange limit, as under these conditions only one resonance should be observed 
(vide infra).  
To test this hypothesis, I examined the binding of two equivalents of PbII to a 
mixture of five equivalents of the Ala/Cys3 peptide (A3) and one equivalent of the 
Leu/Cys3 peptide (B3). Concurrently, I hypothesized that I could take advantage of this 
selective heterotrimer formation using a PbII binding “structural site” to introduce 
asymmetry into other parts of the peptide. For example, a second asymmetric metal 
binding site could be engineered into the scaffold for functional applications (See Chapter 
3). I used the more stable GR peptides for this purpose.40,41 To test these hypotheses, two 
new peptides were synthesized: GRL2WL12AL16CL30H (designated GR-ACH, or A3) 
and GRL2WL16CL30H (designated GR-CH, or B3, Table 2-1).  
It had been previously determined that the inclusion of a Trp substitution in the 
2nd position of our TRI and GR peptides allows for a simple and straightforward method 
for determining peptide concentration and does not cause significant disruption of the 
hydrophobic packing or destabilization of the packing.42 However, even considering the 
lack of concern regarding stability with the LeuàTrp substitution, GR-ACH still 
contains three substitutions and the folding and stabilities of the peptides were, therefore, 
determined using CD spectroscopy and guanidine hydrochloride (GuaHCl) denaturation 
titrations. The folding of both GR-ACH and GR-CH were examined at pH 8.0 (Figure 2-
7). A characteristic CD spectrum of an alpha-helical coiled coil yields a double well with 
minima at 208 and 222 nm. The spectra for GR-ACH and GR-CH show well-folded 
alpha-helical folding with molar ellipticity [Θ] (-34865 and -33785 deg dmol-1 cm2, 
respectively), which is >95% folding for each peptide, compared to an ideal, fully folded 
alpha-helical structure. As observed in Figure 2-7, the midpoint of GR-CH is slightly 
higher than that of GR-ACH indicating a slight decrease in stability, as one might expect, 
when an additional substitution, in this case, L12A, is introduced into the sequences. The 
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midpoints for GR-ACH and GR-CH were fit to 1.83 ± 0.06 and 2.28 ± 0.03 M GuaHCl, 
respectively, and fits of the denaturation curves reveals a ΔG of unfolding of 1.96 ± 0.4 
and 3.04 ± 0.6 kcal/mol, respectively.34 These data confirm a decrease in stability of ~1 
kcal/mol and a ~0.5 M decrease in midpoint when Ala is substituted for Leu in these 
peptides.  
 
Figure 2-7. Overlay of guanidine hydrochloride denaturation titration data of GR-ACH 
(closed circle) and GR-CH (open circle) in 10 mM Phosphate buffer at pH 8.0. Inset: CD 
spectra of GR-ACH before (red) and after (blue) the addition of 7 M GuaHCl.   
As this was the first time GR-ACH and GR-CH were being used to bind PbII, I 
also analyzed the binding of PbII to the Cys3 sites via UV-Vis spectroscopy. Aliquots of 
PbII, as either nitrate or chloride salt solutions, were added to a solution of 60 µM GR-
ACH or GR-CH, resulting in 20 µM 3SCC, in 100 mM TRIS buffer at pH 8.5. As the 
peptides complex PbII, an increase in absorbance at 340-350 nm is observed, 
characteristic of PbIICys3 binding (Figures 2-8A and 2-8C).19,30 For both peptides, 
analysis of the spectra determines a maximal absorbance is reached at one equivalent of 
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PbII added. The immediate flattening out of the traces, as observed in Figures 2-8B and 2-
8D, indicates that PbII binds extremely tightly to the Cys3 sites and association constants 
cannot be directly measured via this technique as no equilibrium is observed between free 
and bound PbII in the presence of our peptides. Linear regression analysis of the data at 
~345 nm provided molar extinction coefficients of 3630 and 3520 M-1cm-1 for GR-CH 
and GR-ACH, respectively, which is comparable to previously reported PbIICys3 
sites.19,36,43,44 
 
Figure 2-8. Titration spectra of PbII into a solution of A) GR-CH and C) GR-ACH at pH 
8.5 in 50 mM TRIS Buffer. Corresponding titration curves showing the 1:1 binding 
stoichiometry of equivalent of PbII added with respect to 3SCC at 348 and 340 nm for B) 
GR-CH and D) GR-ACH.  
Closer analysis of the spectra at ~345 nm demonstrates that there is indeed a 
difference in the maximal absorbance between PbIIS(GR-ACH)3- and PbIIS(GR-CH)3-, 
observed at 340 and 348 nm, respectively. Therefore, mixtures of the two peptides, in 2:1 
and 1:2 ratios, were also analyzed. The resulting mixtures, PbIIS[(GR-ACH)2(GR-CH)1]- 
and PbIIS[(GR-ACH)1(GR-CH)2]-, show absorbance maxima at intermediate distances 
A	 B	
C	 D	
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between the two homotrimeric peptides at 342 and 345 nm, respectively (Figure 2-9A). 
However, when calculated spectra are determined by adding ⅔ and ⅓ of the respective 
homotrimeric spectra, the calculated spectra overlay nearly exactly with that of the data 
obtained for the mixtures of PbIIS[(GR-ACH)2(GR-CH)1]- and PbIIS[(GR-ACH)1(GR-
CH)2]- (Figure 2-9B). This indicates that analysis via UV-Vis of the PbIICys3 peak cannot 
distinguish between a new, heterotrimeric peptide and a mixture of the homotrimeric 
peptides.  
 
Figure 2-9. Overlay of UV-Vis analysis comparing A) experimental PbIIS3 LMCT bands 
of PbII-bound homo- and heterotrimeric 3SCC and B) calculated heterotrimeric spectra 
from the experimental homotrimeric data. A) Experimental UV-Vis spectra of blue: 
PbIIS(GR-ACH)3-, purple: PbIIS[(GR-ACH)2(GR-CH)1]-, green: PbIIS[(GR-ACH)1(GR-
CH)2]-, and red: PbIIS(GR-CH)3-. B) Experimental heterotrimeric mixtures shown in 
purple: PbIIS[(GR-ACH)2(GR-CH)1]-, and green: PbIIS[(GR-ACH)1(GR-CH)2]-, and 
calculated mixtures of homotrimers shown in light blue: ⅔[PbIIS(GR-ACH)3-] 
+⅓[PbIIS(GR-CH)3-] and yellow: : ⅓[PbIIS(GR-ACH)3-] + ⅔[PbIIS(GR-CH)3-]. 
Previously, a and d site Cys3 peptides were shown to have different 207Pb NMR 
shifts as well as slight differences in their apparent pKa values.19,30 Since different 207Pb 
NMR shifts are observed for the a site peptides with and without Ala substitutions, as 
well as the Ala/Leu peptide mixtures, I wanted to assess the difference in the pH 
dependencies for the metal chelate deprotonation of the Ala containing peptide, TRI-AC, 
as well as the heterotrimeric mixtures.  
PbII binding to TRI and GR peptides has a significant pH dependence, as 
evidenced by the absence of the ~350 nm PbIICys3 LMCT band at low pH, and the 
A	 B	
	 75 
presence of this band at higher pH (generally > pH 5).19 There are two models for thiol 
deprotonation to consider when analyzing the pH dependence of PbII-bound 3SCC 
complexes. The equilibrium for cysteine deprotonation can be seen in Scheme 1, where 
the thiol is deprotonated before the metal associates with the ligand.  
PbII + P3-SH ⇌ PbII + P3-S- + H+ ⇌ PbII-S-P3    Scheme 1 
P3-SH, P3-S-, and PbII-S-P3 correspond to the protonated thiol with no associated metal 
ion, deprotonated thiolate with no metal associated and metal-thoilate complex, 
respectively.  This model represents a thiol pKa where the PbII ion is not associated with 
the ligand until after deprotonation of the thiol ligand has occurred. In this situation, the 
deprotonation of the thiol ligand is associated with metal complexation, but deprotonation 
is required before complexation can occur. 
 The second model for thiol deprotonation is described in Scheme 2, where the 
metal ion is associated with the neutral thiol before deprotonation.  
PbII + HS-P3 ⇌ PbII-HSP3 ⇌ PbII-S-P3 + H+    Scheme 2 
HS-P3, PbII-HSP3, and PbII-S-P3 correspond to protonated thiol before metal association, 
metal-associated neutral thiol, and metal associated thiolate, respectively. In this scenario, 
the presence of the PbII ion perturbs the thiol pKa because the ligands are already 
associated with the metal ion before deprotonation. In this case, the sulfur binds to the 
PbII as either a thiol or thiolate. In both cases the final species, PbII-S-P3, is the complex 
that provides the LMCT band at ~340 nm and, therefore, we cannot spectroscopically 
distinguish between the two models.  
 Additionally, it should be noted that although Scheme 1 and Scheme 2 show only 
one proton being released, the deprotonation step may indeed correlate to a multiple 
proton step. To distinguish between a 1 and 2 proton step, all of the pH titration data 
discussed below are fit to three different fitting equations, as derived in the Materials and 
Methods section. The first fit considers only one proton being released (Equation 7). The 
second and third fitting models consider two protons being released in a step-wise 
(Equation 16) or simultaneous (Equation 22) fashion. 
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Ultimately, we may learn multiple things from the analysis of pKa values for these 
PbII-bound peptides. First, determining the pKa values of these metallated peptides is 
essential in order to establish the pH conditions required to form, completely, the PbIIS3 
species. Considering that PbII binding is the key component controlling nucleation of the 
heterotrimeric peptides, these titrations define the useful pH range for these 
heterotrimeric complexes. Additionally, if the pKa values of the heterotrimers are 
sufficiently different from those of the homotrimers, then these analyses could offer 
another confirmation that a new species is indeed being made when Ala/Cys and Leu/Cys 
peptides are mixed together.  
The pH of a solution containing 180 µM (60 µM 3SCC) TRI-AC, [(TRI-
AC)2(TRI-C)1], [(TRI-AC)1(TRI-C)2] or TRI-C (pKa previously reported for TRI-C but 
repeated here for internally consistency) and 30 µM PbII(NO3)2  was increased from 
approximately pH 3 to 9 with small aliquots of KOH. The formation of the trigonal 
pyramidal PbIIS3 complex, as evidenced by the growth of the characteristic LMCT PbIIS3 
at ~345 nm, was observed to be complete by pH 7 for all four samples (Figure 2-10).  
The steepness of the curves of these titrations is directly related to the number of protons 
released upon metal binding. Generally speaking, the pH titration curves for PbIIS(TRI-
C)3- and PbIIS[(TRI-AC)1(TRI-C)2]- are less steep than those for PbIIS(TRI-AC)3- and 
PbIIS[(TRI-AC)2(TRI-C)1]-, supporting a multi-proton release associated occurring for 
both PbIIS(TRI-C)3- and PbIIS[(TRI-AC)1(TRI-C)2]-. Table 2-2 shows the pKa values for 
each experiment for each fitting model (1H+, stepwise 2H+, and simultaneous 2H+).  
Table 2-2. pKa values for PbIIS(TRI-C)3-, PbIIS(TRI-AC)3-, PbIIS[(TRI-AC)2(TRI-C)1]-, 
and PbIIS[(TRI-AC)1(TRI-C)2]- fit to 1-proton, 2-proton stepwise and 2-proton 
simultaneous models.  
Peptide 1 H+ 2 H+, Simultaneous 2 H+, Step-wise 
 pKa1 pKa2 pKa1 pKa2 
PbIIS(TRI-C)3-, 5.91 ± 0.05 11.72 ± 0.03 5.62 ± 0.26 11.33 ± 0.50 
PbIIS(TRI-AC)3- 5.43 ± 0.02 10.83 ± 0.04 - - 
PbIIS[(TRI-AC)2(TRI-C)1]- 5.27 ± 0.04 10.47 ± 0.06 - - 
PbIIS[(TRI-AC)1(TRI-C)2]- 5.51 ± 0.10 10.99 ± 0.16 - - 
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Figure 2-10.  pH titration curves of PbIICys3 at  λmax for homo- and heterotrimers.  Data 
fitted to Equation 22, Blue circles: pKa2 = 10.83 ± 0.04 for PbIIS(TRI-AC)3-, purple 
squares: pKa2 = 10.47 ± 0.06 for PbIIS[(TRI-AC)2(TRI-C)1]-, green squares: pKa2 = 10.99 
± 0.03 for PbIIS[(TRI-AC)1(TRI-C)2]-, and red triangles: pKa2 = 11.33 ± 0.04 for 
PbIIS(TRI-C)3-.  
 The most basic pKa observed, for all three fitting equations, is for PbIIS(TRI-C)3-, 
with a best fit obtained using the two-proton step-wise model (pKa1 = 5.62 ± 0.26, pKa2 = 
11.33 ± 0.50, Table 2-2); however, within error, these values are not different indicating 
the process may indeed be simultaneous. The opposite homotrimer, PbIIS(TRI-AC)3- 
shows a more acidic pKa and fits best to a simultaneous 2 H+ model (pKa2 = 10.8 ± 0.04, 
Table 2-2). These data indicate that the identity of the residue in the layer above the Cys3 
binding site doesn’t perturb the number of protons released during the pH titration of the 
PbII-Pep3 solutions. Interestingly, PbIIS(TRI-C)3- is the only peptide that provided a 
statistically good fit for a two-proton stepwise model, with the other three peptides 
providing ambiguous fits.  
The titration curve of heterotrimer PbIIS[(TRI-AC)2(TRI-C)1]-, which is pure via 
207Pb NMR analysis, fits best to a 2 H+ simultaneous model (pKa2 = 10.47 ± 0.06, Table 
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2-2). The other heterotrimer, PbIIS[(TRI-AC)1(TRI-C)2]- is similar to that of the 
homotrimer PbIIS(TRI-AC)3-, and statistically fits best to a 1 H+ model (pKa = 5.51 ± 0.10, 
Table 2-2). The discrepancy observed for the best fits of PbIIS[(TRI-AC)1(TRI-C)2]- may 
be a direct consequence of the corresponding pKa related to the association of 3SCC from 
2SCC, which occurs at pH  ~5.5.33 It is possible that there is some ambiguity in the fit of 
PbIIS[(TRI-AC)2(TRI-C)1]- because we are observing a concurrent formation of the 
folded peptide as well as deprotonation of the thiols to for the PbIIS3 complex. For direct 
comparison, considering the relatively comparable goodness of fits between the models 
for all the peptides, the pKa2 value for PbIIS[(TRI-AC)1(TRI-C)2]- was fit to 10.99 ± 0.03 
(Table 2-2). Considering a 2 H+ step for each sample a general trend can be determined 
for relative pKa2 values of PbIIS(TRI-C)3- > PbIIS(TRI-AC)3- ≈ PbIIS[(TRI-AC)1(TRI-C)2]- 
> PbIIS[(TRI-AC)2(TRI-C)1]-. In all of these cases full complexation of the completely 
deprotonated PbIIS3 system is obtained by pH 7 indicating that all experiments conducted 
at or above pH 7 should not be influenced by the pKa of PbII-bound thiolate ligands.  
Additionally, when considering the pKa values of the heterotrimers we see that the 
values obtained cannot simply be the sum of a combination of the homotrimeric traces. 
As seen in Figure 2-11, when a calculation is performed, to add two equivalents of 
PbIIS(TRI-AC)3- and one equivalent of PbIIS(TRI-C)3-, a trace is obtained with a pKa2 of 
~11.13. The calculation for the opposite mixture one equivalents of PbIIS(TRI-AC)3- and 
two equivalent of PbIIS(TRI-C)3- provides a pKa value of ~11.50. In both cases these 
values are more basic than the values fitted to the experimental data for PbIIS[(TRI-
AC)1(TRI-C)2]- (pKa2 = 10.99) and PbIIS[(TRI-AC)2(TRI-C)1]- (pKa2 = 10.47). Again, a 
combination of homotrimers in solution would not produce the values observed for the 
heterotrimer samples. These data support a model that when mixing the Ala/Cys and 
Leu/Cys peptides together we are not simply getting a mixture of the homotrimeric 
species but are indeed obtaining new, heterotrimeric 3SCCs. This data, in combination 
with the 207Pb NMR data, supports formation of heterotrimeric 3SCC, nucleated by the 
binding of PbII to Cys3 sites with a mixed Ala/Leu layer above the metal binding site. 
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Figure 2-11. Overlay of experimental pH titration curves of PbIICys3 at  λmax for 
heterotrimers with calculated heterotrimeric spectra from the experimental homotrimeric 
data. Experimental heterotrimeric mixtures shown in closed purple squares: PbIIS[(TRI-
AC)2(TRI-C)1]-, and closed green squares: PbIIS[(TRI-AC)1(TRI-C)2]-, and calculated 
mixtures of homotrimers shown in open purple triangles: ⅔[PbIIS(TRI-AC)3-] + 
⅓[PbIIS(TRI-C)3-] and open green triangles: : ⅓[PbIIS(TRI-AC)3-] + ⅔[PbIIS(TRI-C)3-]. 
Data fitted to Equation 19 provides pKa2 values of 11.3 and 11.5 for PbIIS[(TRI-
AC)2(TRI-C)1]- and PbIIS[(TRI-AC)1(TRI-C)2]-, respectively.  
We then turned to 207Pb NMR to evaluate whether the longer, more stable GR 
peptides exhibited the same behavior as seen for the TRI peptides. 207Pb NMR of 
PbIIS(GR-ACH)3- and PbIIS(GR-CH)3-, 3-5 mM 3SCC with one equivalent enriched 
207PbII(NO3)2 adjusted to pH 7.4 with small aliquots of KOH, exhibited similar 
resonances as the analogous TRI peptides (Figures 2-12a and 2-12d). Additionally, the 
mixed peptide systems, PbIIS[(GR-ACH)1(GR-CH)2]- and PbIIS[(GR-ACH)2(GR-CH)1]-, 
also resulted in similar 207Pb NMR resonances as seen with the TRI peptides (Figures 2-
12b and 2-12c ). Interestingly, the same minor resonance at 5597 ppm appeared in the 
PbIIS[(GR-ACH)1(GR-CH)2]-  spectrum (Figure 2-12b). When considering the 5:1 peptide 
ratio, as mentioned above, if the system is under the fast exchange regime, one should 
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observe a single broad resonance at ~5585 ppm, whereas under slow exchange conditions 
two resonances at ~5575 and ~5600 ppm should be present. Clearly, it is the second 
possibility that results (Figure 2-13). Unlike previous designs, this stoichiometric control 
can be achieved using a single layer of Ala/Leu matching directly above a PbIICys3 layer, 
allowing for a separate asymmetric functionalization of the scaffold toward the C-
terminus.  
 
Figure 2-12. 207Pb NMR spectra of a) PbIIS(GR-CH)3-, b) PbIIS[(GR-CH)2(GR-ACH)1]-, 
c) PbIIS[(GR-CH)1(GR-ACH)2]-, d) PbIIS(GR-ACH)3-. All spectra were recorded at room 
temperature (25 °C) for 5 hr using isotopically enriched PbII(NO3)2, pH 7.4. 
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Figure 2-13. 207Pb NMR of A) PbIIS[(TRI-C)1(TRI-AC)2]-, B) PbIIS(TRI-AC)3- and five 
equivalents of GR-ACH and one equivalent of GR-CH in the presence of 2 equivalents 
enriched PbII(NO3)2. All spectra were recorded at room temperature (25 °C) for 5 hr 
using isotopically enriched 207PbII(NO3)2, pH 7.4. 
These studies are fundamentally interesting in the design community as they 
demonstrate 1) how to prepare controllably A2B type systems using a metal as a template 
and 2) confer this asymmetric selectively using two adjacent layers of the coiled coils 
rather than requiring modification along the entire peptide sequence. This second 
achievement is critical for attaining the ultimate goal of producing selective 
heterotrimeric 3SCCs in order to obtain a scaffold that contains a second, distinct metal 
binding site that may lead to a functional asymmetric redox or catalytically active site. 
This objective requires that the binding of a metal different from PbII occurs at the second, 
functional site rather than being competitive with PbII for the heterotrimeric nucleating 
Cys3 site. Similarly, the second site should have a lower affinity for PbII than the primary 
Cys3 site. Thus, it was necessary to determine the relative binding affinities of metals to 
the nucleating site PbIICys3 and the redox/catalytic site Mn+His3.  
A	
B	
C	
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The analysis of competition of other metals with PbII for the primary structural 
site with thiolate ligands was assessed using GRL2WL16C, designated GR-C (Table 2-1). 
A second metal, such as CoIISO4, was added in a 1:1 metal:trimer ratio, producing a 
possible CoIIS(GR-C)3- complex, at 30 µM metallated 3SCC in 100 mM TRIS buffer, pH 
8.0. PbII was then titrated into the solution and the Pb-S LMCT absorption at 346 nm was 
monitored to track whether PbII displaced the transition metal. The PbII easily displaces 
CoII as these titration curves can be overlaid with the tight binding curves observed for 
the formation of PbIIS(GR-C)3- in the absence of transition metals (Figure 2-14). The 
experiment was also completed in the presence of ZnIISO4 and [CuI(CH3CN)4]BF4. 
Similarly to CoII, addition of PbII easily displaces ZnII as the titration curve can be 
overlaid with the tight PbIIS(GR-C)3- binding curve (Figure 2-14); however, competition 
is observed for PbIICys3 binding when CuI is present. 
 
Figure 2-14. UV-Vis titration curves of transition metal displacement via equivalent of 
PbII added, with respect to 3SCC, to GR-C  (no transition metal: dark blue inverted 
triangle, CoII: light blue square, ZnII: green triangle, and CuI: red circles) at pH 8.5 in 100 
mM Tris-HCl buffer.  
The relative affinity of PbII for a cysteine sulfur vs. imidazole nitrogen metal 
binding site within the same peptide has been determined by the exclusive and 
quantitative binding of PbII to the sulfur site forming PbIIS(GR-CH)3- as observed via both 
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UV-Vis and 207Pb NMR spectroscopies. There was no evidence of PbII binding to the 
His3 site, indicating that minimally, PbII binds preferentially, and possibly exclusively, to 
the sulfur site. It has been reported that CuI has a picomolar affinity for a His3 site in the 
TRI peptides45 suggesting that PbII might go exclusively to the sulfur site while CuI could 
be complexed at the histidine site.  This behavior is indeed observed when PbII is titrated 
into CuI(GR-CH)32-; no competition is observed between PbII and CuI at the cysteine site 
(Figure 2-15). This result indicates that when His3 and Cys3 sites are present, PbII binding 
to the Cys3 site is not inhibited in the presence of CuI.  
 
Figure 2-15. UV-Vis titration curves comparing the competition of CuI and PbII for a 
Cys3 site in the presence and absence of an additional His3 site within the same peptide. 
Equivalents of PbII added, with respect to 3SCC, to GR-C, in the absence and presence of 
CuI is shown in blue inverted triangles and red circles, respectively. PbII addition to GR-
CH in the presence of CuI is shown in green squares. All data collected at pH 8.5 in 100 
mM Tris-HCl buffer. 
 
PbII-Heterotrimers with Remote Transition Metal Binding Sites 
To assess the influence on the PbIICys3 from a second metal binding to a remote 
His3, site, I also analyzed the 207Pb NMR of PbIISMIIN(GR-ACH)3+, PbIISMIIN[(GR-
ACH)2(GR-CH)1]+, PbIISMIIN[(GR-ACH)1(GR-CH)2]+, and PbIISMIIN(GR-CH)3+, where 
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MII is CoIISO4 or ZnIISO4. As seen in Figure 2-16, addition of either CoII or ZnII does not 
cause a perturbation of the PbIICys3 site with the second metal present.† The distance 
between the PbIICys3 site and the MIIHis3 site is ~20 Å, far enough for the paramagnetic 
characteristics of CoII not to influence the NMR spectra originating from the PbIICys3 site.  
Figure 2-16. 207Pb NMR spectra of PbII bound homo- and heterotrimers in the absence 
(B) and presence of a transition metal, CoII (A) or ZnII(C). 0 Ala: PbIISMIIN/O(GR-
CDH)3n+, 1 Ala: PbIISMIIN/O[(GR-CDH)2(GR-ACH)1]n+, 2 Ala: PbIISMIIN/O[(GR-
CDH)1(GR-ACH)2]n+, 3 Ala: PbIISNIIN/O(GR-ACH)3n+, collected at pH 8.5. 
Previous catalytic studies with the TRI and GR peptides examined metal binding 
behavior over a wide pH range, therefore, it was necessary to assess whether our new 
heterotrimers would retain their composition in neutral and basic solution. The 207Pb 
NMR resonances for PbIIS(GR-ACH)3-, PbIIS(GR-CH)3-, PbIIS[(GR-ACH)2(GR-CH)1]-, 
and PbIIS[(GR-ACH)1(GR-CH)2]- combinations at pH 8.4 and 9.4 matched exactly those 
observed at pH 7.4 demonstrating that this metal nucleation strategy can be applied 
broadly (Figure 2-17). 																																																								†	207Pb NMR in the presence of both PbII and CoII was completed with peptides that contain Asp 
residues in the layer directly above the His3 site with respect to the N-termini. These peptides will 
be discussed, at length, in Chapter 3. 	
B	A	 C	
	 85 
 
Figure 2-17. 207Pb NMR spectra of i) PbIIS(GR-CH)3-, ii) PbIIS[(GR-CH)2(GR-ACH)1]-, 
iii) PbIIS[(GR-CH)1(GR-ACH)2]-, iv) PbIIS(GR-ACH)3- at pH 7.4 (panel A), pH 8.4 (panel 
B) and pH 9.4 (panel C). 
 
Analysis of HgII-Nucleated Heterotrimers  
Due to the observed competition between CuI and PbII for sulfur binding (see 
Chapter 4 for an in depth analysis of CuI and PbII competition for a Cys3 site), and the 
attractiveness of being able to include an additional cysteine residue within our peptide 
scaffolds, for example, to introduce a Cupredoxin-like second metal binding site, I next 
assessed the ability of HgII to promote selective heterotrimer formation, instead of PbII. 
As said in Chapter 1, HgII binds tightly to our 3SCCs in both stoichiometric and pH 
dependent fashions. When 3 equivalents of peptide to one equivalent of HgII are mixed 
above pH 7.5, a 3-coordinate HgIICys3 species is obtained. Analysis via 199Hg NMR of a 
standard a-site, such as TRIL2WL16C (Figure 2-18a) results in a chemical shift at -184 
ppm, similar to other aliphatic three-coordinate HgII-thiolate complexes. Similarly to PbII, 
when an Ala substitution is introduced in the layer above the Cys3 binding site an upfield 
shift to -244 ppm is observed (Figure 2-18d). This is the most upfield shift ever observed 
in our TRI peptides for an a site Cys3 peptide. 
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Figure 2-18. 199Hg NMR spectra of a) HgIIS(TRI-C)3-, b) HgIIS[(TRI-C)2(TRI-AC)1]-, c) 
HgIIS[(TRI-C)1(TRI-AC)2]-, d) HgIIS(TRI-AC)3-. All spectra were recorded at room 
temperature (25 °C) for 5 hr using isotopically enriched HgII(NO3)2, pH 8.5. 
When 2:1 and 1:2 ratios of TRI-AC and TRI-C are mixed at pH 8.5, in the 
presence HgII, as previously was done with PbII, peaks at intermediate chemical shifts 
were observed for both HgIIS[(TRI-AC)2(TRI-C)1]- and HgIIS[(TRI-AC)1(TRI-C)2]- 
mixtures (Figures 2-18b and 2-18c). For HgIIS[(TRI-AC)1(TRI-C)2]-, a dominant peak is 
observed, slightly upfield, at -193 ppm with a smaller peak even further upfield at -210 
ppm (Figure 2-18b). The opposite heterotrimeric mixture, HgIIS[(TRI-AC)2(TRI-C)1]-, 
showed the same two peaks as the first heterotrimeric mixture, however, the dominance 
has been shifted to the most upfield shift resonance at -210 ppm with the smaller peak 
observed at -193 ppm (Figure 2-18c). The shifting observed for the 207Pb NMR was 
a 
b 
c 
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consistent with a shift of ~25 ppm between each species. Interestingly, we do not see this 
same equidistance difference for the Hg-bound systems (Figure 2-18). Instead, from the 
most downfield to the most upfield 3SCC we see shifts of ~10, ~17 and ~34 ppm. 
Therefore, 199Hg NMR showed similar heterotrimer production in the presence of HgII 
bound to mixed peptide systems; however, when HgII is the nucleating metal, the 
expected heterotrimer was dominant, but not exclusive, as the opposite heterotrimer was 
also present. Hence, at pH 8.5, HgII binding does promote heterotrimer formation but 
does not allow for selective heterotrimer formation as was observed in the case of 
PbIIS[(TRI-AC)2(TRI-C)1]-. Future studies to determine how the pKa values of the metal-
chelation deprotonation of HgII bound TRI-AC and heterotrimers are necessary to 
determine if a similar decrease in pKa is observed for the HgII-bound heterotrimers in 
comparison to the HgII-homotrimers.  
A second approach for using HgII instead of PbII to nucleate the formation of 
selective heterotrimers was to exploit the preference of HgII to bind only two sulfurs in a 
linear fashion. Previous studies had shown that ratios of 2:1 peptide monomer:HgII 
exploited the preference of HgII to bind in a linear fashion, driving the formation of a 
2SCC. Addition of more peptide results in the conversion of Hg(pep)2 to Hg(pep)3- as the 
ratio of peptide monomer: HgII increases. Therefore, I wanted to determine if forming a 
homodimer of TRI-AC and then adding one equivalent of TRI-C would provide a pure 
HgII-bound heterotrimer. First, I added 199Hg(NO3)2 in a 1:2 ratio with TRI-AC and 
observed only one peak via 199Hg NMR analysis at -867.8 ppm (Figure 2-19). In attempt 
to form a heterotrimer, I then added one equivalent of TRI-C, with respect to the 
concentration of TRI-AC. The NMR spectrum then showed the presence of both 
heterotrimers at -195 and -211 ppm (in addition to residual 2SCC at -867 ppm, Figure 2-
19). These results indicate that HgII is not capable of nucleating the formation of 
heterotrimeric 3SCC regardless of the order of addition (TRI-AC + TRI-C, then add HgII 
OR TRI-AC + Hg, then add TRI-C). These data also confirm that we are accessing the 
true thermodynamic speciation of the heterotrimers rather than kinetically trapping a 
distribution of mixed 3SCCs. 
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Figure 2-19. 199Hg NMR spectra of a) HgIIS(TRI-AC)2, and b) HgIIS(TRI-AC)2 + 1 
equivalent of TRI-C. All spectra were recorded at room temperature (25 °C) for 5 hr 
using isotopically enriched 199HgII(NO3)2, pH 8.5. 
 
PbII-Heterotrimers with Ala/Leu Pairings “below” 
Next, I wanted to address the question of whether heterotrimeric PbII 3SCCs 
could be obtained, selectively, if the Ala/Leu steric pairing was in the layer directly 
below the Cys3 binding site. To do so, I synthesized GRL2WL16CL19AL30H (GR-CAH, 
Table 2-1). PbII binding to Cys3 was confirmed via analysis of UV-Vis spectroscopy. 
Aliquots of PbII(NO3)2 were added to a solution of 60 µM GR-CAH, 20 µM 3SCC, in 
100 mM TRIS buffer at pH 8.5. A peak characteristic of a PbIIS3 LMCT, with a maximal 
absorption observed at 345 nm, grew in until one equivalent of PbII was reached, 
followed by an immediate halt in the increase in absorption. This pattern is again 
indicative of very tight PbIIS3 binding (Figure 2-20). A linear regression analysis of the 
data at 345 nm provided a molar extinction coefficient of only 2595 M-1cm-1, a 25% 
decrease from the lower limit of what is normally observed for PbS3 binding in the TRI 
and GR peptides.  
a	
b	
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Figure 2-20. Titration spectra of PbII into a solution of A) GR-CAH and B) the 
corresponding titration curves showing the 1:1 binding stoichiometry of equivalent of 
PbII added with respect to 3SCC at 343 nm. Data collected at pH 8.5 in 50 mM TRIS 
Buffer. 
To determine if the decreased extinction coefficient was due to poor peptide 
folding, the folding and stability of GR-CAH was determined at pH 8.0 using CD 
spectroscopy and a guanidine hydrochloride (GuaHCl) denaturation titration. A 
characteristic CD spectrum of an alpha-helical coiled coil yields a double well with 
minima at 208 and 222 nm, but the molar ellipiticity [Θ] was determined to be only -
25922 deg dmol-1 cm2, only ~73% folded (Figure 2-21). This indicates that a simple 
change in design from the Ala substitution being above the Cys3 layer to below the 
binding site results in a nearly 20% loss of initial folding in the apo-peptide. As observed 
in Figure 2-21, the midpoint of GR-CAH is difficult to determine since the peptide 
denatures immediately upon addition of GuaHCl and no stable well folded initial state is 
observed; however, the midpoint can be estimated to be, at most, only 1 M GuaHCl. This 
is ~0.8 M lower than the midpoint of GR-ACH indicating the inclusion of an Ala residue 
below the Cys3 layer results in a less stable peptide compared to an Ala substitution 
above the Cys3 site, both of which are less stable than the corresponding GR-CH peptide.    
A	 B	
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Figure 2-21. Guanidine hydrocholoride denaturation titration data of GR-CAH in 10 mM 
Phosphate buffer at pH 8.0. Inset: CD spectra of GR-CAH before (red) and after (blue) 
the addition of 7 M GuaHCl. 
 
I next turned to 207Pb NMR to further characterize PbII binding to GR-CAH. In 
the presence of one equivalent 207PbII at pH 7.4, a chemical shift was observed at 5712 
ppm (Figure 2-22). This is, to date, the most downfield shifted peak observed for a PbIIS3 
environment in an a Cys3 site by approximately 65 ppm. Previously, we saw that 
introduction of an Ala layer directly above an a site Cys3 resulted in an 75 ppm upfield 
shift (5575 ppm) from the corresponding Leu/Cys peptide at 5650 ppm. Indeed, these 
results indicate that inclusion of an Ala layer below the Cys3 site, with respect to the N-
terminus, does not produce a similar upfield shift but actually produces an opposite result 
with a downfield chemical shift. All subsequent attempts to obtain a heterotrimeric 3SCC 
by mixing GR-CH and GR-CAH in the presence of 207PbII does not produce a PbS3 
chemical shift under the reported experimental conditions.  
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Figure 2-22. 207Pb NMR of PbIIS(GR-CAH)3-. Spectrum was recorded at room 
temperature (25 °C) for 5 hr using isotopically enriched PbII(NO3)2, pH 7.4.  
One possibility that PbIIS[(GR-CAH)3-n(GR-CH)n]- heterotrimers are not observed 
is that PbII nucleates heterotrimers from a mixture of GR-CH and GR-CAH but that the 
resulting chemical shift is perturbed so much that we do not see it within the normal 
range (5590-6200 ppm) scanned for PbIIS3 TRI and GR systems. This possibility seems 
unlikely, given the behavior of the trend observed for the original heterotrimers where the 
chemical shifts of PbIIS[(GR-ACH)2(GR-CH)1]- and PbIIS[(GR-ACH)1(GR-CH)2]- fall 
between the chemical shifts of the corresponding PbIIS(GR-ACH)3- and PbIIS(GR-CH)3-  
homotrimers.  Considering the range of Pb NMR signals (>16,000 ppm),30 locating a 
peak that appears in a different chemical shift region may be a non-trivial task.  
A second possibility is that a PbIIS[(GR-CAH)3-n(GR-CH)n]- heterotimer behaves 
differently than the PbIIS[(GR-ACH)3-n(GR-CH)n]- mixtures, with respect to the 
relaxation time of the PbII nucleus, in a way that causes the PbIICys3 signal to no longer 
be detectable. It is also possible that there is rapid exchange of the peptides, considering 
the destabilization observed in the GuaHCl denaturation titration, causing the peptide to 
dissociate or resulting in multiple, interconverting, cysteine conformations. Any of these 
processes could result in the broadening of the 207PbIICys3 signal to the point of being 
undetectable.  
A last consideration is that a statistical distribution is obtained when mixing the 
GR-CAH and GR-CH peptides, in the presence of PbII does not result in selectivity. If 
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this scenario occurs, then it is unlikely that any of the species is populated enough to 
result in a resolvable 207Pb NMR signal, due to decreased concentration of any particular 
species. UV-Vis analysis does confirm the presence of a PbIICys3 chromophore when PbII 
is added to a solution of GR-CAH, which suggests that PbII is most likely binding in the 
PbIIS[(GR-CAH)3-n(GR-CH)n]- mixes; however, thus far a 207Pb NMR signal has 
remained elusive. 
I next measured the pKa corresponding to the metal-chelation deprotonation for 
PbII-bound GR-CAH, and the corresponding PbIIS[(GR-CAH)3-n(GR-CH)n]- heterotrimers, 
to determine if a the pH value used for the NMR analysis was appropriate. The pH of a 
solution containing 180 µM (60 µM 3SCC) peptide and 30 µM PbII(NO3)2 was increased 
from approximately pH 3 to pH 9 with small aliquots of concentrated KOH. PbII binding 
to Cys3 was analyzed via increasing absorbance at 345 nm and was complete by pH 8.0 
(Figure 2-23). All of the data sets were fit to the single proton release, the simultaneous 
two-proton release and the step-wise two-proton release models as described above.  
 
Figure 2-23.  pH titration curves of PbIICys3 at  λmax for homo- and heterotrimers with 
Ala/Leu pairings below the Cys3 site. Data fitted to Equation 22, Blue circles: pKa2 = 
12.06 ± 0.06 for PbIIS(GR-CAH)3-, purple squares: pKa2 = 11.43 ± 0.29 for PbIIS[(GR-
CAH)2(GR-CH)1]-, green squares: pKa2 = 11.49 ± 0.05 for PbIIS[(GR-CAH)1(GR-CH)2]-, 
and red triangles: pKa2 = 11.72 ± 0.04 for PbIIS(TRI-C)3-.  
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The pH titration curves for PbIIS[(GR-CAH)2(GR-CH)1]- and PbIIS[(GR-
CAH)1(GR-CH)2]- provide more acidic pKa values than either of the homotrimers, 
PbIIS(GR-CAH)3- and PbIIS(TRI-C)3- (Figure 2-22). Table 2-3 shows the pKa values for 
each peptide using all three fitting models. For PbIIS(GR-CAH)3-, the data is statistically 
best fit to a one proton step with a pKa of 6.07 ± 0.03 (Table 2-3). PbIIS[(GR-CAH)2(GR-
CH)1]- and PbIIS[(GR-CAH)1(GR-CH)2]- titrations are best fit to a step-wise two-proton 
deprotonation model with pKa1 = 5.56 ± 0.02 and pKa2 =10.91 ± 0.21 and 11.05 ± 0.12, 
respectively (Table 2-3). An overlay of the normalized titrations shows that both 
heterotrimers have more acidic transitions than either of the homotrimers (Figure 2-23).  
In all of these cases full complexation of the completely deprotonated PbIIS3 system is 
obtained by pH 7 indicating that all experiments conducted at or above pH 7 should not 
be influenced by the pKa of the thiolate associated with the PbII ion. These data suggest 
that the lack of 207Pb NMR signal for either the PbIIS[(GR-CAH)2(GR-CH)1]- or the 
PbIIS[(GR-CAH)1(GR-CH)2]- heterotrimeric mixtures is probably not due to the pH value 
of the analyzed solutions.  The similarities in the pKa values, compared to the original 
heterotrimers with the Ala/Leu pairing above the Cys3 site, do not indicate that a 
significantly perturbed 207Pb NMR signal should be expected.  
Table 2-3. pKa values for PbIIS(TRI-C)3-, PbIIS(GR-CAH)3-, PbIIS[(GR-CAH)2(GR-CH)1]-, 
and PbIIS[(GR-CAH)1(GR-CH)2]- fit to 1-proton, 2-proton stepwise and 2-proton 
simultaneous models.  
Peptide 1 H+ 2 H+, Simultaneous 2 H+, Step-wise 
 pKa1 pKa2 pKa1 pKa2 
PbIIS(TRI-C)3-, 5.91 ± 0.05 11.72 ± 0.03 5.62 ± 0.26 11.33 ± 0.50 
PbIIS(GR-CAH)3- 6.07 ± 0.03 12.06 ± 0.06 - - 
PbIIS[(GR-CAH)2(GR-CH)1]- 5.76 ± 0.14 11.43 ± 0.29 5.60 ± 0.12 10.91 ± 0.21 
PbIIS[(GR-CAH)1(GR-CH)2]- 5.78 ± 0.02 11.49 ± 0.05 5.56 ± 0.02 11.05 ± 0.12 
 
While crystal structures of PbII nucleated heterotrimers have been elusive, Dr. 
Leela Ruckthong has recently solved and refined the structures of 
PbIIS(GRCSL16CL30H)3- and PbIIS(GRCSL12AL16C)3- (Table 2-1). Therefore, I will use 
the crystal structures of the homotrimers corresponding to the Ala/Cys 
(GRCSL12AL16C) and Leu/Cys (GRCSL16CL30H) peptides to explore possible 
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explanations for the formation of heterotrimeric species in the presence of PbII and HgII 
(admittedly, non-selectively). 
As discussed in Chapter 1, a comparison of apo-(CSL16C)3 to the crystal 
structures of HgIISZnIIN(GRCSL16L30H)3+, HgIIS(GRCSL12AL16C)3-, and 
ZnIIS(GRCSL12AL16C)3- has revealed that a Cys3 site in an a position, within our 3SCCs, 
is pre-disposed, meaning it contains the correct number of ligands but requires significant 
rearrangement of the ligands for metal binding in either trigonal planar or tetrahedral 
geometries (Figure 2-24). Additionally, comparing apo-(CSL16C)3 to the crystal 
structures of AsIIIS(CSL9C)3 and to PbIISZnIIN(GRCSL16CL30H)3+ has shown that an a 
Cys3 site is pre-organized, meaning that the correct number of binding ligands are present 
and they require no or very little rearrangement, for metal binding in a trigonal pyramidal 
geometry (Figures 2-24C and 2-24D). This trend has been determined to be dependent on 
metal binding geometry and is independent of metal ion size.  
Additionally, pre-disposed metal binding to a Cys3 site and the subsequent 
rearrangement of the sulfur ligands results in enough room between the Cys3 layer and 
the layer directly above it (the 12th position) for a water molecule to either directly bind 
to the metal, as is observed in ZnIIS(GRCSL12AL16C)3- or to hydrogen bond to the p-
orbitals of the sulfur ions, as is observed in HgIISZnIIN(GRCSL16L30H)3+. In the case of 
HgIIS(GRCSL12AL16C)3-, not only does the rearrangement of the pre-disposed site allow 
for a water directly above the HgII ion, but it also allows for three other water molecules 
to situate near the helical interface. These water molecules hydrogen bond both to the 
central water molecule and the p-orbitals of the sulfur ions. Water molecules, thus far, 
have not been observed in any cases where metal binding is pre-organized, although this 
could be due to the symmetry of the unit cell and therefore could correlate to a 
crystallographic artifact and not necessarily the lack of existence of a central water 
molecule. However, to account for an increase in size, from AsIII to PbII for example, the 
changes observed in the peptidic structure occur in the in hydrophobic packing of the Leu 
layer below the Cys3 binding site (the 19th position) rather than cause reorganization of 
the Cys3 site, as observed in the pre-disposed situations (Figure 2-25). 
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Figure 2-24. Pymol representation of the overlay of apo-(CSL16C)3 with 
HgIISZnIIS(GRCSL16CL30H)3n+ (A and B) and apo-(CSL16C)3 with 
PbIISZnIIN(GRCSL16CL30H)3n+ showing the difference between metal binding and pre-
organized metal binding, respectively. A) Top and B) side view showing the overlay of 
apo-(CSL16C)3 and HgIISZnIIN(GRCSL16CL30H)3n+. C) Top and D) side on views of the 
overlay of PbIISZnIIN(GRCSL16CL30H)3n+ and apo-(CSL16C)3.Main chains of 
HgIISZnIIN(GRCSL16CL30H)3n+ are shown in green, apo-(CSL16C)3 in orange, and 
PbIISZnIIN(GRCSL16CL30H)3n+ in purple. Cysteine side chains are shown as sticks. HgII 
is represented as a blue sphere, PbII is represented as a grey sphere. 12Leu and 16Cys side 
chains are shown as sticks with sulfur ions in bright yellow. Figure adapted from Ref 50.  
A
	
B
	
C
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Figure 2-25. Packing of Leu residues (shown as spheres) demonstrating the hydrophobic 
packing below the trigonal pyramidal binding site compared to the apo-structure. Top 
panels: From top down view of the N-termini, representing the packing of a) 12Leu 
below the 9Cys layer in AsIIIS(CSL9C)3 (PDB: 2JGO),42 b) 19Leu below the 16Cys in 
apo-(CSL16C)3 and c) 19Leu below the 16Cys in PbIISZn
II
N(GRCSL16CL30H)3n+. 
Bottom panels: Representing in f) the packing comparison between a) and b). In e) an 
overlay between b) and c) Main atoms of PbIISZnIIN(GRCSL16CL30H)3n+, apo-
(CSL16C)3 and AsIII(CSL9C)3 are represented as purple, orange and red ribbon diagrams, 
respectively. Cys side chains are present as sticks in which the thiols are yellow. Leu 
residues are shown as spheres indicating the packing. Pb(II) and As(III) ions are omitted 
for clarity. Figure adapted from Ref 50.50   
However, analysis of PbIIS(GRCSL12AL16C)3- shows a combination of these two 
situations. The structure (currently under refinement) provides a trigonal pyramidal 
PbIICys3 metal binding site with an endo-configuration, a Pb-S distance of 2.64 Å, a Sγ-Sγ 
distance of 3.45 Å, and a χ1 angle of -57.69° (Figure 2-26). These values are similar to 
those of both apo-CSL16C and PbIISZnIIN(GRCSL16CL30H)3n+ (Pb-S= 2.64 Å, Sγ-Sγ = 
3.29 and 3.49 Å, χ1 = -69.20 and -68.38°, respectively) and support the assignment that 
GRCSL12AL16C is pre-organized for PbII binding (Figure 2-26). In fact, PbII binding to 
Cys3 sites of both GRCSL12AL16C and GRCSL16CL30H are nearly identical in the first 
coordination sphere (Figure 2-27). However, upon introduction of the Ala layer at the 
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12th position, water molecules are now observed in the space provided by the Ala 
substitution in PbIIS(GRCSL12AL16C)3-. No central water is observed on the helical axis 
above the PbII ion, similar to what was not observed in the HgII and ZnII structures; 
however, similar to the waters observed in HgIIS(GRCSL12AL16C)3-, 
PbIIS(GRCSL12AL16C)3- has three water molecules that are near to the helical interface 
in between the helices (Figure 2-28). The water molecules are 3.37 Å from the sulfur ion 
of the coordinating Cys ligands and, therefore, form hydrogen bonds with the p-orbitals 
of the sulfur ions (Figure 2-28).  
 
Figure 2-26. Pymol representation of trigonal pyramidal coordination in 
PbIIS(GRCSL12A16C)3- and comparison with apo-(CSL16C)3. A) Top down view from 
the N-termini of the overlay of PbIIS(GRCSL12A16C)3- and apo-(CSL16C)3 site showing 
a slight expansion of Sγ-Sγ distance from 3.29 to 3.45 Å upon PbII binding. B) Side on 
view of PbIIS(GRCSL12A16C)3- showing endo-conformation with PbII ion directed 
toward the C-terminus, away from the L12A substitution, with a PbII-S distance of 2.68 Å. 
C) Side on view of the overly of PbIIS(GRCSL12A16C)3- and apo-(CSL16C)3 showing 
the pre-organization of L12AL16C sites for PbII binding. Main chain atoms are shown as 
ribbon diagrams in green (PbII structure) and orange (apo-structure), 12Ala (in panel B) 
and 16Cys side chains are shown as sticks with sulfur ions in bright yellow, Ala sticks are 
shown in purple. The PbII ion is shown as a dark grey sphere. Figure adapted from Ref 50.   
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Figure 2-27. Pymol representations of the overlay of PbIISZnIIN(GRCSL16CL30H)3+ and 
PbIIS(GRCSL12AL16C)3-. A) Top down from the N-termini and B) side on view of the 
Cys3 binding site. Main chains are shown in purple and green for the L16C and 
L12AL16C structures, respectively. PbII ions are shown in grey spheres. Cysteine 
residues are shown as sticks and sulfur atoms are shown in bright yellow. Figure adapted 
from Ref 50.   
 
Figure 2-28. Pymol overlay representations showing the surrounding water molecules in 
PbIIS(GRCSL12AL16C)3-. A) Top down and B) side on views of the 
PbIIS(GRCSL12AL16C)3- crystal structure. Main chain helices are shown in green. Sulfur 
atoms are shown in bright yellow. Cys and Ala residues are represented as sticks. PbII 
ions are shown in grey spheres. Water molecules are shown as small red spheres. Figure 
adapted from Ref 50.   
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As mentioned above, previous computational analysis determined that PbIICys3 
binding is very sensitive to steric influences of the secondary coordination sphere. DFT 
analysis was conducted on two model peptide systems, one that coupled a Leu/Cys 
combination and one that coupled an Ala/Cys combination. The lowest energy structure 
corresponded to the Ala/Cys peptide, and also that the lowest energy system was an exo-
confirmer.37 Therefore, we originally hypothesized that perhaps when PbII bound to a 
Leu/Cys homotrimer, such as TRI-C, the Leu residues in the layer above forced an 
unfavorable endo-confirmer, and that TRI-AC would better accommodate the bulky lone 
pair of PbII, allowing for an exo-configuration. If this were true, one could consider that a 
mixture of TRI-C and TRI-AC, say (TRI-AC)2(TRI-C)1, could form an even more 
energetically favorable environment for PbIICys3 binding.  
However, we now know from the crystal structures of both 
PbIISZnIIN(GRCSL16CL30H)3n+ and PbIIS(GRCSL12AL16C)3- that PbII binds to an a site 
Cys3 in the endo-configuration,‡ with the metal oriented below the sulfur plane toward 
the C-terminus, regardless of the identity of the residue in the layer directly above the 
metal binding site. This directly negates the original hypothesis, supported by the DFT 
results, that the PbII would be bound in the exo-conformation with the PbII ion oriented 
towards the N-terminus. It is possible that the difference in the structural predictions and 
the DFT calculations could be due to the lack of water molecules included in the DFT 
models therefore not allowing for hydrogen-bonding interactions to the sulfur ions. 
Additionally, the calculations did not consider the constraints imposed upon the cysteine 
rotamers as would be observed in an α-helix. Inclusion of both hydrogen-bonds as well as 
secondary structural restrictions would most definitely influence the energies associated 
with the predicted states and could skew the relative energies enough to result in a 
different lowest energy model that might agree better with the structural predictions.   
																																																								‡ Endo-configuration is assigned because the β-carbon of the cysteine residue and the metal ion 
are observed on the same plane, with respect to the coordinating sulfur ion. This configuration 
could occur with the metal ion, and the β-carbon oriented toward the N-terminus, pointing “up” in 
the 3SCC, or toward the C-terminus, pointing “down” in the 3SCC. In the cases of the peptides 
discussed in this study all endo-configurations correlate to the latter where the PbII and AsIII ions 
are located below the Cys3 plane closer to the 19Leu residues than the 12Ala/Leu residues. 
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Thus, instead of a heterotrimer better accommodating the bulky lone pair of PbII 
as originally hypothesized, I now believe that the selective formation of heterotrimeric 
species may instead be a direct consequence of the water molecules being able to interact 
with the sulfur p-orbitals of the Cys ligands as observed when an Ala substitution is 
included in the layer directly above the Cys3 binding site, in combination with the 
hydrophobic packing of the lone Leu residue. The endo-confirmation, in addition to the 
direction in which the PbII ion “points” down (toward the C-terminus), confirms that the 
initial idea that the large PbII ion was better accommodated within the hydrophobic 
interior of the 3SCC upon addition of Ala residues, introduced symmetrically or 
asymmetrical, above the Cys3 binding site, was indeed incorrect. Rearrangement of these 
sulfur residues to bind a trigonal pyramidal ion such as PbII or AsIII in the exo 
configuration would result in a significant energy penalty. 
If the selectivity for heterotrimer formation is indeed due to hydrogen-bonding 
stabilization introduced via the L12A substitution in combination with the pre-organized 
Cys3 site for PbII binding then one would expect that PbII binding to an Ala/Cys 
homotrimer would be the most stable. This is contradictory to the CD spectroscopic 
analysis of peptide stability as described above where the Leu/Cys peptide is ~1 kcal/mol 
more stable than the Ala/Cys peptide; however, the denaturation studies are for the apo-
proteins and do not consider how the stability of the peptides might change upon PbIICys3 
binding. It is possible that although the peptide is most stable with all Leu residues in the 
layer above the Cys3 site, and that, upon addition of the bulky PbII the Leu/Cys peptide is 
destabilized. Therefore, one could imagine that a compromise is reached upon the 
combination of a mixed Ala2Leu peptide in the presence of PbII, where the stability of the 
apo-peptide is pacified by the inclusion of a Leu residue but the PbII site is satisfied with 
the asymmetric hydrogen bonding now possible with the 2Ala residues present.  
 The crystal structures of PbIISZnIIN(GRCSL16CL30H)3n+ and 
PbIIS(GRCSL12AL16C)3-, and the differences observed in the spectroscopic analyses, 
allow for one to imagine that the combination of Ala/Cys and Leu/Cys peptides, in the 
presence of PbII, could result in a heterotrimeric peptide that contains an intermediate 
number of water molecules (with respect to the number of water molecules observed in 
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the crystal structures of the homotrimeric peptides) occupying the space introduced by 
the Ala residues. Figure 2-29 shows a top down view of PbIISZnIIN(GRCSL16CL30H)3n+ 
and PbIIS(GRCSL12AL16C)3- and models of the 2:1 and 1:2 mixtures of these peptides. 
This figure shows how the space introduced in the layer above the Cys3 site is greatest, as 
one would expect, for the Ala/Cys homotrimer and smallest, essentially non-existent, for 
the Leu/Cys homotrimer. The heterotrimeric models have intermediate amounts of space 
available that could presumably be occupied by either one or two water molecules, while 
still retaining some hydrophobic packing characteristics due to the presence of the Leu 
residue. The change in symmetry of the hydrogen-bonding network between the water 
molecules and the sulfur ions could explain the changes in the spectroscopic parameters 
observed for the heterotrimeric species. One could also imagine that the introduction and 
alterations of a hydrogen bonding network near the PbIICys3 site proposed here could 
explain the perturbed pKa values observed for PbIIs[(TRI-AC)3-n(TRI-C)n]- heterotrimers.  
The lack of spectroscopic evidence for heterotrimer formation when the Ala 
residues are introduced below the Cys3 binding site could also support this new 
hypothesis. The structural data show that the PbII ion points down toward the C-terminus, 
where the L19A substitution occurs. In this scenario, the orientation of the PbII ion could 
result in the exclusion of water molecules, even with the inclusion of the Ala residues 
below the Cys3 site, resulting in a peptide that looks comparable to the Leu/Cys peptide. 
If the hydrogen bonding introduced via the L12A substitution is indeed required for 
heterotrimer formation then I would not expect to form discrete heterotrimers with the 
GR-CAH peptide since this peptide would not offer any hydrogen-bonding stabilization.  
Ultimately, crystal structures of the PbII heterotrimers are required to confirm this 
hypothesis. Given the trend observed for water molecules in the Ala/Cys and Leu/Cys 
homotrimeric crystal structures, the notion that selective PbII-nucleated A2B 
heterotrimeric 3SCC formation could be a direct consequence of favorable energetics 
obtained from the resulting asymmetric hydrogen bonding interactions due to asymmetric 
inclusion of water molecules within the structures is appealing.  
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Figure 2-29. Top down views of A) PbIIS(GRCSL12AL16C)3- and D) 
PbIISZnIIS(GRCSL16CL30H)3n+  and models of heterotrimeric mixtures, B) PbIIS[(GR-
CH)1(GR-ACH)2]- and C) PbIIS[(GR-CH)2(GR-ACH)1]-. Main chain helices are shown in 
green. Cys residues are represented as sticks with sulfur atoms shown in bright yellow. 
PbII ions are shown in purple spheres. Leu12 and Ala12 residues are shown in green 
space filling spheres. (A) and (D) are Pymol representations from the crystal structures 
reported in Ref 50. (B) and (C) models were prepared in Pymol using the mutagenesis 
option and Pymol’s rotamer library and the PDB of PbIISZnIIS(GRCSL16CL30H)3n+ (PDB 
code not deposited yet). 
I also turned to HgII-bound crystal structures to address the lack of selectivity of 
heterotrimer formation observed when HgII is used as the nucleating metal. As discussed 
in Chapter 1, introduction of Ala residues at the 12th position (HgIIS(GRCSL12AL16C)3-) 
resulted in four water molecules to occupy the space above the HgII ion. One could 
imagine that the hydrogen-bonding network obtained between the central H2O molecule 
and the three water molecules nearer to the helical interface, and between these three 
water molecules and the p-orbitals of the sulfur ions of the Cys resides, could offer added 
stability to the structure when compared to the single central water molecule of 
HgIISZnIIN(GRCSL16CL30H)3n+. However, similarly to the discussion above, the apo-
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peptide itself is most stable when the layer above the Cys3 site is well packed with Leu 
residues. 
 In the case of the HgIIS(GRCSL12AL16C)3- structure there are six hydrogen 
bonding interactions total, two per water molecule located near the helical interface: one 
to the p-orbital of the closest sulfur ion, and one to the central water molecule. In the 
opposite homotrimer, HgIISZnIIN(GRCSL16CL30H)3n+, the central water molecule is 
close enough to hydrogen bond to the p-orbitals of the sulfur ions, resulting in three 
hydrogen-bonding interactions. 
Assuming that the number of water molecules observed in the interior of the 
3SCC correlates to the number of Ala residues present in the layer above the Cys3 site, 
plus one additional central water molecule, consistent with both of the 
HgIIS(GRCSL12AL16C)3- and HgIIS(GRCSL12AL16C)3- crystal structures, one could 
imagine, that an intermediate number of water molecules (two or three) is likely in both 
heterotrimeric scaffolds. It is also possible that the location of the central water ion is 
directly related to the number of Leu residues present, closest with three Leu residues and 
farthest away with three Ala residues. Therefore the hydrogen-bonding capacity of the 
central water molecule could be modulated depending on the heterotrimeric mixture 
(2Leu or 1Leu).  The combination of the number of helical waters present as well as the 
fluctuation in the location of the central water molecule could therefore provide a 
comparable number of hydrogen bonds in either the Ala2Leu or AlaLeu2 heterotrimer, 
therefore explaining the lack of selectivity with HgII-nucleation. 
For example, a system containing one Ala and two Leu residues in the layer 
above the HgIICys3 site would have two water molecules present, where one is at the 
helical interface (directly correlated to the single Ala residues in the 12th layer), and the 
two Leu residues would cause the central water molecule to be pushed closer to the HgII 
ion. In this scenario, the helical water molecule will likely hydrogen bond to both the 
central water molecule and the closest sulfur ion, and the proximity of the central water 
molecule may be such that it can hydrogen bond to the remaining two sulfur ions, 
resulting in a total of four hydrogen-bonding interactions. Conversely, for the system 
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containing two Ala residues and one Leu residue, the central water molecule may not be 
close enough to hydrogen bond to the sulfur atoms but would likely hydrogen bond to 
two water molecules at the helical interfaces, which in turn both hydrogen bond to the 
sulfur ions on the nearest two Cys residues. This, again, provides four hydrogen bonds 
within the network. The comparable number of hydrogen bonds could explain why a 
mixture of Ala2Leu1 and Ala1Leu2 heterotrimers are observed in both the 1:2 and 2:1 
peptide mixtures. This does not contradict the above argument for the stability 
compromise between the presence of a hydrogen-bonding network between both the 
central and helical interface water molecules in addition to peptide stability provided by 
the included Leu residues.  
In all, the original hypothesis that heterotrimers were formed, selectively, due to 
the inclusion of Ala residues to better accommodate the bulky size of a PbII ion has been 
proven false. However, the Ala/Leu pairing in the layer above the metal Cys3 binding site 
seems instead to allow for a hydrogen bonding network between water molecules 
accommodated within the space provided by the smaller Ala hydrophobes and the p-
orbital of the cysteine residues. It seems that the stability of the peptide scaffold is due to 
a compromise in hydrophobic packing between Leu residues and the stability introduced 
via hydrogen bonding networks. In the case of PbII, with no evidence of a central water 
molecule, the Ala2Leu heterotrimer is formed selectively, perhaps due to maximal 
stability of the hydrogen bonding network in the presence of 2Ala residues; however, in 
the case of HgII, where a central water molecule is present, the hydrogen bonding 
network introduced in either the Ala2Leu or AlaLeu2 matchings could be comparable 
therefore removing any selectivity.   
 
Conclusions 
In this chapter I have presented evidence for the successful, selective formation of 
heterotrimeric A2B 3SCCs via methodologies that combine heavy metal nucleation with 
steric matching of natural amino acids (alanine and leucine residues), which is 
hypothesized to result in the inclusion of hydrogen-bonding networks near the metal 
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nucleation site. This design allows for the use of simple, self-assembling α-helices 
containing only coded amino acids to form an asymmetric helical scaffold with space in 
the same construct to incorporate a second metal binding site. Systems that combine 
Ala/Leu pairings in the layer above the Cys3 binding site are on the slow exchange 
regime as determined by 207Pb NMR and do not show coalescence. New 207Pb NMR 
peaks are observed for heterotrimeric mixtures and pKa determination of PbII binding to 
the A2B heterotrimer provides the lowest pKa value for PbII binding to Cys3 sites in our 
peptides to date. Considering that the pKa values of both homotrimers are more basic than 
the A2B heterotrimer, this provides additional evidence that a new species is formed and 
that we are not simply observing a mixture of the two, homotrimeric species. Elongation 
from TRI to GR peptides, addition of a second metal binding site toward the C-termini of 
the 3SCC, and varied pH conditions (pH 7.4-9.4) have proven not to perturb the 
specificity of heterotrimer formation. The presence of CoII or ZnII does not inhibit PbII 
binding and do not influence the 207Pb NMR shifts observed for either the homotrimers or 
heterotrimers. There is no evidence that inclusion of the Ala/Leu pairing in the layer 
below the Cys3 binding site allows for heterotrimer formation.  This is the first example 
of an asymmetric 3SCC scaffold with interior metal binding sites and all natural amino 
acids. With this methodology in hand, one may now use the asymmetry induced at the 
PbIICys3 site to expand asymmetry to other metal binding sites in the same scaffold and 
study more complex metalloenzyme active sites that either have mixed first coordination 
sphere environments or asymmetric 2nd-coordination spheres which provide electrostatic 
or hydrogen binding residues in close proximity to a catalytic center. 	 	
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Chapter 3. Characterization of Symmetric and Asymmetric Transition Metal 
Binding Sites within de Novo Designed Three-Stranded Coiled Coils 
 
Introduction 
While metal induced heterotrimers, as introduced and characterized in Chapter 2, 
are unprecedented in the literature, the ultimate goal of my thesis work was to obtain 
heterotrimeric peptides with a second, also asymmetric, metal binding site capable of 
binding transition metals with potential catalytic or redox-active properties. Once PbII-
nucleated heterotrimers were obtained, my next objective was to build, and characterize, 
a second metal binding site within the same scaffold. I rationalized that once selective 
heterotrimer formation was obtained via PbII nucleation at the Cys3 site, then asymmetry 
could be extended to a second metal binding site in either the primary or secondary 
coordination sphere.  
My initial objective was to expand upon the Carbonic Anhydrase (CA) mimic 
designed and characterized by Dr. Melissa Zastrow, which provided an excellent 
structural model of the primary coordination sphere of CA and catalytic rates for the 
native substrate that were only 400-fold slower than the fastest isozyme, HCAII.1–3 
Previously, all attempts to introduce secondary coordination sphere residues resulted in 
symmetric, three-fold inclusion into the 3SCC. For example, in the secondary 
coordination sphere of ZnII in CA there is a Thr residue that participates in catalysis, and 
when substituted for Ala results in a 100-fold decrease in functionality. Due to the 
symmetry previously imposed upon our 3SCCs due to self-association, inclusion of a Thr 
residue into our scaffolds provided a Thr3His3 environment, a system that does not offer 
increased catalytic efficiency over the original His3 model.4 Additionally, as outlined in 
the introduction of Chapter 2, asymmetric primary coordination spheres for transition 
metal binding are currently not attainable within our symmetric 3SCCs. 
	 110 
In this chapter, I will describe how I used the PbII-nucleated heterotrimer to 
design a transition metal binding site, with a nearby Asp residue, with the hope of 
introducing an acid/base catalyst in close proximity to a ZnII-bound water molecule in a 
His3 site. The CoII ion was used extensively as a spectroscopic probe to characterize the 
new, asymmetric metal binding site. I will explore how CoII UV-Vis, EPR, and XAS 
spectroscopic data support a 6-coordinate CoII site in homotrimeric samples and a 5-
coordinate CoII site. These structures will be compared to CoII-substituted native 
metalloenzymes including CA, carboxypeptidase A (CPA), thermolysin (TML), and 
VanX. Strong evidence of direct coordination of the metal to the new Asp residue, in the 
heterotrimeric peptides, will be presented. Interestingly, ZnII EXAFS of the 
heterotrimeric peptides show little difference from the homotrimeric data indicating two 
things: 1) The addition of the Asp residue does not seem to perturb significantly the 
coordination number of ZnII-binding when compared to the homotrimeric samples. 
Secondly, the data suggest that CoII may be a non-innocent probe for this site when 
compared to ZnII binding. Initial kinetics experiments on the new ZnII-bound 
heterotrimeric systems will be explored, with special comment made on the unexpected 
contributions to esterase activity from the heterotrimer-nucleating PbIICys3 site.  
I will consider the perturbations of the secondary coordination sphere around the 
binding site and how they affect heterotrimer formation as well as CoII binding. One such 
perturbation consists of altering the sequence of the peptide in order to place the Asp 
residue in the same peptide that contains the Ala substitution. Another point of discussion 
will be the perturbation on CoII spectral properties upon the addition of excess PbII to 
peptides containing multiple aspartate residues. The spectroscopic data support a hetero-
binuclear PbIICoII site at the end of the peptide away from the nucleating PbIISCys3 center. 
Other substitutions consist of changing the sterics around the His3 binding site. In 
particular, introduction of a DLeu residue in the layer above the His3 site results in the 
first observed difference in CoII binding between TRI and GR peptides with the same 
coordinating ligands in comparable positions within the sequence. 
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Materials and Methods 
Peptide Synthesis and Purification. Peptides were synthesized on one of two 
instruments: an Applied Biosystems 433A synthesizer or a Biotage Initiator+Alstra 
synthesizer on a Rink Amide Methylbenzhydrylamine (MBHA) resin using standard 
Fmoc-tBu-based protection protocols (HBTu/HOBt coupling).5 Crude peptides were 
cleaved from the resin using trifluoroacetic acid (TFA), ethandithiol, anisole, and 
thioanisole (90:3:2:5), dissolved in double distilled water and lyophilized to dryness. 
Purified peptides were isolated using a Waters 600 HPLC on a reverse phase C18 column 
(flow rate: 20 mL/min, solvent A: 0.1% TFA in water and B:0.1% TFA in 90:10 CH-
3CN:H2O. A linear gradient was used starting at 70:30, A:B and increasing to 20:80 over 
35 min.). ESI-MS was used to confirm the mass of purified peptide and collections were 
lyophilized to yield pure, white powder. Concentrations of all peptides were determined 
by tryptophan absorbance at 280 nm (ε = 5500 M-1cm-1).6 
Circular Dichroism (CD) and Ultraviolet-Visible (UV-Vis) Spectroscopy. CD spectra 
were collected on an AVIV 62DS spectrometer or a Jasco CD-Spectropolarimeter in a 1-
cm quartz cuvette at 25 °C. Guanidine hydrochloride (GuaHCl) titrations were carried out 
at pH 8.0 using an automated titrator with a syringe pump as described previously.7 UV-
Vis spectra were recorded in quartz cuvettes at room temperature on a Cary 100 Bio 
UV/Vis spectrometer. 
Pb(II)-binding titrations. Titrations of PbII into peptide were performed at room 
temperature and monitored via UV-Vis spectroscopy in a 1-cm quartz cuvette. LeadII 
titrations were completed in 50 mM TRIS buffer at pH 8.5 at a peptide concentration of 
30 µM. TRIS adjustments were made using small aliquots of concentrated KOH and HCl. 
Aliquots of a PbII(NO3)2 stock solution (standardized using inductively coupled plasma-
optical emission spectroscopy ICP-OES, Perkin-Elmer Optima 2000 DV with Winlab 
software) were titrated into the peptide solution. For all titrations, the difference spectra 
were obtained by subtracting the background spectrum of the peptide under identical 
conditions but in the absence of metal. After the addition of each aliquot, the solutions 
were stirred for ten minutes to allow for equilibration before recording the absorbance 
spectrum.  
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CoII-binding titrations.  
I) Direct CoII binding. Titrations of CoII into peptide solutions were performed at room 
temperature and monitored via Vis spectroscopy in a 1-cm quartz cuvette. CobaltII 
titrations were completed in 50 mM HEPES buffer (pH 7.5) at a peptide concentration of 
0.3-0.6 mM peptide trimer. HEPES adjustments were made using small aliquots of 
concentrated KOH or HCl. Aliquots of CoIISO4 stock solution (standardized using ICP-
OES, Perkin-Elmer Optima 2000 DV with Winlab software) were titrated into the peptide 
solution and absorbance spectra were recorded from 400-800 nm. For all titrations, the 
difference spectra were obtained by subtracting the background spectrum of the peptide 
in the absence of CoII. After the addition of each aliquot, the solutions were stirred for 
five minutes to allow for equilibration before recording the absorbance spectrum.  
 The titration curves were fitted to a non-linear least squares algorithm using Prism 
5 (GraphPad Software) with the data plotted as a function of absorbance (at the 
appropriate λmax for each peptide) versus total concentration of CoII added. Equation 1 
describes the binding equilibrium for these experiments. 
Co + Pep3  ⇌ CoPep3         Equation 1 
The apparent dissociation constant, Kd,CoPep3, was calculated using Equation 2.  
Kd,CoPep3 = [Pep3]f[Co]f       Equation 2 
                    [CoPep3] 
For the titration, aliquots of CoII were titrated into a solution of Pep3. The absorption 
band between 400 and 700 nm, due to the d-d transitions of CoII-bound to Pep3, was 
monitored and increased as CoII is complexed at the AspXHis3 site. Mass balance 
equations for [Co]T and [Pep]T can be defined and related to [Co]f and [Pep3]f as seen in 
Equations 4 and 6. Subscript ‘T’ indicates total concentrations as detailed in the 
experimental conditions. 
Mass Balance Equations: 
[Co]T = [Co]f + [CoPep3]       Equation 3 
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       [Co]f = [Co]T – [CoPep3]      Equation 4 
[Pep3]T = [CoPep3] + [Pep3]f       Equation 5 
   [Pep3]f = [Pep3]T – [CoPep3]     Equation 6 
Substituting Equations 4 and 6 into Equation 2 yields Equation 7 
Kd = ([Pep3]T – [CoPep3])([Co]T – [CoPep3]) 
                    [CoPep3]      Equation 7 
The Kd value can be directly related to the absorbance observed at λmax for each peptide 
(between 400-700 nm) by substituting [CoPep3] from Equation 8 (where b is the path 
length of the cuvette) into Equation 7.  
Absorbanceλmax = ελmax * [CoPep3] * b     Equation 8 
Rearrangement of Equation 7, in terms of Absorbanceλmax, can then be used to fit the 
titration data at λmax using Prism 5 (GraphPad Software)8 to yield the Kd of CoII-binding. 
ελmax was determined as part of the least squares analysis.   
 
II) CoII-binding pH Titrations. CoII was added to a solution of peptide and diluted to a 
concentration of 0.43 mM PbII(GRL2WL12AL16CL30H)3- in water. The pH was titrated 
by adding small aliquots of 5M KOH to the solution. The pH was monitored and allowed 
to stabilize before analysis of the CoIIAspXHisX band (λ≈560 nm) was conducted.   
 
NMR Spectroscopy. NMR samples were prepared by dissolving pure, lyophilized 
peptide in 10% D2O. Metallopeptides were prepared by addition of isotopically enriched 
207Pb(NO3)2 (92.4%, Oak Ridge National Laboratory, TN) to non-buffered solutions of 3-
5 mM peptide trimer. All samples were adjusted to the desired pH using small aliquots of 
concentrated KOH or HCl. 207Pb NMR spectra were recorded at a frequency of 145.9 
MHz on a Varian 700 MHz spectrometer at 25 °C with spin = 0, 0.20 ms relaxation time, 
and 20 ms acquisition time. Linear predictions (0-30 points) were performed to remove 
noise, and the real FID was determined as previously described.9–11 The data were 
processed with an exponential line broadening of 400-600 Hz using MestRe-C 
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software.12 The 207Pb NMR shifts are reported as the observed signal plus ~2986 ppm, 
and referenced by tetramethyllead (δ=0 ppm; toluene) using 1 M Pb(NO3)2 in D2O 
(natural abundance salt, δ=-2986 ppm) as an external standard. The external standard was 
run after each experimental collection to adjust for any shifting of the magnetic field.  
 
Electron Paramagnetic Resonance (EPR) Spectroscopy. EPR spectra were recorded 
using a Bruker X-band EMX electron spin resonance spectrometer with an Oxford 
Instruments liquid helium cryostat at ~7 K. All samples were prepared at ~1mM CoSO4, 
with 0.5 equivalents of CoII with respect to peptide trimer to ensure minimal free CoII was 
present. All samples were prepared in pH 7.5 HEPES buffer (final concentration ~30 
mM) with pH adjusted using small aliquots of concentrated KOH and H2SO4. Glycerol 
was added (25-50%) as a glassing agent. All EPR parameters were obtained via the 
fitting of collected spectra to obtain simulated spectra using EPR data fitting software 
(SpinCount).13  
 
X-ray Absorption Spectroscopy (XAS). Solutions of 1.0 mM PbIISMn+N/O(3SCC) were 
prepared with 30-50 mM HEPES buffer at pH 7.5. An excess of peptide (1.0 mM apo-
3SCC) was present to ensure the free ZnII or CoII concentration was minimal (<0.01%). 
The samples were pH adjusted then mixed with 50% glycerol (glassing agent) and loaded 
into a sample cell and frozen in liquid nitrogen for transport and analysis. All XAS 
measurements were performed at Stanford Synchrotron Radiation Lightsource, SSRL, 
(Beam line: 7-3). A Si(220) double crystal monochromator was utilized, with a flat Rh-
coated vertically collimating harmonic rejection mirror. Data were collected with a beam 
size of 1 x 9 mm2 and the X-ray energy was calibrated by collecting the absorption 
spectrum of a Co, or Zn, foil as a reference, placed between two ionization chambers 
situated after the sample, at the same time as the fluorescence data were collected, with 
the first infection point assigned as 7709.5 and 9670 eV, for CoII and ZnII data, 
respectively. The samples during data acquisition were maintained at a temperature of 
~7-9 K, and the data were measured in fluorescence mode with a 30-element energy 
resolving Ge detector. The data were collected using 10 eV steps in the pre-edge region, 
0.25 eV for the edge region, and 0.05 Å-1 increments for the extended x-ray absorption 
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fine structure (EXAFS) region up to k=13 Å-1, with integration times of 1 s in the pre-
edge and edge regions and 1-20 s (k3 weighted) in the EXAFS region for a total scan time 
of ~40 min. The raw data were examined for glitches and the fluorescence from the good 
channels was then utilized for averaging. The EXAFS data were analyzed using the 
EXAFSPAK14 suite of programs, where the theoretical amplitude and phase parameters 
used were calculated using FEFF 915 using two metal-ligand distances, the Debye-Waller 
factors for the Zn-O or Co-O and Zn-NHis or Co-NHis shells and E0 as the only adjustable 
parameters. For the remaining histidine distances, for the our shell scattering, assuming a 
rigid imidazole ring with distances and angles that equals to the average Co-histidine or 
Zn-histidine models found in the Cambridge Crystallographic data base, the imidazole 
Debye-Waller factors were defined taking into consideration that the σ2 value for each of 
these scattering paths will increase proportionally, were taken and used from the previous 
calculated data by Bunker et al.16 for an ordered imidazole. 
Magnetic Circular Dichroism (MCD) Spectroscopy. All MCD data collection and 
analysis was done in collaboration with Dr. Amy Speelman and Ashely McQuarters of 
Nicolai Lehnert’s laboratory at the University of Michigan. Solutions of ~2.0 mM 
PbIISMn+N/O(3SCC) were prepared with 30-50 mM HEPES buffer at pH 7.5. An excess of 
peptide (2.0 mM apo-3SCC) was present to ensure the free CoII concentration was 
minimal (<0.01%). The samples were pH adjusted then mixed with 50% ethylene glycol 
(glassing agent) and loaded into a sample cell and frozen in liquid nitrogen for transport 
and analysis. The MCD setup employs an Oxford SM4000 cryostat and a JASCO J-815 
CD spectrometer. The SM4000 cryostat consists of a liquid helium-cooled 
superconducting magnet providing horizontal magnetic fields of 0-7 T. The J-815 
spectrometer uses a gaseous nitrogen-cooled xenon lamp and a detector system consisting 
of two interchangeable photomultiplier tubes in the UV-Vis and NIR range. The samples 
were loaded into a 1.5-00 K variable temperature insert (VTI), which offers optical 
access to the sample via four optical windows made from Suprasil B quartz. The MCD 
spectra were measured in [θ] = mdeg and converted to Δε (M-1cm-1T-1) using the 
conversion factor Δε=θ/(32980•cdB), where c is the concentration, B is the magnetic field, 
and d is the path length. The product cd can be substituted by AMCD/εUV-vis, where A is the 
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absorbance of the sample measured by the CD spectrometer. The spectra were recorded 
at 2 K in a magnetic field of 7 T.  
 
Competitive ZnII-binding Titrations.  The apparent ZnII-binding constants were 
determined using a primary standard competition with the colormetric ZnII chelator, 
Zincon (2-carboxy-2’-hydroxy-5’-(sulfoformazyl)benzene). ZnII forms a 1:1 complex 
with Zincon (Zi) that offers a distinct absorption band at 620 nm (ε~16,000 M-1cm-1) at 
pH 9.0 and an apparent dissociation constant (Kd,app) of 3.5 x 10-8 M (consistent with 
reported Kd,app for ZnIIZi at pH 9.0).17–19 The parameters were evaluated at pH 9.0 (50 
mM CHES, 0.1 M Na2SO4) by titrating aliquots of ZnII (stock solutions were 
standardized using ICP-OES, Perkin-Elmer Optima 2000 DV with Winlab software) into 
a solution of 10 µM Zi. A 5 cm pathlength cell was used for the calibration titration of 
Zn-Zi binding at pH 9.0. For experiments involving removal of ZnII from ZnZi by peptide, 
an excess of Zi over ZnSO4 was used to ensure complete ZnII binding to Zi (10 µM Zi 
and 5 µM ZnII). For the opposite titration, where ZnII is bound to the peptide and removed 
via addition of Zi, the peptide was in excess (2 µM Pep3 and 1 µM ZnII). Both approaches 
should give similar apparent binding constants for ZnIIPep3, indicating equilibrium has 
been reached. The binding equilibrium for this competition can be expressed by Equation 
9. 
ZnPep3 + Zi ⇌ Pep3 + ZnZi         Equation 9 
The apparent dissociation constant of ZnPep3, Kd,ZnPep3, can be calculated using Equation 
10, where [Pep3]f and [Zi]f are free trimer and Zi, respectively. 
Kcomp = Kd,ZnPep3 = [Pep3]f[ZnZi]      Equation 10 
 Kd, ZnZi      [ZnPep3][Zi]f 
The forward reaction, defined as Zi titrated into ZnIIPep3, results in an absorption band at 
620 nm that increases as Zi is added to the ZnIIPep3 solution as a result of complexation 
of ZnII to form the ZnZi complex. The mass balance equations for [Zi]f and [Pep3]f can be 
described and related to [Zn]f and [Pep3]f as seen in Equations 12 and 14. Subscript ‘T’ 
indicates total concentrations as detailed in the experimental conditions. 
Mass Balance Equations: 
[Zi]T = [Zi]f + [ZnZi]        Equation 11 
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 [Zi]f = [Zi]T – [ZnZi]       Equation 12 
 
[Pep3]T = [ZnPep3] + [Pep3]f       Equation 13 
               [Pep3]f = [Pep3]T – [ZnPep3]    Equation 14 
Substituting Equations 12 and 14 into Equation 10 yields Equation 15.  
 
Kd,ZnPep3 = ([Pep3]T – [ZnPep3])[ZnZi]     Equation 15 
 Kd, ZnZi        [ZnPep3]([Zi]T- [ZnZi]) 
This equation can then be directly related to the absorbance observed at 620 nm by 
substituting [ZnZi] from Equation 16 (where b is the path length of the cuvette) into 
Equation 15. 
Absorbance620 nm = ε620nm * [ZnZi] * b     Equation 16 
Rearrangement of Equation 15 can then be used to fit the titration data at Abs 620 using 
Prism 5 (GraphPad Software)8 to yield the apparent Kd,ZnPep3 of ZnII-binding. An 
analogous approach was used for the reverse titration, defined as Pep3 titrated into a 
solution of ZnZi. ελmax was determined as part of the least squares analysis.   
 
Esterase Activity Assays. The esterase activities of ZnII-bound peptides (homotrimer 
PbIIS(GRL2WL12AL16CL30H)3- and heterotrimers PbIIS[(GR-ACH)2(GR-CH)]-, 
PbIIS[(GR-ACH) 2(GR-CDH)]n+, and PbIIS[(GR-ACH)2(GR-CTH)] n+) were determined 
spectrophometrically with pNPA (p-nitrophenol acetate) substrate (0.3-6.0 M) at room 
temperature in a 1-cm quartz cuvette. Data were collected at 348 nm, the isosbestic point 
for p-nitrohenol and p-nitropholate anion (ε = 5000 M-1cm-1).20 The observed activities 
were corrected for background ester hydrolysis in the absence of enzyme. The control 
reaction, ZnIISO4 in the presence of substrate and absence of enzyme, did not exhibit any 
activity above that of the blank (pNPA in buffer). Activities were determined at pH 9.5, 
50 mM CHES, 0.1 M Na2SO4. The substrate solution was prepared fresh daily in 
acetonitrile (3.0 mM pNPA). A cuvette containing 50 mM buffer, water, 6% acetonitrile 
(for consistency across substrate concentrations, due to solubility of the substrate), and 
pNPA was used as a background absorbance followed by addition of peptide (10 µM 
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ZnSO4 and 50 µM peptide, to ensure all ZnII was bound) to measure esterase activity. The 
increase in absorption at 348 nm was measured every 25 seconds for a minimum of 10 
min, and longer for the slower rates. Initial rates for each substrate concentration were 
determined from linear fits of product formation versus elapsed time. These slopes, the 
initial rates, ν, were then plotted as function of substrate concentration ([pNPA]) and 
fitted to the Michaelis-Menten equation (Prism 5, GraphPad Software)8, from which 
kcat/KM, kcat and KM values, with errors, were determined. Control experiments in the 
absence of the HisX, AspXHisX, and ThrXHisX, for PbIIS[(GR-AC)2(GR-C)]-, were 
completed to determine the esterase activity of the PbIIS3 site in the GR peptides, which 
was measured as non-negligible and will be discussed below. 
 
CO2 Hydration Activity Assays. Initial rates of CO2 hydration were measured at 25 °C 
on an OLIS RSM Stopped-Flow Spectrophotometer. CO2 itself does not have spectral 
properties that can be monitored, so a pH-indicator method was utilized to track the 
reactions. A buffer/indicator combination of CHES/thymol blue (pH 9.5, λmax = 590 nm, 
ε= 40,500 M-1cm-1)21 was used with an ionic strength of 0.1 M Na2SO4. Saturated 
solutions of CO2 were prepared by bubbling CO2 gas (Matheson Tri-Gas, Inc., Research 
Grade) through doubly distilled water for at least 20 minutes. Dilutions were made using 
gas-tight glass syringes and a final check of substrate concentration was determined 
during each concentration point as previously reported.4,21,22 Substrate concentrations 
ranged from 2-20 mM CO2. The substrate solution was mixed by the stopped-flow with 
either a catalyst solution (contains: buffer, indicator, PbIISZnIIN/O(GR-ACH)3+, and apo-
GR-ACH or control solution (contains: buffer, indicator and apo-GR-ACH). Each shot 
contained 50 mM buffer, 25 µM indicator, and 0.1 M Na2SO4. Control shots contained 88 
µM apo-GR-ACH and catalyst shots contained 88 µM PbIIS(GR-ACH)3- and 40 µM 
ZnSO4, ensuring final PbIISZnIIN/O(GR-ACH)3+ concentration of 40 µM. The experimental 
buffer factors were close to those that were calculated theoretically, as previously 
reported.1,4,21,22 Several seconds worth of absorbance data was collected upon rapid 
mixing of the substrate solution with the buffer/indicator solution by the stopped-flow 
apparatus. Initial rates were determined from the initial portion of the reaction (generally 
less than 10% of the reaction observed). At least 6 replicates at each substrate 
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concentration were averaged and the rate for the control was subtracted from that of the 
corresponding catalyst reaction. The difference, resulting in the initial rate of the ZnII-
catalyst, was plotted as a function of CO2 concentration and fitted using the Michaelis-
Menten equation in Prism 5 (GraphPad Software).8  
 
Results and Discussion 
Design of a Heterotrimeric 3SCC 
Armed with the ability to use PbII binding and steric matching to obtain 
heterotrimeric assemblies, I examined whether it would be possible to add a single 
acid/base catalyst in the layer above the His3 site. I used the GR family of peptides to 
mitigate the decreased stability caused by disrupting a third leucine layer. Because of the 
ambiguity for the location of the hydroxyl group presented by threonine, as discussed in 
Chapters 1 & 2, I instead inserted an aspartatic acid in the 26th position, as either 
orientation of the carboxylate would present an oxygen atom toward the His3 metal 
binding site (Figure 3-1). The resulting peptide was GRL2WL16CL26DL30H, 
designated GR-CDH (Table 3-1). An aspartate was chosen over glutamate to ensure that 
the ZnII could not simultaneously bind to the three histidine residues as well as the 
carboxylate moeity, which would be reminiscient of an M(His)3(Carboxylate)X(H2O)Y 
site found in iron/manganese superoxide dismutases. Models showed that the aspartate 
should form a hydrogen bond with the ZnII bound water, with a nearest oxygen-ZnII 
distance of 3.6 Å, compared to a metal-carboxylate distance of 1.8 Å with a modeled Glu  
(Figures 3-1A and 3-1B). Therefore, the first generation of heterotrimeric 3SCCs would 
conatin two metal binding sites. The first is used to nucleate the formation of the 
asymmetric scaffold via binding of PbII, and the second is used to bind transition metals. 
These heterotrimers would be obtained by mixing GR-ACH and GR-CDH in the 
presence of PbII to provide PbIIS[(GR-ACH)2(GR-CDH)1]n+ and PbIIS[(GR-ACH)1(GR-
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CDH)2]n+ (Table 1).* Protein stability and folding of GR-ACH and PbII binding to GR-
ACH is disucssed in Chapter 2. These results will be compared to GR-CDH below.  
 
Figure 3-1. Pymol models of possible hydrogen-bonding residues in the layer directly 
above a His3 transition metal binding site in a 3SCC. The metal-binding ligands are His 
residues and the hydrogen-bonding residues contain hydroxyl (Thr) or carboxylic acid 
(Asp or Glu) moieties with nitrogen atoms in blue and oxygen atoms in red. Metal ions 
are colored grey. The heterotrimeric assembly is emphasized by two green helices and 
one blue helix. (A) Side-on view of a modeled Asp1His3 site (Asp-ZnII distance of 3.6 Å). 
(B) Side-on view of a modeled Glu1His3 site (Glu-ZnII distance of 1.8 Å). Side-on views 
of modeled Thr1His3 sites with the hydroxyl group rotated (C) “out” toward the helical 
interface and (D) “in” toward the hydrophobic core (Thr-OH2 “in” distance is 4.3 Å). 
Models are generated using the crystal structure of HgIISZnIIN/O(CSL9PenCL23H)3n+ 
(PDB: 3PBJ).1  																																																								
* The nomenclature used to describe the metal complexes studied herein is as follows: When PbII 
is bound to the Cys3 site, the peptide, for example GR-CH, will be referred to as: PbIIS(GR-CH)3-, 
where ‘S’ represents the atom that coordinates the PbII ion. When CoII or ZnII are bound to a 
AspXHis3 site, there is a presumed mixed coordination sphere of nitrogen atoms from the His 
ligands and oxygen atoms from either the Asp carboxylic acid moieties or exogenous solvent 
molecules. ZnIIN/O or CoIIN/O will be used to indicate transition metal binding at the AspXHis3 site 
with an expected mixed primary N/O coordination sphere. The charge of the complex 
corresponds to the sum of the oxidation states of the metals, minus the charge of the coordinated 
ligands. In the case of a PbIICys3 site, the charge is (-), from PbII and three thiol ligands. When 
Asp residues are included in the sequence an (n+) charge is assigned due to the ambiguity of both 
of the protonation state of the Asp ligands in the presence of a transition metal as well as the 
coordination environment of the transition metal, for example: PbIISCoIIN/O(GR-CDH)3n+. In the 
absence of a transition metal, PbII binding to an Asp containing peptide will still be charged as 
(n+) due to the ambiguity of the protonation state of the Asp ligands in the hydrophobic protein 
environment, such as PbIIS(GR-CDH)3n+. 
A B 
C D 
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Table 3-1. Peptide Sequences 
Peptide Abbr. Sequence 
       abcdefg 
TRI  Ac-G LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
TRIL2W  Ac-G WKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
TRIL9CL23H  Ac-G LKALEEK CKALEEK LKALEEK HKALEEK G-NH2 
TRIL16C  Ac-G LKALEEK LKALEEK CKALEEK LKALEEK G-NH2 
TRIL12A16C  Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRIL12DL16C  Ac-G LKALEEK LKADLEEKCKALEEK LKALEEK G-NH2 
TRIL16Pen  Ac-G LKALEEK LKALEEKPenKALEEK LKALEEK G-NH2 
TRIL2WL23H  Ac-G WKALEEK LKALEEK LKALEEK HKALEEK G-NH2 
TRIL9CL23H  Ac-G LKALEEK LKALEEK CKALEEK HKALEEK G-NH2 
TRIL2WL19DLL23H TRI-DLH Ac-G WKALEEK LKALEEK LKADLEEKHKALEEK G-NH2 
   
GRAND GR Ac-G LKALEEK LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL16C GR-C Ac-G LKALEEK LKALEEK CKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL12AL16C GR-AC Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL16CL26DL30H GR-CDH Ac-G LKALEEK LKAAEEK CKALEEK LKADEEK HKALEEK G-NH2 
GRL2WL12AL16CL30H GR-ACH Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK HKALEEK G-NH2 
GRL2WL16CL30HL33D GR-CHD Ac-G LKALEEK LKAAEEK CKALEEK LKADEEK HKADEEK G-NH2 
GRL2WL12AL16CL26DL30H GR-ACDH Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK HKADEEK G-NH2 
GRL2WL16CL26TL30H GR-CTH Ac-G LKALEEK LKAAEEK CKALEEK LKATEEK HKALEEK G-NH2 
GRL2WL16CL30H GR-CH Ac-G LKALEEK LKAAEEK CKALEEK LKADEEK HKALEEK G-NH2 
GRL2WL16CL26DLL30H GR-CDLH Ac-G LKALEEK LKAAEEK CKALEEK LKADLEEKHKALEEK G-NH2 
   
CoilSer  Ac-E WEALEKK LAALESK LQALEKK LEALEH G-NH2 
CSL9PenL23H  Ac-E WEALEKKPenAALESK LQALEKK HEALEH G-NH2 
 
The stability of GR-CDH was investigated because three hydrophobic layers have 
been perturbed. CD spectroscopy and guanidine hydrochloride (GuaHCl) denaturation 
titrations were used to determine the folding and stability of GR-CDH (Figure 3-2). A 
characteristic CD spectrum with a double well with minima at 208 and 222 nm was 
observed, indicative of alpha-helical coiled coil structure. The spectrum for GR-CDH 
showed relatively good folding with a molar ellipticity [Θ] of -26046 deg dmol-1 cm2, 
which corresponds to ~74% initial folding compared to an ideal, fully folded alpha-
helical structure. This model cannot be fit to a two step denaturation curve due to the lack 
of a defined folded state before addition of GuaHCl, but analysis of Figure 3-2 shows a 
midpoint at approximately 1 M for the denaturation of GR-CDH. The GR-CDH shows 
~20% less α-helical content, in the absence of denaturant, as compared to GR-ACH and 
has a lower midpoint (~1 M compared to ~2 M for GR-ACH).   
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Figure 3-2. Guanidine hydrochloride denaturation titration data of 8 µM 3SCC GR-CDH 
in 10 mM Phosphate buffer at pH 8.0. Inset: CD spectra of GR-CDH before (red) and 
after (blue) the addition of 7 M GuaHCl. 
PbII binding to GR-CDH was analyzed via UV-Vis spectroscopy to determine if 
the presence of Asp/His combined mutations affected the binding of PbII to the Cys3 site. 
Aliquots of PbII(NO3)2 were added to a solution of 60 µM GR-CDH, resulting in 20 µM 
3SCC, in 100 mM TRIS buffer at pH 8.5. As the peptides complex PbII, an increase in 
absorbance at 348 nm is observed, characteristic of PbIICys3 binding9,11,23,24 and 
consistent with PbII binding to GR-CH (Figure 3-3A). Analysis of the spectra determines 
a maximal absorbance is reached at one equivalent of PbII added. The immediate leveling 
out of the titration curve at one equivalent of PbII added, as observed in Figure 3-3B, 
indicates that PbII binding is extremely tight to the Cys3 sites and association constants 
cannot be directly measured via this technique as no equilibrium is observed between free 
and bound PbII in the presence of our peptides, which again is consistent with GR-ACH. 
Linear regression analysis of the data at 348 nm provided molar extinction coefficients of 
3470 M-1cm-1, which is comparable to previously reported PbIICys3 sites (3520 M-1cm-1 
for GR-ACH from Chapter 2). Therefore, I have determined that PbII binds preferentially 
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to the Cys3 site in the homotrimeric aggregate even in the presence of an L26D 
subsitution, leaving open the posibility of adding a transition metal to the 
aspartate/histidine site.   
 
 
Figure 3-3. UV titration spectra of the addition of PbII into a solution of A) 20 µM 
(3SCC) GR-CDH and B) the corresponding titration curve showing the 1:1 binding 
stoichiometry of equivalents of PbII, added with respect to 3SCC, at 348 nm. Data 
collected at pH 8.5 in 50 mM TRIS Buffer. 
 
Spectroscopic Characterization of CoII-Bound Homotrimers 
Because ZnII is spectroscopically silent, CoII is often added to biomolecules to act 
as a spectroscopic probe to elucidate metal site structure.25–29 Here, I used CoII UV-Vis, 
EPR, and XAS spectroscopies to monitor CoII-binding to the second metal binding site 
included in the homo- and heterotrimeric constructs. Perturbations of the CoII 
spectroscopy in these heterotrimeric constructs, nucleated via PbII binding to the Cys3 site 
with a neighboring Ala/Leu steric matching layer, should allow for distinction between 
symmetric and asymmetric second metal binding sites. I started with analysis of the CoII 
site of two homotrimeric systems, which are expected to structurally resemble both CA 
and our previously studied 3SCC CA mimic (HgIISZnII(OHX)N/O(TRIL9CL23H)3n+, 
discussed in Chapter 1, Table 3-1)1.  
Aliquots of CoIISO4 were added to solutions of GR-ACH and GR-CDH, in 50 
mM HEPES at pH 7.5. One equivalent of PbII(NO3)2 was also present in both solutions. 
Upon addition of CoII to the homotrimeric PbIIS(GR-ACH)3-, a broad peak at 517 nm (ε = 
A	 B	
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30 M-1 cm-1) was observed (Figure 3-4) and attributed to CoII binding to the His3 site. The 
homotrimeric spectrum, resulting from the asprtate modified peptide, PbIIS(GR-CDH)3n+, 
displayed a red-shifted peak at 543 nm (ε = 83 M-1 cm-1) after CoII addition (Figure 3-4). 
Thus, to understand the structure, it is worthwhile considering the spectroscopic behavior 
of CoII. 
 
Figure 3-4. UV-Vis overlay of PbIISCoIIN/O(GR-CH)3n+, in red, and PbIISCoIIN/O(GR-
CDH)n+, in purple at pH 7.5 in 50 mM HEPES buffer. Data are plotted as molar 
extinction coefficient (determined using CoII concentration) versus wavelength.  
In general, CoII geometry is separated into three groups, which may be 
distinguished by the extinction coefficients of the d-d transitions of these systems. First, 
octahedral CoII complexes usually do not exceed extinction coefficients of ~50  
M-1cm-1.30,31 Conversely, tetrahedral CoII complexes can have extinction coefficients of 
300 M-1cm-1 or greater.26 Five-coordinate CoII complexes generally fall between these 
two extremes with extinction coefficients of 50-250 M-1cm-1. However, ambiguity is 
often encountered due to distortion of the CoII coordination geometry. Therefore, 
assigning coordination number based on UV-Vis characteristics is a non-trivial task; 
however, in the case of both PbIISCoIIN(GR-ACH)3+ and PbIISCoIIN(GR-CDH)3n+,  the low 
extinction coefficients (ε ~ 30-80 M-1 cm-1, Table 3-2) and broad single peaks of these 
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spectra indicate relatively high symmetry at the CoII binding site, and probably octahedral 
coordination geometry.  
Table 3-2. Electronic absorption values for CoII bound complexes 
Complex Solvent λmax, nm (ε, M-1cm-1) 
PbIISCoIIN/O(GR-ACH)3+ HEPES Buffer (pH 7.5) 517 (30) 
PbIISCoIIN/O(GR-CDH)3n+ HEPES Buffer (pH 7.5) 543 (83) 
PbIISCoIIN/O(GR-CHD)3n+ HEPES Buffer (pH 7.5) 517 (30) 
HgIISCoIIN/O(GR-CDH)3n+ HEPES Buffer (pH 7.5) 543 (83) 
CoIIN/O(TRIL2WL23H)32+ HEPES Buffer (pH 7.5) 517 (35) 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1)]n+ HEPES Buffer (pH 7.5) 517 (147), 545 (155), 590 (124), 628 (~35) 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2)]n+ HEPES Buffer (pH 7.5) 517 (152), 547 (173), 583 (133) 
⅔(PbIISCoIIN/O(GR-ACH)3+)+ 
⅓ (PbIISCoIIN/O(GR-CDH)3n+) - calc 
HEPES Buffer (pH 7.5) 523 (48) 
⅓(PbIISCoIIN/O(GR-ACH)3+)+ 
⅔(PbIISCoIIN/O(GR-CDH)3n+) - calc 
HEPES Buffer (pH 7.5) 540 (83) 
CoIIN/O[(GR-ACH)2(GR-CDH)1)]n+ HEPES Buffer (pH 7.5) 519 (130), 545 (144), 590 (112) 
CoIIN/O[(GR-ACH)1(GR-CDH)2)]n+ HEPES Buffer (pH 7.5) 519 (117), 545 (131), 590 (~80) 
PbIISCoIIN/O[(GR-ACH)2(GR-CHD)1)]n+ HEPES Buffer (pH 7.5) 515 (58), 590 (~30) 
PbIISCoIIN/O[(GR-ACH)1(GR-CHD)2)]n+  HEPES Buffer (pH 7.5) 513 (47), 590 (~18) 
PbIISCoIIN/O(GR-ACDH)3n+ HEPES Buffer (pH 7.5) 543 (110) 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1)]n+ HEPES Buffer (pH 7.5) 517 (200), 544 (215), 586 (167), 626 (~60) 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2)]n+  HEPES Buffer (pH 7.5) 524 (152), 544 (165), 592 (120) 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1)]n+ HEPES Buffer (pH 7.5) 543 (68) 
PbIISCoIIN/O(TRI-DLH)34+ HEPES Buffer (pH 7.5) 517 (~59), 541 (62), 588 (~33) 
PbIISCoIIX(GR-CDLH)3n+ HEPES Buffer (pH 7.5) 507 (~11) 
CoIIX(TRIL2W) HEPES Buffer (pH 7.5) 505 (~9) 
[CoII(BPZG)Cl]38  CH2Cl2 504 (133), 546 (~150), 593 (255), 615 (~100) 
CoII-CPA27 TRIS Buffer (pH 7.0) 505 (120), 550 (155), 585 (160) 
CoII-Thermolysin28 HEPES Buffer (pH 7.0) 495 (60), 550 (80) 
CoII-VanX48 TRIS Buffer (pH 7.6) 515 (110), 550 (110), 595 (~83) 
CoII-HCAII30 H2O, pH 7.1 513 (180), 556 (250), 615 (190), 641 (200) 
CoII(tris-pyrazolyl)30 H2O, ≤7.8 507 (40) 
CoII (tris-pyrazolyl)30 H2O, ≥8.0 460 (sh), 478 (45), 615 (20), 641 (25) 
Scarpelini39 Bertini32VanX49TML28CPA27 
Figure 3-5 shows an overlay of the visible spectra of PbIISCoIIN(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+ with HgIISCoIIN/O(GR-CDH)3n+ and CoIIN/O(TRIL2WL23H)32+ 
(data for both peptides without PbII were collected by Dr. Melissa Zastrow, Table 1). 
Nearly identical spectra between 400-700 nm are observed for PbIISCoIIN/O(GR-ACH)3+ 
and CoIIN/O(TRIL2WL23H)32+, indicating that elongation of the peptide sequence from 
TRI to GR does not effect the CoII binding to a His3 a-site. It also supports the 
assumption that the presence of the PbIICys3 site does not perturb CoII binding to a His3 
site. The similarity observed between PbIISCoIIN(GR-CDH)3n+ and HgIISCoIIN/O(GR-
CDH)3n+ shows that the identity of the heavy metal bound to the Cys3 site does not 
influence the CoIIHis3 visible spectrum.  
	 126 
 
Figure 3-5. UV-Vis overlay of PbIISCoIIN/O(GR-CH)3n+ (red), PbIISCoIIN/O(GR-CDH)3n+ 
(purple), HgIISCoIIN/O(GR-CDH)3n+ (dashed green), and CoIIN/O(TRIL2WL23H)3n+ 
(dashed blue) at pH 7.5 in 50 mM HEPES buffer. Data are plotted as molar extinction 
coefficient (determined using CoII concentration) versus wavelength.  
Apparent dissociation constants, Kd,CoPep3, for CoII binding to the His3 site, with 
and without an Asp3 mutation in the layer directly above the metal binding site (with 
respect to the N-termini) were determined using a non-linear least square fitting analysis 
(Equation 7). Titration data at λmax = 517 and 543 nm, for GR-ACH and GR-CDH, 
respectively, were plotted as a function of CoII concentration, adjusting for any non-
specific binding of CoII and fitted as derived in the Methods Section.4 The binding 
affinities of CoII obtained for GR-ACH and GR-CDH, at pH 7.5, are Kd = 40.9 ± 6.2 and 
49.5 ± 7.7 µM, respectively (Figure 3-6, Table 3-3). The value obtained for CoII binding 
to a His3 site is the same within error as that reported previously by Dr. Melissa Zatrow 
for a His3 site in a comparable TRI peptide (Kd = 35 ± 4).4 The Asp3His3 value is only 
slightly elevated in comparison to the reported value (Kd = 25 ± 9)4 but is still within the 
experimental error. These results are particularly interesting because concurrent 
experiments have shown that CuI binding affinities to Cys3 and His3 sites are dependent 
on the length of the peptide analyzed (See Chapter 4). This indicates that relative metal 
binding affinities appear to be dependent on the metal and the metal binding site/peptide 
analyzed. Furthermore, within error, the dissociation constant for CoII binding to a His3 
and Asp3His3 site are the same. 
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Figure 3-6. UV-Vis titration and titration curves of CoIISO4 added to a solution of 1.73 
mM PbIIS(GR-CH)3- (A and B) and 2.13 mM PbIIS(GR-CDH)3n+ (C and D) at pH 7.5 in 
50 mM HEPES buffer. The titration data (A and C) are plotted as absorbance versus 
wavelength and the titration curves (B and D) are plotted as absorbance at λmax versus 
[CoII]. The trace that correlates to one equivalent of [CoII] added, with respect to 3SCC, is 
shown in red. The black circles represent the raw data and the non-linear best-fit curve is 
shown as a black line (Equation 7, as described in the Materials and Methods section).  
Dr. Melissa Zastrow previously determined that CoII binds to the His3 site of 
TRIL2WL23H (Table 3-1) with analogous spectral features observed between pH 5.5 to 
pH 9.8.4 Comparison of the UV-Vis traces of the CoII d-d bands of PbIISCoIIN/O(GR-
ACH)3+  and HgIISCoIIN/O(TRIL9CL23H)3+ revealed that elongation of the peptide from 
TRI to GR did not alter the UV-Vis features of a CoIIHis3 site (Figure 3-5). Additionally, 
the metal bound at the Cys3 site, HgII or PbII, made no difference in terms of the CoII-
binding UV-Vis data. I confirmed the similarities of CoII binding to His3 sites in GR and 
TRI peptides again by analyzing the pH dependence of PbIISCoIIN/O(GR-ACH)3+ where 
CoII binding is observed starting at pH ~5.5 and the spectral trace is essentially 
unchanged until pH ~9.0 (Figure 3-7). The primary goal of this pH titration was to 
determine if CoII binding to a His3 site in a GR peptide is the similar to the same site in a 
A B 
C D 
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TRI peptide, and whether at pH of 7.5 was appropriate for analyzing CoII-bound homo- 
and heterotrimers. The data reported here confirm that complete complexation of CoII is 
observed before pH 7.5 and that the spectra look identical between GR and TRI CoIIHis3 
sites.  
Table 3-3. Apparent dissociation constants for CoII binding to AspXHis3 
sites in the TRI and GR peptides at pH 7.5. 
Peptide Kd, app (µM) 
PbIISCoIIN/O(GR-ACH)3+ 41 ± 6 
PbIISCoIIN/O(GR-CDH)3n+ 50 ± 8 
PbIISCoIIN/O(GR-CHD)3n+ 350 ± 80 
HgIISCoIIN/O(GR-CDH)3n+ 35 ± 4* 
CoIIN/O(TRIL2WL23H)32+ 25 ± 4* 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 20 ± 2 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2)]n+ 7.9 ± 3.9 
PbIISCoIIN/O[(GR-ACH)2(GR-CHD)1)]n+ 10 ± 6 
PbIISCoIIN/O[(GR-ACH)1(GR-CHD)2)]n+ 18 ± 8 
PbIISCoIIN/O[(GR-ACH)2(GR-CTH)1)]n+ 13 ± 2  
PbIISCoIIN/O(GR-ACDH)3n+ 11 ± 3 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1)]n+ 11 ± 1 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2)]n+ 22 ± 2 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1)]n+ 25 ± 10 
PbIISCoIIN/O(TRI-DLH)34+ 39 ± 9 
*Data collected by Dr. Melissa Zastrow.4  
 
I then looked to CoII-substituted native enzymes to help elucidate the metal 
environment in our homotrimeric systems. Bertini et al. has extensively studied both 
CoII-substituted CA as well as small molecule CA mimics with complexes that retain 
enzymatic activity.29,32 In the cases of both the small molecule mimics and the native 
enzyme there are significant pH-dependencies of these systems, ascribed to the acid-base 
properties of the active site. The UV-Vis spectrum of CoIICA provides a maximal 
extinction coefficient of 300 M-1cm-1, indicative of a probable four-coordinate, 
tetrahedral metal environment. The extreme decrease in extinction coefficient observed in 
both homotrimeric systems, PbIISCoIIN/O(GR-ACH)3+, and PbIISCoIIN/O(GR-CDH)3n+, 
suggests both higher symmetry and higher coordination number.  
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Figure 3-7. UV-Vis spectra representing the pH titration of 0.43 mM PbIISCoIIN/O(GR-
ACH)3n+ with inset: the corresponding titration curve at 517 nm. The spectral data are 
plotted as absorbance versus wavelength and the titration data are plotted as absorbance 
at 517 nm versus pH. The pH titration was initiated at low pH and increased using small 
aliquots of concentrated KOH. The black circles represent the raw absorbance data at 517 
nm. 
Interestingly, when comparing to CoII[tris-(3,5-dimethyl-1-
pyrazolylmethyl)amine] hydrate, a CA small molecule mimic with approximate trigonal 
bipyramidal geometry and N4O coordination, at pH ~7.7-8.0, we see a very similar trace 
when compared to PbIISCoIIN/O(GR-ACH)3+ (Figure 3-8, Table 3-2).33,34 Conversely, 
when the pH of the pyrazolylmethyl complex is increased, the trace looks more like the 
PbIISCoIIN/O(GR-CDH)3n+ homotrimer (Table 3-2). The spectra of CoII[tris-(3,5-dimethyl-
1-pyrazolylmethyl)amine] hydrate is different at high and low pH, presumably due to a 
transition from CoII-OH2 to CoII-OH. The similarities between the lower pH spectra with 
PbIISCoIIN/O(GR-ACH)3+ (at pH 7.5) and the similarities between the higher pH spectra 
with PbIISCoIIN/O(GR-CDH)3n+ (at pH 7.5) could indicate that the negative environment 
introduced by the Asp3His3 peptide could promote deprotonation of a bound water 
molecule at lower pH than the corresponding His3 containing peptide.   
It has been reported that CoII-bound CA yields octahedral geometries upon 
oxidation to CoIII.35 To address the possibility of air-oxidation of CoII to CoIII, the above 
experiments were repeated anaerobically. Samples were prepared identically to aerobic 
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samples with the exception of being in an inert atmosphere glove box using oxygen-free 
buffer solution, water, peptide stocks and metal stocks. In the cases of both PbIIS(GR-
ACH)3- and PbIIS(GR-CDH)3n+, addition of CoIISO4 in an anaerobic environment resulted 
in identical UV-Vis spectra as the aerobic experiment (Figure 3-9). These results indicate 
that our CoII-bound systems are not air sensitive and oxidation from CoII to CoIII is not 
observed. Future studies will address the changes of the d-d absorption bands following 
the chemical oxidation of CoII to CoIII. 
 
Figure 3-8. (A) pH dependence of the electronic spectra of the CoII[tris-(3,5-dimethyl-1-
pyrazolylmethyl)amine] hydrate complex in water shown as ε (dm3mol-1cm-1) vs. 
Wavenumber (cm-1 x 10-3). From the top, pH 9.55, 9.3, 9.15, 8.9, 8.7, 8.3, 7.9, 7.7, 7.6, 
7.2, 6.2, 5.0. The pH of the solid line (8.3) is that resulting from dissolving the complex 
in water at 10-3 mol dm-3 concentration. Panel A adapted from Ref 32. (B) UV-Vis 
overlay of PbIISCoIIN/O(GR-CH)3n+, in red, and PbIISCoIIN/O(GR-CDH)n+, in purple at pH 
7.5 in 50 mM HEPES buffer. Data are plotted as molar extinction coefficient (determined 
using CoII concentration) versus wavenumber (cm-1 x 103).32 
 
Figure 3-9. UV-Vis overlay of (A) PbIISCoIIN/O(GR-CH)3n+ and (B) PbIISCoIIN/O(GR-
CDH)3n+ collected aerobically (red lines) and anaerobically (black dashed lines) at pH 7.5 
in 50 mM HEPES buffer. Data are plotted as molar extinction coefficient (determined 
using CoII concentration) versus wavelength.  
A B 
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In order to obtain metrical parameters for the CoII coordination environment, X-
ray absorption spectroscopy (XAS) was used to analyze CoII bound homotrimers. 
Samples consisted of ~2 mM PbII-bound 3SCC, 0.5 equivalents of CoIISO4, ~30-50 mM 
buffer and ~50% glycerol. Data was collected at ~7-11 K. XAS data were collected and 
processed in collaboration with Dr. Aniruddha Deb of the Penner-Hahn Laboratory 
(University of Michigan). Examination of the X-ray absorption near edge structure 
(XANES) shows a pre-edge feature at 7710 eV consistent with a CoII 1s-3d transition 
(Figure 3-10). This transition is symmetry forbidden and is more intense as the symmetry 
around the metal center is relaxed; therefore, a correlation can be drawn between the 
intensity of this peak and the coordination number of the CoII complex. In particular, the 
area under the peak, as well as the number obtained by dividing the height of the pre-
edge peak by the main edge height, can then be compared to values determined from 
complexes with known coordination numbers and geometries. For PbIISCoIIN/O(GR-
ACH)3+ the values for both the area under the pre-edge peak, in percentage, and the ratio 
of the pre-edge:edge peaks are 5.8 and 2.0, respectively (Table 3-4). The addition of the 
Asp mutation provides an increase in the pre-edge peak area to 7.6, but a slight decrease 
in the ratio of the pre-edge:edge peaks to 1.9. These values, for both of these peptides, are 
consistent with with 5-coordinate CoII small molecules complexes (Cambridge Structural 
Database).36  
 
Figure 3-10. XANES spectra of the CoII (A) pre-edge and (B) edge of homotrimers: 1.0 
mM PbIISCoIIN/O(GR-ACH)3n+ (red) and 1.0 mM PbIISCoIIN/O(GR-CDH)3n+ (purple) at pH 
7.5 in 30 mM HEPES.  
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Table 3-4. CoII XANES pre-edge:edge height area and pre-edge area for CoII binding 
to AspXHis3 sites in homo- and heterotrimeric GR peptides at pH 7.5. 
Peptide Pre-edge Area (%) Pre-edge:Edge 
Ratio 
PbIISCoIIN/O(GR-ACH)3+ 6.0 2.0 
PbIISCoIIN/O(GR-CDH)3n+ 7.6 1.9 
PbIISCoIIN/O(GR-CHD)3n+ 5.5 2.2 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 5.8 2.0 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2)]n+ 9.4 2.8 
PbIISCoIIN/O(GR-ACDH)3n+ 6.6 2.0 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1)]n+ 10.3 3.5 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2)]n+ 15.4 6.3 
 
A nearest-neighbor peak, typical of scattering observed by direct nitrogen and/or 
oxygen metal coordination, dominates the extended X-ray absorption fine structure 
(EXAFS) data and is best fit with a single nitrogen/oxygen shell at ~2.10 Å (Table 3-5 
and Figure 3-11). There is also evidence in both homotrimer samples of outer shell 
scattering typical of histidine coordination (Figures 3-11A and 3-11C, 2.5 < R < 4 Å). 
Multiple models with varying numbers of imidazole and oxygen ligands were used to fit 
these data, but the best fit was determined to be six oxygen/nitrogen ligands with an 
average CoII-N/O distance of 2.115 Å for both PbIISCoIIN/O(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+, with DW: 1.5 & 7.6, F=404 and DW: 2.2 & 6.6, F=291, 
respectively, where DW is the Debeye Waller factor and F is the goodness of fit (Table 3-
5).  
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Figure 3-11. Fourier transform of CoII EXAFS of (A) 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ 
and (C) 1.0 mM PbIISCoIIN/O(GR-CDH)3n+ at pH 7.5 in 30 mM HEPES. CoII EXAFS (B) 
PbIISCoIIN/O(GR-ACH)3n+ and (D) PbIISCoIIN/O(GR-CDH)3n+. Experimental data is shown 
in black and best fits for N3O3 CoII-coordination are shown in red dashed lines. 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
	 134 
Table 3-5. EXAFS fitting parameters for CoII binding to AspXHis3 sites in homo- and 
heterotrimeric GR peptides at pH 7.5. 
Peptide 
CoII-L 
distance 
(Single), Å 
CN* 
Multi-
scattering 
shell 
CoII-L 
distance 
(Multi), Å 
DW 
(Multi) F 
PbIISCoIIN/O(GR-ACH)3+ 2.10 6 
N3O3 2.115 1.5, 7.6 404 
N2O4 2.103 3.4, 6.3 316 
PbIISCoIIN/O(GR-CDH)3n+ 2.10 6 
N3O3 2.115 2.2, 6.6 291 
N2O4 2.101 4.9, 5.7 269 
PbIISCoIIN/O(GR-CHD)3n+ 2.08⌘ - - - - 344 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 2.07 5 or 6 
N3O2 2.075 1.3, 9.2 573 
N2O3 2.070 2.0, 10 434 
N3O3 2.085 2.8, 9.0 474 
N2O4 2.085 4.0, 7.7 377 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2)]n+ 2.07 5 or 6 
N3O2 2.080 5.0, 9.0 248 
N3O3 2.085 2.8, 9.0 226 
PbIISCoIIN/O(GR-ACDH)3n+ 2.09 6 
N3O3 2.105 3.7,8.8 281 
N2O4 2.093 5.3,6.4 277 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1)]n+ 2.05⌘ - - - - 226 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2)]n+ 1.98 4 
N2O2 1.995 4.2, 9.4 218 
N3O1 1.995 5.1, 6.0 278 
Single indicates fits of direct N/O ligands only. Multi indicates fits considering backscattering of His and Asp 
residues. *CN is coordination number used for the multi-scattering fits. For PbIISCoIIN/O[(GR-ACH)1(GR-
CDH)2)]n+, the data would not fit to N2O4 or N2O3 primary coordination spheres. DW and F correspond to 
Debye Waller factors and goodness of fit parameters, respectively. ⌘Samples indicative of mixed CoII 
coordination numbers, therefore fits with multi-scattering secondary spheres were not conducted. 
 
Interpretation of the CoII XAS data has proven non-trivial. The EXAFS bond 
distances are simply too long, when compared to small model complexes, to correlate to 
five-coordinate, or lower, binding sites. However, the EXAFS bond distances contradict 
the data obtained via analysis of the pre-edge/edge ratios and the pre-edge area values, 
which support a CoII coordination number of five. With data that supported both 6- 
(EXAFS distances) and 5-coordinate (XANES analysis), I wanted to address the 
possibility of a mixed 6- and 4-coordinate environment. If indeed the samples were 
comprised of mostly 6-coordinate CoII ligation but a small amount of 4-coordinate 
ligation, this could explain why the pre-edge/edge ratios and the pre-edge area values are 
slightly higher than 6-coordinate complexes, while the EXAFS data are dominated by the 
longer 6-coordinate species. Therefore, I analyzed whether a mixture of 4- and 6-
coordinate distances would provide two peaks, resolvable via fitting of the EXAFS data. 
Simulated mixtures of two average bond distances were analyzed, the shorter bond 
distance was set at 1.98 Å, consistent with a Co-N/O bond distance in a tetrahedral 
complex, and the second bond length, correlating to the 6-coordinate CoII species, was 
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varied from 2.10 to 2.19 Å at 0.02-0.03 Å intervals (Figure 3-12). At the smallest 
difference in distance between the two distances only one peak is observed in the 
EXAFS; however, an increase of the long distance from 2.10 Å to 2.13 Å provided a 
simulated spectrum with a visible shoulder, correlating to the 1.98 Å distance scatterer 
(Figure 3-12, green trace). As the difference between the distances increases, the peaks 
become more resolved. The EXAFS data, with best-fit distances of 2.115 Å, correlates to 
a difference of 0.135 Å when compared to a 4-coordinate distance of 1.98 Å. Therefore, 
if the homotrimer samples contained both 4- and 6-coordinate CoII species we might 
expect to see a shoulder correlating to the lower coordination species. Both homotrimer 
samples show very symmetric peaks and, therefore, do not obviously support the 
presence of a 4-coordinate species in the sample; however, this possibility cannot be 
completely ruled out at this time. 
 
Figure 3-12. Overlay of simulated Fourier Transform traces for fits of mixed four- and 
six-coordinate CoII complexes with varying CoII-ligand 6-coordinate distances. All traces 
have four-coordinate distances set at 1.98 Å with varied six-coordinate distances from 
2.10 Å (red), 2.13 Å (green), 2.15 Å (dark blue), 2.17 Å (purple) and 2.19 Å (light blue).  
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X-band EPR spectra were collected for both the PbIISCoIIN/O(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+ homotrimers at 4K. Samples were prepared analogously to the 
XAS samples. Both homotrimeric peptides produced two relatively axial signals similar 
to each other and to that of CoII-substituted CA (Figure 3-13).33,37 Grell and Bray suggest 
a 4-coordinate environment for the similarly axial signal for CoIICA.37 However, 
considering both the very low extinction coefficients as determined by UV-Vis 
spectroscopy, for both of the homotrimers, and the EXAFS fits providing bond distances 
that are too long to be consistent for either 4- or 5-coordinate CoII environments, I 
propose that both PbIISCoIIN/O(GR-CDH)3- and PbIISCoIIN/O(GR-ACH)3+ are 6-coordinate 
CoII species. The similarities in the EPR data are most likely due to both tetrahedral and 
octahedral coordination environments having cubic symmetry, both of which result in 
quartet ground states and, therefore, the similar EPR spectra.  
 
Figure 3-13. X-Band EPR spectra of 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ (red) and 1.0 mM  
PbIISCoIIN/O(GR-CDH)3n+ (purple) at pH 7.5 in 30 mM HEPES, collected at 10 K. 
At this time, the differences between the XANES and EXAFS data have proven 
difficult to explain. However, the majority of the spectroscopic data including the low 
extinction coefficients observed via UV-Vis analysis, the relatively axial spectra obtained 
via EPR analysis and the long 2.115 Å distances obtained from EXAFS fits support 
highly symmetric, and probably 6-coordinate, CoII centers in both PbIISCoIIN/O(GR-
ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+. The perturbations observed in the UV-Vis spectra 
support different coordination ligands between the Asp3His3 and His3 sites. The CoII site 
	 137 
in (GR-ACH)3 is mostly likely made up of three histidine residues and three oxygen 
atoms, presumably from coordinated water molecules. The CoII center of (GR-CDH) is 
most likely still 6-coordinate but could have one less histidine ligand and a direct Asp 
ligand, such as CoIIN2Carboxylate1(OH2)3; however, at this time I cannot rule out a 
N3(OH2)3 environment in which the bound molecules are perturbed by hydrogen-bonding 
to the nearby Asp3 layer.    
In collaboration with the laboratory of Nicolai Lehnert, I also analyzed 
PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ via Magnetic Circular Dichorism 
(MCD) Spectroscopy. Samples were prepared similarly to the EPR and XAS samples 
with the exception of using ethylene glycol as a glassing agent instead of glycerol. 
PbIISCoIIN/O(GR-ACH)3+ provided an MCD spectra with a  negative signal centered at 
593 nm and a positive signal at 550 nm (Figure 3-14A). PbIISCoIIN/O(GR-CDH)3n+ 
exhibited only one strong negative band at 490 nm (Figure 3-14B).  
 
Figure 3-14. Absorbance (top) and MCD (bottom) spectra of ~2.0 mM PbIISCoIIN/O(GR-
ACH)3n+ (A) and PbIISCoIIN/O(GR-CDH)3n+ (B) at pH 7.5 in 50 mM HEPES, collected at 
RT (Absorbance) and 2K (MCD). 
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According to Kaden et al. there are three general groups used to characterize the 
overall fingerprint of CoII MCD spectra, dependent on the coordination geometry of the 
metal ion. Octahedral systems exhibit an absorption maximum of low intensity centered 
near 500 nm (Figure 3-15A).38 Tetrahedral CoII complexes exhibit a significant negative 
band at low frequency (~600-700 nm) with a smaller positive band at higher frequency 
(~500-600 nm, Figure 3-15B). For intermediate pentacoordinate CoII complexes, the 
spectra general show multiple bands of negative ellipticity ranging in energy from 500-
700 nm, and sometimes a positive band is also observed at higher energy (~500 nm 
Figure 3-15C). Following these general guidelines, PbIISCoIIN/O(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+ show tetrahedral and octahedral characteristics, respectively.  
 
Figure 3-15. Absorbance (top) and MCD (bottom) spectra of octahedral Co(H2O)62+ (A), 
tetrahedral Co(hisH_1)22- (B), and penta-coordinate Co(Me6tren)Br2 in CHCl3 (C). Figure 
adapted from Ref XX.38 
To address the subtle spectroscopic differences observed between the two 
homotrimers a new peptide was synthesized, GRL2WL16CL30HL33D (GR-CHD, Table 
3-1). This peptide is similar to the GR-CDH peptide in that they both contain 3-fold Asp 
substitutions, however the Asp layer has been moved from the N-terminal side of the His3 
binding site in GR-CDH to below the metal on the C-terminal side providing GR-CHD.  
The stability and initial folding of GR-CHD were analyzed via CD spectroscopy 
and GuaHCl denaturation titrations. The double well feature of an alpha-helical bundle 
was once again observed (Figure 3-16) providing a molar ellipticity [Θ] of  -18816 deg 
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dmol-1 cm2, which corresponds to only ~53% initial folding, compared to an ideal, fully 
folded alpha-helical structure. The decrease observed in folding may be due to the close 
proximity of the Asp residues with respect to the C-termini of the coiled coil, perhaps 
resulting in more fraying of the peptide in attempt to solvate the charged Asp residues. 
Fits of the data to a two-step denaturation provide a ΔG°unfolding  of 2.4 ± 0.9 kcal/mol and 
a midpoint of denaturation is observed at about 2.5 M GuaHCl. These data indicate that 
although the initial folding is only about 50% the peptide itself is relatively stable to 
denaturation via addition of GuaHCl as observed by an increased midpoint compared to 
GR-ACH or GR-CDH (2.0 and 1.0 M, respectively).  
 
Figure 3-16. Guanidine hydrochloride denaturation titration data of GR-CHD (10 µM 
3SCC) in 10 mM Phosphate buffer at pH 8.0. Inset: CD spectra of GR-CHD before (red) 
and after (blue) the addition of 7 M GuaHCl. 
Aliquots of CoIISO4 were added to a solution of 1.05 mM GR-CHD, yielding 0.35 
mM 3SCC, in 50 mM HEPES at pH 7.5, with one equivalent of PbII(NO3)2 also present. 
UV-Vis analysis of PbIISCoIIN/O(GR-CHD)3n+ revealed a trace identical to that of 
PbIISCoIIN/O(GR-ACH)3+ and not PbIISCoIIN/O(GR-CDH)3n+ with an absorbance maximum 
at 543 nm (ε= 33 M-1cm-1) (Figure 3-17, Table 3-2). This indicates that when the Asp 
residues are introduced below the His3 site they do not effect CoII binding, conversely to 
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what was observed for the PbIISCoIIN/O(GR-CDH)3n+ homotrimer. The CoII dissociation 
constant was determined for PbIISCoIIN/O(GR-CHD)3n+, using Equation 7, to be 350 ± 80 
µM, which is the weakest binding of CoII to a His3 site by 10-fold (Figure 3-18, Table 3-
3).  EPR analysis of PbIISCoIIN/O(GR-CHD)3 shows that the CoII ion exhibits a 
comparable axial signal (Figure 3-19) as seen with the previous two homotrimers.  
 
Figure 3-17. UV-Vis overlay of PbIISCoIIN/O(GR-CH)3n+ (red), and PbIISCoIIN/O(GR-
CDH)3n+ (purple), and PbIISCoIIN/O(GR-CHD)3n+ (black dashed) at pH 7.5 in 50 mM 
HEPES buffer. Data are plotted as molar extinction coefficient (determined using CoII 
concentration) versus wavelength. 
 
Figure 3-18. UV-Vis titration (A) and titration curve (B) of CoIISO4 added to a solution 
of 0.35 mM PbIIS(GR-CHD)3- at pH 7.5 in 50 mM HEPES buffer. The titration data are 
plotted as absorbance versus wavelength and the titration curve is plotted as absorbance 
at 507 nm versus [CoII]. The trace that correlates to one equivalent of [CoII] added, with 
respect to 3SCC, is shown in red. The black circles represent the raw data and the non-
linear best-fit curve is shown as a black line (Equation 7, as described in the Materials 
and Methods section).  
A B 
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Figure 3-19. X-Band EPR spectra of 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ (red), 1.0 mM 
PbIISCoIIN/O(GR-CDH)3n+ (purple), and 1.0 mM PbIISCoIIN/O(GR-CHD)3n+ (dark blue), at 
pH 7.5 in 30 mM HEPES, collected at 10 K.  
Analysis of the XANES for PbIISCoIIN/O(GR-CHD)3n+ reveals a pre-edge/edge 
peak ratio of 2.0, which is consistent with both the PbIISCoIIN/O(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+ homotrimers, and the pre-edge area falls between those of the 
homotrimers with a value of 6.6 (Figure 3-20, Table 3-4). The edge peak is slightly lower 
in intensity when compared to the PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ 
homotrimers, perhaps indicating some mixture is obtained at the site with a lower 
coordination number (Figure 3-20). Due to the possible mixed coordination as evidenced 
by the XANES data, only a single-shell fit was conducted for PbIISCoIIN/O(GR-CHD)3n+ 
revealing an average CoII-N/O distance of 2.08 Å (4.9 DW, F= 344, Table 3-5, Figure 3-
21). This distance is 0.02 Å shorter than those determined for the first-shell fits of the 
PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ homotrimers (Figure 3-21, Table 
3-5).  
	 142 
 
Figure 3-20. XANES spectra of the CoII (A) pre-edge and (B) edge of homotrimers: 1.0 
mM PbIISCoIIN/O(GR-ACH)3n+ (red), 1.0 mM PbIISCoIIN/O(GR-CDH)3n+ (purple), and 1.0 
mM PbIISCoIIN/O(GR-CHD)3n+ (dark blue) at pH 7.5 in 50 mM HEPES buffer.  
 
Figure 3-21. Fourier transform of CoII EXAFS of (A) 1.0 mM PbIISCoIIN/O(GR-CHD)3n+ 
at pH 7.5 in 50 mM HEPES. CoII EXAFS (B) 1.0 mM PbIISCoIIN/O(GR-CHD)3n+. 
Experimental data is shown in black and single shell fitting is shown for the Fourier 
transform as a dashed red line. 
In combination, these data support a model that the spectroscopic signatures for 
the Asp3 peptides above the His3 site are not perturbed solely by the introduction of 
negative charge in close proximity to the metal binding site; however, the subtle spectral 
differences observed between the GR-CDH and GR-ACH homotrimers could arise from 
the CoII interacting directly with the Asp ligands in the PbIISCoIIN/O(GR-CDH)3n+ 
homotrimer. Another possibility is that the three aspartic acid residues orient in a way 
that perturbs the hydrogen bonding of the CoII-bound water molecules, I cannot yet 
distinguish between these possibilities spectroscopically. The UV-Vis spectrum of 
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PbIISCoIIN/O(GR-CHD)3n+ suggests similar coordination to PbIISCoIIN/O(GR-ACH)3+, but 
there are inconsistencies between the PbIISCoIIN/O(GR-CHD)3n+ and  PbIISCoIIN/O(GR-
ACH)3+ CoII apparent dissociation constants (350 and 41 µM, respectively) and EXAFS 
average CoII-N/O distances (2.08 and 2.10 Å, respectively, for single shell fits only, 
Table 3-5). It is possible that the Asp3 residues below the His3 site provide hydrogen-
bonding interactions to bound-CoII water molecules but are too far to directly coordinate 
to the metal ion, resulting in some perturbations to the CoII site that are not completely 
consistent with either PbIISCoIIN/O(GR-ACH)3+ or PbIISCoIIN/O(GR-CDH)3n+ homotrimer. 
 
Spectroscopic Characterization of CoII-Bound Heterotrimers 
While homotrimeric dual site peptides are interesting as they further demonstrate 
the ability to differentiate metal binding positions in proteins, the major innovation of 
these studies is to generate asymmetric metal environments within a simple, otherwise 
highly symmetric scaffold. To evaluate whether PbII-nucleated heterotrimer formation 
affords a remote metal binding site with first or second sphere asymmetric coordination 
geometry, I probed the binding of CoII to PbIIS(A3-nBn) type heterotrimers, where n=1 and 
2. When CoII is added to a mixture of two equivalents of GR-ACH and one equivalent of 
GR-CDH in the presence of one equivalent of PbII one would expect to produce the 
hetereotrimeric PbIIS[(GR-ACH)2(GR-CDH)1]n+ peptide. However, I can predict the 
spectral behavior if the two peptides instead form 2:1 mixtures of homotrimers. If I 
simply look at a calculated mixture of the two homotrimeric UV-Vis spectra, simulated 
by adding the two homotrimeric spectra together in the appropriate stoichiometry 
(Ala2Leu1 or Ala1Leu2), the prediction is that a peak at 523 nm (ε = 48 M-1 cm-1, Figure 
3-22, Table 3-2) would result for the Ala1Leu2 whereas the Ala2Leu1 mixture should 
result in a peak at 540 nm (ε = 83 M-1 cm-1, Figure 3-22, Table 3-2).  
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Figure 3-22. UV-Vis of PbIISCoIIN/O(GR-CH)3n+ (red) and PbIISCoIIN/O(GR-CDH)3n+ 
(purple) at pH 7.5 in 50 mM HEPES buffer overlaid with calculated spectra for 
⅔[PbIISCoIIN/O(GR-CH)3n+] + ⅓[PbIISCoIIN/O(GR-CDH)3n+] (black) and 
⅔[PbIISCoIIN/O(GR-CDH)3n+] + ⅓[PbIISCoIIN/O(GR-CH)3n+] (light blue). Experimental data 
(red and purple) and calculated spectra (black and light blue) are plotted as molar 
extinction coefficients (determined using CoII concentration) versus wavelength.  
Addition of CoIISO4 to solutions of PbIIS[(GR-ACH)2(GR-CDH)1]n+ or PbIIS[(GR-
ACH)1(GR-CDH)2]n+, in and 50 mM HEPES at pH 7.5, resulted in a significantly 
different spectrum than the calculated spectrum mentioned above. Indeed, four peaks at 
517 nm (ε = 147 M-1 cm-1), 545 nm (ε = 155 M-1 cm-1), 590 nm (ε = 124 M-1 cm-1) and 
628 nm (ε = 35 M-1 cm-1) were observed for PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ 
(Figure 3-23, Table 3-5). Similarly, when CoII was added to the opposite heterotrimeric 
mixture, PbIIS[(GR-ACH)1(GR-CDH)2]n+, a similar spectrum was observed with three 
peaks at 517, 547, and 583 nm with slightly increased extinction coefficients of 152, 173 
and 133 M-1cm-1, respectively (Figure 3-23, Table 3-5). The shoulder at 628 nm is not as 
prominent in the PbIIS[(GR-ACH)1(GR-CDH)2]n+ sample. The increased extinction 
coefficients and increased number of features in both of these spectra indicate a decrease 
in symmetry due to the d-d CoII transition becoming less forbidden, therefore, supporting 
a decrease in CoII coordination number and/or a change in symmetry in comparison to the 
homotrimeric sites. CoII dissociation constants were also determined by non-linear fits of 
the titration data to be 19.7 ± 1.9 and 7.9 ± 3.9 µM for PbIIS[(GR-ACH)2(GR-CDH)1]n+ 
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and PbIIS[(GR-ACH)1(GR-CDH)2]n+, respectively (Figure 3-24, Table 3-3). These 
dissociation constants are 2-4-fold higher than the homotrimers, indicating slightly tighter 
binding of CoII to a site that contains one or two Asp residues.  
 
Figure 3-23. UV-Vis overlay of homotrimers PbIISCoIIN/O(GR-CH)3n+ (red) and 
PbIISCoIIN/O(GR-CDH)3n+ (purple) and heterotrimers: PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+ (blue) and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (green) at pH 7.5 in 50 mM 
HEPES buffer. Data are plotted as molar extinction coefficients (determined using CoII 
concentration) versus wavelength. 
To address whether I was observing induced heterotrimeric selectivity due to PbII 
or simply just seeing a statistical distribution of the mixed peptides, I also analyzed CoII 
binding to the heterotrimeric peptide mixtures in the absence of PbII. These mixtures, 
[(GR-ACH)2(GR-CDH)1]n+ and [(GR-ACH)1(GR-CDH)2]n+ showed similar spectra with 
peaks at 517 and 545 nm and a peak/shoulder at 590 nm (Figure 3-25A), with decreased 
extinction coefficients. When a statistical spectrum was calculated (where A = GR-ACH 
and B = GR-CDH), and the mixture contained A3 (8/27), A2B (12/27), AB2 (6/27) and B3 
(1/27), (Figure 3-25B), the spectrum for the heterotrimer [(GR-ACH)2(GR-CDH)1]n+ 
overlays very well with the experimental CoIIN/O[(GR-ACH)2(GR-CDH)1]n+ spectrum. 
This observation indicates that in the absence PbII the distribution of species is indeed 
statistical, but when PbII was present one sees metal-induced selectivity of a 
heterotrimeric species as evidenced by the multiple transitions, increase in extinction 
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coefficients and slight change in peak ratios. Therefore, in the absence of PbII, 
heterotrimer formation is observed as a statistical distribution that contains both 
heterotrimeric and both homotrimers species. This confirms that PbII is necessary for 
singular and selective formation of the heterotrimer peptides. 
 
 
 
Figure 3-24. UV-Vis titration and titration curves of CoIISO4 added to a solution of 0.52 
mM PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (A and B) and 0.41 mM PbIISCoIIN/O[(GR-
ACH)1(GR-CDH)2]n+ (C and D) at pH 7.5 in 50 mM HEPES buffer. The titration data (A 
and C) are plotted as absorbance versus wavelength and the titration curves (B and D) are 
plotted as absorbance at λmax versus [CoII]. The trace that correlates to one equivalent of 
[CoII] added, with respect to 3SCC, is shown in red. The black circles represent the raw 
data and the non-linear best-fit curve is shown as a black line (Equation 7, as described in 
the Materials and Methods section).  
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C D 
	 147 
 
Figure 3-25. (A) UV-Vis overlay of CoII binding to heterotrimers in the presence of PbII: 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (blue) and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ 
(green) and in the absence of PbII: CoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (dashed blue) and 
CoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (dashed green). (B) UV-Vis overlay of CoII binding to 
heterotrimers in the absence of PbII: CoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (dashed blue), and 
CoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (dashed green), and the corresponding UV-Vis traces 
for calculated statistical mixture of (GR-ACH)2(GR-CDH)1 (black) and (GR-ACH)2(GR-
CDH)1 (red) as determined from the experimental CoII homo- and heterotrimers (See 
Chapter 2 for discussion of the statistical distribution). All experimental and calculated 
spectra are plotted as molar extinction coefficient (determined using CoII concentration) 
versus wavelength. 
I also looked at CoII-binding to Asp1 and Asp2 heterotrimeric mixtures where the 
Asp residues are located below the His3 binding site. In the presence of PbII, 2:1 and 1:2 
mixtures of GR-ACH and GR-CHD would provide PbIIS[(GR-ACH)2(GR-CHD)1]n+ and 
PbIIS[(GR-ACH)1(GR-CHD)2]n+, respectively. Addition of CoII to these mixtures (0.5 
mM 3SCC each) resulted in traces that more closely resembled the CoII-bound 
homotrimers than the CoII-heterotrimers with the Asp residues above the His3 layer. CoII 
binding to PbIIS[(GR-ACH)2(GR-CHD)1]n+ resulted in a peak at 515 nm with a shoulder 
at 590 nm (ε = 58 and 32 M-1 cm-1, respectively,  Figure 3-26, Table 3-2). The opposite 
heterotrimer, PbIIS[(GR-ACH)1(GR-CHD)2]n+ produced a similar spectrum upon binding 
CoII with a λmax at 513 nm and a similar shoulder at 590 nm with slightly decreased 
extinction coefficients (ε = 47 and 18 M-1 cm-1, respectively, Figure 3-26, Table 3-2). 
These extinction coefficient values are comparable to PbIISCoIIN/O(GR-ACH)3+ and 
PbIISCoIIN/O(GR-CDH)3n+, suggesting similarly high symmetry of the CoII center and 
probable high coordination number.  
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Figure 3-26. UV-Vis overlay of homotrimers PbIISCoIIN/O(GR-CH)3n+ (red), 
PbIISCoIIN/O(GR-CDH)3n+ (purple), and PbIISCoIIN/O(GR-CHD)3n+ (dashed black) and 
heterotrimers: PbIISCoIIN/O[(GR-ACH)2(GR-CHD)1]n+ (orange) and PbIISCoIIN/O[(GR-
ACH)1(GR-CHD)2]n+ (blue). Data are plotted as molar extinction coefficient (determined 
using CoII concentration) versus wavelength. 
CoII apparent dissociation constants were also determined by non-linear fits of the 
titration data to be 10.1 ± 5.6 and 17.5 ± 7.7 µM for PbIISCoIIN/O[(GR-ACH)2(GR-
CHD)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CHD)2]n+, respectively (Equation 7, Figures 
3-27A, Table 3-3). The apparent dissociation constants for these two heterotrimeric 
mixtures, with one or two aspartic acid residues below the His3 site, are 10-fold tighter 
than the PbIISCoIIN/O(GR-CHD)3n+ homotrimer and are comparable to the original 
heterotrimers: PbIIS[(GR-ACH)2(GR-CDH)1]n+ and PbIIS[(GR-ACH)1(GR-CDH)2]n+. This 
could be due to Asp residues introduced asymmetrically below the His3 site preferring 
rotamers that can interact with the CoII site differently in comparison to when the Asp 
residues are introduced symmetrically where three negatively charged residues in close 
proximity to the CoII site may be less favorable. However, I do not expect direct 
coordination to the CoII ion due to the dissimilarities between the PbIIS[(GR-ACH)3-n(GR-
CDH)n]n+ and PbIIS[(GR-ACH)3-n(GR-CHD)n]n+ heterotrimers. In all, the sites produced 
by the heterotrimers where the Asp residue is included in the layer below the His3 site 
provided significantly smaller perturbations to the UV-Vis spectra in comparison to the 
heterotrimers that contain the Asp substitution in the layer above the His3 site. The 
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coordination geometry of CoII, when bound to PbIIS[(GR-ACH)2(GR-CHD)1]n+ and 
PbIIS[(GR-ACH)1(GR-CHD)2]n+, is probably relatively symmetric, as evidenced by the 
relatively low extinction coefficients.  
 
Figure 3-27. UV-Vis titration and titration curves of CoIISO4 added to a solution of 0.5 
mM PbIISCoIIN/O[(GR-ACH)2(GR-CHD)1]n+ (A and B) and 0.5 mM PbIISCoIIN/O[(GR-
ACH)1(GR-CHD)2]n+ (C and D) at pH 7.5 in 50 mM HEPES buffer. The titration data (A 
and C) are plotted as absorbance versus wavelength and the titration curves (B and D) are 
plotted as absorbance at λmax versus [CoII]. The trace that correlates to one equivalent of 
[CoII] added, with respect to 3SCC, is shown in red. The black circles represent the raw 
data and the non-linear best-fit curve is shown as a black line (Equation 7, as described in 
the Materials and Methods section).  
XAS was used to analyze CoII bound heterotrimers. Analysis of the XANES at 
both the pre-edge and edge show that the when only one Asp residue is introduced into 
the system, as in PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+, the trace looks very similar to 
the homotrimeric peptides (Figure 3-28). Indeed the pre-edge/edge ratio is 2.0 and the 
area under the pre-edge peak is 6.0 (Table 3-4). However, when analyzing the opposite 
heterotrimer, PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+, with two Asp residues in close 
proximity to the His3 site, the pre-edge peak is more intense and the edge peak is less 
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intense (ratio of 2.8, Table 3-4) and the pre-edge peak area is elevated to 9.4 (Table 3-4) 
– evidence which all supports the symmetry around the CoII site being lessened, which in 
turn supports a lower coordination environment in comparison to the homotrimeric 
samples.  
 
Figure 3-28. XANES spectra of the CoII (A) pre-edge and (B) edge of homotrimers: 1.0 
mM PbIISCoIIN/O(GR-ACH)3n+ (red) and 1.0 mM PbIISCoIIN/O(GR-CDH)3n+ (purple) and 
heterotrimers: 1.0 mM PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (blue) and 1.0 mM 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (green) at pH 7.5 in 50 mM HEPES buffer. 
As was the case with the homotrimers, the EXAFS data show a similar dominate 
peak in both PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ and PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+ at ~2.07 Å. Both samples show evidence of outer shell histidine scattering 
patterns (Figure 3-29, 2.5 < R < 4 Å). Multiple models with varying numbers of 
imidazole nitrogen atoms and other oxygen ligands (water or carboxylate) were used to 
fit these data, but the best fit was determined to be five oxygen/nitrogen ligands with an 
average CoII-N/O distance of 2.08 Å (1.3 & 9.3 DW, F=573, Table 3-5) for 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and a slightly shorter distance of 2.075 Å for 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (5.0 & 9.0 DW, F=248, Table 3-5). Contrary to 
both PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ homotrimers, the best 
distances obtained via fitting of the heterotrimer EXAFS data are consistent with a 5-
coordinate CoII-coordination. The XANES trace of the PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+, where one Asp is included in the CoII binding site, looks very similar to the 
proposed 6-coordinate homotrimers, but it has EXAFS best fit distances that are shorter 
and more comparable to those of the PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ heterotrimer. 
The decrease observed in bond distances from 2.115 Å to ~2.08 Å is consistent with a 
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one integer decrease in coordination number from the homotrimer (proposed 6-
coordinate) to heterotrimer peptides, resulting in probable 5-coordinate environments.  
 
Figure 3-29. Fourier transform of CoII EXAFS of (A) PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+ and (C) PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ at pH 7.5 in 50 mM HEPES 
buffer. CoII EXAFS (B) 1.0 mM PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and (D) 1.0 mM 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+. Experimental data is shown in black and best fits 
for N3O2 CoII-coordination are shown in dashed red lines. 
The combination of XANES and EXAFS data suggests that the PbIISCoIIN/O[(GR-
ACH)2(GR-CDH)1]n+ heterotrimer is probably a mixture of mostly 5- and some 6-
coordinate CoII species and the PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ heterotrimer is a 
more pure 5-coordinate CoII species. The best derived distances from the EXAFS fits 
correspond well with reported values for five-coordinate CoII small molecule complexes, 
as reported by the Cambridge Structural Database (4-coordinate ≈ 1.996 Å, 5-coordinate 
≈ 2.065 Å, 6-coordinate ≈ 2.13 Å).36 The increased bond distances and overall lower pre-
edge:edge ratio of the homotrimers, in comparison to the heterotrimers, further supports 
higher coordination of CoII-bound homotrimeric peptides.  
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Furthermore, CoII X-band EPR spectra collected at 4K of the heterotrimer systems 
show very similar spectra to each other, which vary dramatically in comparison to the 
homotrimer systems. Heterotrimeric EPR samples were prepared identically to 
homotrimeric samples at 2 mM total peptide trimer with 1 mM CoII in ~50 mM HEPES, 
pH 7.5, with ~50% glycerol. The EPR of both PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+and 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ produce spectra with slightly more rhombic 
characteristics with turning points at geff(x,y,z) = 5.3, 3.4 and 2.0 (Figure 3-30). Simulations 
of the PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+heterotrimer were obtained using SpinCount 
(Figure 3-31).13 The discrepancies between the data of PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+and the EPR simulation could be due to a mixture of CoII environments present 
in the sample, as supported by the XAS data. Regardless, the heterotrimers are more 
rhombic in character than the axial homotrimeric signals.  
 
Figure 3-30. X-Band EPR spectra of homotrimers: 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ 
(red) and 1.0 mM PbIISCoIIN/O(GR-CDH)3n+ (purple) and heterotrimers: 1.0 mM 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (blue) and 1.0 mM PbIISCoIIN/O[(GR-ACH)1(GR-
CDH)2]n+ (green) at pH 7.5 in 30 mM HEPES buffer, collected at 10 K. 
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Figure 3-31. X-Band EPR spectra of 1.0 mM PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ at 
pH 7.5 in 30 mM HEPES buffer, collected at 4 K. Blue spectrum: data, black dashed line: 
simulation.  
The MCD spectra of PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ and 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ provide similar traces to on another with multiple 
intense negative bands (542, 553, and 570 nm for PbIISCoIIN/O[(GR-ACH)1(GR-
CDH)2]n+and 539 and 577 nm for PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+, Figures 3-32A 
and 3-32B, respectively). As mentioned above, multiple negative bands observed in the 
MCD spectra are consistent with less symmetric, 5-coordinate CoII environments. A 
decrease in symmetry from a d7 Oh symmetry (ground state: 4T1g) to a pentacoordinate 
CoII species would result in a new ground state of either 4E’g or 4A2 for D3h or C4v 
symmetry, respectively. The difference in the singly or doubly degenerate ground state 
would show different MCD terms; however, without explicit assignments of the observed 
transitions I cannot yet assign the coordination geometry of the proposed 5-coordiante 
heterotrimeric species. 
R
el
at
iv
e 
In
te
ns
ity
 
	 154 
 
Figure 3-32. Absorbance (top) and MCD (bottom) spectra of ~2.0 mM PbIISCoIIN/O[(GR-
ACH)2(GR-CDH)1]n+ (A) and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (B) at pH 7.5 in 50 
mM HEPES, collected at RT (Absorbance) and 2K (MCD). 
In all, these MCD data are in agreement with the EPR and XAS data, further 
confirming lower symmetry and lower coordination number in the CoII-bound 
heterotrimers compared to the CoII-homotrimers. The MCD data of both homotrimers and 
both heterotrimers are relatively simple, and, especially in the case of the homotrimers 
(Figure 3-14A and 3-14B), therefore support that only one species is present in the 
samples. Unfortunately, the literature on biological samples with CoII bound is quite 
muddled and not nearly as plentiful as one might expect considering the frequency of 
how often CoII is used as a probe for ZnII-metalloenzymes. Further studies to determine 
the coordination geometry is necessary to further elucidate the identities of the specific 
transitions observed.  
Clearly, no combination of the spectra of the homotrimers, as obtained via UV-
Vis, EPR, MCD, or XAS can reproduce the spectra of the heterotrimeric CoII complexes. 
This strongly suggests that the asymmetry of the heterotrimer, induced by the PbII 
binding, can be extended to a second, asymmetric transition metal binding site as 
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confirmed by the perturbed physical properties observed upon CoII binding. 207Pb NMR 
analysis of the homotrimers, PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+, and 
the heterotrimers, PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and PbIISCoIIN/O[(GR-
ACH)1(GR-CDH)2]n+, afforded no change in the chemical shifts (Figure 3-33), further 
confirming that the addition of CoII does not alter the PbIICys3 environment of these 
species.  
 
Figure 3-33. 207Pb NMR spectra of 3-5 mM PbII bound homo- and heterotrimers in the 
absence (left) and presence (right) of CoII. 0 Ala: PbIISMIIN/O(GR-CDH)3n+, 1 Ala: 
PbIISMIIN/O[(GR-CDH)2(GR-ACH)1]n+, 2 Ala: PbIISMIIN/O[(GR-CDH)1(GR-ACH)2]n+, 3 
Ala: PbIISNIIN/O(GR-ACH)3n+, collected at pH 8.5. 
To summarize the coordination preferences of the homo- and heterotrimers, 
EXAFS analysis supports average CoII-N/O bond distances consistent with 6-coordinate 
metal binding sites for the homotrimers, mostly 5-coordinate for PbIISCoIIN/O[(GR-
ACH)1(GR-CDH)2] and a probable mixed 5/6-coordinate CoII site in PbIISCoIIN/O[(GR-
ACH)2(GR-CDH)1]. Concurrently, the EPR and UV-Vis data show similarities among 
the heterotrimers and similarities among the homotrimers, but there is a stark difference 
between the traces from the symmetric and asymmetric scaffolds.  
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Small molecules with similar coordinating ligands have been previously 
synthesized and characterized with bound CoII. Scarpellini et al. prepared a family of 
compounds that contain a tris-amine scaffold that contains one carboxylate oxygen 
moiety.39 The [CoII(BPZG)(OAc)] complex was found to have five ligands with a first 
coordination sphere consisting of two substituted pyrazole ligands, a tripodal nitrogen, a 
solvent molecule and a monodentate coordinating carboxylate group (Figure 3-34). This 
five-coordinate complex afforded a very similar visible spectrum to the [PbIISCoIIN/O(GR-
ACH)2(GR-CDH)1]n+ heterotrimer with four peaks at 504, 546, 593, and 615 nm with 
extinction coefficients of 133, ~150, 255, and ~100 M-1cm-1, respectively (Table 3-2). 
Additionally, reports by Jacobsen et al. and Kunz et al. using pyrazolyl and substituted 
imidazole, respectively, show spectra related to this heterotrimer complex with energy 
and extinction coefficients consistent with a five-coordinate environment (Figure 3-34, 
Table 3-2).40,41  
   
Figure 3-34. Schematic representations of (A) [(4-TIPhMe)CoIICl]Cl, (B) 
[CoII(BPZG)(OAc)], and (C) [(4-TIPiPr)CoIICl]Cl. Figure adapted from Ref 69, 70, and 71.  
Initially, the aspartate residues introduced at the 26th position was engineered with 
the intention of providing an acid-base catalyst in close proximity to the His3 site. 
However, due to the significant perturbations in spectral fingerprints between the CoII-
bound homo- and heterotrimers we were forced to consider the possibility of direct 
oxygen coordination to the CoII when aspartate residues are present in an asymmetric 
fashion. The binding sites of Carboxypeptidase A (CPA), a ZnII-metalloenzyme that 
catalyzes endopeptidase and C-terminal exoesterase reactions, and thermolysin (TML), a 
ZnII-metalloproteinase, offer similar metal-binding environments with 
His2CarboxylateX(OH2)Y motifs (the number of coordinating oxygen atoms from the 
carboxylate moiety (X) and waters molecules (Y) is dependent on the study referenced, 
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Figure 3-35).42–44 Indeed, the CoII UV-Vis traces of both CPA and TML look strikingly 
similar to our CoII-bound heterotrimers with similar energies and extinction coefficients 
(Table 3-2).28,45 The EPR of CoII-substituted CPA shows a similarly rhombic signal to the 
reported heterotrimers with g-valueseff of 5.40, 2.84 and 1.90.46  
 
Figure 3-35. Coordination spheres of A) carboxypeptidase A (CPA, PDB: 1YME)43 and 
B) thermolysin (TML, PDB: 1LNF).42 ZnII ions are shown as grey spheres. Selected 
amino acids of active site ligands are shown as stick figures where N atoms are 
highlighted in blue and oxygen in red. Water molecules are shown as smaller red spheres 
and hydrogen bonds are shown as dashed yellow lines.  
VanX, an essential gene product for vancomycin resistance in bacteria, is a 
monomeric ZnII-binding protein with a metal binding site that coordinates ZnII in a 
tetrahedral fashion to two His residues, one Asp residue, and an exogenous solvent 
molecule (Figure 3-36).47,48 CoII-substituted VanX produces a UV-Vis spectrum with 
molar absorptivities of ~100 M-1cm-1 with absorbance maxima at ~510, 550 and 590 nm, 
similar to my CoII-bound heterotrimers (Table 3-2).49 Additionally, CoII EPR provided a 
similarly rhombic-like spectrum with geff(x,y,z) values of 1.92, 3.71, and 5.64. These data 
support a 5-coordinate environment for CoII-bound VanX. Interestingly, the EXAFS fits 
for CoII-VanX provide best fits values for 5-coordinate environments of ~2.0 Å, a value 
that seems to better correlate to a 4-coordinate CoII site. Regardless, the similarities 
between my CoII-bound heterotrimers, and CoII-substituted CPA, VanX, and TML 
support the conclusion that direct carboxylate coordination is occurring when CoII is 
introduced to a His3 site with either one or two Asp residues in close proximity.  
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Figure 3-36. Primary coordination sphere of VanX (PDB: 1R44).48 ZnII ion is shown as a 
grey sphere. Selected amino acids of active site ligands are shown as stick figures where 
N atoms are highlighted in blue and oxygen in red. Water molecules are shown as smaller 
red spheres.  
At this point, an analysis of the interior of the 3SCC provided from the previously 
reported ZnHis3OH2 crystal structure (HgIISZnIIN/O(CS-L9PenCL23H)3n+, PDB: 3PBJ)1 
was warranted to determine if manipulation of the CoII binding site could accommodate a 
His2OXOH2-like coordination. Using the molecular modeling program COOT,50 an 
aspratate was mutated into the layer above the His3 site to mimic the [PbIISCoIIN/O(GR-
ACH)2(GR-CDH)1]n+ heterotrimeric system. Rotation of the imidazole rings and 
aspartate residue, as well as movement of the metal ion closer to the N-terminus of the 
3SCC, afforded metal-His distances of 1.98 and 2.0 Å, metal-O distances for the 
aspartate oxygen atoms of 2.2 and 2.0 Å and a metal-OH2 distance of 1.95 Å (Figure 3-
37). These distances are comparable to those observed in CPA, TML, and VanX, and 
only slightly shorter than the distances obtained from the EXAFS fittings for my 
heterotrimers (Model average N/O: 2.03 Å vs. EXAFS average: 2.075 Å, Table 3-
5).42,43,48  
	 159 
 
Figure 3-37. (A) Side-on and (B) top down views of a Pymol model with a His2Asp1OH2 
primary coordination sphere in a heterotrimeric 3SCC. The metal-binding ligands are His 
and Asp residues with nitrogen atoms in blue and oxygen atoms in red. The metal ion is 
colored blue and the potential water molecule as a red sphere. The heterotrimeric 
assembly is emphasized by two teal helices and one purple helix. A third, un-coordinated 
His residue is also shown. Models are generated using the crystal structure of 
HgIISZnIIN/O(CSL9PenCL23H)3n+ (PDB: 3PBJ).1 
When the metal ion is moved up toward the N-termini and toward the helical 
interface to offer direct coordination to two His and the Asp residues, this results in a 
metal-His distance to the third histidine residue of 4.0 Å. This distance is too far for metal 
coordination and supports the assignment that the direct Asp metal- coordination requires 
the third His residue to become uncoordinated (although it could form a hydrogen bond 
with a coordinated water). Closer examination of the crystal structure of TML reveals a 
third His residue in close proximity to the binding site at a distance of 4.2 Å (Figure 3-
35B).42 This histidine is proposed to offer hydrogen-bonding properties to the Zn-bound 
water (2.3 Å from ZnII and 2.7 Å from the uncoordinated His residue). Therefore, in 
COOT I also modeled in a water molecule in between the metal and the uncoordinated 
His residue (2.0 Å from the ZnII ion and 2.2 Å from the uncoordinated His residue). I also 
overlaid the crystal structure of the ZnIIHis3 site from 
HgIISZnII(OH)N/O(CSL9PenCL23H)3+ with the COOT His2AspOH2 model to obtain a 
displacement of the ZnII ion of 1.4 Å (Table 3-1, Figure 3-38).1 Although this is just a 
model and a crystal structure of the heterotrimer is necessary to confirm the structural 
parameters, I feel this image is a good first estimate of how CoII could be coordinated in 
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the heterotrimeric peptides. This model is consistent with all spectral data and 
demonstrates that an asymmetric primary His2OX(OH2)Y coordination environment is 
possible within the heterotrimers without significant interruption of the trimer packing or 
folding.  
 
Figure 3-38. Overlay side-on view of HgIISZnIIN/O(CSL9PenCL23H)3n+ (green helices 
and grey metal ion sphere) and a Pymol model with a His2Asp1OH2 primary coordination 
sphere in a 3SCC (teal and purple helices, blue metal ion sphere). The metal-binding 
ligands are His and Asp residues with nitrogen atoms in blue and oxygen atoms in red. 
The movement of the metal ion of 1.4 Å toward the Asp residue in the pymol model is 
shown. Models are generated using the crystal structure of 
HgIISZnIIN/O(CSL9PenCL23H)3n+ (PDB: 3PBJ).1 
This data shows that the primary objective of preparing a transition metal in an 
asymmetric first coordination environment using non-covalent, self-assembling, 
heterotrimeric, α-helical 3SCCs, has been achieved. The primary goal of obtaining an 
asymmetric secondary coordination sphere for a potential catalytic site by introduction of 
an aspartate in close proximity to a His3 site is not supported by comparison of the CoII-
bound spectral data. However, arguably more interestingly, the spectral data is more 
consistent with a change in the primary coordination sphere resulting in a less-symmetric, 
five-coordinate N2OX(OH2) binding site.  
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Indeed, when the T199 of CA is mutated to Asp, the ZnII-bound hydroxide is 
displaced and direct carboxylate ligation is observed, essentially abolishing catalytic 
activity.51 The coordination of a carboxylate residue, while still coordinating all three 
histidine residues, requires significant conformational changes in the polypeptide 
backbone of CA. Although our 3SCCs have previously provided an excellent scaffold to 
mimic CA, both structurally in the first coordination sphere and kinetically, this sort of 
substantial conformational change is not possible within the rigid alpha-helical structure 
of our scaffolds. I propose that a CoII metal ion can bind to either all three histidine 
residues or a combination of two histidine residues and an Asp residue, but the 3SCC 
structure cannot accommodate the conformational changes required for direct 
CoIIHis3Asp coordination. Future studies will analyze the perturbations on this transition-
metal binding site by incorporating residues that are less likely to coordinate directly to 
the metal and, therefore, better fulfill the roll of an acid base catalysis model (Thr or Ser 
instead of Asp, See Chapter 5).  
 
Testing the Versatility of Heterotrimer Formation: Combined Ala/Asp Mutations 
As discussed in Chapter 2, 207Pb NMR analysis of a 1:2 ratio of Ala:Leu 
containing peptides indicates that PbIIS[(GR-ACH)1(GR-CH)2]- as well as PbIIS[(GR-
ACH)2(GR-CH)1]- are formed as indicated by the presence of two peaks at ~5600 and 
~5625 ppm. In the opposite configuration, a 2:1 ratio of Ala:Leu containing peptides, 
such as, yields only a single peak for PbIIS[(GR-ACH)2(GR-CH)1]- with a chemical shift 
of ~5600 ppm, indicating formation of a single heterotrimeric 3SCC. However, CoII 
EXAFS analysis of the Mn+His3 site that binds transition metals suggests that 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]- provides a more pure 5-coordinate CoII 
environment than PbIIS[(GR-ACH)2(GR-CDH)1]-, which looks like it may contain a 
mixture of 5- and 6-coordinate CoII. This observation lead me to ask three questions, first, 
could I obtain a pure heterotrimer, via 207Pb NMR, while including the Ala and the Asp 
substitution within the same peptide? Second, would a peptide containing four 
substitutions, Ala, Cys, Asp, and His, be well folded and stable? And lastly, would the 
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CoII EXAFS of this new heterotrimeric mixture provide a pure 5-coordinate CoII site, 
supporting a wholly pure species at both the PbII site and the CoII site? 
First, I synthesized and characterized GRL2WL12AL16CL26DL30H, or GR-
ACDH (Table 3-1). For heterotrimer formation, GR-ACDH will be mixed, in the 
presence of PbII, with GR-CH, which was characterized in Chapter 2. CD spectroscopy 
and GuaHCl denaturation titrations were used to determine the folding and stability of 
GR-ACDH (Figure 3-39). The CD spectrum showed a peak at 222 nm, indicative of 
alpha-helical colied coil structure, but the second feature at 208 nm was not well resolved. 
Additionally, GR-ACDH showed very poor folding with a molar ellipticity [Θ] of -16056 
deg dmol-1 cm2, which corresponds to only ~48% initial folding compared to an ideal, 
fully folded alpha-helical structure, compared to ~95% folding for the complimentary 
GR-CH peptide (See Chapter 2). This model cannot be fit to a two step denaturation 
curve due to the lack of a defined folded state before the addition of GuaHCl, but analysis 
of Figure 3-36 shows a midpoint of less than 1 M for the denaturation of GR-ACDH. GR-
ACDH, therefore, folds ~30% less compared to GR-CDH and ~50% less compared to 
GR-ACH. A progressive decrease in denaturation mid-point can be observed from 2.28 
M for GR-CH, 1.83 M for GR-ACH to ~1M for GR-CDH and less than 1M for GR-
ACDH (Figure 3-40). 
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Figure 3-39. Guanidine hydrochloride denaturation titration data of GR-ACDH in the 
absence (open circle) and presence (closed circles) of PbII and CoII, yielding 
PbIISCoIIN/O(GR-ACDH)3n+, in 10 mM Phosphate buffer at pH 8.0, [3SCC] = 8 µM. Inset: 
CD spectra of GR-ACDH before (red) and after (blue) the addition of 6 M GuaHCl. 
 
 
Figure 3-40. Overlay of guanidine hydrochloride denaturation titration data of GR-ACH 
(light blue circle), GR-CH (dark blue circle), GR-CDH (green triangle), and GR-ACDH 
(orange square) in 10 mM Phosphate buffer at pH 8.0.  
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PbII binding to GR-ACDH was analyzed via UV-Vis spectroscopy where aliquots 
of PbII(NO3)2 were added to a solution of 20 µM (3SCC) GR-ACDH in TRIS buffer at 
pH 8.5 (Figure 3-41). The peptide complexed PbII, as observed in the previous peptides, 
with a characteristic LMCT band at 341 nm. Saturation of the Cys3 site is observed at one 
equivalent of PbII and linear regression analysis of the increase in absorbance as a 
function of total PbII added provided a molar extinction coefficient of 2902 M-1cm-1. This 
confirms that PbII binds comparably to GR-ACDH, even when four mutations are 
contained within the peptide sequence, and the corresponding lower initial folding.  
 
Figure 3-41. Titration spectra of PbII into a solution of A) 20 µM GR-ACDH and B) the 
corresponding titration curves showing the 1:1 binding stoichiometry of equivalent of 
PbII added with respect to 3SCC at 341 nm. Data collected at pH 8.5 in 50 mM TRIS 
Buffer. 
Previously, heavy metals, such as HgII, have been shown to offer increased 
stability to the 3SCCs when bound to a Cys3 site. I therefore waned to determine if the 
presence of PbII, in addition to CoII, would offer some increased stability and folding for 
GR-ACDH. Interestingly, the addition of CoII and PbII offer no increased stability as 
evidenced in the CD spectrum of PbIISCoIIN/O(GR-ACDH)3n+ having a molar ellipticity 
[Θ] of -16578 deg dmol-1 cm2, corresponding to only ~49% initial folding (Figure 3-39). 
This indicates that even when two metal ions are bound to GR-ACDH there is still no 
significant increase in initial folding or added stability toward GuaHCl denaturation. 
However, since I saw evidence of PbII binding via UV-Vis, I decided to try to 
analyze this new, albeit relatively unstable, peptide via 207Pb NMR, in hopes that the 
stability offered by the opposite peptide required to form the desired heterotrimer (GR-
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CH) would offer enough stability to compensate for the GR-ACDH peptide. In the 
presence of both PbII and CoII the same chemical shifts are observed for PbIISCoIIN/O(GR-
ACDH)3n+, PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+, and PbIISCoIIN/O[(GR-CH)2(GR-
ACDH)1]n+, indicating that even though the stability of GR-ACDH is low the 
heterotrimer formation at the PbII site is not hindered by including the Ala and Asp 
residues on the same peptide.  
Next, I wanted to determine if the inclusion of the Ala and Asp residues on the 
same peptide offered any changes to the UV-Vis spectra of the CoII d-d bands of the 
homotrimer, PbIISCoIIN/O(GR-ACDH)3n+, and both heterotrimers, PbIISCoIIN/O[(GR-
CH)1(GR-ACDH)2]n+, and PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+. Aliquots of CoIISO4 
were added to homotrimeric and heterotrimeric solutions with ~0.5-0.75 mM 3SCC, and 
one equivalent of PbII(NO3)2, in 50 mM HEPES buffer at pH 7.5. Consistent with the 
original peptides as outlined above, CoII binding to the homotrimer PbIISCoIIN/O(GR-
ACDH)3n+ resulted in one, broad peak at 543 nm with an elevated extinction coefficient 
(ε = 110 M-1 cm-1, Figure 3-42, Table 3-2). This value is slightly greater in comparison to 
6-coordinate CoII complexes and on the low end of the range of 5-coordinate CoII 
complexes. A slightly tighter apparent dissociation constant of 10.5 ± 3.1 µM was 
determined by fitting the CoII titration data to Equation 7 (5-times tighter than that of 
PbIISCoIIN/O(GR-CDH)3n+, Figures 3-43A and 3-43B, Table 3-3).  
A similar increase, of about 20%, in extinction coefficient is observed upon the addition 
of CoII to PbIIS[(GR-CH)1(GR-ACDH)2]n+, the heterotrimer that offers a pure 207Pb NMR 
spectrum (Figure 3-40C). The overall trace is very similar to that observed for 
PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ with three peaks at 517 nm (ε = 200 M-1 cm-1), 
544 nm (ε = 215 M-1 cm-1), 586 nm (ε = 167 M-1 cm-1) and a shoulder at 626 nm (ε ~ 60 
M-1 cm-1, Figure 3-43C, Table 3-2). In the case of PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+, 
more peak definition is observed at 586 nm. Interestingly, the same overall trace is 
observed, but with only a very small increase in extinction coefficient in comparison to 
the original heterotrimers, when CoII is added to the opposite heterotrimeric mixture, 
PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+. Three peaks were observed at 524 nm (ε = 152 
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M-1 cm-1), 544 nm (ε = 165 M-1 cm-1), 592 nm (ε = 120 M-1 cm-1, Figure 3-43E, Table 3-
2). 
 
Figure 3-42. UV-Vis overlay of original homotrimers PbIISCoIIN/O(GR-CH)3n+ (dashed 
red) and PbIISCoIIN/O(GR-CDH)3n+ (dashed purple) and original heterotrimers: 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ (dashed blue) and PbIISCoIIN/O[(GR-ACH)1(GR-
CDH)2]n+ (dashed green). The new homotrimer PbIISCoIIN/O(GR-ACDH)3n+ (purple) and 
new heterotrimers: PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+ (blue) and PbIISCoIIN/O[(GR-
CH)1(GR-ACDH)2]n+ (green) are also shown. All data were collected at pH 7.5, 50 mM 
HEPES buffer. Data are plotted as molar extinction coefficient (determined using CoII 
concentration) versus wavelength. 
The apparent CoII dissociation constants were determined by fitting the titration 
data to be 11.2 ± 1.2 and 21.8 ± 2.4 µM, for PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+ and 
PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+, respectively (Equation 7, Figures 3-43D and 3-
43E, Table 3-3). These dissociation constants, unlike the case of PbIISCoIIN/O(GR-
ACDH)3n+, are essentially the same as those obtained for the original heterotrimeric 
mixtures. The increase in extinction coefficient of PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+, 
while not observed for PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+, could support the original 
hypothesis that including the Ala and Asp substitutions on the same peptide could 
provide a pure heterotrimer, as evidenced by 207Pb NMR, as well as a more pure 5-
coordinate CoII site, as indicated by the UV-Vis data, presumably related to an even less 
symmetric and less octahedral-like site.  
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Figure 3-43. UV-Vis titration and titration curves of CoIISO4 added to a solution of 0.53 
mM PbIISCoIIN/O(GR-ACDH)3n+ (A and B), 0.50 mM PbIISCoIIN/O[(GR-ACDH)1(GR-
CH)2]n+ (C and D), and 0.50 mM PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+ (E and F) at pH 
7.5 in 50 mM HEPES buffer. The titration data (A, C and E) are plotted as absorbance 
versus wavelength and the titration curves (B, D, and F) are plotted as absorbance at λmax 
versus [CoII]. The trace that correlates to one equivalent of [CoII] added, with respect to 
3SCC, is shown in red. The black circles represent the raw data and the non-linear best-fit 
curve is shown as a black line (Equation 7, as described in the Materials and Methods 
section).  
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  CoII X-band EPR spectra were collected, at ~10 K, for PbIISCoIIN/O(GR-
ACDH)3n+, PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+, and PbIISCoIIN/O[(GR-CH)2(GR-
ACDH)1]n+. Samples were prepared identically to the previous EPR and XAS samples. 
Little difference was observed between the original homo- and heterotrimers and the new 
mixtures, where the Ala and Asp substitutions were contained within the same peptide. 
The homotrimeric sample, PbIISCoIIN/O(GR-ACDH)3n+, showed similar axial behavior as 
the original homotrimers and the new heterotrimers showed comparably more rhombic 
signals, as previously observed and described (Figure 3-44). These data suggest that the 
spectroscopic fingerprints, as analyzed via UV-Vis and EPR, are very similar from 
homotrimer to homotrimer, regardless of which helix contains the Ala or Asp residues. 
The same can be said for the striking similarities observed between the heterotrimeric 
samples.   
 
Figure 3-44. X-band EPR spectra of homotrimers: 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ 
(red) and 1.0 mM PbIISCoIIN/O(GR-ACDH)3n+ (purple) and new heterotrimers: 1.0 mM 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2]n+ (blue) and 1.0 mM PbIISCoIIN/O[(GR-
ACDH)2(GR-CH)1]n+ (green) at pH 7.5 in 30 mM HEPES, collected at 10 K. 
The biggest variation observed between the original heterotrimers (where Ala and 
Asp substitutions are on different peptides) and the new heterotrimers, PbIISCoIIN/O[(GR-
CH)1(GR-ACDH)2]n+, and PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+, was observed when 
comparing the CoII XAS data. First, I looked to the XANES spectrum for the 
homotrimeric PbIISCoIIN/O(GR-ACDH)3n+ sample (all samples for homo- and 
heterotrimers containing GR-ACDH were prepared analogously to the EPR and XAS 
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samples above). Analysis of the XANES at both the pre-edge and edge show that when 
the Ala and Asp residues are included on the same helix the trace looks very similar to 
the original homotrimeric peptides (Figure 3-45), with only a slight decrease in intensity 
observed at the edge peak (Table 3-4). The pre-edge/edge ratio is still 2.0 and the area 
under the pre-edge peak is 6.6 (Table 3-4). The EXAFS data show similar features as 
described above with a dominate peak at ~2.1 Å and evidence of outer shell histidine 
scattering patterns (Figure 3-43, 2.5 < R < 4 Å). Similar models as described above were 
used to fit the data, with two equally good best fits determined to be six oxygen/nitrogen 
ligands (3His and 3 oxygen atoms, or 2His and 4 oxygen atoms) with an average CoII-
N/O distances of ~2.1 Å (3.7-5.3 & 6.4-8.8 DW, F= 277-281, Table 3-5, Figures 3-46A 
and 3-46B). This primary coordination distance is only slightly shorter than the best fits 
for the PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ samples (2.115 Å, Table 3-
5) suggesting similar coordination number and geometry between all three homotrimers.  
 
Figure 3-45. XANES spectra of the CoII (A) pre-edge and (B) edge of homotrimers: 1.0 
mM PbIISCoIIN/O(GR-ACH)3n+ (red) and 1.0 mM PbIISCoIIN/O(GR-ACDH)3n+ (purple) and 
heterotrimers: 1.0 mM PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+ (blue) and 1.0 mM 
PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2]n+ (green) at pH 7.5 in 50 mM HEPES. 
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Figure 3-46. Fourier transform of CoII EXAFS of (A) PbIISCoIIN/O(GR-ACDH)3n+, (C) 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+, and (E) PbIISCoIIN/O[(GR-ACDH)1(GR-CH)2]n+ at 
pH 7.5 in 50 mM HEPES buffer. CoII EXAFS (B) 1.0 mM PbIISCoIIN/O(GR-ACDH)3n+, 
(D), 1.0 mM PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+, and (F) 1.0 mM PbIISCoIIN/O[(GR-
ACDH)1(GR-CH)2]n+. Experimental data is shown in black and best fits for N3O3 (red) 
and N2O4 (blue) shells are shown in dashed lines for PbIISCoIIN/O(GR-ACDH)3n+. Single 
sphere fit is shown in a dashed red line for PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+. Best 
fits for N3O2 (red) and N2O3 (blue) shells are shown in dashed lines for PbIISCoIIN/O[(GR-
ACDH)1(GR-CH)2]n+. 
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However, when I analyzed the heterotrimers, PbIISCoIIN/O[(GR-CH)1(GR-
ACDH)2]n+, and PbIISCoIIN/O[(GR-CH)2(GR-ACDH)1]n+, the differences were much more 
apparent. First, the XANES of PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+ showed a lower 
edge peak intensity and a higher pre-edge peak intensity, which correlates to a decrease 
in symmetry at the CoII site, with a calculated pre-edge/edge ratio of 3.5 and a pre-edge 
peak are of 10.3 (Table 3-4). A similar EXAFS trace is once again observed (Figure 3-
46C) with obvious outer-sphere scattering; however, because the XANES data support a 
possible mixed coordination number CoII-complex (seemingly in between four- and five-
coordinate), only a single-shell fit was conducted revealing an average CoII-N/O distance 
of 2.048 Å (9.2 DW, F= 226, Table 3-5, Figures 3-46C and 3-46D). This is the shortest 
distance (by 0.035 Å) yet measured within these systems, again supporting a decrease in 
coordination to a five-coordination CoII center. Thus far, the spectroscopic evidence 
suggests this heterotrimer is the most pure in terms of the formation of the heterotrimeric 
scaffold (207Pb NMR) and has the most 5-coordinate like CoII center (UV-Vis and EPR), 
and, the XAS supports the lowest symmetry at the CoII center and is most consistent with 
a 5-coordinate environment.  
Then, I analyzed the opposite heterotrimer, PbIISCoIIN/O[(GR-CH)2(GR-
ACDH)1]n+ and the differences were even more surprising. According to the UV-Vis, this 
heterotrimer looks very similar, with respect to the energy of the observed transitions and 
the extinction coefficients, to the original PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ 
heterotrimer. The EPR also looks very similar to that of the original 1:2 Ala:Leu 
heterotrimer. However, the XAS data tell a different story. The XANES data show a 
significant decrease in edge height as well as a significant increase in the pre-edge height, 
indicating an even bigger change in the symmetry around the CoII site in comparison to 
any of the previously analyzed peptides. In fact, the pre-edge/edge ratio was determined 
to be 6.3 and the pre-edge area was measured at 15.4, a 50% increase in both values over 
the PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+ heterotrimer. Fits of the EXAFS data provide 
average CoII-N/O distances of 1.995 Å (4.2-5.1 & 9.4-6.0 DW, F=218-278, Figures 3-
46E and 3-46F, Table 3-5). The two best fits were for four primary coordinated ligands, 
with equally good fits for N2O2 and N3O environments (Table 3-5). The decrease in 
average bond length from 2.085 to 1.995 Å is consistent with a decrease in coordination 
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number from five- to four-coordinate; however, the UV-Vis and EPR data are consistent 
and comparable with the previously assigned 5-coordinate samples. Therefore, collection 
of another set of XAS data is required to determine if this sample is actually best 
described as a four-coordinate CoII center or if this reported XAS data set is an anomaly.  
 Although there is some ambiguity in the reliability of the PbIISCoIIN/O[(GR-
CH)2(GR-ACDH)1]n+ XAS sample, the spectroscopic analysis of this new set of peptides, 
where the Ala and Asp residues are included on the same helix, have provided some very 
important insights. It appears that the GR-ACDH homotrimer is considerably destabilized 
in comparison to GR-ACH, GR-CDH and GR-CH, but this decreased stability has not 
shown a significant effect on PbII binding via either UV-Vis or NMR analysis. 
Additionally, the decrease in average CoII-N/O distance in combination with the elevated 
extinction coefficients for the PbIISCoIIN/O[(GR-CH)1(GR-ACDH)2]n+ heterotrimer 
support that the primary hypothesis of this section has be achieved, which was to obtain a 
heterotrimer that is pure at both the PbII and CoII sites. 
 Armed with the GR-ACDH peptide, I also wanted to determine how CoII binding 
would be affected if one of the His residues was removed from the binding site, in 
agreement with an uncoordinated third His ligand in TML as well as the lack of a third 
His3 ligand in CPA (see discussion above). To study this sort of binding site I used a 
heterotrimeric mixture where the Ala, Asp and His residues were included in the same 
peptide, GR-ACDH, and a complimentary peptide sequence were no ligands are available 
at the CoII binding site, GRL2WL16C, or GR-C (Table 3-1). The resulting heterotrimer, 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1]n+ showed CoII binding via UV-Vis analysis with a 
maximum absorbance at 543 nm (ε  = 68 M-1cm-1), which looks very similar in shape to 
the PbIISCoIIN/O(GR-CDH)3n+ and PbIISCoIIN/O(GR-ACDH)3n+ homotrimers, but does have 
a lower extinction coefficient (Table 3-2, Figure 3-47). Indeed, even the CoII dissociation 
constant is intermediate at 24.6 ± 11.5 µM (compared to 11.4 and 49.5 µM for 
PbIISCoIIN/O(GR-ACDH)3n+ and PbIISCoIIN/O(GR-CDH)3n+, respectively, Table 3-2). 
Multiplying the spectra obtained from PbIISCoIIN/O(GR-ACDH)3n+ by ⅔, because the 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1]n+ heterotrimer is ⅔ GR-ACDH, provides a UV-Vis 
spectra nearly identical to that obtained when adding CoII to the PbIIS[(GR-ACDH)2(GR-
C)1]n+ mixture (Figure 3-44). Therefore, it appears that when CoII is added to PbIIS[(GR-
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ACDH)2(GR-C)1]n+ I may actually be obtaining 100% CoII binding to PbIIS(GR-
ACDH)3n+. Further analysis is necessary to distinguish between a CoII-bound 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1]n+ heterotrimer and CoII binding to the PbIIS(GR-
ACDH)3n+ component of the mixture.  
 
Figure 3-47. UV-Vis overlay of homotrimers PbIISCoIIN/O(GR-CH)3n+ (red), and 
PbIISCoIIN/O(GR-CDH)3n+ (purple), with heterotrimer: PbIISCoIIN/O[(GR-ACDH)2(GR-
C)1]n+ (orange) at pH 7.5 in 50 mM HEPES buffer. The calculated spectra of 
⅔[PbIISCoIIN/O(GR-ACDH)3n+] is shown in dashed black. Experimental and calculated 
spectra are plotted as molar extinction coefficient (determined using CoII concentration) 
versus wavelength. 
 These data indicate that complete removal of this His residue from the binding 
site does not provide the same CoII binding environment as observed in the 
PbIISCoIIN/O[(GR-ACH)n(GR-CDH)3-n]n+ or the PbIISCoIIN/O[(GR-ACDH)n(GR-CH)3-n]n+ 
heterotrimers. It is possible that the CoII coordinates to Asp and His residues on different 
helices within the trimer and, therefore, removing all coordinating ligands from one 
strand does not provide the proper ligand geometry to provide the CPA/TML-type of CoII 
center.  
However, even though complete removal of one His residue does not provide a 
CPA/TML His2Ox(H2O)Y type of site, the mixture still binds CoII, with a UV-Vis 
spectrum that supports a relatively symmetric environment (as evidenced by the low 
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extinction coefficient) with comparable dissociation constants as seen in the 
PbIISCoIIN/O(GR-ACDH)3n+ and PbIISCoIIN/O(GR-CDH)3n+  homotrimers (Table 3-3). EPR, 
XAS and/or crystallography analysis is necessary to further elucidate CoII-binding in 
PbIISCoIIN/O[(GR-ACDH)2(GR-C)1]n+. Additionally, inclusion of the Asp and His residues 
on opposite helices, such as making a heterotrimer with peptides such as two equivalents 
of GR-ACH and one equivalent of and Asp-only peptide (GRL2WL16CL26D) could 
offer more insight into the necessity of the third His residue in close proximity to the 
binding site.  
 
Effect of Excess PbII on the Transition Metal Binding Site 
Previously, the addition of excess PbII to 3SCCs, homo- or heterotrimeric, with 
only a Cys3 substitution in the peptide sequence, showed no perturbation on the formation 
of the intended heterotrimeric scaffold. Next, I wanted to determine how excess PbII 
would affect the CoII binding to peptides with a second, remote binding site.  To do so, 
aliquots of PbII(NO3)2 were added to a solution of 0.66 mM PbIISCoIIN/O(GR-ACH)3+ or 
0.5 mM PbIISCoIIN/O(GR-CDH)3n+, and the CoII d-d transitions at ~500-600 nm were 
observed for perturbations.  In the case of PbIISCoIIN/O(GR-ACH)3+, the addition of three 
equivalents of PbII, in addition to the equivalent bound to the Cys3 site, provided no 
change in the spectra (Figure 3-48A). However, when excess PbII was added to 
PbIISCoIIN/O(GR-CDH)3n+, a decrease in the peak intensity is observed as well as a blue-
shift in the peak maxima from 543 nm to 517 nm (Figure 3-48B).  
A continuous decrease in the absorbance at 543 nm was observed from 0-1 
equivalents as a function of excess added PbII. Afterwards, no further change was seen 
upon an additional equivalent of excess PbII was added (Figure 3-48C). The spectrum of 
the new blue-shifted species observed with one equivalent of excess PbII is nearly 
identical to that of PbIISCoIIN/O(GR-ACH)3+ with a maximum absorbance at 517 nm and 
an extinction coefficient of 33 M-1cm-1 (Figure 3-48B). These data suggest that excess 
PbII does not perturb CoII when coordinated to a His3 site; however, when Asp residues 
are present, as in PbIISCoIIN/O(GR-CDH)3n+, the addition of excess PbII alters the CoII 
	 175 
environment. This results in a UV-Vis trace similar to PbIISCoIIN/O(GR-ACH)3+, 
supporting similar CoII behavior.  
 
Figure 3-48. Titration spectra of excess PbII into a solution of (A) 0.66 mM 
PbIISCoIIN/O(GR-ACH)3n+, and (B) 0.5 mM PbIISCoIIN/O(GR-CDH)3n+. The trace that 
correlates with one equivalent of additional PbII is shown in red. (C) The corresponding 
titration curve to (B), showing the 1:1 binding stoichiometry of one additional equivalent 
of PbII added with respect to 3SCC at 543 nm. Data collected at pH 7.5 in 50 mM HEPES 
Buffer. 
PbII is known to bind to oxygen-rich environments, such as the Ca2+ binding sites 
of calmodulin.52–54 Therefore, I suspect that the excess equivalent of PbII is interacting 
with the Asp residues near the CoIIHis3 site. This, in turn, prevents the previous CoII-Asp 
interactions, whether it is prohibiting the direct coordination of the Asp residues to the 
CoII or disrupting hydrogen bonding between the Asp residues and water ions bound to 
the CoII. At this time we cannot spectroscopically differentiate between these scenarios.  
These experiments offer two new considerations. First, excess PbII should be 
avoided in samples of PbIISCoIIN/O(GR-CDH)3n+ because it could interfere with the CoII 
environment leading to perturbed spectra. Second, and most exciting, these data suggest 
A B 
C 
	 176 
that we may be seeing evidence of one peptide scaffold, with two metal binding sites, that 
is capable of binding three metal ions. This is the first of two scenarios where the 
spectroscopy presented in my thesis work supports a hetero-binuclear site forming within 
a single metal binding site within a 3SCC (See Chapter 4 for the discussion of a potential 
PbIICuI hetero-binuclear site). A crystal structure and/or XAS analysis is required to 
further explore a potential PbII-CoII interaction. 
 
CoII-binding to His3 sites with Perturbed Secondary Spheres.  
 I have described multiple scenarios in which the secondary sphere around the CoII 
binding site has been altered and the spectroscopic changes that resulted. Introduction of 
an Asp3 layer directly above the His3 site provides a slightly different UV-Vis trace, but 
relatively comparable EPR and XAS data, when compared to the CoIIHis3 site. 
Introducing this Asp3 site below the His3 site provides even less spectroscopic 
perturbations on CoII binding, when compared to the PbIISCoIIN/O(GR-ACH)3+ 
homotrimer. Addition of an extra equivalent of PbII to PbIISCoIIN/O(GR-CDH)3n+ changes 
the UV-Vis trace to reveal a spectrum similar to that of PbIISCoIIN/O(GR-ACH)3+. In these 
scenarios, the most perturbation is observed when the layer above the His3 site is altered.  
 As discussed in Chapter 1, altering the sterics around a CdIICys3 site allows for 
control over the CdII coordination number. CdII(TRIL2WL16C)3- provides a mixture of 
three- and four-coordinate species (Table 3-1).55 CdII(TRIL12AL16C)3 provides space 
for a water molecule to coordinate to the CdII ion resulting in a pure four-coordinate site 
(Table 3-1).56 Conversely, added hydrophobic bulkiness, as provided in both 
CdII(TRIL16Pen)3- and CdII(TRIL12DLL16C)3- completely blocks the access of water to 
the site providing pure three-coordinate environments (Table 3-1).56,57 Due to the 
heterotrimers discussed above providing evidence of mixed CoII environments, I wanted 
to introduce a DLeu layer above the His3 site in hopes of enforcing a single coordination 
number, analogously to the CdIIS3 example. Therefore, I wanted to see how inclusion of a 
DLeu layer would perturb the CoII binding to a His3 site. So, I analyzed CoII binding to 
TRIL2WL19DLL23H, TRI-DLH (Table 3-1).  Aliquots of CoIISO4 were added to a 
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solution of 0.5 mM TRI-DLH (3SCC) at pH 7.5 and analyzed via UV-Vis spectroscopy 
from 400-800 nm. Upon complexation of CoII to TRI-DLH, a broad peak at 541 nm (ε = 
62 M-1 cm-1) was observed with two shoulders at 517 nm (ε = 59 M-1 cm-1) and 588 nm (ε 
= 33 M-1 cm-1, Figure 3-49, Table 3-2). Interestingly, these energies correspond to the 
transitions observed in the heterotrimeric PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ and 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ peptides; however, the extinction coefficients 
associated with these transitions are significantly decreased (less than 50% of the 
heterotrimers) and are consistent with the intensities observed in the PbIISCoIIN/O(GR-
ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+ homotrimers.  
 
Figure 3-49. UV-Vis overlay of homotrimers PbIISCoIIN/O(GR-CH)3n+ (red), and 
PbIISCoIIN/O(GR-CDH)3n+ (purple), with PbIISCoIIN/O(TRI-DLH)3n+ (teal) at pH 7.5 in 50 
mM HEPES buffer. Experimental data are plotted as molar extinction coefficient 
(determined using CoII concentration) versus wavelength. 
The dissociation constant for CoII binding to the DLeuHis3 site was determined 
using a non-linear least squares fitting analysis (Equation 7) in Prism 5 (GraphPad 
Software).8 Titration data at λ = 600 nm were plotted as a function of CoII concentration, 
adjusting for non-specific CoII binding, and fitted as described in the Methods Section. 
The binding affinity obtained for CoIIN/O(TRI-DLH)32+ at pH 7.5 is 38.3 ± 8.7 µM (Figure 
3-50, Table 3-3). This value is very similar to the CoII dissociation constants for 
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PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+, indicating that the DLeu 
substitution does not appear to alter the ability of CoII to bind to the His3 site.   
 
Figure 3-50. UV-Vis titration and titration curves of CoIISO4 added to a solution of 0.5 
mM 3SCC TRI-DLH (A) at pH 7.5 in 50 mM HEPES buffer. The titration data (A) are 
plotted as absorbance versus wavelength and the titration curves (B) are plotted as 
absorbance at λ600 nm versus [CoII]. The trace that correlates to one equivalent of [CoII] 
added, with respect to 3SCC, is shown in red. The black circles represent the raw data 
and the non-linear best-fit curve is shown as a black line (Equation 7, as described in the 
Materials and Methods section).  
An X-band EPR spectrum was collected for CoIIN/O(TRI-DLH)3n+ at 4K. The EPR 
spectrum for this sample is very different than any of the previously discussed samples. 
In fact, this sample looked very much like CoII-coordinated to tris[2-
(dimethylamino)ethyl]amine, Me6TREN,† which is known to from a trigonal bipyramidal 
CoII-complex (Figure 3-51). 58 The similarity observed between CoIIN/O(TRI-DLH)3n+  and 
CoII(Me6TREN)X (where X is a bound Cl- or Br-) suggest that when a DLeu layer is 
introduced in the layer above the His3 site, CoII adopts a trigonal-bipyramidal geometry, 
with relatively high symmetry around the metal ion (due to the low extinction 
coefficients as determined via UV-Vis).   
																																																								
† Data collected at the University of Michigan for Feng Shao, a visiting scholar from the lab of Talal 
Mallah (Institut de Chimie Moléculaire et des Matériaux d'Orsay, CNRS, Université Paris Sud 11, 91405 
Orsay Cedex, France.) Feng synthesized the CoII-bound complex and I collected the EPR data. 
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Figure 3-51. X-band EPR spectra of 1.0 mM CoIIN/O(TRI-DLH)3n+ (black) and 0.4 mM 
CoIIN/X(Me6Tren)X (purple) at pH 7.5 in 50 mM HEPES, collected at 4K. 
Then, I inserted the DLeuHis3 binding site into a GR peptide, 
GRL2WL16CL26DLL30H, or GR-CDLH (Table 3-1), with the ultimate goal of utilizing 
PbII-nucleated heterotrimers to study the perturbed environment of CoII sites consisting of 
varied numbers of DLeu residues (comparable to the AspXHis3 studies above). However, 
when CoII-binding studies via UV-Vis spectroscopy revealed that CoII binds to the 
homotrimer, PbIIS(GR-CDLH)3n+, non-specifically (Figure 3-52).4 This is the first scenario 
in which elongating from a TRI peptide to a GR peptide resulted in the inability to bind 
CoII. Therefore, future studies will be necessary to determine conditions where the 
desired heterotrimer can be formed with GR peptides or one may need to revert to 
forming heterotrimers with the TRI peptides. 
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Figure 3-52. (A) UV-Vis titration of CoIISO4 added to a solution of 1.48 mM PbIIS(GR-
CDLH)3n+ at pH 7.5 in 50 mM HEPES buffer. The titration data are plotted as absorbance 
versus wavelength. The trace that correlates to one equivalent of [CoII] added, with 
respect to 3SCC, is shown in red. (B) UV-Vis overlay PbIISCoIIN/O(GR-CDLH)3n+ (blue) 
and CoIIX(TRIL2W)3n+ (red). Experimental data are plotted as molar extinction 
coefficient (determined using CoII concentration) versus wavelength. 
 
Spectroscopic Comparison of ZnII Heterotrimers to CoII Heterotrimers  
In comparison to CoII, many spectroscopic techniques are unavailable to ZnII due 
to the d10 electronic configuration, which makes it difficult to analyze the difference 
between ZnII-bound homo- and heterotrimers. Additionally, crystal structures of ZnII-
bound to heterotrimers as well as ZnII-bound to a symmetric Asp3His3 site, have proven 
elusive. However, some meterical parameters can be obtained via ZnII XAS. The goal of 
this study was to determine if a similar change in coordination number is observed 
between the ZnII-bound homo- and heterotrimers as observed in the CoII-bound samples, 
which should be evidenced by both the XANES edge as well as the distances observed 
from the EXAFS best fits.  
Samples consisted of 2 mM PbII-bound 3SCC, 1 mM ZnIISO4, ~30-50 mM buffer 
(HEPES, pH 7.5 and CHES, pH 9.5) and ~50% glycerol; all data were collected at ~7-
11K. In general, the XANES spectra for all homo- and heterotrimers at both pH 7.5 and 
9.5 are quite similar, indicating the overall coordination number and geometry of the ZnII 
centers do not change significantly upon addition of aspartate residues or a change in pH 
between the samples (Figures 3-53A and 3-53B, respectively). However some variation 
A B 
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is observed at the different pH values in the relative intensities and peak energies (Figures 
3-53C and 3-53D). Analysis of the edge peak at ~9667 eV, for the pH 7.5 samples, 
reveals that when one aspartic acid or no aspartic acid residues are present, very similar 
edge intensities are observed. In contrast, the presence of two or three aspartic acid 
residues results in systematic increases in the edge intensities (Figure 3-53D). This trend, 
increasing edge intensity with respect to the number of aspartic acid residues present, is 
observed at pH 9.5 as well.  The only exception is the PbIISZnIIN/O[(GR-ACH)1(GR-
CDH)2]n+ sample with two aspartic acid residues, which shows the lowest edge intensity 
(Figure 3-53C). The samples trend to higher edge energy with increasing numbers of 
aspartic acid residues available in the binding site for both pH values (Figure 3-53D).  
 
 
Figure 3-53. Overlay of XANES spectra showing the difference of the ZnII edge at pH 
7.5 (A) and 9.5 (B) of homotrimers: 1.0 mM PbIISCoIIN/O(GR-ACH)3n+ (red) and 1.0 mM 
PbIISCoIIN/O(GR-CDH)3n+ (purple) and heterotrimers: 1.0 mM PbIISCoIIN/O[(GR-
ACH)2(GR-CDH)1]n+ (blue) and 1.0 mM PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ (green). 
Figures (C) and (D) show the correlation of normalized edge intensity and edge energy 
verses the number of Asp residues in the ZnII binding site, respectively, at pH 7.5 (red 
squares) and pH 9.5 (blue circles).  
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Overlaying the XANES spectra for each sample at the two pH values provides 
nearly identical spectra for both PbIISZnIIN/O(GR-CDH)3n+ and PbIISZnIIN/O[(GR-
ACH)1(GR-CDH)2]n+; however, subtle yet apparent differences are observed for 
PbIISZnIIN/O(GR-ACH)3+ and PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+ (Figure 3-54). The 
similarities observed in the general traces indicate the same coordination number and 
geometry; however, observed differences may correlate to different coordinating 
ligands,59 say N2O2 versus N3O, or perhaps can be attributed to different protonation 
states of a presumed ZnII-bound water molecule. Introduction of potential hydrogen 
bonding residues, such as the aspartate residues in my case, could result in perturbations 
to the pKa of the ZnII-bound water, and this could be the reason for the slight changes 
observed in the edge region.   
 
 
Figure 3-54. Overlay of XANES spectra showing the different of the ZnII edge from pH 
7.5 (red) and 9.5 (blue) for PbIISCoIIN/O(GR-ACH)3n+ (A),  PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+ (B),  PbIISCoIIN/O[(GR-ACDH)1(GR-CDH)2]n+ (C) and PbIISCoIIN/O(GR-
CDH)3n+ (D), all samples are at 1.0 mM.  
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Similarly to what was observed for the CoII samples, a nearest-neighbor peak, 
typical of scattering observed by direct nitrogen and/or oxygen metal coordination, 
dominates the EXAFS data and is best fit with a single nitrogen/oxygen shell at ~2.00 Å 
(Table 3-6 and Figure 3-55). There is also evidence in all of the ZnII-bound homo- and 
heterotrimer samples, at pH 7.5 and 9.5, for outer shell scattering typical of histidine 
coordination (Figures 3-55, 3-56, 3-57, 3-58, 3-59, 3-60, 3-61, and 3-62, 2.5 < R < 4 Å). 
Multiple models with varying numbers of imidazole and oxygen ligands were used to fit 
these data including 4-, 5-, and 6-coordinate environments. In the case of every sample, at 
both pH values, the best-fit data correlated to a 4-coordinate environment (Table 3-6). 
Unfortunately, EXAFS fitting does not allow for the distinction between N3O and N2O2 
fits. In the cases of PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+ at pH 7.5 and 
PbIISZnIIN/O(GR-ACH)3+ at pH 9.5, the fits for N3O are not good (indicated by the very 
large goodness of fit values, Table 3-6). This latter point contradicts numerous crystal 
structures (e.g., of HgIISZnII(OH)N/O(TRIL9CL23H)3+) that definitively show a tetrahedral 
ZnIIHis3(OH2) polyhedron.  
Table 3-6. EXAFS fitting parameters for ZnII binding to AspXHis3 sites in homo- and 
heterotrimeric GR peptides at pH 7.5 and 9.5. 
Peptide Shell 
 
pH ZnII-L 
distance, Å 
DW F 
PbIISZnIIN/O(GR-ACH)3+ 
N2O2 
7.5 1.969 6.2, 4.5 71 
9.5 1.973 7.9, 2.3 58 
N3O1 7.5 1.969 7.6, 1.2 67 
PbIISZnIIN/O(GR-CDH)3n+ 
N2O2 
7.5 1.964 5.0, 2.1 74 
9.5 1.966 4.1, 3.5 47 
N3O1 9.5 1.965 5.7, 0.5 54 
PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 
N2O2 
7.5 1.969 4.7, 2.5 83 
9.5 1.965 4.1, 3.7 71 
N3O1 9.5 1.965 5.5, 1.1 80 
PbIISZnIIN/O[(GR-ACH)1(GR-CDH)2)]n+ 
N2O2 
7.5 1.960 5.0, 3.8 80 
9.5 1.967 4.7, 3.7 77 
N3O1 
7.5 1.961 6.8, 1.2 86 
9.5 1.967 6.0, 1.0 83 
All fits include multi-scattering parameters for His residues. N3O1fits for PbIISZnIIN/O(GR-ACH)3+ at pH 9.5, 
PbIISZnIIN/O(GR-CDH)3n+ at pH 7.5, and  PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1)]n+ at pH 7.5 resulted in 
unreasonable ZnII-L distances of >2.4 Å or negative DW factors and have therefore been omitted. DW and F 
correspond to Debye Waller factors and goodness of fit parameters, respectively.  
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Figure 3-55. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O(GR-ACH)3n+ (A, 
C) and the ZnII EXAFS (B, D) at pH 7.5. Experimental data is shown in black and the 
equally good fits for N3O1 for the FT and EXAFS are shown in A and B (red dashed line) 
and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-56. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O[(GR-ACH)2(GR-
CDH)1]n+ (A, C) and the ZnII EXAFS (B, D) at pH 7.5. Experimental data is shown in 
black and the equally good fits for N3O1 for the FT and EXAFS are shown in A and B 
(red dashed line) and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-57. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O[(GR-ACH)1(GR-
CDH)2]n+ (A, C) and the ZnII EXAFS (B, D) at pH 7.5. Experimental data is shown in 
black and the equally good fits for N3O1 for the FT and EXAFS are shown in A and B 
(red dashed line) and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-58. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O(GR-CDH)3n+ (A, 
C) and the ZnII EXAFS (B, D) at pH 7.5. Experimental data is shown in black and the 
equally good fits for N3O1 for the FT and EXAFS are shown in A and B (red dashed line) 
and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-59. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O(GR-ACH)3n+ (A, 
C) and the ZnII EXAFS (B, D) at pH 9.5. Experimental data is shown in black and the 
equally good fits for N3O1 for the FT and EXAFS are shown in A and B (red dashed line) 
and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-60. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O[(GR-ACH)2(GR-
CDH)1]n+ (A, C) and the ZnII EXAFS (B, D) at pH 9.5. Experimental data is shown in 
black and the equally good fits for N3O1 for the FT and EXAFS are shown in A and B 
(red dashed line) and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-61. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O[(GR-ACH)1(GR-
CDH)2]n+ (A, C) and the ZnII EXAFS (B, D) at pH 9.5. Experimental data is shown in 
black and the equally good fits for N3O1 for the FT and EXAFS are shown in A and B 
(red dashed line) and for N2O2 are shown in C and D (blue dashed line). 
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Figure 3-62. Fourier transform of ZnII EXAFS of 1.0 mM PbIISZnIIN/O(GR-CDH)3n+ (A, 
C) and the ZnII EXAFS (B, D) at pH 7.5. Experimental data is shown in black and the 
equally good fits for N3O1 for the FT and EXAFS are shown in A and B (red dashed line) 
and for N2O2 are shown in C and D (blue dashed line). 
As shown in Table 3-6, the change in bond distances and goodness of fits from 
N2O2 to N3O fitting parameters is negligible (except in the cases of PbIISZnIIN/O[(GR-
ACH)2(GR-CDH)1]n+ at pH 7.5 and PbIISZnIIN/O(GR-ACH)3+ at pH 9.5), indicating two 
things. First, these similarities indicate that the identities of the coordinating ligands 
cannot be elucidated from the EXAFS fits to help explain the difference in the XANES 
spectra; however, with bond distances of 1.96 ± 0.1Å, the EXAFS fits do corroborate a 
four-coordinate ZnII environment for all of the peptide samples. Second, when compared 
to reported four-coordinate small molecule ZnII complexes (Table 3-7), we see that all of 
the distances provided from the fits are only slightly shorter, again supporting a 4-
coordinate environment in all of my ZnII-bound homo- and heterotrimers.  
 
A B 
C D 
	 192 
Table 3-7. ZnII-N/O bond distances for relevant ZnIIN3O small molecule complexes 
Complex R(ZnII-N)avg, Å R(ZnII-O), Å Reference 
{[PimiPr,tBu]ZnOH}(ClO4) 2.082 1.860a 73 
[(TriMIm)ZnII(OH2)](BF4)2 2.129 2.003b 75 
[L1ZnII(OH2)(BNPP)26H2O 2.028 1.984b 74 
[L1ZnII(OH)]ClO41.5H2O 2.015 2.046a 74 
aZn-O ligand is (OH). bZnII-O ligand is (OH2). 
73–75 
Ultimately, crystal structures are required to characterize the identities of the 
coordinating ligands within the ZnII-bound systems further. It is of great significance to 
note the difference in coordination number, obtained via XAS analysis, and supported via 
EPR and UV-Vis spectroscopy for the CoII species, between the ZnII and CoII systems. At 
this point, a 5- or 6-coordinate environment best characterizes all but one of the CoII-
bound peptides but ALL of the ZnII XAS data suggest 4-coordinate ZnII environments. 
This is very interesting to note since it supports the contention that in all the cases of my 
homo- and heterotrimeric peptide scaffolds that CoII is a non-innocent spectroscopic 
probe for ZnII. As mentioned above, CoII is regularly used as a spectroscopic probe for 
ZnII but CoII is also commonly used because when substituted in ZnII-metalloenzymes 
significant activity is often retained.25,60,61 However, studies have indicated that CoII has a 
tendency to adopt higher coordination numbers when substituted for ZnII in both small 
molecules and native metalloenzymes.26,35,62–64 Indeed, CoII-substituted CA has been 
reported to adopt four-,26,63,65 five-,26,35,63 and six-coordinate35,64 geometries. The work 
presented here is a clear indication of a case when CoII-coordination does not necessarily 
offer a good picture for what is happening with ZnII. 
To characterize the properties of ZnII binding further, I used the colorimetric 
chelator, Zincon (Zi), in competitive binding titrations, to measure the apparent 
dissociation constants of ZnII to both homo- and heterotrimeric peptides at pH 9.0. First, I 
determined the ZnII binding to PbIIS(GR-CH)3- to determine if the metal bound to the 
Cys3 site had any influence on the ZnII-His3 binding. An apparent dissociation constant of 
0.17 ± 0.09 µM was obtained from the fit from Equation 15 using Prism 5 (GraphPad 
Software)8 and is comparable to the value obtained, by Dr. Melissa Zastrow, of 0.11 ± 
0.05 µM for HgIISZnIIN/O(GR-CH)3n+ (Figure 3-63, Table 3-8).4 This supports the 
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assumption that the ZnII binding affinity is independent of the metal bound the Cys3 
structural (HgII) or nucleation (PbII) site.  
 
Figure 3-63. Competitive ZnII-binding titrations versus Zincon at pH 9.0 for PbIIS(GR-
CH)3- in the forward (10 µM PbIISZnIIN/O(GR-CH)3n+ + Zi) and reverse (5 µM ZnIIZi + 
PbIIS(GR-CH)3n+) direction. Representative UV-Vis spectra for the titration in the A) 
forward and B) reverse directions. C) Titration curve of Abs at 620 nm as a function of 
[Zi] for the forward titration and D) Titration curve of Abs at 620 nm as a function of 
[3SCC] for the reverse titration.  
Table 3-8. Apparent dissociation constants for ZnII binding to AspXHis3 
sites in the TRI and GR peptides at pH 9.0. 
Peptide Kd, app (µM) 
PbIISZnIIN/O(GR-ACH)3+ 0.17 ± 0.10 
HgIISZnIIN/O(GR-CDH)3n+ 0.0031 ± 0.0010* 
HgIISZnIIN/O(GR-CTH)3n+ 0.0023 ± 0.0014* 
HgIISZnIIN/O(GR-CH)3n+ 0.11 ± 0.05* 
PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 1.10 ± 0.60 
PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1)]n+ 0.71 ± 0.30 
*Data collected by Dr. Melissa Zastrow.4  
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Then, I determined the apparent dissociation constant of ZnII to the heterotrimer, 
PbIIS[(GR-ACH)2(GR-CDH)1]n+, to be 1.1 ± 0.6 µM (Figure 3-64A and 3-64B, Table 3-8). 
This value is a factor of ten larger than the corresponding homotrimers, perhaps due to 
the preference of ZnII to bind the nitrogen atoms of the His3 layer more so than the Asp 
ligands as introduced in the heterotrimer. A second, and perhaps more likely possibility, 
is that the introduction of only one Asp residue introduces a hydrogen bonding 
interaction to a ZnII-bound water molecule resulting in a perturbation of the ZnII binding 
affinity. Future studies of the ZnII binding affinity for the opposite heterotrimer, 
PbIIS[(GR-ACH)1(GR-CDH)2]n+, may help determine a trend in ZnII binding preferences.  
 
 
Figure 3-64. Competitive ZnII-binding titrations versus Zincon, in the forward (10 µM 
ZnIIPep3 + Zi) and reverse (5 µM ZnIIZi + 3SCC) directions at pH 9.0 for heterotrimers 
with asymmetric second metal binding sites. Plots show titration data of Abs at 620 nm 
vs [Zi] or [3SCC] for PbIIS[(GR-ACH)2(GR-CDH)1]- (A: forward, B: reverse) and for 
PbIIS[(GR-ACH)2(GR-CTH)1]- (C: forward, D: reverse).  
At this particular point, I was also curious about the possibility of placing one Thr 
residue in close proximity to the His3 site, which would directly mimic CA. I analyzed 
ZnII binding to PbIIS[(GR-ACH)2(GR-CTH)1]n+, where GR-CTH is 
A B 
C D 
	 195 
GRL2WL16CL26TL30H (Table 3-1). This mixture provided a dissociation constant of 
0.71 ± 0.30 µM (Figures 3-64C and 3-64D, Table 3-8), comparable to the PbIIS[(GR-
ACH)2(GR-CDH)1]n+ heterotrimer. In the cases of both Thr and Asp heterotrimers we see 
dissociation constants that are weaker than the corresponding homotrimers by a factor of 
~200-fold (0.0031 ± 0.0005 µM and 0.0023 ± 0.0014 µM for HgIISZnIIN/O(GR-CDH)3n+ 
and HgIISZnIIN/O(GR-CTH)3n+, respectively, Table 3-8). The weaker ZnII binding to the 
heterotrimers, in comparison to the homotrimers, is opposite of what was observed for 
CoII binding to the same peptides. (CoII binding to PbIIS[(GR-ACH)2(GR-CTH)1]n+ 
produces an apparent dissociation constant of 12.5 ± 2.3 µM, Table 3-3). The differences 
in the dissociation constants between ZnII and CoII may be a direct consequence of the 
different coordination environments as suggested by the EXAFS analyses.  A second 
explanation for the opposite trends observed between metals is that when an oxygen 
containing ligand is introduced, asymmetrically, the propensity of the CoII to bind to it, 
and therefore uncoordinating one His ligand, is more likely than that for ZnII, which may 
prefer to stay bound to all three His residues regardless of the secondary coordination 
sphere changes. 
In general, CoII binds to the peptides in this study with apparent dissociation 
constants of 8-50 uM (at pH 7.5, with the exception of PbIISCoIIN/O(GR-CHD)3n+), 
whereas ZnII binds tighter with apparent dissociation constants of 3 nm – 1 µM (at pH 
9.0). This trend is consistent with that observed in native metalloenzymes, such as CA 
and CPA, where ZnII binding is ~103 tighter than CoII binding. ZnII binding is also ~10-3 
M tighter in CA (Kd = 4.0 pm) compared to the reported values here, but is on the same 
order of magnitude when compared to ZnII-CPA (Kd = 4.7 nM).66,67 This trend is also 
consistent with CoII binding, where CoII-binds to CA with an apparent dissociation 
constant of 20 nM (10-3 M tighter than my systems) and to CPA with Kd = 1.5 µM 
(comparable to my systems).67,68 These data support that whether the site is N2O2 or N3O, 
like CPA or CA, respectively, that ZnII binds tigther than CoII, as is also observed in 
nature. Future studies at comparable pH values should be conducted (current studies for 
CoII binding are at pH 7.5 and ZnII are at 9.0) before further comparisons between CoII 
and ZnII binding affinities are made.  
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Preliminary Kinetics Studies of ZnII-bound heterotrimers 
As mentioned in Chapter 1, Dr. Melissa Zastrow determined that elongation from 
HgIISZnIIN/O(TRIL9CL23H)3n+ to HgIISZnIIN/O(GR-CH)3n+ resulted in a 20% decrease in 
catalytic efficiency from 23.3 ± 0.3 M-1s-1 to 18.5 ± 0.6 M-1s-1 for pNPA hydrolysis 
(Table 3-9).4 Addition of a Thr residue, resulting in the homotrimeric 3-fold substituted 
HgIISZnIIN/O(GR-CTH)3n+ peptide, resulted in a slightly decreased catalytic efficiency of 
14.8 M-1sec-1 (Table 3-9). Conversely, when she included an Asp residue, resulting in the 
HgIISZnIIN/O(GR-CDH)3n+ homotrimer, she observed a catalytic efficiency comparable to 
the original TRI peptide of 24.2 ± 2.5 M-1s-1 (Table 3-9). Although the work done for this 
chapter focused heavily on the spectroscopic characterization of heterotrimeric peptides, I 
also wanted to present preliminary kinetic data to determine if the heterotrimeric peptides 
offered any improvement over the catalytic efficiencies provided by the homotrimeric 
scaffolds.  
Table 3-9. Kinetic parameters for hydrolysis of pNPA by homo- and heterotrimeric 
TRI and GR peptides at pH 9.5. 
Peptide kcat/KM, M-1s-1 kcat, s-1 KM, mM 
HgIISZnIIN/O(TRIL9CL23H)3n+ 23.3 ± 0.3 0.040 ± 0.012 1.5 ± 0.5 
HgIISZnIIN/O(GR-CH)3n+ 18.5 ± 0.6 0.064 ± 0.007 3.5 ± 0.5 
HgIISZnIIN/O(GR-CDH)3n+ 24.2 ± 2.5 0.024 ± 0.004 1.0 ± 2.0 
HgIISZnIIN/O(GR-CTH)3n+ 14.8 ± 1.4 0.056 ± 0.026 3.8 ± 2.1 
HgIIS(TRIL9C)3- 1.9 ± 0.3 -  - 
PbIISZnIIN/O[(GR-ACH)2(GR-CH)1]n+ 23.5 ± 1.9 0.011 ± 0.001 0.5 ± 0.1 
PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1)]n+ 25.1 ± 2.5 0.021 ± 0.003 0.8 ± 0.2 
PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1)]n+ 20.6 ± 2.1 0.030 ± 0.007 1.5 ± 0.7 
PbIIS[(GR-AC)2(GR-C)1]n+ 11.2 ±1.6 0.740 ± 0.025 6.8 ± 3.0 
Data for all peptide catalysts with HgII bound were collected by Dr. Melissa Zastrow.4 
To achieve this objective, I evaluated PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1]n+ and 
PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+ for their hydrolytic activity towards pNPA. Both 
PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+ and PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1]n+ show 
saturation kinetics for pNPA hydrolysis at pH 9.5 (Figures 3-65A and 3-65B). The 
catalytic efficiencies are 20.6 ± 2.1 and 25.1 ± 2.5 M-1s-1 (Table 3-9), both of which are 
within error of the rates determined for the original HgIISZnIIN/O(TRIL9CL23H)3+ system. 
The rates for these systems are 0.030 ± 0.007 and 0.021 ± 0.003 sec-1, respectively for 
PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1]n+ and PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+, 
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compared to 0.04 s-1 for the original model (Table 3-9). The KM values are both slightly 
lower than the original mimic (~2 mM) at 1.5 ± 0.5 and 0.8 ± 0.2 mM for 
PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1]n+ and PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+, 
respectively (Table 3-9). The lower KM rates suggest that even though the ZnII binding is 
weaker, there is better substrate access to the ZnII site. At this point it seemed as though 
the heterotrimers offer comparable rates when compared to the original 
HgIISZnIIN/O(TRIL9CL23H)3n+ and HgIISZnIIN/O(GR-CDH)3n+ homotrimers.  
 
 
Figure 3-65. pNPA hydrolysis by (A) 10 µM PbIISZnIIN/O[(GR-ACH)2(GR-CDH)1]n+, (B) 
10 µM PbIISZnIIN/O[(GR-ACH)2(GR-CTH)1]n+, (C) 10 µM PbIISZnIIN/O[(GR-ACH)2(GR-
CH)1]n+ and (D) 10 µM PbIIS[(GR-AC)2(GR-C)1]n+ at pH 9.5 in 50 mM CHES buffer, 0.1 
M Na2SO4. Plots show the initial rates at pH 9.5 vs [pNPA] and the corresponding fits, 
for three replicates, as fitted to the Michaelis-Menten equation. 
Next, I wanted to determine if the catalytic efficiency of a PbII-bound heterotrimer 
with a symmetric ZnIIHis3 binding site, PbIISZnIIN/O[(GR-ACH)2(GR-CH)1]n+, was 
comparable to a similar ZnIIHis3 in HgIISZnIIN/O(GR-CH)3+. PbIISZnIIN/O[(GR-ACH)2(GR-
CH)1]n+ showed saturation kinetics for pNPA hydrolysis at pH 9.5 with a catalytic 
efficiency of 23.5 ± 1.9 M-1s-1 (Figure 3-65C, Table 3-9). The rate and KM for this 
peptide were determined to be 0.011 ± 0.001 s-1 and 0.51 ± 0.08 M (Table 3-9). This rate 
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is nearly 30% higher than the HgII-bound homotrimer. The values determined for the rate 
and KM are the lowest reported for any TRI or GR system, indicating very good substrate 
access and also a very slow rate (resulting in a comparable catalytic efficiency). These 
values indicate that something else, other than just catalysis at the ZnIIHis3 site, is likely 
occurring within this scaffold to contribute to pNPA hydrolysis.  
This observation led me to analyze the hydrolysis of pNPA by PbIIS[(GR-
AC)2(GR-C)1]- (where GR-AC is GRL2WL12AL16C and GR-C is GRL2WL16C, Table 
3-1) to determine the contribution to catalysis due to the PbIICys3 site. Interestingly, in 
the absence of the His3 site, I still observed saturation kinetics for pNPA hydrolysis at pH 
9.5 (Figure 3-65D). The catalytic rate obtained is 11.2 ± 1.6 M-1s-1 with a rate of 0.074 ± 
0.025 s-1 and a KM of 6.8 ± 3.0 M (Table 3-9). This is a significantly elevated KM 
indicating that the substrate has much poorer access to the active site, which is now the 
PbIICys3 site; however, the rate is quite high in comparison to those reported for the 
ZnIIHis3 rates (Table 3-9).1,4  
Interestingly, this is not the first report of PbII catalyzing ZnII reactions. Berreau 
and coworkers characterized the catalysis of amide cleavage reactions by a PbII-bound 
small molecule mimic, the design of which was inspired by mononuclear ZnII centers, in 
comparison to a comparable ZnII-bound complex.69 Although DFT calculations suggest 
that the reaction pathways differ between ZnII- and PbII-bound complexes, the same 
amide methanolysis product is observed for both catalysts. In fact, at a given temperature, 
the PbII-bound mimic provided an observed rate of amide methanolysis that was ~10-fold 
faster than the corresponding ZnII mimic.70 These results indicate that the hydrolysis of 
pNPA by the PbIICys3 site in my scaffolds is not completely unprecedented.  
Therefore the discovery of pNPA hydrolysis via the PbIICys3 site has multiple 
implications. First, direct comparison of my PbII systems to Melissa’s reported HgII 
systems is not a straightforward process, as the HgIICys3 site was found not to contribute 
to catalysis (Table 3-9).1 Second, determination of the contribution of PbIICys3 catalysis 
vs. the ZnIIAaaXHis3 (where Aaa is Asp or Thr) catalysis is a non-trivial determination, as 
the ZnII rate is not simply the difference in the total rate from the PbIICys3 rate. Therefore, 
I have determined that although my constructs are indeed catalytically active toward 
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pNPA hydrolysis, there are new and non-trivial contributions to the reaction to consider. 
Thus, direct comparison of the ZnII-bound PbII-heterotrimeric and HgII-homotrimeric 
systems is elusive.  
It should be noted that if the primary coordination sphere of the ZnII ion has been 
modified, such as N2O2, then these heterotrimers will not be good CA mimics, regardless 
of the ambiguity due to contribution to pNPA hydrolysis from the PbIICys3 site. An N2O2 
site may instead be more appropriate mimic for CPA or TML, which catalyze peptidase 
chemistry.42–44,71 In CA, mutation of a primary coordinating His ligands to a 
carboxyamide can sometimes retain catalytic activity toward pNPA hydrolysis, but it is 
always greatly diminished.72 In the case of mutations from His ligands to carboxylate 
residues (H94D, H94E, H199D, or H199E), which could presumably provide an N2O2 
primary coordination sphere, pNPA hydrolysis is, maximally, 30% of wild-type CA.72 
Therefore, it is possible that my heterotrimers have provided a primary coordination 
sphere that is not conducive for esterase activity at the ZnII site.  
Considering the ability of the PbIICys3 site to catalyze pNPA hydrolysis, I also 
conducted one single kinetic experiment to determine if such a contribution would also 
be observed for CO2 hydration. PbIISZnIIN/O(GR-ACH)3+ exhibits saturation kinetics for 
CO2 hydration at pH 9.5 (Figure 3-66). A catalytic efficiency of 7.4 x 104 M-1s-1 with a 
rate of 310 s-1 and KM of 4.3 mM were obtained. Errors are not included since the 
experiment was not repeated in triplicate. These values correlate well to those reported 
for HgIISZnIIN/O(GR-CH)3+ of kcat/KM = 7.4 ± 3.4 x 104 M-1s-1, kcat = 730 ± 290 s-1, and KM 
= ~9.8 mM. These data indicate that PbIISZnIIN/O(GR-ACH)3+ and HgIISZnIIN/O(GR-CH)3n+ 
have the same kinetic parameters. Since HgII was found not to contribute to CO2 
hydration, we can make the preliminary conclusion that a PbIICys3 site will also not likely 
contribute to the hydration of CO2, since the ZnII sites should be comparable between the 
two samples. These data, in tandem with the pNPA rates, suggest that while the PbII-
nucleated heterotrimers may result in a very convoluted comparisons within the pNPA 
hydrolysis reaction kinetics, that the CO2 hydration kinetics might be a straightforward 
comparison between homotrimeric and heterotrimeric peptides with potential asymmetric 
ZnII binding sites. Such a conclusion is gratifying as the CO2 hydration chemistry is the 
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naturally evolved reaction for CA and represents, ultimately, the most stringent test for 
designed metalloprotein hydratases. 
 
Figure 3-66. CO2 hydration by 10 µM PbIISZnIIN/O[(GR-ACH)2(GR-CH)1]n+ at pH 9.25 in 
50 mM CHES buffer, 0.1 M Na2SO4. The initial rates vs. [CO2] are fitted to the 
Michaelis-Menten equation. Catalyst rates is shown in light pink squares, blank rates are 
shown in blue circles, and the difference rates are shown in red triangles.  
 
Conclusions 
  Herein I have presented the first steps at characterizing transition metal binding 
to symmetric and asymmetric binding sites within PbII-nucleated heterotrimeric scaffolds. 
Inspired by the acid/base Thr residue in CA, T199, which provides a hydrogen-bonding 
interaction to the native ZnII-bound solvent molecule, I introduced an Asp residue into the 
peptide sequence in the layer directly above the His3 binding site, with respect to the N-
terminus, of a de novo designed 3SCC. Applying the methodology introduced in Chapter 
2, PbII-nucleated heterotrimers with one, or two, Asp residues in close proximity to the 
His3 transition metal binding site were then obtained. CoII was used as a spectroscopic 
probe to characterize the resulting homo- and heterotrimeric systems with varying 
numbers of Asp residues near the active site. CoII spectroscopy of the symmetric peptides, 
PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3n+, provide UV-Vis, EPR and XAS 
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data comparable to that of CoII-substituted CA and CA small molecule mimics. The first 
generation of heterotrimeric peptides with asymmetric transition metal binding sites, 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+, 
provided CoII spectroscopic data comparable to that of CoII-substituted CPA, TML, or 
VanX. Indeed, the spectroscopic data support direct carboxylate coordination within the 
heterotrimeric peptides as well as a lower coordination number, probably 5-coordinate, 
for the heterotrimers as compared to the homotrimers (more consistent with 6-coordinate 
CoII complexes). The CoII site appears more 5-coordinate in the PbIISCoIIN/O[(GR-
ACH)1(GR-CDH)2]n+ heterotrimer, where two Asp residues are in close proximity to the 
His3 site.  
Inclusion of the Asp residues below the His3 binding site, in both symmetric and 
asymmetric fashions, provided spectroscopic data similar to that of the homotrimeric 
PbIISCoIIN/O(GR-ACH)3+ system. This supports a model with comparable 6-coordination 
of the CoII environments in PbIISCoIIN/O(GR-CHD)3-, PbIISCoIIN/O[(GR-ACH)2(GR-
CHD)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CHD)2]n+. These data demonstrate that 
simple inclusion of negative charge from carboxylate moieties in close proximity of the 
His3 site is not responsible for the subtle differences observed between the 
PbIISCoIIN/O(GR-ACH)3+ and PbIISCoIIN/O(GR-CDH)3- homotrimers. These data also 
indicate that the inclusion of the Asp residues has geometric restrictions required to form 
the asymmetric CoII centers comparable to those in PbIISCoIIN/O[(GR-ACH)2(GR-
CDH)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+. 
The initial goal of including an Asp residue to provide hydrogen-bonding 
interactions for a metal-bound water molecule is not supported by CoII spectroscopic 
analysis. Instead of perturbations to the second coordination sphere to mimic the ZnII 
binding site of CA, I have actually modified the primary coordination sphere, providing 
spectroscopic characteristics that support direct CoII-carboxylate coordination, resulting 
in a likely N2O3 ligation similar to CPA and TML. This is likely a direct consequence due 
to the propensity of CoII to bind to the oxyanion provided by the Asp ligand. Additionally, 
it is very likely that a chelate effect occurred when the DXXH sequence was employed to 
introduce an Asp ligand in the layer above the His3 site. 
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 Similar conclusions can be made for the second generation of CoII-bound homo- 
and heterotrimers in which the Ala and Asp residues are included on the same helix 
within the 3SCC. This alteration was made to optimize the purity of both the heterotrimer 
formation (2:1 Ala/Leu pairing at the PbIICys3 site confirmed by 207Pb NMR) as well as 
the CoII site (supported via analysis of CoII spectroscopy). The CoII UV-Vis and EPR data 
of PbIISCoIIN/O(GR-ACDH)3n+, PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+, and 
PbIISCoIIN/O[(GR-ACH)1(GR-CH)2]n+ are consistent with the corresponding first-
generation peptides. The XAS data for PbIISCoIIN/O(GR-ACDH)3n+ and PbIISCoIIN/O[(GR-
ACDH)1(GR-CH)2]n+ again support 6- and 5-coordinate CoII environments, respectively. 
In fact the PbIISCoIIN/O[(GR-ACH)1(GR-CH)2]n+ data is consistent with a pure PbII site as 
well as a more 5-coordinate-like CoII complex at the Asp2His3 site. However, XAS 
parameters are more consistent with a 4-coordinate CoII center were observed for 
PbIISCoIIN/O[(GR-ACDH)2(GR-CH)1]n+.  
 ZnII XAS analysis of  PbIISZnIIN/O(GR-ACH)3+, PbIISZnIIN/O(GR-CDH)3n+ and the 
corresponding heterotrimers provides consistent evidence at pH 7.5 and 9.5, for four-
coordinate ZnII environments in all of the homo- and heterotrimer samples. Although the 
exact identity of the four ligands cannot be determined via XAS, these data indicate that 
CoII binds with a different geometry and coordination number, in all cases, when 
compared to ZnII; therefore, CoII appears to be a non-innocent probe for ZnII binding 
within these constructs. Initial kinetic experiments indicate that the PbIICys3 site is 
catalytically active toward pNPA hydrolysis; however, CO2 hydration by 
PbIISZnIIN/O(GR-ACH)3+ is comparable to HgIISZnIIN/O(GR-CH)3n+, indicating that future 
direct comparison can be made for the CO2 kinetic parameters.  
 Overall, this work suggests that the goal of obtaining PbII-nucleated 
heterotrimeric 3SCCs with asymmetric transition metal binding sites has been reached 
when binding CoII and ZnII. The CoII spectroscopy supports the formation of an 
asymmetric primary coordination sphere. These asymmetric CoII bound peptides share 
many spectral characteristics with CoII-substituted CPA, TML and VanX. This is the first 
report of asymmetric transition metal binding sites within self-associating 3SCCs. ZnII 
binding was also o
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cannot say whether or not the primary coordination sphere has been altered, the 
modifications included in the peptide sequence, either the first or second coordination 
sphere, must be different than the corresponding homotrimers.  
 Additionally, due to the differences in the coordination numbers between CoII and 
ZnII, supported by XAS analysis, it is possible that the inclusion of an Asp residue in the 
layer directly above the His3 site provided the intended asymmetric ZnII secondary 
environment, as inspired by the T199 residue of CA. The ZnII XAS data support 4-
coordinate ZnII centers at both neutral and high pH, which could correspond to His3OH2 
environments with a nearby Asp residue. If the primary coordination sphere was indeed 
altered for ZnII binding, then the site would no longer be the intended CA mimic, as 
discussed above. However, if the ZnII coordination is indeed His3O, as evidenced by X-
ray crystallography and generally comparably good XAS fits (compared to N2O2), it is 
possible that the Asp (or Thr) residue has provided an asymmetric secondary 
coordination sphere. Inclusion of an acid/base catalyst in the 26th position could hydrogen 
bond with the presumed ZnII-bound water molecule, as observed in CA.  
Initial kinetic studies indicate that the PbIICys3 site is not active toward CO2 
hydration, which could allow for future studies to determine, straightforwardly, if the 
ZnII-bound heterotrimers, with Asp nearby residues, offer improved catalytic activity or 
perturbed kinetic pKa values for the ZnII bound water.  
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Chapter 4. De Novo Designed Metallopeptides:  
Unexpected homo- and hetero-binuclear CuI Cys3 Sites 
Introduction 
Copper is an important trace metal that is indispensible for essentially all 
organisms. The hallmark of copper reactivity in biological systems is its redox property, 
which leads to a variety of copper proteins that catalyze oxidoreductase and 
mono/dioxygenase reactions or carry out electron transfer.1–11 These reactions are critical 
for many cellular functions; however, copper is a potential toxin if not regulated properly. 
Free copper ions carry out Fenton-type reactions that produce deleterious reactive oxygen 
species, which can cause lipid, nucleic acid, and protein damage.12,13 These effects 
demand a tight homeostatic regulation of copper acquisition, distribution and use. For 
example, the most common copper related disorders in humans are Menkes and Wilson 
diseases, which are related to defects of the human P1B-type ATPases (ATP7A and 
ATP7B, respectively).14–19 Too much copper can result in Wilson’s disease, where the 
brain and liver are overloaded with copper and, because of copper’s proficiency at redox 
chemistry, can lead to negative effects such as the production of unwanted hydroxyl 
radicals in the body. Clinical symptoms of excessive copper overload can range from 
liver failure to neurological defects. Conversely, in Menkes Disease too little copper is 
transported across the gut, causing insufficient loading of copper into copper-dependent 
enzymes. This deficiency can result in symptoms ranging from neurological defects, 
delayed development and ultimately death. Therefore, strict regulation of copper 
homeostasis is vital. 
The uptake and transport of copper ions involve cell surface transporters (Ctr1)20 
and copper chaperones. Three pathways with three distinct metallochaperones have been 
proposed to deliver copper to the mitochondria (Cox17 pathway), the Golgi (Atx1 
pathway), and the cytosolic superoxide dismutase (CCS pathway).21–24 Intracellular 
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copper trafficking is achieved through ligand exchange of these metallochaperones with 
their delivery target via thermodynamic and kinetic control. The mechanistic details of 
transfer, however, are not completely understood on the molecular level. Over the years, 
two- and three-coordinate copper-thiol/thiolate species have been proposed to be key 
intermediates.23–26 Regardless of the differences between the proposed pathways, all of 
these copper metallochaperones contain similar thiol-rich copper Sn binding sites.  
As summarized in Chapter 1, the Pecoraro lab has demonstrated that de novo27–32 
designed Cys3 containing peptides provide binding environments amenable for HgII, PbII, 
CdII, and AsIII binding to address heavy metal selectivity, specificity and coordination 
preference in a protein environment.33–47 In Chapter 2 I described how a Cys3 site can be 
used to bind PbII, with varied steric matching in the secondary coordination environment 
to provide space for a stabilizing hydrogen bonding network, to provide heterotrimeric 
3SCC. Additionally, a past group member, Dr. Fangting Yu, extensively studied many 
systematically designed structural and functional models of the CuIHis3 type-2 copper 
center of native CuNiR (see Chapter 1 for a brief summary).48–50 Considering the 
extensive work previously conducted in the Pecoraro lab regarding heavy metal 
homeostasis with thiolphilic metals such as HgII, PgII, AsIII, etc…, in combination with the 
thiolphilicity of CuI, it was surprising that no one had yet analyzed CuI binding to a Cys3 
site within the TRI and GR families of 3SCC. 
In this chapter, I will describe how the investigation of CuI binding to Cys3 sites 
within de novo designed 3SCCs, under physiologically relevant pH conditions, provides 
an unexpected binuclear CuI site as supported via UV-Vis and XAS spectroscopy. The 
association constants of the CuI2Cys3 centers within peptides that have different 
secondary coordination spheres have been determined using a primary standard 
competition titration with bathocuproinedisulfonate (BCS2-). Additionally, previously 
measured CuIHis3 binding constants can be used to confirm the combined association 
constants by observing CuI competition for binding in a peptide that contains both a Cys3 
and a His3 binding site. The similarities observed between CuI binding to Cys3 sites 
within the TRI/GR peptides and CuI metallochaperones will be discussed as well as the 
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resulting implications of the structure-function relationship of binuclear CuI binding sites 
in thiol-rich binding pockets.   
Furthermore, I hoped to use the CuI affinities to determine the ever-elusive 
PbIICys3 binding affinities via competition between CuI and PbII for the same Cys3 site. 
However, UV-Vis titrations of such competition experiments reveal data that support CuI 
binding to a Cys3 environment in the presence of PbII, therefore, suggesting formation of 
a heterobinuclear CuIPbIICys3 metal center. Such a site is both unexpected and   
unprecedented within our TRI and GR families of 3SCCs and has never been reported in 
biology.    
 
Materials and Methods 
General Procedures. All samples containing CuI were prepared and handled in an inert 
atmosphere glove box using oxygen-free buffer, water, and acetonitrile. A stock CuI 
solution was prepared in degassed acetonitrile using [Cu(CH3CN)4]BF4 salt. Stock CuI 
concentrations of 100-200 mM were determined by spectrophotometric titrations using 
2,9-dimethyl-1,10-phenanthroline, DMP.51  
Peptide Synthesis and Purification. Peptides were synthesized on one of two 
instruments: an Applied Biosystems 433A synthesizer or a Biotage Initiator+Alstra 
synthesizer on a Rink Amide Methylbenzhydrylamine (MBHA) resin using standard 
Fmoc-tBu-based protection protocols (HBTu/HOBt coupling).52 Crude peptides were 
cleaved from the resin using trifluoroacetic acid (TFA), ethandithiol, anisole, and 
thioanisole (90:3:2:5), dissolved in double distilled water and lyophilized to dryness. 
Purified peptides were isolated using Waters 600 HPLC on a reverse phase C18 column 
(flow rate: 20 mL/min, solvent A: 0.1% TFA in water and B: 0.1% TFA in 90:10 
CH3CN:H2O. A linear gradient was used starting at 70:30, A:B and increasing to 20:80 
over 35 min.). ESI-MS was used to confirm the mass of purified peptide and collections 
were lyophilized to yield pure, white powder. Concentrations of all peptides were 
determined by tryptophan absorbance at 280 nm (ε = 5,500 M-1cm-1).53 
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Ultraviolet-Visible (UV-Vis) Spectroscopy. UV-Vis spectra were recorded in 1-cm 
quartz cuvettes at room temperature on a Cary 100 Bio UV/Vis spectrometer.  
PbII-binding titrations. Titrations of PbII into peptide were performed at room 
temperature and monitored via UV-Vis spectroscopy in a 1-cm quartz cuvette. LeadII 
titrations were completed in 50 mM TRIS buffer at pH 8.5 at a peptide concentration of 
30 µM. TRIS adjustments were made using small aliquots of concentrated KOH and HCl. 
Aliquots of PbII(NO3)2 or PbCl2 stock solutions (standardized using inductively coupled 
plasma-optical emission spectroscopy) were titrated into the peptide solution. For all 
titrations, a background spectrum of buffer and water were subtracted from the peptide 
and metallated samples.  
Competitive CuI-binding titrations.  
BCS2- and Pep3 competition for CuI binding.  A competitive chelation assay was used to 
determine the affinity of CuI to Cys3-containing TRI or GR peptides. 
Bathocuproinedisulfonate, BCS2-, is a well-defined CuI chelator, binds CuI in a 2:1 ratio 
providing a colored [Cu(BCS)2]3- species (λmax = 483 nm; ε
483 nm = 13,300 M-1cm-1; log β2 
= 19.8).54 A solution of 40 µM CuI and 80 µM peptide (50 mM buffer: MES, pH 6.5, 
HEPES, pH 7.5, or CHES, pH 9.0) was prepared in a 1-cm quartz anaerobic cuvette in an 
inert atmosphere glove box and titrated with an ~6 mM BCS2- solution. The increase in 
absorbance at 483 nm was followed using UV-Vis spectroscopy. All titration additions 
were carried out in the glovebox. Prism 5 (GraphPad Software)55 was used to fit the 
spectrophotometric data taking into account the protonation equilibrium of BCS2- (pKa = 
5.7).54  
Four models were considered to derive fitting equations for the determination of the 
binding affinities of CuI to Cys3 containing peptides. The first model addresses the 
formation of a mononuclear CuIPep3 species, as shown below in Model 1. If the data fits 
to this model then weak binding of the second equivalent of CuI to the peptide is expected, 
as it supports the formation of 100% mononuclear CuIPep3 before any binuclear CuI2Pep3 
is formed. 
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Model 1. The binding equilibrium for the first scenario, where CuI binds to apo-peptide to 
form CuICys3, can be expressed by Equation 1.  
Cu + 2 BCS2- ⇌ [Cu(BCS)2]3- + Pep3      Equation 1 
The apparent association constant of CuIPep3 can be calculated using Equation 2.  
Kcomp = KBCS =  [Cu(BCS)2][Pep3]f 
 KCuCys3   [BCS2-]f2[CuPep3]      Equation 2 
Where KCuCys3, the association constant of one equivalent of CuI binding to a 3SCC, is to 
be fit and KBCS is a known value.54 Mass balance equations for [Cu]T, [Pep3]T, and  
[BCS2-]T can be as seen in Equations 3-5.  
Mass Balance Equations: 
[Pep3]T = [Pep3]f + [CuPep3] 
     [Pep3]f = [Pep3]T – [CuPep3]     Equation 3 
[Cu]T = [CuPep3] + [Cu(BCS)2] + [Cu]f 
  [CuPep3] = [Cu]T – [Cu(BCS)2]     Equation 4 
[BCS2-]T = [BCS2-]f + [HBCS-]f + 2[Cu(BCS)2]    Equation 5 
Where: 
HBCS- ⇌ BCS2- + H+       Equation 6 
Ka = [BCS2-]f[H+] 
              [HBCS-]f 
[HBCS-]f = [BCS2-]f[H+] 
  Ka        Equation 7 
Therefore: 
 [BCS2-]T = [BCS2-]f + [BCS2-]f[H+] + 2[Cu(BCS)2] 
          Ka      
        [BCS2-]f = [BCS2-]T-2[Cu(BCS)2] 
                    (1 + ([H+]/Ka)    Equation 8 
 
Substituting Equations 3, 4 and 8 into Equation 2 yields Equation 9.  
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Kcomp =             [Cu(BCS)2]([Pep3]T –[Cu]T + [Cu(BCS)2])         Equation 9 
                       ([Cu]T-[Cu(BCS)2])(([BCS]T-[Cu(BCS)2])/(1+([H+]/Ka)))    
        
The KCuCys3 value can be directly related to the absorbance observed at 483 nm by 
substituting [Cu(BCS)2] from Equation 10 (where b is the path length of the cuvette) into 
Equation 9.  
Absorbance483 nm = ε483 nm * [Cu(BCS)2] * b     Equation 10 
The data does not converge to Equation 9 as derived from Model 1. This supports that a 
model in which one equivalent of CuI binds to all Pep3 before any binuclear CuI2Pep3 is 
formed is not correct. This is supported by the presence of a CuI2Pep3 species at low 
concentrations of CuI as observed in the XAS data (see below).   
Model 2. An alternative approach addresses an independent step-wise model where first a 
CuIPep3 species is formed followed by a CuI2Pep3 species upon addition of excess CuI 
(greater than one equivalent) as expressed in Equation 11. 
CuI + Pep3 ⇌ CuIPep3 + CuI ⇌ CuI2Pep3     Equation 11 
However, this model is under parameterized and I cannot write an analytical equation to 
evaluate the individual stepwise constants.  
Model 3. Since I cannot write an equation to analyze the independent stepwise model 
(Model 2), I attempted to simplify the data into two regions corresponding to the 
competition of BCS2- with each independent equivalent of CuI. This model assumes that 
all of the peptide is loaded with CuI to form the mononuclear CuIPep3 species before the 
second equivalent of CuI binds to form the binuclear CuI2Pep3 species; however, the 
fitting is done by splitting the data into two regions corresponding to 0 ≤ Cu ≤ 1 and 1 ≤ 
Cu ≤ 2. CuI binding can be expressed by Equations 12 and 13.  
CuI + Pep3 ⇌ CuIPep3        Equation 12 
CuIPep3 + CuI ⇌ CuI2Pep3       Equation 13 
The data corresponding to the first equivalent of CuI binding corresponds to Model 1 and 
will be fitted with Equation 9. The corresponding BCS2- competition model for the fitting 
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the second half of the equation to Equation 13 can be seen in Equation 14 and the 
derivation is as follows.  
Cu2Pep3 + 4 BCS2- ⇌ 2[Cu(BCS)2]3- + Pep3     Equation 14 
The apparent association constant of CuI2Cys3 can be calculated using Equation 15.  
Kcomp =   KBCS    =   [Cu(BCS)2][CuPep3]f 
 KCu+CuCys3      [BCS2-]f2[Cu2Pep3]     Equation 15 
Where KCu+CuCys3, the association constant of one equivalent of CuI binding to a pre-
formed mononuclear CuI-Pep3 species, is to be fit and KBCS is a known value.54 New 
mass balance equations for [Cu]T and [Pep3]T can be seen in Equations 17 and 18. The 
same mass balance for [BCS2-]T from Equation 8 is still appropriate here. 
Mass Balance Equations: 
[Pep3]T = [CuPep3] + [Cu2P3] 
     [CuPep3] = [Pep3]T – [Cu2Pep3]     Equation 16 
[Cu]T = [Pep3] + [Cu(BCS)2] + [Cu2Pep3] 
  [Cu2Pep3] = [Cu]T – [Pep3]T – [Cu(BCS)2]    Equation 17 
 
Substituting Equations 16, 17 and 8 into Equation 15 yields Equation 18.  
Kcomp =             [Cu(BCS)2](2[Pep3]T –[Cu]T + [Cu(BCS)2])         Equation 18 
               ([Cu]T-[Pep3]-[Cu(BCS)2])(([BCS2-]T-2[Cu(BCS)2])/(1+([H+]/Ka)))2   
         
The KCu+CuCys3 value can be directly related to the absorbance observed at 483 nm by 
substituting [Cu(BCS)2]3- from Equation 10 (where b is the path length of the cuvette) 
into Equation 18.  
This allows for the first data region to be analyzed with Equation 9 and the second half of 
the data to be fitted to Equation 18; however, attempts to fit each set of truncated data to 
Equations 9 and 18, respectively, results, once again, in nonconvergence.  
Model 4. A fourth scenario, where CuI binds to apo-protein to form CuI2Cys3 (with no 
mononuclear CuICys3 species) can be expressed by Equation 19.  
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Cu2Pep3 + 4 BCS2- ⇌ 2[Cu(BCS)2]3- + Pep3     Equation 19 
The apparent association constant of CuI2Cys3 can be calculated using Equation 20.  
Kcomp = (KBCS)2 = [Cu(BCS)2]2[Pep3]f 
  KCu2Cys3    [BCS2-]f4[Cu2Pep3]     Equation 20 
Where KCu2Cys3, the association constant of CuI binding to apo-peptide to form a 
binuclear CuI2Cys3 site, is to be fit and KBCS is a known value.54 New mass balance 
equations for [Cu]T and [Pep3]T can be seen in Equations 21 and 22. The same mass 
balance for [BCS2-]T from Equation 8 is still appropriate here. 
Mass Balances: 
[Cu]T = 2[Cu2Pep3] + [Cu(BCS)2] + [Cu]f 
  [Cu2Pep3] = ½([Cu]T – [Cu(BCS)2])     Equation 21 
 
[Pep3]T = [Cu2Pep3] + [Pep3]f 
   [Pep3]f = [Pep3]T – [Cu2Pep3]    Equation 22 
Substituting Equations 8, 21 and 22 into Equation 20 yields Equation 23.  
Kcomp =             [Cu(BCS)2]2([Pep3]T – (½([Cu]T – [Cu(BCS)2])))            Equation 23 
                 ([BCS2-]f + [BCS2-][H+](1/Ka) + 2[Cu(BCS)2])4(½([Cu]T – [Cu(BCS)2])) 
            
The KCu2Cys3 value can be directly related to the absorbance observed at 483 nm by 
substituting [Cu(BCS)2]3- from Equation 10 (where b is the path length of the cuvette) 
into Equation 23.  
For the experiment, where aliquots of BCS2- are titrated into a solution of CuI-bound Pep3, 
an absorption band at 483 nm is due to the [CuI(BCS)2]3- complex, and increases as CuI is 
complexed by BCS2-. Analysis of a decrease in CuI-Pep complex at 266 nm is convoluted 
due to absorbance in the UV region by the [CuI(BCS)2]3- complex. The titration data at 
Abs 483 were fit by rearranging Equation 9, Equations 9 and 18, for their respective 
regions of titration data, and Equation 23, alone in Prism 5 (GraphPad Software).55 The 
data would not converge to either Equation 9 or a combination of Equations 9 and 18. 
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The data will fit to Equation 23, but there are too many unknown parameters to fit to 
Model 2. Subsequently, I will present XAS data at pH 7.5 that suggests at very low CuI 
concentration a significant amount of a CuI2Pep3 species is observed. If Model 4 is indeed 
correct, then this suggests that the binding affinity for CuI to Pep3 to form the 
mononuclear site is comparable to the second equivalent of CuI binding to CuIPep3 to 
form the dinuclear CuI2Pep3 species.  
Direct CuI-binding titrations. Titrations of CuI into peptide were performed at room 
temperature and monitored via UV-Vis spectroscopy in a 1-cm quartz anaerobic cuvette. 
CuI titrations were completed in 50 mM degassed potassium phosphate (KPhos) buffer at 
pH 8.0 at a peptide concentration of ~50-150 µM (17-50 µM 3SCC). KPhos adjustments 
were made using small aliquots of concentrated KOH and HCl. Aliquots of a 
[Cu(CH3CN)4]BF4, dissolved in degassed acetonitrile and diluted in degassed H2O, were 
titrated into the peptide solution. For all titrations, a background spectrum of buffer and 
water were subtracted from the peptide and metallated samples.  
Equation 24 can express the binding equilibrium for the competition experiment of CuI 
binding to a peptide with both Cys3 and His3 sites, GRL2WL16CL30H. Similarly to the 
BCS2- titrations, it is assumed that no free CuI is present in solution during these titrations. 
Additionally, due to the non-convergence of Equations 9 and 18, in addition to the 2:1 
binding stoichiometry observed in the direct CuI binding experiments, it is assumed that 
no mononuclear CuI species is formed. A final assumption is that the binding affinity of 
CuI to a His3 site does not influence the affinity of CuI binding to a Cys3 site in the same 
peptide scaffold, and vice versa. 
2CuHis3 + Cys3 ⇌ Cu2Cys3 + 2His3      Equation 24 
The competition constant for CuI binding to the Cys3 and His3 sites can be calculated 
using Equation 25. 
Kcomp = KCu2Cys3  =  [Cu2Cys3][His3]f2     Equation 25 
            (KCuHis3)2     [Cys3]f[CuHis3]2 
Where KCu2Cys3 is the association constant to be fit, KCuHis3 is the association constant 
determined from CuI binding to a His3 site in the absence of a Cys3 site and KBCS is a 
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known value.54 A value of 5.0 x 1012 M-1 is used for KCuHis3, as previously reported for 
TRIL2WL23H of 5.0 x 1012 M-1.56 For the titration, where aliquots of CuI are titrated into 
a solution of GRL2WL16CL30H, an absorption band at 266 nm is due to the Cu2Cys3 
complex, and increases as CuI is complexed at the Cys3 site. Mass balance equations for 
[Cu]T, [Cys3]T, and [His3]T can be defined and related to [Pep3]T as seen in Equations 23, 
24, 25, and 26.  
Mass Balance Equations: 
[Cu]T = [CuHis3] + 2[Cu2Cys3] + [Cu]f 
 [CuHis3] = [Cu]T – 2[Cu2Cys3]     Equation 23 
 
[Pep3]T = [His3]T = [Cys3]T       Equation 24 
[His3]T = [CuHis3] + [His3]f 
                 [His3]f = [His3]T – [CuHis3]    Equation 25 
[Cys3]T = [Cu2Cys3] + [Cys3]f 
   [Cys3]f = [Cys3]T – [Cu2Cys3]    Equation 26 
Substituting Equations 23-26 into Equation 21 yields Equation 27.  
 KCu2Cys3    =  [Cu2Cys3]([Pep3]T – [Cu]T + 2[Cu2Cys3])2 
(KCuHis3)2         ([Pep3]T-[Cu2Cys3])([Cu]T-2[Cu2Cys3])2   Equation 27 
The KCu2Cys3 value can be directly related to the absorbance observed at 266 nm by 
substituting [Cu2Cys3] from Equation 28 (where b is the path length of the cuvette) into 
Equation 27.  
Absorbance266 nm = ε266 nm * [Cu2Cys3] * b     Equation 28 
Unfortunately, the number of variables in this equation can not be reduced sufficiently to 
be inputted properly into Prism 5 (GraphPad Software)55; however, the equation can be 
manually used to individually determine Kcomp for each titration point (vide infra). A 
discussion of the associated assumptions made for this model, listed above, can be found 
below.  
CuI and PbII competition for Cys3 binding.  CuI and PbII competition experiments were 
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conducted at room temperature and monitored via UV-Vis spectroscopy in a 1-cm quartz 
anaerobic cuvette. Competition experiments were performed in 50 mM degassed TRIS 
buffer at pH 7.5 or 8.5 at a peptide concentration of 30 µM. Aliquots of PbII or CuI were 
titrated into the peptide solution and competition was analyzed via increases or decreases 
in the PbIIS3 LMCT band at ~340 nm, indicating binding or displacement of PbII by CuI, 
respectively. PbIICys3 and CuICys3 sites both show features at ~266 nm and therefore 
straightforward analysis of the competition at this wavelength is non-trivial. For all 
titrations, the difference spectra were obtained by subtracting the background spectrum of 
the peptide under identical conditions but in the absence of metal.  
207Pb NMR Spectroscopy. NMR samples were prepared, anaerobically, by dissolving 
pure, lyophilized peptide in degassed 10% D2O in an inert atmosphere box. 
Metallopeptides were prepared by addition of isotopically enriched 207Pb(NO3)2 (92.4%, 
Oak Ridge National Laboratory, TN) and CuI from a stock solution of [Cu(CH3CN)4]BF4 
dissolved in acetonitrile, to non-buffered solutions of 3-5 mM peptide trimer. All samples 
were adjusted to the desired pH using small aliquots of concentrated KOH or HCl. 207Pb 
NMR spectra were recorded at a frequency of 145.9 MHz on a Varian 700 MHz 
spectrometer at 25 °C with spin = 0, 0.20 ms relaxation time, and 20 ms acquisition time. 
Linear predictions were performed to remove noise, and the real FID was determined as 
previously described.46,57,58 The data were processed with an exponential line broadening 
of 400-600 Hz using MestRe-C software.59 The 207Pb NMR shifts are reported as the 
observed signal plus ~2986 ppm, as reference by tetramethyllead (δ=0 ppm; toluene) 
using 1 M Pb(NO3)2 in D2O (natural abundance salt, δ=-2986 ppm) as an external 
standard. The external standard was run after each experimental collection to adjust for 
any shifting of the magnetic field. All NMR samples containing CuI were prepared in an 
inert atmosphere glove box adding one equivalent of CuI followed by any necessary 
adjustment of pH.  
 
X-ray Absorption Spectroscopy. Solutions of 1.0 mM CuIS(3SCC) were prepared 
anaerobically with 30-50 mM HEPES buffer at pH 7.5. An excess (1.0 mM) of apo-
3SCC was present to ensure the free CuI concentration was minimal (<0.01%). The 
samples were pH adjusted then mixed with 50% glycerol (glassing agent) and loaded into 
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a sample cell and frozen in liquid nitrogen for transport and analysis. All XAS 
measurements were performed at Stanford Synchrotron Radiation Lightsource, SSRL, 
(Beam line: 7-3). A Si(220) double crystal monochromator was utilized, with a flat Rh-
coated vertically collimating harmonic rejection mirror. Data were collected with a beam 
size of 1 x 9 mm2 and the x-ray energy was calibrated by collecting the absorption 
spectrum of a Cu foil as a reference, placed between two ionization chambers situated 
after the sample, at the same time as the fluorescence data were collected, with the first 
infection point assigned as 8980.3 eV. The samples during data acquisition were 
maintained at a temperature of ~7-9 K, and the data were measured in fluorescence mode 
with a 30-element energy resolving Ge detector. The data were collected using 0.25 eV 
steps in the XANES region (1 sec. integration time), and 0.05 Å-1 increments for the 
extended X-ray absorption fine structure (EXAFS) region up to k=13.5 Å-1, with an 
integration times of 1-20 s (k3 weighted) in the EXAFS region for a total scan time of 
~40 min. The raw data were examined for glitches and the fluorescence from the good 
channels was then utilized for averaging. The EXAFS data were analyzed using the 
EXAFSPAK60 suite of programs, where the theoretical amplitude and phase parameters 
used were calculated using FEFF 9.61 An initial E0 value of 9,000 eV was used to convert 
data to k-space, and the background was removed using a 3-region cubic spline. 
Results and Discussion 
 In Chapter 2, I determined that CuI will compete with PbII when only one metal 
binding site (Cys3) is present in a GR or TRI peptide (Figure 4-1). In the presence of one 
equivalent of CuI, PbII titrated into GRL2WL16C (Table 4-1) resulted in an extinction 
coefficient of ~2000 M-1cm-1 at λ345 nm, approximately half of the maximal extinction 
coefficient observed for PbIIS3 in the absence of CuI. This lead me to believe that not only 
does CuI bind to the Cys3 site provided within our GR and TRI peptides, but that CuI also 
binds with a relatively high association constant considering the competition observed 
with PbII for the site, and our previous knowledge that PbII binds with an affinity so high 
that we are not currently able to accurately measure PbIICys3 affinities. Therefore, I set 
out to characterize CuI binding to Cys3 sites with the hope that I could eventually use the 
CuI and PbII competition to better characterize PbIICys3 binding.  
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Figure 4-1. Titration curve of PbII into a solution of GRL2WL16C (blue inverted 
triangles), CuI(GRL2WL16C)3n+ (red circles) and CuI(GRL2WL16C)3n+ (green squares) 
shown as absorbance at 346 nm divided by concentration of PbII added (ε at λ346) versus 
the equivalent of PbII added, with respect to the total concentration of 3SCC. Data 
collected at pH 8.5 in 100 mM Tris-HCl buffer. 
 
Table 4-1. Peptide Sequences 
Peptide Sequence 
             abcdefg 
TRI Ac-G LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
TRIL12AL16C Ac-G LKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRILWL12AL16C Ac-G WKALEEK LKAAEEK CKALEEK LKALEEK G-NH2 
TRILWL12DLL16C Ac-G WKALEEK LKADLEEKCKALEEK LKALEEK G-NH2 
TRIL2WL16C Ac-G WKALEEK LKALEEK CKALEEK LKALEEK G-NH2 
GRAND Ac-G LKALEEK LKALEEK LKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL16C Ac-G WKALEEK LKALEEK CKALEEK LKALEEK LKALEEK G-NH2 
GRL2WL16CL30H Ac-G WKALEEK LKALEEK CKALEEK LKALEEK HKALEEK G-NH2 
CoilSer Ac-E WEALEKK LAALESK LQALEKK LEALEH G-NH2 
CSL9C Ac-E WEALEKK CAALESK LQALEKK LEALEH G-NH2 
GRANDCoilSer Ac-E WEALEKK LAALESK LQALEKK LQALEKK LEALEH G-NH2 
GRCSL12DLL16C Ac-E WEALEKK LAADLESKCQALEKK LQALEKK LEALEH G-NH2 
GRCSL16CL30H Ac-E WEALEKK LAALESK CQALEKK LQALEKK HEALEH G-NH2 
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CuI binding to Cys3 containing 3SCCs 
Spectroscopic Determination of CuI Binding Stoichiometry to Cys3-Containing 
3SCCs 
 Native copper metallochaperone studies revealed that CuICys3 centers provide a 
characteristic LMCT band at ~266 nm. Aliquots of CuI (stock [Cu(CH3CN)4]BF4 
dissolved in degassed acetonitrile and diluted in H2O) were added in an inert atmosphere 
box to a solution of TRIL2WL16C (Table 4-1). As the peptide complexes CuI, an 
increase in absorbance is observed at 266 nm (Figure 4-2A).  Plotting the change in 
absorbance at 266 nm, divided by the concentration of total CuI added (the effective 
extinction coefficient at 266 nm), versus the concentration of total CuI added provides a 
titration curve that shows a steep increase in absorbance to two equivalents of CuI added 
(with respect to 3SCC concentration) followed by a flattening out of the titration curve 
(Figure 4-2B). The CuI2Cys3 extinction coefficient at λ266 nm is calculated to be 15,860 M-
1cm-1. Interestingly, this data supports two equivalents of CuI binding to one equivalent of 
trimer.  
 
Figure 4-2. Titration spectra of CuI into a solution of TRIL2WL16C at pH 8.0 in 50 mM 
KPhos buffer (Panel A). Titration curve showing the 2:1 binding stoichiometry of CuI to 
3SCC at 266 nm shown as absorbance at 266 nm divided by concentration of CuI added 
(ε at λ266) versus the equivalent of CuI added, with respect to the total concentration of 
3SCC (panel B).  
 
A	 B	
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 The titration was repeated using the peptide TRIL2W (Table 4-1) to determine if 
CuI showed nonspecific binding to the exterior of the 3SCC, which might result in a 
contribution to the 266 nm band observed in the titration of CuI to TRIL2WL16C. 
Aliquots of CuI were added, in an inert atmosphere box, to a solution of TRIL2W (3SCC). 
No complexation of CuI is observed and virtually no change is seen in the UV spectra 
even after the addition of five equivalents of CuI have been added (Figure 4-3A). These 
results indicate that the 2:1 ratio of CuI to 3SCC corresponds to two CuI atoms binding to 
the Cys3 binding site without the presence of non-specific binding to the exterior of the 
3SCC (Figure 4-3B).  
 
Figure 4-3. Titration spectra of CuI into a solution of TRIL2W at pH 8.0 in 50 mM 
KPhos buffer (Panel A). Titration curve showing the 2:1 binding stoichiometry of CuI to 
3SCC at 266 nm shown as absorbance at 266 nm divided by concentration of CuI added 
(ε at λ266) versus the equivalent of CuI added, with respect to the total concentration of 
3SCC (panel B).  
X-ray absorption spectroscopy (XAS) was used to obtain metrical parameters for 
the coordination environment when CuI is bound to TRIL2WL16C. Samples consisted of 
1 mM CuI, 2 mM 3SCC, ~30-50 mM HEPES buffer, pH 7.5, and 50% glycerol. 
Examination of the X-Ray absorption near-edge structure (XANES) can give information 
about the coordination number and the oxidation state of the bound metal. The intensity 
of the pre-edge peak is particularly useful in this regard, as the height of the 1sà4p 
transition observed at 8,983 eV with respect to the edge peak (8,995 eV) is indicative of 
coordination number. For thiolate-rich CuI species, an intense peak with a ratio of ~0.9 or 
greater, when compared to the edge height, reflects a CuI coordination number of two 
(diagonal or linear geometry). A moderate peak height with a ratio of ~0.5-0.7 is 
A	 B	
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indicative of three-coordinate CuI binding, and an essentially non-existent pre-edge peak 
is observed for four-coordinate species.62–65 The intense feature observed for CuI-bound 
TRIL2WL16 has a ratio of approximately 0.83, and falls in between the reported values 
for 2- and 3-coordinate CuI complexes (Figure 4-4).  
 
Figure 4-4. XANES of CuI2(TRIL2WL16C)3-. Data collected at ~7K, pH 7.5 HEPES 
buffer.  
Fitting of the extended X-Ray absorption fine structure (EXAFS) spectra can be 
used to determine CuI bond distances. A nearest-neighbor peak, typical of scattering 
observed by direct sulfur coordination, dominates the EXAFS spectrum at ~2.2 Å (Figure 
4-5). There is a second unique peak observed at a longer distance (~2.65 Å) that is not 
consistent with ligands previously observed in our 3SCC, such as sulfur, nitrogen, or 
oxygen coordination. Due to the intensity of the pre-edge peak I used fitting models that 
included both two and three sulfur ligands, as well as varying numbers of oxygen ligands 
to fit the data. However, due to the out-of-phase components for sulfur and oxygen 
scatterers, it is difficult, using XAS spectroscopy, to elucidate if oxygen ligands are 
present in addition to the sulfur ligands. Fits with only two sulfur ligands consistently 
provided worse fits than three-sulfur fits (Table 4-2). No combination of sulfur, oxygen, 
and/or nitrogen provided a fit that accounted for the long distance scatterer at ~2.65 Å. 
Considering the UV-Vis spectroscopy data showing a 2:1 binding stoichiometry of 
CuI:3SCC, I also included a Cu-Cu interaction in the fits, which finally provided a fit that 
accounted for the second peak observed at ~2.65 Å. 
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Figure 4-5. EXAFS and FT data (black) and fitting (red) for CuI2(TRIL2WL16C)3- with 
(A)(B) S3Cu1 and (C)(D) S3O1Cu1 shells. 
Table 4-2 and Figure 4-5 show the best EXAFS fits for CuI-bound TRIL2WL16C 
at pH 7.5. The fits support a model where two CuI ions are coordinated to three sulfur 
atoms at 2.20 Å and exhibit one CuI-CuI interaction at 2.66 Å. The addition of an oxygen 
parameter (Table 4-2), as seen in Figure 4-5, results in a slightly better fit with a CuI-O 
distance of 2.08 Å. The CuI-S distances of 2.20 Å falls in between reported two- and 
three-coordinate CuI centers (2.16 and 2.28 Å, respectively).66  
At this particular point, Dr. Leela Ruckthong built models of a proposed binuclear 
CuI center in an a site Cys3. Figure 4-6 shows a binuclear CuI center substituted for the 
AsIII ion in AsIIIS(CSL9C)3, with the binuclear site laying directly on the three-fold axis of 
the 3SCC. Two water molecules were included, one above, and one below, the binuclear 
site to provide tetrahedral CuI coordination, as trigonal pyramidal CuI geometry is 
unprecedented. The CuI-OH2 distances were set arbitrarily at 2.0 Å for modeling 
purposes. The CuI-CuI distance was fixed at 2.66 Å, with the CuI ion closer to the C-
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termini of the 3SCC having to be moved slightly closer to the C-termini than the AsIII 
ion. The CuI-S distances were optimized to satisfy all torsion angle requirements of the 
Cys3 ligands. With the CuI-CuI distance fixed, the resulting CuI-S distances ranged from 
2.44-2.46 Å. These distances are ~0.2 Å too long in comparison to the XAS fits. 
Conversely, fixing the CuI-S distances at 2.2 Å resulted in a CuI-CuI distance of 2.4-2.5 
Å, too short in comparison to the XAS fits. Attempts at rotating the Cys3 rotamers to 
provide a model consistent with both the CuI-S distances of 2.2 Å, while maintaining a 
CuI-CuI distance of 2.66 Å, were unsuccessful.  
Table 4-2. EXAFS parameters of Cu2IS(TRIL2WL16C)3- 
Shell Component Fit Result 
S2Cu1a 
Cu-S 
 
 
Cu-Cu 
R =2.19 
σ2 = 0.00517 
R = 2.65 
σ2 = 0.0517 
F = 141 
S3Cu1 
Cu-S 
 
 
Cu-Cu 
R =2.20 
σ2 = 0.00644 
R = 2.66 
σ2 = 0.00761 
F = 129 
S3O1Cu1 
Cu-S 
 
Cu-O 
 
Cu-Cu 
R = 2.19 
σ2 = 0.00358 
R = 2.08 
σ2 = 0.00763 
R = 2.66 
σ2 = 0.00671 
F = 79.0 
S2S1*Cu1 
Cu-S 
 
Cu-S* 
 
Cu-Cu 
R = 2.19 
σ2 =0.00358 
R =2.37 
σ2 =0.011 
R = 2.66 
σ2 =0.0086 
F = 98.0 
R = distance in Å, σ2 = Debeye Waller Factor in Å2, ΔE0 is 
fixed at -10. aFit only converged when σ2 values were 
linked.  
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Figure 4-6. Side-on view of a pymol representation of a modeled symmetric binuclear 
CuI site bound to three sulfur atoms. Site is modeled from the AsIIIS(CSL9C)3 structure 
(PDB: 2JGO).44 Main chain atoms are shown in green, water molecules are shown in 
small red spheres, cysteine residues are shown as sticks with sulfur atoms highlighted in 
yellow and CuI ions are shown as grey spheres. The CuI-CuI distance is fixed at the 
EXAFS determined 2.67 Å and the water molecules are placed 2.0 Å either above the top 
CuI or below the lower CuI in the binuclear site. Resulting CuI-S distances are 2.33 Å 
(avg), which is approximately 0.12 Å longer than the EXAFS derived Cu-S distance.  
 
Figure 4-7. Top-down view of a pymol representation of a modeled binuclear CuI site 
bound to three sulfur atoms, shifted off of the helical axis toward the helical interface. 
The site is modeled from the AsIIIS(CSL9C)3 structure (PDB: 2JGO).44 Main chain atoms 
are shown in green, water molecules are shown in small red spheres, cysteine residues are 
shown as sticks with sulfur atoms highlighted in yellow and CuI ions are shown as grey 
spheres. The CuI-CuI distance is fixed at 2.67 Å and the water molecules are 2.0 Å above 
and below the CuI binuclear site. Resulting CuI-S distances are 2.21-2.22 Å (avg) and 
CuI-S* distance is 2.5-2.6 Å (avg).  
 
CuI 
CuI 
Long CuI-S* 
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Since the above attempts did not provide CuI-S and CuI-CuI distances consistent 
with the XAS data, we then modeled the system where the CuI-CuI center was shifted off 
of the helical axis toward the helical interface of two of the helices (Figure 4-7). Again, 
arbitrary CuI-OH2 distances were set at 2.0 Å to provide tetrahedral model geometry. The 
shifting of the binuclear site provided a model that could accommodate both a CuI-CuI 
distance of 2.66 Å and two CuI-S distances of 2.2 Å. However, to compensate for this 
adjustment, a longer third CuI-S* distance, denoted with an asterisk to differentiate it 
from the shorter thiolate, was measured at 2.47 – 2.56 Å (Figure 4-7). Re-fitting the 
EXAFS data with a S2S1*Cu1 coordination provided CuI-S distances and a CuI-CuI 
interaction at 2.19 Å and 2.66 Å, respectively, with a longer CuI-S* distance of 2.37 Å 
(Table 4-2, Figure 4-8). Visually, the discrepancy between the raw data and the previous 
best fits observed at the long distance scatterer (~2.66 Å) has been adjusted for and the fit 
via inclusion of a longer distance CuI-S* distance (Figure 4-8). The fitted CuI-S* distance 
is still slightly shorter than the distance provided from the model (fit: 2.37 vs. model: 
2.45 Å). It is possible that there is some phase interference in the XAS data between the 
CuI-CuI interaction and the CuI-S* distance, resulting in the discrepancy in distances 
between the EXAFS fit and the model data.  
  
Figure 4-8. EXAFS (A) and FT (B) data (black) and fitting (red) for 
CuI2(TRIL2WL16C)3- with a S2S*1Cu1 shell. 
In both of these models the location of the CuI ions, with respect to the sulfur 
ligands, provides a trigonal pyramidal CuI binding geometry. As mentioned above, 
trigonal pyramidal CuI sites are largely unprecedented. Previously, I accounted for this by 
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inclusion of a water molecule above, and below, the modeled binuclear CuI2Cys3 sites to 
provide a tetrahedral geometry for both copper ions. However, the XANES analysis of 
CuI2(TRIL2WL16C)3- does not support a tetrahedral CuI geometry. Therefore, I returned 
to the model to address the CuI ions moving in different directions while maintaining a 
2.66 Å separation from one another (Figure 4-9). Shifting, asymmetrically, the binuclear 
site provided a model where each metal ion has two 2.2 Å CuI-S distances and one long 
CuI-S* distance of 2.8-2.9 Å. In this scenario, the long distance CuI-S* is to different 
helices. For example, if the “top” CuI, with respect to the N-terminal, is 2.2 Å from the 
sulfur ions of Cys residues of helices A and B, then the “bottom” CuI would be 2.2 Å 
from helices B and C. In this model the long CuI-S* distance is still longer than the fit 
CuI-S* distance (fit: 2.37 vs. model: 2.8-2.9 Å). It is possible that the CuI-S* distance 
obtained from the EXAFS fit is convoluted due to the heavy Cu-Cu scatterer and at this 
time I believe that the models here offer three possibilities of how a binuclear CuI site is 
accommodated within a Cys3 site. Ultimately, a crystal structure is required to further 
elucidate the structure of such a binuclear site.  
 
Figure 4-9. (A) Top-down and (B) side-on view of a Pymol representation of a modeled 
symmetric binuclear CuI site bound to three sulfur atoms. Site is modeled from the 
AsIIIS(CSL9C)3 structure (PDB: 2JGO).44 Main chain atoms are shown in green, cysteine 
residues are shown as sticks with sulfur atoms highlighted in yellow and CuI ions are 
shown as grey spheres. The CuI-CuI distance is fixed at the EXAFS determined 2.67 Å. 
Resulting CuI-S distances are 2.2 Å, consistent with the EXAFS fits, and CuIS* distances 
are 2.8-2.9 Å, ~0.4 Å longer than the EXAFS derived CuI-S* distance.  
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 I next analyzed CuI binding to TRIL2WL12DLL16C and TRIL2WL12AL16C to 
see if altering the sterics in the layer directly above the Cys3 binding site, with respect to 
the N-termini, provided any differences in the UV spectroscopy or the titration data 
(Table 4-1, Figures 4-10A and 4-10C). Similarly to TRIL2WL16C, aliquots of CuI were 
added in an inert atmosphere box to a solution of TRIL2WL12DLL16C and 
TRIL2WL12AL16C. An increase at 266 nm was observed upon peptide complexation of 
CuI, for both peptides until two equivalents of CuI had been added, at which point the 
absorbance at 266 nm ceased to increase upon further additions of CuI (Figure 4-10C and 
4-10D). In both cases the titration data plateau at two equivalents of CuI and the 
absorbance at two equivalents of CuI added correspond to extinction coefficients of 
17,170 and 16,440 M-1cm-1. Preliminary XAS data analysis for both CuI-bound 
TRIL2WL12DLL16C and TRIL2WL12AL16C indicates that both of these peptides 
behave similarly to CuI2(TRIL2WL16C)3-.  
 
Figure 4-10. Titration spectra of CuI into a solution of (A) TRIL2WL12DLL16C and (C) 
TRIL2WL12AL16C at pH 8.0 in 50 mM KPhos buffer. Titration curves showing the 2:1 
binding stoichiometry of CuI to 3SCC for (B) TRIL2WL12DLL16C and (D) 
TRIL2WL12AL16C at 266 nm shown as absorbance at 266 nm divided by concentration 
of CuI added (ε at λ266) versus the equivalent of CuI added, with respect to the total 
concentration of 3SCC. 
A	 B	
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 Preliminary XAS and UV-Vis analysis of CuI binding to TRI and GR peptides 
containing Cys3 sites at pH 9.0 have shown different behavior when compared to the pH 
7.5 data. The UV-Vis titration of CuI into TRIL2WL16C at pH 9.0 provides a similar 
increase in absorbance at 266 nm with a binding curve that shows slightly less linear 
character in the region of 0-2 eq. of CuI (Figure 4-11); however, saturation is still 
observed at two equivalents of CuI, supporting the formation of a binuclear site. XAS 
data at pH 9.0 adding one equivalent of CuI provides evidence for a mononuclear CuI site, 
while when two equivalents of CuI are present a CuI-CuI interaction is observed, 
supporting formation of the binuclear site at higher equivalents of CuI (data not included). 
At this point, more analysis is necessary but a model where the mononuclear site is 
formed at low concentrations of metal with formation of the binuclear site at higher metal 
concentrations is consistent with the biphasic nature observed via the UV-Vis titration. 
These differences between pH 7.5 and 9.0 indicate that the model of binding CuI to a 
Cys3 site is pH dependent. 
 
Figure 4-11. The titration spectra of CuI into a solution of TRIL2WL16C at pH 9.0 in 50 
mM CHES buffer (Panel A). Titration curve showing the 2:1 binding stoichiometry of 
CuI to the 3SCC at 266 nm. The data are shown as absorbance at 266 nm divided by 
concentration of CuI added (ε at λ266) versus the equivalent of CuI added with respect to 
the total concentration of 3SCC (panel B). 
Comparison of Spectroscopic Features to Native CuI-Metallochaperones 
 I then looked to thiol-rich CuI native metalloproteins to compare the metrical and 
spectroscopic features observed in my binuclear CuI2Cys3 site. There are many CuI 
metallochaperones that share similar spectroscopic characteristics with 
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CuI2(TRIL2WL16C)3-. AMT1 and ACE1 are CuI metalloregulatory proteins that share 
50% sequence identity, contain 6-12 cysteine residues in the CuI binding domains, and 
bind 4-6 CuI ions in vitro.67,68 EXAFS analysis supports trigonal coordination of 
CuIACE1 with a CuI-S distance of 2.26 Å and a CuI-CuI distance of 2.68 Å (Table 4-3) 
and UV-Vis titrations support a polynuclear CuI-thiolate center made up of six or seven 
metal ions.66,68 CuIAMT1 showed a characteristic UV peak at 266 nm that saturates at 
four equivalents of CuI, and fits of the EXAFS data provide a CuI-S distance of 2.26 Å 
and a CuI-CuI distance of 2.75 Å (Table 4-3).67 Pickering et al. determined a correlation 
between pure trigonal CuI coordination (CuI-S = 2.28 Å) and pure diagonal CuI 
coordination (2.16 Å), providing less than 20% diagonal coordination in the polynuclear 
CuI clusters of both AMT1 and ACE1 (Table 4-3). CuICtr1, a membrane bound CuI 
transporter, contains six cysteine residues, binds four equivalents of metal with CuI-S 
distances of 2.248 Å and CuI-CuI distances of 2.706 Å (Table 4-3).54 Interestingly, the 
CuI-S bond distances determined from the fits of my EXAFS data are 2.20 Å, which is an 
intermediate distance between the 2- and 3-coordinate extremes indicating that the CuI 
binuclear center may have some digonal coordination contribution, or that it has two 
short and one long CuI-S bonds resulting in an intermediate distance. A crystal structure 
is needed to elucidate further the structure of the proposed binuclear CuI center within the 
TRI peptides.  
Table 4-3. EXAFS parameters of native CuI metallochaperones. 
Protein Cu-S Cu-Cu Reference 
CuI2(TRIL2WL16C)3- 2.20, 2.37* 2.66 This Work 
ACE1 2.26 2.68 66 
AMT1 2.26 2.75 67 
Ctr1 2.248 2.706 54 
CopZ 2.241 - 64 
CopY 2.256 2.685 64 
Cox19 2.261 2.664 74 
Cox17 2.250 2.705 73 
Cox11 2.245 2.706 72 
 
 The Cop and Cox families of metalloregulatory proteins are also largely involved 
in copper homeostasis.69 CopZ, a CuI chaperone, binds one equivalent of CuI with a CuI-
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S distance of 2.241 Å (Table 4-3).64 CopZ delivers CuI to CopY, a copper-inducible 
repressor protein, which shows a 2:1 CuI:protein binding stoichiometry with CuI-S 
distance of 2.256 Å and a CuI-CuI distance of 2.685 Å (Table 4-3).70,71 In both cases the 
CuI-S distance is slightly longer than what is observed in CuI2(TRIL2WL16C)3-, but the 
CuI-CuI distance observed in CopY is very similar to what I have observed. Cox19, 
Cox17 and Cox11 show similar characteristics as well with CuI-S distances of 2.24-2.26 
Å and a CuI-CuI distances of 2.66-2.71 Å (Table 4-3).72–74  
 In all of the cases of the above mentioned CuI metalloregulatory proteins, more 
than three cysteine residues are present in the CuI binding cavities, and generally at least 
four thiol ligands are utilized in forming the bi- or polynuclear CuI centers. Cox17 is an 
oligiomeric protein that binds three equivalents of CuI per monomer and contains seven 
cysteine residues, three of which are critical for functionality.75 Single CysàSer 
mutations of the critical Cys or Ser substitutions of any of the non-essential cysteine 
residues do not inhibit CuI binding.73 Additionally, proteins with CysàSer modification 
of up to three of the nonessential ligands (Cys16,36,47Ser) still binds CuI and is functional. 
The single mutations of the critical Cys residues as well as the triple mutation all provide 
EXAFS fits that are comparable to the wild-type Cox17 with CuI-S distances of 2.242-
2.253 Å and a CuI-CuI distances of 2.698-2.716 Å (Table 4-3). No manipulation of the 
AsIIIS(CSL9C)3 crystal structure allowed for a fourth proteinacious ligand to bind to the 
metal center, such as the external Lys and Glu residues that form salt bridges at the 
helical interface. The similarities observed between the bi- and polynuclear CuI centers of 
the native metalloregulatory proteins and the simplified CuI2Cys3 complexes obtained 
when binding CuI to the TRI peptides may in fact be due to exogenous solvent molecules 
that fill out the coordination sphere, as mentioned above and are included in the models 
as seen in Figures 4-6 and 4-7. However, the XAS data do not support additional solvent 
molecules directly coordinated to the CuI ions.  
Due to the minimal crystallographic data for the CuI-metallochaperones and the 
essential lack of proposed polyhedral geometry of the native CuI clusters, it is difficult to 
make direct comparisons between the CuI2 spectroscopic data and proposed models 
discussed in this work and the native systems. Crystal structures of CuI2(CSL16C)3- are 
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necessary to further elucidate the structure of the proposed binuclear CuI site (Table 4-1); 
however, at this point it is mostly likely, considering the XAS and UV-Vis data, in 
combination with the models described above, that CuI2(TRIL2WL16C)3- best support an 
intermediate 2- to 3-coordinate CuI environment with two short and one long CuI-S 
distance.  
CuI-bound crystal structures are notoriously difficult to obtain due to the air 
sensitivity of the CuI center; however, CuI2(TRIL2WL16C)3- exposed to air shows no 
alteration in the 266 nm peak via UV spectroscopic analysis, even after 20 hours of 
continuous stirring while exposed to oxygen (Figure 4-12).  Therefore, we are hopeful 
that crystal structures may be accessible.  
 
Figure 4-12. UV-Vis titration of CuI2(TRIL2WL16C)3-, stirring while exposed to air, for 
24 hours. Initial scan is shown in red.  
One additional consideration for the slightly shorter CuI-S bond distances 
observed in TRIL2WL16C as compared to native systems is the very different topology 
in the secondary structure of the proteins. CopZ, CopA, Ccc2, Hah1 (also called Atox1), 
and Atx1 all contain varying numbers of similar ferredoxin-like βαββαβ-folds with 
MXCXXC motifs.23 Solution structures have been solved for both apo- and CuI-bound 
Atx1 and Ccc2 (Figure 4-13).26 In the case of Atx1, upon complexation of CuI, 
significant rearrangement of the alpha-helical region occurs; however, this rearrangement 
is not observed upon CuI binding to Ccc2. The only CuI-bound metallochaperone crystal 
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structure available is of CuIHah1 (Figure 4-14).18 Similar to the solution structures of 
Atx1 and Ccc2, the crystal structure of Hah1 shows CuI binding at the N-terminal end of 
the first alpha-helix to two cysteine residues from each dimer.  
 
Figure 4-13. NMR solution structural model (PDB code: 2GGP) of a heterodimer of the 
S. cerevisiae copper metallochaperone Atx1 and one of two N-terminal cytosolic domains 
of its cognate P1-type copper-transporting ATPase Ccc2.26 Cysteinyl (yellow) thiol 
coordinated CuI (red sphere) stabilizes a transient complex between similar βαββαβ 
(ferredoxin)-structural folds (red, α-helix; blue, β-strand). Figure adapted from Ref 23.  
 
Figure 4-14. X-Ray crystal structure (PDB code: 1FEE) of the homodimer, Hah1.18 Main 
chain atoms are shown in red (α-helix), blue (β-strand) and grey (loop regions), cysteine 
residues are shown as sticks with sulfur atoms highlighted in yellow and CuI ion is shown 
as an orange sphere. 
	 234 
CopZ, CopA, Ccc2, Hah1, and Atx1 all deliver CuI directly to their target 
molecule. Transport of CuI via metallochaperones Cox17 and Cox11 require accessory 
factors and, although the CuI binding sites share metrical parameters and spectroscopic 
features with CopZ, CopA, Ccc2, Hah1, and Atx1, their secondary structures vary 
dramatically.23,76 Cox17, as mentioned above, is a eukaryotic copper metallochaperone 
for Sco1 and Cox11. Cox17 contains a CX9C motif, that doesn’t participate in CuI 
binding, but actually binds CuI at the helical hairpin of two alpha-helices (Figure 4-15).77 
This structural motif is also found in Cox19.74 Conversely, Cox11, a CuI 
metallochaperone for the CuA site of cytochrome oxidase, is dominated by beta-sheets 
that form an immunoglobulin-like β-barrel fold with only one tethering trans-membrane 
alpha-helix (Figure 4-15).78  
 
Figure 4-15. NMR solution structural models of Cox17 (PDB: 2RNB, left)77 and Cox11 
(PDB: 1SP0, right).78 Main chain atoms are shown in red (α-helix), blue (β-strand) and 
grey (loop regions), cysteine residues are shown as sticks with sulfur atoms highlighted in 
yellow and CuI ion is shown as an orange sphere. 
In all, CuI metallochaperones vary significantly in secondary and tertiary 
structures; yet provide very similar metrical parameters and spectroscopic features. From 
the various crystal structures collected by Dr. Leela Ruckthong we can say with some 
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certainty that we would not expect significant perturbations of the 3SCC as a whole when 
binding CuI as was observed in native proteins, particularly Atx1. Although the cysteine 
residues may rotate to accommodate predisposed metal binding (such is the case when 
binding HgII or ZnII, see Chapters 1 and 2 for a discussion on predisposed vs. 
preorganized metal binding to Cys3 sites), the overall protein shows little perturbation 
upon metal complexation. These differences could be a direct consequence of the many 
years of evolution behind native CuI metallochaperones and their ability to adapt 
appropriately upon CuI binding, whereas the Cys3 site within our 3SCC has less 
flexibility due to the relatively rigid 3SCC motif resulting in slightly altered metrical 
parameters. A second, perhaps more likely scenario, is that the differences observed are a 
consequence of the necessity of native CuI metallochaperones to interact with other 
proteins in order to both obtain and, subsequently, deliver the CuI ion. Therefore the 
dynamics of the native proteins are probably a reflection of the recognition elements and 
uptake/transport requirements of copper homeostasis.  
Ogawa and coworkers recently reported the first polynuclear metal binding site 
within a 3SCC, with a similar sequence compared to the TRI and GR peptides.79,80 The 
peptide, AQ-C16C19 employs a heptad repeat of IAALENK with alternating Ile and Leu 
layers in the a and d sites. Substitution of the Ile16 and Leu19 layers with Cys residues 
provided a Cys6 metal binding site that has been shown to bind four equivalents of CdII 
providing a CdII4S6O4 multinuclear center within the 3SCC (Figure 4-16). Three of the 
four CdII ions bind to three sulfur ions each and to one Glu20 residue in e positions 
resulting in tetrahedral geometries for each metal ion. These three CdII ions bind in a 
plane in between the 16th and 19th Cys3 layers with the fourth CdII ion directly above, 
toward the N-terminal, which binds exclusively to the Cys residues in the 16th positions 
with a fourth, exogenous water molecule, again in a tetrahedral geometry. Upon binding 
of the CdII cluster a bulge in the peptide secondary structure occurs resulting in a break in 
the alpha helices. This break occurs at the 17Ala and 18Ala positions and allows for the 
Glu residues to rotate to a position that can coordinate directly to the CdII ions located at 
the helical interface. The CdII-S distances range from 2.34 – 2.73 Å (avg = 2.53 Å) and 
the CdII-O distances range from 1.91 – 2.49 Å (avg = 2.18 Å).  
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Figure 4-16. (A) Top-down and (B) side-on view of a pymol representation of the 
CdII4(AQ-C16C19)3n+ complex based on the X-ray crystal structure (PBD: 4G1A).79 
Main chain atoms are shown in green, cysteine and glutamate residues are shown as 
sticks with sulfur atoms highlighted in yellow and oxygen atoms highlighted in red, and 
CdII ions are shown as peach spheres.  
A change in the alpha-helical structure in TRI and GR upon metal binding is 
currently unprecedented but a crystal structure is required to completely rule out this 
possibility. However, the CdII-CdII distance is 4.0 Å, significantly longer than the 2.66 Å 
separation observed in my binuclear CuI site, and therefore this sort of arrangement is not 
likely within my system. When modeling the CuI2Cys3 site within the crystal structure of 
AsIII(CSL9C)3 we did determine that significant structural perturbations would have to 
occur for the Glu residues to interact with the a metal bound to the interior of the TRI and 
GR peptides. Therefore, although a multinuclear site has been observed in a similar 
peptide scaffold to the TRI peptides, the polyhedral geometry observed for CdII4S6O4 
would not allow for the metrical parameters observed via XAS analysis of my CuI2Cys3 
centers.  
A crystal structure has been obtained for CuI binding to CopZ, an Atx-1 like 
copper chaperone from the Gram-positive bacterium Bacillus subtilis. XAS analysis of 
CuI-bound CopZ does not show evidence of a CuI-CuI interaction; however, the crystal 
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structure tells a different story. Under anaerobic conditions, a CopZ dimer crystal was 
obtained in the space group P21 at 1.5 Å refinement, where four CuI ions are found at the 
interface of the two monomers. The CuI ions have two different coordination 
environments, one of which shows trigonal coordination and the second of which shows 
distorted digonal coordination. The trigonal copper ions coordinate to two cysteine 
residues and one histidine residue and the digonal copper ions coordinate to only two 
cysteine residues. Upon closer inspection of the CuI coordination of one pair of CuI ions, 
with respect to the sulfur ions only, provided a short CuI-S distance of 2.2 Å, a longer 
CuI-S* distance of 2.5 Å and a CuI-CuI distance of 2.6 Å (Figure 4-17A). These values 
are very similar to those obtained for my binuclear CuI center in TRIL2WL16C via XAS 
analysis. Therefore, I re-visited the model of two CuI ions in a crystal structure of our 
trimers, where one copper ion is very close to a trigonal planar geometry in the center of 
the Cys3 site and the second CuI ion is at the helical interface interacting with two of the 
sulfur ions (Figure 4-17B). This model provided a short CuI-S distance of 2.23 Å, a 
longer CuI-S* distance of 2.4 Å and a CuI-CuI distance of 2.7 Å, again, very similar to the 
experimental XAS distances. At this time, the best supported model for how two copper 
ions are binding to the same Cys3 site within a 3CSS includes one trigonal planar CuI ion 
and one digonal-like CuI ion, similar to the crystal structure of CopZ. 
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Figure 4-17. (A) Top-down view of a Pymol representation of a modeled binuclear CuI 
site bound to three sulfur atoms. Site is modeled from the ZnIIS(CSL12AL16C)3- structure 
(PDB: not deposited). Main chain atoms are shown in green, cysteine residues are shown 
as sticks with sulfur atoms highlighted in yellow and CuI ions are shown as orange non-
bonded spheres. The CuI-CuI distance is fixed at the EXAFS determined 2.67 Å. 
Resulting CuI-S distances are 2.23 Å, consistent with the EXAFS fits, and CuIS* distances 
are 2.4 Å. (B) Top-down view of a Pymol representation of the binuclear CuI site from 
the X-ray crystal structure of the tetranuclear metal site of CopZ dimer bound to three 
cysteine ligands (PDB: 2QIF).81 Main chain atoms are shown in grey, cysteine residues 
are shown as sticks with sulfur atoms highlighted in yellow and CuI ions are shown as 
orange non-bonded spheres. The CuI-CuI distance is measured at 2.6 Å, CuI-S and CuI-S* 
distances are 2.2Å and 2.5 Å, respectively. 
CuI Binding Affinities for Cys3-Containing 3SCCs 
 The affinity of CuI binding to TRIL2WL16C was determined by competitive 
chelation assay using a primary standard, bathocuproinedisulfonate, BCS2-, as a chelator. 
Complexation of CuI by BCS2- can be monitored with Visible spectroscopy as evidenced 
by the increase in absorption at 483 nm (Figure 4-18). Titrations were carried out in an 
inert atmosphere box where aliquots of BCS2- were added to a solution of 40 µM CuI and 
80 µM TRIL2WL16C with 50 mM buffer at various pH values. The data were analyzed 
in Prism 5 (GraphPad Software)55 using multiple CuI binding models and ultimately fit 
with a nonlinear regression using Equations 10 and 23. Assumptions made in the model 
used to fit the data include that no mononuclear CuI species is formed, as supported by 
the linearity of the UV titration data. Attempts to fit the data using models corresponding 
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to one equivalent of CuI binding to 3SCC to form a mononuclear CuI center (Equation 9) 
or to a sequential binding pattern (where one additional equivalent of CuI binds to CuI-
bound 3SCC, Equation 18) were unsuccessful due to non-convergence between the 
model and data sets. Additionally, the presence of the CuI-CuI peak in the EXAFS data, 
collected at significant excess of 3SCC, also supports essentially immediate formation of 
a Cu2IS3 center. A second assumption is that there is no free CuI present due to the high 
affinity of CuI to the Cys3 site, as evidenced by the sharpness observed in the Abs 
increase as observed in the UV-Vis titration data (Figure 4-2).  
 
Figure 4-18. (A) Titration spectra of BCS2- added to CuI2(TRIL2WL16C)3- at pH 7.5, 
HEPES buffer, showing an increase in absorbance at 483 nm, indicative of [CuI(BCS)2]3- 
formation. (B) Titration curve of [BCS2-] versus Absorbance at 483 nm. Data is shown in 
black dots and fit is shown as a solid line.  
Based on the BCS2- competition, at both pH 6.5 and 7.5 the affinity (KCu2Cys3) for 
two CuI ions binding to TRIL2WL16C, for the binuclear site, were fitted to yield values 
of 6.6 ± 1.1 x 1028 and 3.2 ± 0.4 x 1028 M-2, respectively (Figure 4-18, Table 4-4). 
Elongation of the peptide from TRIL2WL16C to GRL2WL16C results in a 2-fold tighter 
affinity, at pH 7.5, of 2.49 ± 0.3 x 1030 M-2 (Tables 4-1 and 4-4). Removal of 
hydrophobic packing in the layer directly above the Cys3 site, GRL2WL12AL16C (Table 
4-1), provides a comparable binding affinity to GRL2WL16C at 1.94 ± 0.2 x 1030 M-2 
(Table 4-4). Analysis of two pH extreme values, 6.5 and 9.0, for GRCSL12DLL16C 
shows an increase in binding affinity at higher pH from 4.90 ± 1.4 x 1028 M-2 to 2.38 ± 
0.8 x 1031 M-2 (Table 4-4).  
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Table 4-4. CuI affinities to native CuI binding proteins and TRI/GR 3SCC 
Protein pH Ka, M-2 or M-1 Reference 
TRIL2WL16C 6.5 6.61 ± 1.1 x 10
28  
7.5 3.17 ± 0.4 x 1028  
GRL2WL16C 7.5 2.49 ± 0.3 x 1030  
GRL2WL12AL16C 7.5 1.94 ± 0.2 x 1030  
GRCSL12DLL16C 
6.5 4.90 ± 1.4 x 1028  
9.0 2.38 ± 0.8 x 1031  
Atx1 6.0 ~1016 82 
 8.0 1.4 – 2.4 x 1018 54 
Ctr1 8.0 2.1 – 7.1 x 1018 54 
Ccc2 8.0 6.3 – 7.1 x 1018 54 
Hah1 7.0 2.6 – 5.6 x 1017 85 
MNK1 7.0 3.6 x 1017 85 
CopZ 7.5 6.6 x 1014 86 
CopA 7.5 6.8 x 1011 86 
Wilson Protein* 6.5 0.2 – 4.8 x 10
6 83 
7.5 2.2 – 6.3 x 1010 84 
 
Interestingly, the binding affinities obtained for GRCSL12DLL16C, 
GRL2WL12AL16C, and GRL2WL16C are similar, implying that the CuI2Cys3 sites are 
comparable in all three peptides (Tables 4-1 and 4-4). Comparison of the crystal 
structures of HgIISZnIIN/O(GRCSL16CL30H)3+ and apo-(GRCSL12DLL16C)3 indicates 
that inclusion of a DLeu layer directly above the Cys3 site, with respect to the N-terminal, 
does not allow for a water molecule to occupy the space above the Cys3 plane, as was 
observed for the HgIICys3 site in HgIISZnIIN/O(GRCSL16CL30H)3+ (as discussed in 
Chapter 1 and Chapter 2, Figure 4-19). This was determined by measuring the distance 
between the water molecule in HgIISZnIIN/O(GRCSL16CL30H)3+ and the plane of the δ-
methyl group of the Leu layer of both of the Leu and DLeu residues to be 3.80 and 1.33 Å, 
respectively (Figure 4-19).82 The CuI affinity and crystal data, together, negate a possible 
water ligand to complete a tetrahedral coordination geometry as discussed above with 
respect to the binuclear models (Figures 4-6 and 4-7). These data instead support the third 
or fourth models (Figures 4-9 and 4-17) where the CuI ions move, asymmetrically, from 
the helical axis, with an intermediate two- and three-coordinate CuI environment 
provided by two short CuI-S and one long CuI-S* ligands or where one CuI ion is trigonal 
planar at the helical axis with the second CuI ion at the helical interface.  
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Figure 4-19. Pymol visualization representing the distances measured from the plane 
generated by the core δ-methyl carbon atom of the 12Leu residue to the water ion in 
HgIISZnIIN(GRCSL16L30H)3+ compared to the related distance measured from the plane 
generated by the core δ-methyl carbon atom of the 12DLeu residue in apo-
(GRCSL12DLL16C)3 to the water of the opposite crystal structure. Main atoms of the 
apo-(GRCSL12DLL16C)3 are shown in red and HgIISZnIIN(GRCSL16L30H)3+ in green. 
The HgII metal ion and the water molecule are shown as blue and red spheres, 
respectively. Cysteine residues and one Leu/DLeu residue are shown as sticks with sulfur 
ions highlighted in yellow. Figure adapted from reference 81. 
Measuring the binding affinities of CuI binding to various metallochaperones has 
proven to be a non-trivial task, largely due to the difficulty associated with measuring 
affinities for individual metal ions that make up the polynuclear sites that often form in 
these proteins; however, various CuI affinities for thiol-rich sites have been determined. 
Atx1 and Wilson Protein show an increase in binding affinity upon an increase of pH 
from 6.0 to 8.0 and 6.5 to 7.5, respectively,54,83–85 similarly to the trend observed in 
GRCSL12DLL16C from pH 6.5 to 9.0 (Table 4-4). High affinities are also reported for 
Atx1, Ctr1, and Ccc2, at pH 8, of 1.4 – 7.1 x 1018 M-1, per each equivalent of CuI-bound 
(Table 4-4).54 MNK1 and Hah1 (both of which bind one equivalent of CuI) provide 
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affinities one order of magnitude lower of 3.6 and 2.6 – 5.6 x 1017 M-1, both measured at 
pH 7.0  (Table 4-4).86 Wilson Protein, CopZ, and CopA bind CuI with lower affinities 
ranging from 106 – 1014 M-1 (all of which bind one equivalent of CuI, Table 4-4).84,85,87 
With KCu2Cys3 values of 1028 – 1031 M-2, for two equivalents of CuI binding to a single 
Cys3 site in our TRI and GR peptides, it appears that CuI binds to our peptides with 
affinities that fall within the range of native CuI metallochaperones.  
Previous work by Dr. Fangting Yu extensively characterized CuI binding to His3 
TRI peptides. Using the BCS2- competition experiment, she determined a binding affinity 
for TRIL2WL23H of 5.0 x 1012 M-1, which is approximately half of the value determined 
for the binuclear CuICys3 sites as reported above.48 Additionally, in Chapter 2, I 
determined that if a His3 site is present in a peptide, such as GRL2WL16CL30H, CuI 
does not inhibit PbIICys3 binding. These data, considered together, led me to ask if CuI 
would compete for a His3 or Cys3 when the sites were present in the same peptide (in the 
absence of a second metal ion). There are three expected outcomes of this experiment, 
complete preference for the His3 site, complete preference for the Cys3 site, or a 
competition for CuI binding between both the His3 and Cys3 sites. If CuI binds 
exclusively to the His3 site before binding to the Cys3 site we would expect to see no 
change at 266 nm for the first one equivalent of CuI added. The opposite situation would 
occur if CuI binds exclusively to the Cys3 site before binding to the His3 site. In this case, 
we would see an increase in the 266 nm transition and a plateau at two equivalents, as 
observed in TRIL2WL16C. If competition occurs, we should see an increase at 266 nm 
from the beginning of the titration, but it should take more than two equivalents of CuI to 
fill the Cys3 site.  
Aliquots of CuI were added, in an inert atmosphere box, to a solution of 
GRL2WL16CL30H (Table 4-1), in 50 mM KPhos buffer at pH 8.0 (Figure 4-20). An 
immediate increase in absorbance at 266 nm upon the first addition of CuI negated the 
model for complete preference for CuI binding to the His3 site. However, at two 
equivalents of CuI added the 266 nm peak was not saturated and an extinction coefficient 
of only ~8000 M-1cm-1 was observed at two equivalents, only about 50% of what is 
expected for a saturated Cu2ICys3 site (Figure 4-20B). After three equivalents of CuI were 
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added with respect to the concentration of 3SCC, we see a sharp transition in the titration 
curve and the band at 266 nm stops increasing upon further additions of CuI (Figure 4-
20B). Therefore, it is obvious that the last of the three possibilities mentioned above 
exists, and when CuI is added to a peptide that contains both a Cys3 and His3 binding site, 
competition is observed for CuI binding.  
 
Figure 4-20. Titration spectra of CuI into a solution of (A) GRL2WL16CL30H at pH 8.0 
in 50 mM KPhos buffer. Titration curve (B) showing a plateau at 3 equivalents of CuI as 
absorbance at 266 nm divided by concentration of CuI added (ε at λ266) versus the 
equivalents of CuI added, with respect to the total concentration of 3SCC.  
A new model can be derived to determine the CuI binding affinity for the Cys3 
site as a function of competition with the His3 site. Additional assumptions must be 
considered in addition to those made when fitting the CuI affinity data with BCS2-. Again, 
we assume that due to tight binding there is no free CuI in solution, every mole of CuI 
added to the sample solution is assumed to bind. Additionally, we assume that there is no 
mononuclear CuICys3 site formed (the same model as for the BCS2- titrations); therefore, 
when CuI binds to the Cys3 site we get half the amount of binuclear metallated 3SCC. 
Lastly, and perhaps most important to note, is that I have assumed for the purposes of this 
model that the binding affinity of CuI to a His3 site does not influence the affinity of CuI 
binding to a Cys3 site in the same peptide scaffold, and vice versa.  
The model as derived in Equations 27 and 28, considering the above-mentioned 
assumptions, cannot be simplified enough for fitting in Prism 5 (GraphPad Software)55. 
However, we can use the values of the measured parameters and those known based on 
initial values and measured parameters, [Cu2Cys3], [His3]f, [Cys3]f, and [CuHis3], to 
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determine Kcomp at each data point, which can then be used with Ka of 
CuI(TRIL2WL23H)3+ to determine an estimated Ka for CuI2Cys3 binding. With the 
following mass balance equations for [Cu]T, [Cys3]T and [His]T we can rearrange to 
determine Kcomp for each titration point (Table 4-5). Plotting Kcomp versus [CuI]T results in 
a parabolic curve indicating that at very low and at very high concentrations of CuI the 
assumptions made during the derivation break down (Figure 4-21). Conversion of Kcomp 
to Ka for Cu2ICys3 reveals a similar parabolic curve with maximum Ka values at the 
beginning and at end of the titration with a range of Ka values from 8.0 x 1022 – 2.3 x 1025 
M-2 (Figure 4-21). The discrepancy of 3-4 orders of magnitude observed between this 
technique and the BCS2- competition experiment is likely due to the CuIHis3 Ka being for 
a TRI peptide and, is probably related to the folding free energy of the peptide.88 
Considering the increase stability of GR compared to TRI, this difference could lead to 
an underestimation for a His3 site in a GR peptide, and, in turn, an underestimated Ka 
calculated for the Cu2ICys3 site. 
Table 4-5. Measured Kcomp and calculated Cu2ICys3 Ka 
values for CuI competition in GRL2WL16CL30H 
Cu, µM Kcomp Ka, M-2 
12.50 2.000 5.00 x 1025 
25.00 0.558 1.4.0 x 1025 
37.50 0.167 4.17 x 1024 
50.00 0.099 2.46 x 1024 
62.50 0.074 1.86 x 1024 
75.00 0.031 7.70 x 1023 
87.50 0.004 9.79 x 1022 
100.0 0.001 2.00 x 1022 
112.5 0.018 4.55 x 1023 
125.0 0.051 1.26 x 1024 
137.5 0.120 3.00 x 1024 
150.0 0.308 7.71 x 1024 
166.5 1.951 4.88 x 1025 
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Figure 4-21. Plots showing (A) Kcomp values and (B) calculated KCu2Cys3 values for 
CuI2Cys3 binding versus total concentration of CuI added to GRL2WL16CL30H as 
determined from the data in Figure 4-20 from 0-3 equivalents of CuI with respect to the 
concentration of 3SCC. The black circles represent the values calculated using Equation 
28 as described in the Materials and Methods section. 
Regardless, this method provides a second approach for determining the binding 
affinities of CuI to Cys3 sites. The affinity of CuI to the His3 site has been shown to vary 
when the sterics of the secondary coordination sphere and/or the electrostatics around the 
metal binding site are altered; therefore, one could imagine altering the His3 site to either 
higher or lower affinity, based on the corresponding expected Cys3 Ka, to tailor this 
experiment to varying affinities for the Cys3 site.    
Heterobinuclear Binding to Cys3 sites in 3SCCs 
 As mentioned above, PbII and CuI compete for binding at a Cys3 site within the 
TRI and GR peptides. This was first observed when titrating PbII into a solution of 
GRL2WL16C in the presence of one equivalent of CuI. In comparison to PbII binding to 
GRL2WL16C, in the absence of another metal, the extinction coefficient observed for the 
PbIIS3 species, in the presence of CuI, was approximately 2,000 M-1cm-1, about half of 
that observed in the absence of CuI. This observation suggested competition between CuI 
and PbII for the thiolate site.  As discussed above, CuI may have high affinity both for 
His3 and Cys3 environments. In contrast, PbII strongly favors Cys3 sites and has shown no 
affinity for the tris histidine region of the 3SCC. Therefore, I then analyzed the ability of 
PbII to complex to a Cys3 site in the presence of CuI, but this time both a Cys3 and a His3 
site were present in the peptide. Indeed, when PbII was titrated into 
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CuI(GRL2WL16CL30H)3+; no competition was observed between PbII and CuI at the 
cysteine site (Figure 4-1). This result indicated that when His3 and Cys3 sites were 
present, PbII binding to the Cys3 site was not inhibited in the presence of CuI. Again, both 
PbIICys3 and CuICys3 choromophores have features at 266 nm, so overlapping 
contributions make interpreting the changes at this wavelength non-trivial. 
 I could now apply the observations that CuI competed with PbII for Cys3 binding 
in GRL2WL16C and that CuI formed a binuclear center with the three cysteine residues 
to interpret more clearly the Pb/Cu competition experiment. Given that there was one 
equivalent of CuI present in solution site prior to adding PbII and that this copper would 
form a binuclear structure, this meant that 50% of the Cys residues in GRL2WL16C were 
available for PbII binding. The strong binding observed from 0-0.5 equivalents of PbII 
added, the relatively sharp plateau observed from 0.5-2.5 equivalents of PbII, as well as 
the extinction coefficient of 50% the expected value supports this model. Therefore, we 
suspect that 50% of the Cys3 sites are occupied by binuclear CuI binding leaving 50% 
open for PbII complexation.   
 I then looked at the reverse titration where aliquots of CuI were added to a 
solution of one equivalent PbII bound to GRL2WL16C (40 µM 3SCC), in an inert 
atmosphere box, 100 mM TRIS buffer at pH 7.5 (Figure 4-22). No change was observed 
at the LMCT PbIIS3 346 nm peak upon addition of one equivalent of CuI, but an increase 
was observed at 266 nm (Figures 4-22B and 4-22C). Additionally, a closer analysis of the 
spectra that correlate to 0-1 equivalent CuI spectra yielded an isosbestic point at 330 nm 
(Figure 4-22C) indicating that two absorbing species were simultaneously present in 
solution. From 1-3 equivalents of CuI I saw a depletion of the 346 nm peak with a 
continuous increase in the 266 nm peak, and a new isosbestic point was observed at 270 
nm (Figure 4-22D). After three total equivalents of CuI were added the entire PbIIS3 peak 
at 346 nm disappeared (Figures 4-22B and 4-22D). The combination of no decrease 
observed at 346 nm but an increase in absorbance at 346 nm indicated that PbII was not 
being displaced, but CuI was being complexed by the peptide at the Cys3 site. This 
suggested that the first equivalent of CuI was binding in the presence of PbII, presumably 
forming a hetero-binuclear metal site of CuISPbIIS(GRL2WL16C)3 complex. One should 
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recognize that if a CuI2 center was being formed under these conditions, it would require 
that PbII be removed, which would have diminished the 346 nm absorption band. I assign 
this isosbestic point at 330 nm as the conversion of a PbIIS3 center to CuIPbIIS3. Given the 
available x-ray structures for PbII bound to thiolate derived CS peptides, the simplest 
model would position the PbII below the sulfur plane towards the C-termini and the CuI 
would be found above the plane towards the N-termini. This is the first instance of a bi-
nuclear site that contains one equivalent of CuI and one equivalent of PbII.  
 
Figure 4-22. Titration spectra of CuI into a solution of (A) PbII(GRL2WL16C)3- at pH 
7.5 in 100 mM TRIS buffer. Titration curve (B) of absorbance at 346 nm as a function of 
total equivalents of CuI added with respect to the concentration of 3SCC. No change in 
the absorbance is observed for the first equivalent of CuI added, then a decrease is 
observed from 1-3 equivalents of CuI and a plateau is reached once three equivalents of 
CuI is reached. (C) Titration spectra of 0-1 equivalents of CuI added to 
PbII(GRL2WL16C)3- with an isosbestic point at 330 nm. (D) Titration spectra of 1-3 
equivalents of CuI added to PbII(GRL2WL16C)3- with an isosbestic point at 270 nm. The 
final absorption spectrum is identical to that observed for CuI2(GRL2WL16C)3- alone.  
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The fact that three equivalents of CuI are required to displace one equivalent of 
PbII to form the binuclear CuI site indicates competition between CuI and PbII for the C-
terminal side binding site. However, regardless of the direction of the titration (CuI added 
to PbIIS(Pep)3- or PbII added to Pep3 with one equivalent of CuI (presumably resulting in 
0.5 equivalents of CuI2(Pep3)-), an intermediate heterobinuclear site formed, preventing 
direct determination of the PbIICys3 affinities via competition with CuI. 
Because CuI is diamagnetic, I reasoned that 207Pb NMR spectroscopy would 
further probe the existence of the heterobinuclear site. First, I could directly probe the 
PbII ions presence at the Cys3 site as displacement of a cysteine would cause a marked 
shift in the spectrum. Second, as detailed in Chapter 2, the 207Pb NMR signal of PbII-
bound TRI and GR peptides is very sensitive to perturbations of the secondary 
coordination sphere. Decreasing the sterics of the Leu layer directly above a PbIICys3 site 
via LeuàAla substitution caused a 75 ppm upfield shift in the PbIIS3 spectrum.46 
Considering the close proximity expected between CuI and PbII ions that bind to the same 
Cys3 site, I next wanted to determine if the presence of CuI resulted in a change in the 
chemical shift of PbIIS(TRIL2WL16C)3-, which might reflect changing conformations of 
the cysteine side chains upon binding copper.  
First, I re-analyzed a sample of 12 mM TRIL2WL16C, 4 mM 3SCC, dissolved in 
degassed 10% D2O with 1 equivalent of 207Pb (4 mM). The sample was prepared in an 
inert atmosphere box. As expected, a peak was observed at 5651 ppm, consistent with 
previously reported a site Cys3 spectra with no additional mutations in the layers above or 
below the metal binding site (Figure 4-23). I then added one equivalent of CuI, 
anaerobically, to the sample and re-collected the 207Pb NMR data. Interestingly, the 207Pb 
NMR signal was observed at 5648 ppm, essentially unperturbed in signal intensity and 
chemical shift, (Figure 4-23). This data corroborates the UV-Vis titration in which the 
addition of one equivalent of CuI does not cause a decrease in the PbIIS3 peak observed at 
~350 nm. However, this result is surprising in that the addition of another metal ion in 
close proximity to the PbIICys3 site did not perturb the chemical shift significantly. This 
could be due to the PbIICys3 bonding interactions dominating the chemistry when only 
one equivalent of CuI is added to a PbIICys3 site. In reference to the models above, it is 
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possible that the PbIICys3 site forms as previously observed and characterized in 
PbIISZnIIN(GRCSL16CL30H)3-, where the Cys3 site is pre-organized for PbII binding and 
the Cys rotamers require minimal changes to bind PbII. The addition of CuI results may 
then result in a distorted linear structure toward the helical interface. Most surprising is 
that neither the PbII nor the CuI electronic spectra are perturbed in the presence of one 
equivalent of the opposite metal.  
 
Figure 4-23. 207Pb NMR spectra of PbII(TRIL2WL16C)3- (bottom) and 
CuIPbII(TRIL2WL16C)3 (top). All spectra were recorded at room temperature (25 °C) for 
5 hr using isotopically enriched PbII(NO3)2, pH 7.5. 
Initial models of a heterobinuclear site, provided from Dr. Leela Ruckthong, have 
been made by altering the crystal structure of PbIIS(GRCSL16CL30H)3- (Table 4-1). 
Without altering the location of the PbII ion in the crystal structure, we added in a CuI ion 
at ~2.2 Å from the sulfur atoms of the cysteine ligands. The resulting model provided a 
CuI-PbII distance of only 2.66 Å, and an apparent overlap of the CuI and PbII ion spheres 
(Figure 4-24). Realizing that this distance is likely too short to allow formation of the 
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heterobinuclear center due to repulsion and that a CuI-PbII bond is highly unlikely, we 
then moved the CuI ion away from the PbII ion, towards the N-termini, to a distance 
where the CuI and PbII ion space filling spheres no longer overlapped, resulting in a more 
reasonable CuI-PbII distance of 3.23 Å (Figure 4-25). However, the CuI-S distances are 
now significantly elongated to 2.51 Å. This distance is much longer than the CuI-S 
distances in any of the above-mentioned CuI metalloregulatory proteins or for my CuI2 
center; however, it is not unlikely that the geometry and/or the coordination number of 
the CuI ion change when forming an unprecedented CuIPbII heterobinuclear site. 
Ultimately, XAS analysis and, ideally, a crystal structure are required to determine how 
CuI and PbII are interacting within the same Cys3 binding site. 
 
Figure 4-24. Side-on (A) and Top-down (B) views of a pymol representation of a 
modeled symmetric binuclear CuIPbII site bound to three sulfur atoms. Site is modeled 
from the PbIIS(GRCSL16CL30H)3- structure (PDB code not yet deposited).82 Main chain 
atoms are shown in teal, water molecules are shown in small red spheres, cysteine 
residues are shown as sticks with sulfur atoms highlighted in yellow and CuI and PbII ions 
are shown as blue-grey and grey spheres, respectively. The PbII ion is not altered from the 
crystal structure and PbII-S distances are 2.65 Å. The CuI-S distances are fixed at 2.20 Å. 
CuI-PbII distance measures to 2.66 Å, the water molecule is 2.03 Å above the CuI ion.  
CuI 
PbII 
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Figure 4-25. Side-on view of a Pymol representation of a modeled symmetric binuclear 
CuIPbII site bound to three sulfur atoms. Site is modeled from the 
PbIIS(GRCSL16CL30H)3- structure (PDB code not yet deposited).82 Main chain atoms are 
shown in teal, water molecules are shown in small red spheres, cysteine residues are 
shown as sticks with sulfur atoms highlighted in yellow and CuI and PbII ions are shown 
as blue-grey and grey spheres, respectively. The PbII ion is not altered from the crystal 
structure and PbII-S distances are 2.65 Å. The water molecule is 2.00 Å above the CuI ion. 
The CuI-PbII distance has been elongated to 3.23 Å, which results in a CuI-S distance of 
2.51 Å. 
Knowing that CuI does not inhibit PbIIS3 binding GRL2WL16CL30H, and with 
data supporting a heterobinuclear CuIPbIICys3 site, I next wanted to analyze if CuI 
binding to PbIIs(GRL2WL16CL30H)3- would provide evidence of CuICys3 or CuIHis3 
binding, exclusively. To a solution of PbIIS(GRL2WL16CL30H)3-, I added 0.5 
equivalents of CuI (Figure 4-26). In the absence of CuI an extinction coefficient at 266 
nm (determined by the absorbance divided by the concentration of PbII) was ~13,500  
M-1cm-1, consistent with other PbIICys3 reports.41,46,57 The increase in absorbance at 266 
upon the addition of 0.5 equivalents of CuI provides an extinction coefficient for CuI-
bound Cys3 (CuIPbII(GRL2WL16CL30H)3, since the PbIICys3 feature persists) of ~2,500 
M-1cm-1 (determined by the increase in absorbance at 266 nm divided by the 
concentration of CuI added). The direct CuI titrations into Cys3 peptides reported above 
provided CuI2Cys3 extinction coefficients at 266 nm of ~16,000 M-1cm-1, therefore, I 
would have expected ~4,000 M-1cm-1 if all of the added CuI (only 0.5 equivalent in this 
CuI	
PbII	
	 252 
case) bound exclusively to the Cys3 site. Instead, it appears that when 0.5 equivalents of 
CuI is added to PbIIS(GRL2WL16CL30H)3- approximately 0.25 equivalents bind to the 
Cys3 site presumable leading to the other 0.25 equivalents bind to His3 site. These data 
indicate that the binding affinity of the second equivalent of CuI to the Cys3 site is 
comparable to the binding affinity of CuI to a His3 site, and also to the binding affinity of 
the PbII to the Cys3 (supported by three equivalents of CuI required to displace one 
equivalent of PbII from a Cys3 site). 
 
Figure 4-26. Overlay of titration spectra of 70 µM PbIIS(GRL2WL16CL30H)3- in the 
absence (red) and presence of 0.5 equivalents of CuI (blue) at pH 7.5 in 100 mM TRIS 
buffer. 
Conclusions 
 In this chapter I have provided spectroscopic evidence that supports the first 
homobinuclear CuI2 and heterobinuclear CuIPbII centers obtained within the TRI and GR 
families of peptides. Previously, studies of metal binding single Cys3 a sites in TRI and 
GR peptides have resulted in exclusively mononuclear metal centers. UV-Vis and XAS 
spectroscopies support this claim. Titrations of CuI into Cys3 containing peptides provide 
2:1 binding stoichiometry of metal:3SCC and a heavy long distance back scatterer is 
observed in the Fourier Transform of the collected EXAFS data, consistent with a CuI-
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CuI interaction. Alteration of the sterics in the layer directly above the Cys3 binding site, 
with respect to the N-termini of the 3SCC, of Leu12Ala or Leu12DLeu show similar CuI 
binding stoichiometries indicating that the binuclear Cu2I site forms even when more 
(Leu12Ala) or less (Leu12DLeu) space is available within the hydrophobic core of the 
scaffold. The similarities in the binding constants and spectroscopic data obtained, 
regardless of the steric bulk included in the layer above the Cys3 binding site, best 
supports a model in which the CuI ions have two short CuI-S bonds and one longer CuI-S* 
bond with a pseudo-linear/T-shaped coordination geometry. This stoichiometry is not 
observed with TRIL2W ruling out contributions to the spectroscopic features of non-
specific CuI binding to exterior Glu or Lys residues. Primary standard competitive 
binding assays with BCS2- provide KaCu2Pep3 values of 1028 – 1031 M-2. The binding 
affinities seem to be dependent on both pH and the length of the peptide analyzed (TRI or 
GR). Secondary competitive binding assays of CuI to two different sites (Cys3 and His3) 
within the same 3SCC provide comparable binding affinities to those obtained via BCS2- 
competition. The binding affinities and stoichiometries as determined via UV-Vis 
spectroscopy of both TRI and GR Cys3 containing peptides correlate well with native CuI 
metallochaperones. Additionally, bi- and polynuclear CuI complexes show similar 
characteristic XAS features with comparable CuI-S and CuI-CuI bond lengths. In general 
the measured bond lengths reported in this chapter are slightly shorter than those 
observed in native systems, perhaps due to the differences observed in secondary and 
tertiary structure between native metallochaperones and our de novo designed 3SCC; 
however, due to the lack of structural data or proposed polynuclear CuI-cluster geometry 
within metallochaperones, it is difficult to address the consistently shorter distances 
observed. Additionally, the binding constants obtained for the binuclear CuICys3 sites in 
the TRI and GR peptides are approximately twice as tight as the mononuclear constants 
reported for native CuI-metallochaperones, providing assumed comparable binding 
affinities for single CuI ions. 
 With the initial hopes of obtaining PbIICys3 binding affinities via direct 
competition with CuI binding, spectroscopic analysis of peptides containing both CuI and 
PbII actually support the formation of an unprecedented CuIPbII hetero-binuclear site. 
When one equivalent of CuI is present in a solution of peptide, which contains a Cys3 site, 
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only 0.5 equivalents of PbIICys3 binding is observed, even upon addition of excess PbII 
supporting the notion that 0.5 equivalents of the Cys3 site is already occupied by a 
CuICys3 binuclear center. Conversely, when CuI is added to a PbIIS-bound peptide, the 
PbIICys3 site is not perturbed until greater than one equivalent of CuI is present, but 
evidence of CuI-Cys3 coordination is observed. This supports that CuI is binding while 
PbII is not perturbed, supporting a CuIPbIICys3 heterobinuclear site. Additionally, analysis 
of PbIICys3 site via 207Pb NMR shows no perturbation on the PbII coordination in the 
presence of one equivalent of CuI. Three total equivalents of CuI are required to 
completely displace the PbII ion, suggesting competition is observed between the binding 
of the second equivalent of CuI and the PbII ion. It appears that the order of metal addition 
matters with respect to competition observed between the binuclear CuI site and 
heterobinuclear CuIPbII site indicating that there may be kinetic influences on the CuI/PbII 
Cys3 competition. This is the first report of a mixed CuIPbII binuclear complex. 
Additionally, it appears that the second equivalent of CuI that binds to the Cys3 binuclear 
site is competitive with both PbIICys3 binding and CuIHis3 binding.  
 This study demonstrates the versatility of metal binding to a Cys3 site within a 
highly simplified scaffold. The binding of other metals, such as HgII, CdII, PbII, and ZnII, 
have been previously studied within Cys3 substituted GR and TRI peptides. In the case of 
HgII, the metal preference for binding linearly can be utilized, stoichiometrically, to 
enforce formation of a 2SCC, but appropriate pH and 1:3 metal:monomer stoichiometry 
provides a model of a biologically relevant three-coordinate trigonal planar HgIICys3. The 
sterics around the Cys3 site within GR and TRI peptide can be altered to enforce higher or 
lower coordination geometry of CdII. These steric changes also provide spectroscopic 
perturbations when PbII is bound to Cys3 sites. However, in the case of CuI it appears that 
a high affinity binuclear site is produced, regardless of the sterics around the Cys3 site. 
Additionally, it appears that the Cys3 affinity is such that one equivalent will bind in the 
presence of PbII forming an unprecedented and very interesting heterobinuclear site.  
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Chapter 5. Conclusions and Implications 
 
 De novo peptide design has offered a powerful approach to obtain redox- and 
catalytically active metal binding sites within simplified and symmetric protein 
environments allowing for the study of the structure-function relationship of native 
metalloenzymes. In the last five years, the Pecoraro laboratory has designed and 
characterized systems with the highest catalytic efficiency, in aqueous solutions, for CO2 
hydration, as inspired by the ZnIIHis3 site in Carbonic Anhydrase (CA), and for nitrite 
reduction, as inspired by the type two CuI/IIHis3 site in Copper Nitrite Reductase 
(CuNiR).1–4 While these systems are the fastest reported mimics for the native reactions 
of their corresponding metalloenzyme inspirations, the inherent symmetry of the three-
stranded coiled coil (3SCC) motif restricts not only the type of sites that can be obtained 
(three-fold symmetric primary coordination ligands) but also limits any modifications to 
the binding sites (i.e. introduction of a acid-base catalyst would occur on each helix 
resulting in a three-fold modification near the metal binding site). Additionally, 
asymmetric primary coordination spheres were unattainable prior to this work. The 
primary goal of my thesis was to lift these symmetry-related restrictions by obtaining 
selectively asymmetric, heterotrimeric 3SCCs.  
 I have reported the first heterotrimeric 3SCCs obtained utilizing only natural 
amino acids that is not only metal-nucleated but that also only requires steric 
modifications in the layer directly above the nucleation site (Chapter 2). The requirement 
of only two corresponding layers to make selective heterotrimers results in space within 
the peptide scaffold to include a second metal binding site with potential catalytic redox 
or hydrolytic activity; therefore, resulting in the first report of a dual-site heterotrimeric 
3SCC. The methodology to obtain selective heterotrimers employs mixing 
stoichiometrically two peptides, each containing Cys substitutions at the 16th position of 
the sequence, where one peptide has a Leu residue at the 12th position and the 
	 260 
complementary peptide contains an Ala substitution at the 12th position. These peptides 
are referred to as TRI-C and TRI-AC, respectively. Inclusion of a second metal binding 
site requires elongation of the peptide from 30 residues (the TRI peptides, sequence: Ac-
G (LKALEEK)4 G-NH2) to 37 residues (the GR peptides, with five heptad repeats instead 
of four) resulting in sequences GR-ACH and GR-CH, respectively.  
 From pH 7.4 – 9.4, mixing Ala/Cys and Leu/Cys peptides (either TRI or GR) in a 
2:1 ratio in the presence of PbII results in a pure heterotrimeric species as evidenced by a 
single 207Pb NMR chemical shift (δ = 5600 ppm), which is unique compared to either 
PbII-bound homotrimeric peptide (δ = 5650 and 5575 for PbIIS(GR-CH)3- and PbIIS(GR-
ACH)3-, respectively). The presence of two chemical shifts, when PbIIS(GR-ACH)3- and 
PbII[(GR-ACH)2(GR-CH)1]- are mixed, (correlating to the GR-ACH homotrimer and the 
PbII[(GR-ACH)2(GR-CH)1]- heterotrimer at δ = 5575 and 5600 ppm, respectively), 
indicates that a new species is indeed obtained and that coalescence is not the explanation 
for a single peak in the 207Pb NMR spectra. Additionally, I analyzed the perturbed pKa of 
the thiol deprotonation in the presence of PbII, which can be analyzed via observation of 
the PbIICys3 LMCT band growing in with a fully deprotonated Cys3 site is complexed 
with PbII. This analysis provided that the PbII[(TRI-AC)2(TRI-C)1]- thiol pKa2 is acid 
shifted, significantly, to 10.47 ± 0.06, compared to PbIIS(TRI-AC)3- and PbIIS(TRI-C)3- 
homotrimers at 10.83 ± 0.04 and 11.72 ± 0.03, respectively. These results, corroborate 
the 207Pb NMR data, and support the model that a new species is formed when two 
equivalents of the Ala/Cys peptide and one equivalent of the Leu/Cys peptide are mixed 
together in the presence of PbII. 
 207Pb NMR analysis of the opposite peptide ratio, GR-ACH and GR-CH in a 1:2 
stoichiometry, also provides a new chemical shift at 5625 ppm, suggestive of another 
heterotrimeric species but a small population of the 2:1 heterotrimer is also observed at 
5600 ppm. These data support a model where 1:2 or 2:1 pairing of Ala/Leu residues in 
the layer directly above a PbIICys3 site provides heterotrimeric peptides, but only the 2:1 
ratio yields a single species. The presence of ZnII or CoII does not perturb the PbIICys3 
LMCT band observed via UV-Vis analysis or the 207Pb NMR signals for either 
heterotrimer, supporting the contention that metal binding to a remote His3 site does not 
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inhibit or prevent PbII binding and heterotrimer selectivity. Analysis of CoII binding at the 
His3 site of the homo- and heterotrimeric mixtures, in the absence of PbII, indicates that a 
statistical-like distribution is obtained, confirming the necessity of PbII to nucleate 
selective heterotrimer formation. 
Analysis of the crystal structures of PbIISZnIIN(GRCSL16CL30H)3- and 
PbIIS(GRCSL12AL16C)3-, obtained by Dr. Leela Ruckthong, has allowed for a new 
hypothesis to been formulated addressing why the heterotrimers are selectively formed. 
The occupancy of water molecules within the 3SCC structures of 
PbIISZnIIN(GRCSL16CL30H)3- and PbIIS(GRCSL12AL16C)3- is very different.5 In the 
Ala/Cys structure three water molecules are observed at the helical interface, which 
hydrogen bond to the p-orbitals of the sulfur ions. Conversely, the Leu layer above the 
Cys3 site prevents occupation of water molecules in similar locations in 
PbIISZnIIN(GRCSL16CL30H)3-. Therefore, the heterotrimers, which would contain an 
intermediate number of Ala residues in the layer directly above the Cys3 site, would 
presumably also allow for water occupancy in the space provided by said Ala 
substitutions. Therefore, one could imagine that an optimal combination of hydrogen 
packing (from the Leu residue) and hydrogen bonding (from waters included due to the 
Ala residues) would provide enhanced stability over the homotrimeric systems, which 
contain either only hydrogen-bonding (PbIIS(GRCSL12AL16C)3-) or only the 
hydrophobic packing (PbIISZnIIN(GRCSL16CL30H)3-).  
This stability-compromise model, considering a balance between hydrophobic 
packing and hydrogen bonding interactions, can also be applied to the lack of selectivity 
observed when HgII is used, instead of PbII, to nucleate heterotrimer formation. The 199Hg 
NMR shows that heterotrimers are formed, but that selectivity is not observed. HgII[(TRI-
AC)2(TRI-C)1]- and HgII[(TRI-AC)1(TRI-C)2]- provide intermediate chemical shifts (-210 
and -193 ppm, respectively) compared to the HgII(TRI-AC)3- and HgII(TRI-C)3- 
homotrimers (-244 and -184 ppm), but peaks corresponding to both heterotrimers are 
present in either the 2:1 or 1:2 Ala:Leu mixture. In the corresponding homotrimeric HgII 
crystal structures, a central water molecule is observed.5 In the heterotrimeric scaffolds, 
the presence of a central water molecule could function as a moderator in the hydrogen-
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bonding network. This could result in a comparable number of hydrogen bonding 
interactions in both heterotrimer mixture, and thus providing comparable added stability 
to both heterotrimers and, therefore, removing discrimination between the 2:1 and 1:2 
species. Of the heavy metals tested, only PbII leads to a single heterotrimeric species. HgII 
does bias toward heterotrimer formation, but mixtures appear for either mixture.  
Attempts to obtain heterotrimers with the Ala/Leu pairing below the Cys3 binding 
site have not yet been successful. This could be due to the preferred orientation of PbII 
when binding to a Cys3 site, which has consistently proven to be in an endo-configuration 
pointing toward the C-terminus in both PbIISZnIIN(GRCSL16CL30H)3- and 
PbIIS(GRCSL12AL16C)3- crystal structures. One could then imagine that introduction of 
the Ala below the Cys3 site would not result in the introduction of water molecules (to 
date no water molecules have been observed below the metal binding sites when LLeu 
layer is present). Therefore, the hydrogen-bonding/hydrophobic packing stabilization 
combination cannot occur, which seems to stabilize specific heterotrimer formation.  
From a design aspect, future directions for this project include studies to 
determine if heterotrimer selectivity can be achieved if the Cys3 site is moved to a d site 
with the Ala/Leu pairings in an a site, either above, or below, the metal binding site. A 
recent crystal structure of PbIIS(CSL12C)3- provides an endo-configuration of PbII-
binding, but the metal ion is actually pointing up toward the N-terminus. It is possible 
that the endo-confirmation of the PbII would prevent occupation of water molecules upon 
inclusion of an Ala layer above a d PbIICys3 site, resulting in no added stability of a 
hydrogen bonding network as previously discussed and eliminating selectivity for 
heterotrimer formation. On the other hand, if this is the case, introduction of the Ala/Leu 
pairing below a d PbIICys3 site may restore heterotrimer selectivity since the Ala residues 
are on the “opposite” side of the Cys3 binding site where water molecules may be 
observed.  
Additionally, one could address whether selective PbII-nucleated heterotrimer 
formation would be obtainable at different locations along the helical backbone. Above I 
mentioned moving from an a site to a d site, but one could also imagine moving from the 
middle of the 3SCC (12/16 positions) to the C-terminal end, say with Ala/Leu pairings in 
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the 26th position and a Cys3 at the 30th position. Of course, being so close to the end of 
the helical scaffold would then lead to the question of whether the Ala residue should be 
more solvent exposed, compared to the Cys3 site, resulting in inverting the mutations to a 
26th position Cys3 site and Ala/Leu pairing in the 30th position.  
With the methodology in hand to obtain asymmetric 3SCC, I then addressed 
extending the asymmetry from the Ala/Leu Cys3 site to a second, remote transition metal 
binding site (Chapter 3). To do so I included an Asp residue in the layer above the His3 
binding site, resulting in GR-CDH. One chemical shift at ~5600 ppm is observed when 
this peptide is mixed, 1:2, with GR-ACH in the presence of PbII. Spectroscopic analysis 
of both of the CoII-bound homotrimeric peptides provided similar characteristics, 
including low extinction coefficients (~30 and ~80 M-1cm-1 for PbIISCoIIN/O(GR-ACH)3+ 
and PbIISCoIIN/O(GR-CDH)3n+, respectively), comparable axial EPR spectra, and average 
Co-L bond distances of 2.115 Å. The heterotrimeric mixtures, PbIISCoIIN/O[(GR-
ACH)2(GR-CDH)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+ provide CoII 
spectroscopic fingerprints that are similar to each other but starkly different than the 
homotrimers. The heterotrimers provide extinction coefficient of ~150-200 M-1cm-1, 
significantly more rhombic-like EPR spectra and shorter average Co-L distances of 
2.075-2.08 Å. Switching the location of the Asp residue from the Leu/Cys peptide to the 
Ala/Cys peptide (matching GR-CH and GR-ACDH) resulted in a similar trend in 
spectroscopic characteristics where the homotrimers, PbIISCoIIN/O(GR-ACDH)3+ and 
PbIISCoIIN/O(GR-CH)3n+, looked similar to each other and to those discussed above and 
the heterotrimers looked different than the homotrimers but comparable to 
PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and PbIISCoIIN/O[(GR-ACH)1(GR-CDH)2]n+. 
These similarities indicate that the location of the Asp with relation to the Ala or Leu 
substitution is perhaps irrelevant in terms for selective heterotrimer formation, but the 
peptide stability of GR-ACDH is significantly decreased.  
All of the spectroscopic data support a 6-coordinate,6,7 highly symmetric CoII 
binding site in the homotrimers and a less symmetric, 5-coordinate8 (perhaps closer to 4-
coordinate in some cases) CoII environment in the heterotrimers. These data also indicate 
that CoII binds similarly to CA in the homotrimers and similarly to CoII-substituted 
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carboxypeptidase A (CPA), thermolysin (TML), or VanX in the heterotrimers, in 
particularly PbIISCoIIN/O[(GR-ACH)2(GR-CDH)1]n+ and PbIISCoIIN/O[(GR-ACDH)2(GR-
CH)1]n+.9–14 Both of these heterotrimers provide pure PbIIS3 sites (via 207Pb NMR 
analysis), and the EPR spectra look very similar; however, a slightly elevated extinction 
coefficient (ε544 nm = 215 M-1cm-1 from 155 M-1cm-1) and slightly shorter bond distances 
(2.05 Å, single sphere fit) with elevated pre-edge area (10.3 from 5.8) and pre-edge:edge 
ratios (3.5 from 2.0) all support a more pure CoII center in the for PbIISCoIIN/O[(GR-
ACDH)2(GR-CH)1]n+ heterotrimer. The spectroscopic data, in general for the 
heterotrimeric species, supports direct Asp coordination to the CoII ion (resulting in the 
probable uncoordination of one His residue).  
Further perturbations were made to the CoII binding site including moving the 
Asp ligand below the His3 site (resulting in 6-coordinate like spectral features), and 
inserting a DLeu layer directly above the His3 site (resulting in low extinction coefficients 
and an EPR spectrum indicative of a trigonal bipyramidal geometry in TRI-DLH but 
resulted in non-specific binding in GR-CDLH). All of the CoII spectroscopic data 
combined support the success of the primary goal of Chapter 3, an asymmetric 
environment has indeed been obtained at a remote site within the heterotrimer systems. 
The initial goal of obtaining an asymmetric second coordination sphere to mimic CA is 
not supported via the CoII spectroscopy; however, an asymmetric primary coordination 
sphere IS supported.    
However, contrary to the CoII spectroscopy, ZnII XAS of PbIISZnIIN/O(GR-
ACH)3n+, PbIISZnIIN/O(GR-CDH)3n+, and the corresponding heterotrimers provides 
consistent evidence for four-coordinate ZnII environments in all of the homo- and 
heterotrimer samples at pH 7.5 and 9.5. This coordination number assignment is 
equivalent to the crystallographically determined values for the homotrimer lacking 
aspartate. These data suggest two things, first, that ZnII binding to the heterotrimers does 
not coordinate the same as CoII and, second, that, CoII is, therefore, a non-innocent probe 
in the heterotrimeric systems. These observations suggest that perhaps the ZnII 
coordination in my heterotrimers is not completely unlike the coordination of ZnII in CA. 
Unfortunately, ZnII XAS cannot readily distinguish between N3O or N2O2 primary 
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coordination spheres, so the first coordination sphere environment around the ZnII atom 
may indeed be asymmetric, even though the spectroscopy supports a 4-coordinate site. 
However, it is clear that even if the first coordination sphere is unperturbed, the second 
coordination sphere, as originally desired, must have asymmetric amino acid side chain 
disposition. An interesting experiment would be to analyze the ZnII bound heterotrimers 
(and the corresponding PbIISZnIIN(GR-CTH)3n+ homotrimer) to determine how, or 
whether, the inclusion of a Thr residue, instead of an Asp residue, changes the ZnII 
metrical parameters. Additional neutral analogues to address would be Asn or Gln 
residues in the layer above the His3 site. 
Taking together the results of Chapters 2 and 3, one could imagine a surplus of 
future directions for this project. First, I will address the possible hydrolytic avenues one 
could pursue. In Chapter 3, I determined the PbIICys3 site to be catalytically active toward 
pNPA hydrolysis; however, CO2 hydration by PbIISZnIIN/O(GR-ACH)3n+ is comparable to 
HgIISZnIIN/O(GR-CH)3n+,15 indicating that future direct comparison can be made for the 
CO2 kinetic parameters. Therefore, one could imagine the vast possibilities for future 
kinetic studies using the heterotrimers reported here, new heterotrimers with varied 
acid/base or directly coordinating ligands, and even, perhaps, heterotrimers obtained with 
different nucleating metals.  
Considering the results and conclusions of this thesis as a whole, a new avenue to 
analyze selective heterotrimer formation would be to use AsIII as the nucleating metal. As 
mentioned in Chapters 1 and 2, Cys3 sites are pre-organized for AsIII, similarly to PbII, 
and AsIII found in an endo-confirmation toward the C-terminus in AsIII(CSL9C)3, again 
similar to PbII.16 AsIII also has a lone pair and is very large, which could result in similar 
binding compared to PbII. Additionally, AsIII has been shown to stay complexed to a Cys3 
site under extremely acidic conditions and even HPLC purification does not result in 
removal of AsIII from a Cys3 site.17 These situations indicate very tight binding, tighter 
than both PbII and HgII, both of which are removed upon HPLC purification. Therefore, if 
AsIII can nucleate heterotrimer formation the resulting peptide scaffold may be 
impervious to CuI competition and oxidative side effects from redox chemistry.  
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On one hand there are a plethora of studies to be completed using the presented 
ZnII-bound AspXHis3 systems with regards to CO2 hydration. Analysis of improved 
hydrolytic activity with the introduction of a single Asp ligand could be addressed. Or, 
perhaps the inclusion of a charged residue near the ZnII site perturbs the kinetic pKa of 
the ZnII-bound solvent molecule. Mentioned in Chapter 1, the previous CA mimic, 
HgIISZnIIN/O(TRIL9CL23H)3n+ has a catalytic pKa of 8.8, two log units higher than that of 
HCAII.18,19 All subsequent modifications made to Dr. Melissa Zastrow’s mimic 
(inclusion of Thr3 or Asp3 residues) all resulted in elevated pKa values.15 Therefore an 
interesting question to ask is what is required, within our simplified construct, to provide 
a decrease in kinetic pKa? A full pH profile of CO2 hydration kinetics is necessary to 
determine if the simple inclusion of one Asp residue near a His3 site results in the desired 
decrease in pKa. The same analysis but with a single Thr residue would be a natural 
progression from the Asp1His3 pH profile.  
In CA, substitution of the acid/base catalyst T199 with an Asp residue it has been 
shown that the protein rearranges to allow for direct ZnII-coordination to the Asp, in 
addition to all 3His residues in the active site.20 This results in abolishment of catalytic 
activity in CA. However, the ZnII XAS data, in combination with the models provided in 
Chapter 3, strongly support the idea that the rigidity of the 3SCC prevents ZnII 
coordination to all three His residues as well as direct coordination to the Asp residue. 
Therefore, the effect on catalytic activity due to coordination restrictions imposed on the 
metal binding site by the secondary structure is also an important question to ask.  
Current work in the Pecoraro laboratory is also addressing the effects of CoII 
coordination if a Glu residue is included in the layer above, or below, a His3 binding site. 
Initial models, as described in Chapter 3, suggests that inclusion of a Glu residue in the 
26th position would probably result in direct coordination of the carboxylic acid moiety 
directly to the metal ion, while still coordinated to the His3 site. With the knowledge that 
a CoII ion seems to prefer a chelation effect from an sequence containing L26DL30H, it 
would be very interesting to see if we see comparably AspXHis2 binding or if indeed the 
CoII ion coordinates to the Glu as well as the His3 site. ZnII analyses in these peptides 
would also be a natural progression.  
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Another exciting avenue to address would be adding different metals to the 
CarboxylateXHis3 site such as Fe or Mn. The CoII data supports direct ligation of the Asp 
residue, but requires one His residue to uncoordinated from the metal. The combination 
of a Glu residue and addition of Fe or Mn could allow for analysis of a very different 
metalloenzyme, such as Fe- or Mn-superoxide dismustases.21–23 These proteins have 
active sites in which the metal, Fe or Mn, binds to three His ligands and one carboxylate. 
If indeed the additional length offered from Glu compared to Asp can allow for direct 
carboxylate coordination and ligation to all three His residues, then this would provide 
another avenue to study asymmetric primary coordination spheres with our 3SCCs to 
mimic native metal binding sites. 
The CuHis3 secondary coordination sphere of CuNiR contains an acid/base Asp 
ligand;24 however, the entirety of Chapter 4 indicates that utilizing a PbII-nucleated 
heterotrimer to study CuNIR activity will be non-trivial, at best. First to consider is the 
competition observed between CuI and PbII for the Cys3 site. The data in Chapter 4 
suggest that the addition of the PbII first, to form the heterotrimer at the Cys3 site, and the 
presence of the His3 site may prevent the CuI from binding to the Cys3 site. Additionally, 
with the asymmetric addition of an Asp residue near the His3 site, this may also help 
promote CuIHis3 binding. Additionally, the effects of a hetero-binuclear CuIPbIICys3 site 
on the formation of heterotrimers should be addressed, as it is possible that if 
heterotrimers can still be obtained, with CuI also present at the PbIICys3 site, albeit 
unlikely, that the site may not offer any redox activity and could actually offer stability to 
the heterotrimer formation. However, extensive controls considering the specificity of 
where CuI binds in such a heterotrimer would be required.  
The next condition to consider is the optimal pH of 5.8, at which Dr. Fanting Yu 
observed CuNIR activity in the TRI peptides.3,4,25 As discussed in Chapter 2, the pKa of 
thiol deprotonation, presumably directly related to PbIICys3 binding, is very near to this 
pH, and the selectivity for heterotrimer formation at this pH would need to be 
investigated. Last, but certainly not least, thiol groups are prone to form disulfides under 
oxidative conditions. Therefore, the study of the redox-active site may only be analyzable 
under reductive conditions, potentially limiting the characterization of a CuNIR mimic.  
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With respect to both of these considerations, the CuIPbIICys3 site, and the 
sensitivity to oxidation of the Cys residues, this could be another situation in which using 
an AsIII-nucleated 3SCC could be extremely beneficial. Of course, this project would be 
contingent on the characterization of AsIII-nucleated heterotrimer formation. Studies to 
address the formation of a binuclear CuIAsIIICys3 site would be required, as well as 
studies to address the Cys3 sensitivity to oxidation while AsIII is bound.  
Of great personal interest would be the continuation of the potential hetero-
binuclear PbIICoII site as evidenced by the change in spectra of PbIISCoIIN/O(GR-CDH)3n+ 
upon the addition of excess PbII. As discussed in Chapter 3, the addition of one additional 
equivalent of PbII to PbIISCoIIN/O(GR-CDH)3n+ resulted in a CoII d-d band identical to that 
of PbIISCoIIN/O(GR-ACH)3n+. If the PbII ion is binding to the Asp residues a PbII-CoII 
scatterer should be observed via XAS, which in turn would provide evidence of a 3SCC 
with two engineered metal binding sites, a Cys3 and an Asp3Hsi3 site, that binds three 
equivalents of metal. If the selectivity of each site is properly addressed, one could 
imagine that three different metal ions could selectively bind to one 3SCC, such as a 
PbIICys3 site, a CoIIHis3 site and perhaps a CaIIAsp3 site (considering the affinity for CaII 
for oxygen rich metal binding sites).26   
In Chapter 4, I reported evidence of the first binuclear metal site within the TRI 
and GR peptides observed when only one layer of metal binding ligands is included in the 
peptide sequence (GR-C and TRI-C). Both EXAFS and UV-Vis spectroscopies support a 
CuI2Cys3 center with a Cu-Cu interaction at 2.66 Å two or three Cu-S distances at 2.20 Å, 
and a UV transition at 266 nm. Modifications to the sterics in the layer directly above the 
Cys3 (L12A or L12DL) provide very similar spectroscopic characteristics indicating the 
formation of the binuclear site. Most likely the CuI ions are intermediate between 2- and 
3-coordinate with two short Cu-S distances and a longer Cu-S interaction. This sort of 
binuclear CuI site is often seen in nature and ideally, CuI binding to ours systems could be 
used to understand better CuI metallochaperones, regulators and CuI homeostasis in 
general. Two different modes of competition, including a primary standard with BCS2-, 
as well as a secondary competition with the His3 site in the same construct, reveal binding 
affinities of 1028 – 1031 M-2.  
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AgI has been shown to bind similarly to CuI in thiolate-rich environments; 
therefore, I have conducted initial studies on AgI binding to Cys3 sites in 3SCCs.  For 
both TRI-C and TRI-AC, UV analysis supports three equivalents of AgI binding per 
3SCC. This stoichiometry, one metal ion per thiol residue, is comparable to that observed 
by Ogawa and coworkers.27 Initial XAS analysis supports either a 2- or 3-coordinate Ag-
S environment; however, further analysis is necessary to characterize the AgISCys3 
systems, primarily due to the previous samples having been prepared at a significant 
excess of 3SCC. The sample preparation could therefore be the reason a AgI-AgI 
interaction has not been observed at this time, even though the UV experiment provides 
evidence for multiple AgI ions in the binding site.  
Drawing inspiration from Ogawa’s reported structure of the CdII4S6 cluster, as 
discussed in Chapter 4, one could imagine that three silver ions could bind, each to two 
cysteine residues, at the helical interface.28 This could also explain why a AgI-AgI 
interaction has not been observed via XAS analysis, since the CdII-CdII distance is too 
long, at 4 Å, and a comparable distance would not be unrealistic for AgI binding within 
such a similar scaffold. Once again, AgI binding could be offering a very different 
binding geometry compared to the binuclear CuI2 site, or any of the previously analyzed 
heavy metals within a Cys3 site. It is possible that in our 3SCCs the AgI ions bind to the 
sulfur ligands only, and no Glu residues as observed in the CdII4S6 cluster, therefore 
retaining the full α-helical structure of the 3SCC.  
Arguably more interesting, and more convoluted, than the binuclear CuI site is 
what happens when both PbII and CuI are added to a peptide with a Cys3 site. When one 
equivalent of CuI is present and PbII is titrated into the peptide, only half the expected 
PbIICys3 extinction coefficient is observed, supporting a model where 50% of the Cys3 
site is blocked from PbII binding – presumably due to 50% of the total peptide binding the 
CuI as a CuI2Cys3 site. The addition of excess PbII does not displace the CuI from the Cys3 
site. If PbII is added to the peptide first, then one equivalent of CuI does not perturb the 
PbII spectroscopy (UV-Vis or 207Pb NMR), but evidence for CuICys3 binding is observed, 
supporting CuI and PbII binding simultaneously to the Cys3 site. Two more equivalents of 
CuI (three equivalents total) are required to completely remove PbII from the Cys3 site. 
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These data, combined, indicate that one equivalent of PbII and the second equivalent of 
CuI compete for binding to the Cys3 site.  
However, if a His3 site is also present in the sequence, such at GR-CH, with one 
equivalent of CuI present, PbII binding is not inhibited at the Cys3 site. This indicates that 
the CuI2Cys3 site is not formed, because the above experiments show that PbII cannot 
disrupt the binuclear CuI site. Therefore, the CuI is probably partially occupying the His3 
site and partially occupying the Cys3 site, with no formation of the binuclear CuI2Cys3 
site. All of these data together support the view that there are kinetic implications in the 
binding of CuI and PbII to the Cys3 site, and that the order of metal addition directly 
influences the formation of the CuI2Cys3 or CuIPbIICys3 site.  
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